Document yKqZNNepL44GO83Gb6BvLyBV

Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 1 of 277 PAGEID #: 61002 EXHIBIT J IN THE UNITED STATES DISTRICT COURT Case: 2:13-md-02433-EAS-Ep@ fDOT$E34tf10 0 flfd lI (O^ W ^ P a a 2 of 277 PAGEID #: 61003 EASTERN DIVISION IN RE: E.I. DU PONT DE NEMOURS AND COMPANY C-8 PERSONAL INJURY LITIGATION CASE NO. 2:13-MD-2433 JUDGE EDMUND A. SARGUS, JR. MAGISTRATE JUDGE ELIZABETH P. DEAVERS This document relates to: Carla Marie Bartlett v. E. I. du Pont de Nemours and Company, Case No. 2:13-cv-170. John M. Wolf v. E. I. du Pont de Nemours and Company, Case No. 2:14-cv-095. DECLARATION OF BARRY S. LEVY, M.D., M.P.H I, Barry S. Levy, declare and state as follows: 1. I prepared the Expert Report of Barry S. Levy, M.D., M.P.H, dated November 20, 2014 ("Expert Report") and a true and accurate copy is attached as Exhibit 1. 2. Each of the opinions in the Expert Report is stated to a reasonable degree of medical and scientific certainty, and was arrived at using reliable methods. 3. If called as a witness, I would testify competently to the matters stated in the Expert Report. 4. I declare under penalty of perjury under the laws of the United States of America that the foregoing is true and correct. Dated: /?/>y / a , z &/ ^ O -J /Y /*If- Barry. Levy, M D., M.P.H. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 3 of 277 PAGEID #: 61004 CONFIDENTIAL SUBJECT TO MDL PROTECTIVE ORDER DuPont's Knowledge of the Adverse Health Effects of C-8 and Its Compliance with Applicable Public Health and Related Standards of Conduct Barry S. Levy, M.D., M.P.H November 20, 2014 Prepared for: Plaintiffs' Steering Committee In Re: E. I. du Pont de Nemours and Company C-8 Personal Injury Litigation Case No. 2:13-MD-2433 (S . D. Ohio) Barry S. Levy, M.D., M.P.H., P.C. 20 North Main Street, Suite 200 P.O. Box 1230 Sherborn, HA 01770 508-650-1039 E-mail: blevy@igc.org Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 4 of 277 PAGEID #: 61005 The following is my report containing my opinions concerning DuPont's knowledge of the adverse health effects of C-8. It documents what DuPont knew or should have known at various points in time over several decades, and what actions DuPont took or failed to take in response to what it knew or should have known about the health effects of this chemical, and how these actions deviated from applicable public health and related standards of conduct. Background and Experience I am an occupational and environmental health physician and epidemiologist with more than 35 years of experience in this field. I received a Bachelor of Science degree summa cum laude (with highest honors) from Tufts College, a Master of Public Health (M.P.H.) degree from the Harvard School of Public Health, and a Doctor of Medicine degree from Cornell University Medical College. I completed residencies in Internal Medicine at the University Hospital and the Beth Israel Hospital in Boston, and in Preventive Medicine at the Centers for Disease Control. I am Board-certified in both Internal Medicine and in Occupational Medicine, and licensed to practice medicine in Massachusetts and Connecticut. I have worked as a Medical Epidemiologist for the Centers for Disease Control, for which I received the U.S. Public Health Service Commendation Medal; as a faculty member at the University of Massachusetts Medical School, where I founded and directed the Occupational Health Program and was promoted to the rank of Professor with tenure; and in a number of other positions as an educator, researcher, practitioner, consultant, and organizational leader. I am currently an Adjunct Professor of Public Health at Tufts University School of Medicine, where I have directed the required Introduction to Environmental and Occupational Health Course in the Combined M.D./M.P.H. Program since 1993. I have written more than 200 journal articles and book chapters and edited 17 books, including six editions of the textbook now entitled Occupational and Environmental Health: Recognizing and Preventing Disease and Injury and two editions of the book Preventing Occupational Disease and Injury. I have served in leadership roles of several professional organizations, including serving as president of the American Public Health Association in 1997. I have received a number of awards and honors, including leading awards of the American Public Health Association, the Association of Teachers of Preventive Medicine, the American College of Preventive Medicine, and the New England College of Occupational and Environmental Medicine for career-long achievements. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 5 of 277 PAGEID #: 61006 I have clinically evaluated thousands of individuals who had developed, or were at risk of developing, a wide range of adverse health effects as a result of environmental and/or occupational exposure to chemical substances. My curriculum vitae, including a list of all of my publications within the past 10 years, is attached as Attachment A. Prior Testimony A list of all other cases in which I testified as an expert at trial or deposition during the last four years is attached as Attachment B. Compensation My services in this matter are being charged at a rate of $600 per hour. Methodology I reviewed extensive relevant material, including, but not limited to, internal DuPont documents and reports, documents and reports from the Minnesota Mining and Manufacturing Company (3M), reports of consultants, documents and reports from federal and state government agencies, non-industry reports, published and non-published reports of epidemiologic and other studies, depositions (and deposition exhibits) of DuPont officials and others, other court documents, and related materials. A list of specific materials/documents that I have considered is attached as Attachment C. In assessing DuPont's response (or lack of response) to healthrelated information of which it was aware at various points in time, I asked the question: "What would a reasonable company do to act on this information?" I considered, in light of various contemporaneous statements and guidelines, additional specific questions, such as: "What additional information would a reasonable company gather, or what additional research would it pursue?" "With whom, and with what interpretation, would a reasonable company share this information?" To assist me in assessing DuPont's actions (or inaction), I searched for, identified, and reviewed applicable standards of conduct, including principles and standards of public health as well as occupational and environmental health, codes of ethical conduct, and duties and responsibilities affirmed by DuPont's own health officials. (These applicable standards of conduct are cited later in this report.) In formulating the opinions stated herein, I have employed the same analysis and level of scientific rigor that I apply in my other medical and scientific endeavors. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 6 of 277 PAGEID #: 61007 -4- CHRONOLOGICAL SEQUENCE OF DEVELOPMENTS 1950s and 1960s In 1951, DuPont began use of C-8* in dispersion polymerization in the manufacture of fluoropolymers at its Washington Works plant in West Virginia. There were "few precautions in handling." (Source: EID951571) By 1954, DuPont began to be concerned about the potential toxicity of C-8. (Source: EID077622) By 1961, DuPont researchers concluded that C-8 was toxic. Its toxicology section chief stated that it should be "handled with extreme care." DuPont researchers also concluded: "The C8 and C9 acids...have the ability to increase the size of the liver of rats at low doses." (Source: EID718828-829) By 1962, DuPont was aware that fluorocarbon dispersing agents adversely affect the liver in rats and dogs. DuPont was aware that rats that had been administered ammonium perfluorocaprylate (C*PFC) developed moderate enlargement of the liver and slight enlargement of the kidneys, adrenals, and testes. (Source: HLAB000254) It was also aware that dogs that had received either CaFDA or C9FDA had evidence of liver dysfunction and decreased plasma cholesterol. (Source: HLAB000261-274) By then, DuPont was also aware that rats that had been administered AHT (another fluorocarbon dispersing agent) developed increased liver size, increased activity of alkaline phosphatase (a liver enzyme), increased phospholipids, and decreased glycogen. (Source: HLAB000261-274) DuPont was also aware at this time that "Cumulative liver, kidney and pancreatic changes can be induced in young rats by relatively low doses of C8APFC." (Source: EID122849-854 and Robert W. Rickard deposition, August 27, 2014, Exhibit 6) In 1966, DuPont became aware that perfluorochemicals (PFCs) in groundwater move rapidly into other nearby bodies of water. (Source: EID193614-618) By August 31, 1966, DuPont was aware that, without a pretreatment, a small amount of perfluorocarboxylic acid dispersing agent, in a land fill, "would be leached into the ground water." (Source: EID193614 and Robert W. Rickard deposition, August 27, 2014, Exhibit 9) *In this report, the term "C-8," with the chemical formula C?HFi502, refers both to perfluorooctanoic acid (PFOA) and ammonium perfluorooctanoate (APFO), the ammonium salt of PFOA. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 7 of 277 PAGEID #: 61008 1970s In 1970, DuPont became aware that a large group of company foremen and salesmen had higher incidence rates of myocardial infarction ("heart attack"), cerebrovascular disease (such as stroke), diabetes mellitus, and cancer than high-level executives at the company. (Source: EID713244-270) On May 8, 1970, Richard S. Waritz, Research Manager, Bio-Sciences Group, in a letter to W.E. Hilton, Fluorocarbons Division, Washington Works, entitled "Toxicological Information on C8A P F C ," stated: "C^APFC and C9APFC cause liver enlargement, but we don't know what is the lowest repeated oral dosage that will cause it. We have no repeated oral dosage study to indicate if C8APFC or CqAPFC accumulates in the body to toxic levels. We do not know the eye or skin irritation potential for C8APFC or CqAPFC and we do not know whether the liver enlargement effect occurs only in rats or in other species as well." He further stated: "In addition, we recommend a 90-day feeding study in rats and dogs including a one-generation reproduction-teratogen study in rats....This study is recommended because we have no chronic studies on any of these surfactants and no adequate studies in non-rodent species." (Source: EID072196-199 and Robert W. Rickard deposition, August 27, 2014, Exhibit 8) By May 13, 1975, DuPont employees in a memo entitled "Investigation of Current 'Teflon' Waste Disposal," stated: "The problems with disposing of 'Teflon' waste are fear of toxicity, either from the 'Teflon' itself or additives in some products. Although the fears of contamination of underground water supplies by 'Teflon' scrap may be exaggerated, the possibility of small amounts of undesirable materials such as 'Triton' and C-8 being present does exit. For this reason, we have elected to not landfill 'Teflon' waste at the local landfill, where large quantities of underground water serving both the Plant and the surrounding area are present." (Source: EID916604-605 and Robert W. Rickard deposition, August 27, 2014, Exhibit 10) On June 27, 1978, DuPont advised its employees that 3M had found elevated organic fluorine levels in blood of 3M workers exposed to fluorinated surfactants. DuPont then started an internal review and periodic sampling of the blood of employees to determine their C-8 concentrations. (Source: EID951571) This policy of informing employees was confirmed by Robert W. Rickard, Ph.D., DuPont Distinguished Scientist, Health and Environmental Sciences, in his deposition when he stated: "It's -- in our normal process, when we have new information we think it's relevant, we will inform our employees." (Source: Robert W. Rickard deposition, August 27, 2014, p. 95, lines 17-20). Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 8 of 277 PAGEID #: 61009 However, when asked "What did DuPont do in 1978 after it informed its employees of these organic fluorine blood results to see if anybody outside of its plants were being exposed to C-8?," he stated: "I am not aware that we did anything relative to that at that point in time..." (Source: Robert W. Rickard deposition, August 27, 2014, p. 97, lines 7-13) In 1978, Bruce Karrh, M.D., Corporate Medical Director at DuPont, wrote in a professional journal: "It is the duty of every company's management to discover and reveal the unvarnished facts about health hazards." He further stated that "a company should disclose health-hazard information. It should be candid, and lay all the facts on the table. This is the only responsible and ethical way to go. This approach is the correct one, of course, and it is the way we try to proceed at Du Pont." (Source: Karrh BW. A company's duty to report health hazards. Bulletin of the New York Academy of Medicine 1978; 54 [8]: 782-788.) At least by May 15, 1978, DuPont was aware of a paper by W.S. Guy and colleagues, which had been presented at a symposium in 1975 and published by the American Cancer Society in 1976. The paper described organofluorocompounds in human plasma and suggested that there was widespread contamination of human tissues with trace amounts of organofluorocompounds derived from commercial products, such as those that are used as water repellants and oil repellents in the treatment of fabrics and leather. (Source: EID107111-129) By September 20, 1978, DuPont reviewed medical records of 11 operators and 18 laboratory workers who had had long-term exposure to C-8 and found that more of them than anticipated had abnormal liver function tests. (Source: EID080233-234) (DuPont had already known that C-8 was a hepatotoxin.) It did not report this finding to any government agency or to any community near its manufacturing facilities that were handling C-8. Although some DuPont officials were "disturbed by the frequency of borderline elevated liver function" (Source: RL001770), Dr. Karrh stated, "...neither Dr. Pell nor I see any adverse health effects reported in this study." (Source: EID096511) By July 10, 1979, DuPont tested 55 employees of its Chamber Works plant in New Jersey, where fluorochemicals were handled, and 25 members of a Wilmington, Delaware, control group for blood levels of organofluorine. The mean level for Chamber Works employees was slightly higher (0.15 ppm) than a Wilmington control group (0.094 ppm), but all measured levels were considered to be "normal" (less than 1.0 ppm). Although the measured levels were more than 50 percent higher in the Chamber Works employees than in the Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 9 of 277 PAGEID #: 61010 -7- control group, DuPont recommended that the program to determine blood fluorine levels in employees be discontinued and that they be advised that the program was being discontinued "due to uniformly favorable results." (Sources: EID232293-300 and EID110523) By 1979, DuPont knew that C-8 (a) caused metabolic abnormalities, including uncoupling of oxidative phosphorylation in rat liver mitochondria that were oxidizing succinate, and (b) seemed to alter the immunochemical reactions of bovine (cow) serum albumin. It also knew that C-8 caused (a) liver enlargement in rats and, at high doses, death; and (b) increases in plasma enzyme levels "indicative of cellular damage" in beagle dogs and, at high doses, death. It also knew that rats that inhaled C-8 for 4 hours developed liver enlargement and corneal opacity. (Sources: EID924173-175 and EID924170-172) In 1979, DuPont knew that (a) a subacute inhalation test on rats caused liver injury, (b) an eye irritation test on rabbits caused moderate eye irritation, and (c) a skin irritation test on rabbits caused mild skin irritation. (Source: EID107151-152) In 1979, DuPont established a provisional C-8 acceptable exposure level (AEL) for its employees at 0.01 mg/m' (8-hour time-weighted average). This AEL was based on reversible liver changes seen in rats that had been exposed to 8 mg/m', for 4 hours a day, for 5 days a week, for 2 weeks. (Source: EID924654) (In 1982, DuPont established a permanent AEL at this level, with the notation "Avoid skin contact." [Source: EID942335-336]) In 1979, DuPont found increased C-8 levels in the blood of eight employees potentially exposed to C-8 at the Washington Works facility, including in FEP polymerization workers (2.2-3.5 ppm) and TFE dispersion polymerization operators (9.5-21.1 ppm). The average C-8 level among the eight employees in the study was 8.2 ppm. DuPont concluded that there were "no adverse health effects attributable to C-8." It decided not to report to EPA under 8 (e) of the Toxic Substances Control Act because (a) "fluorine in blood per se was disclosed in a 1976 article" and (b) "no adverse health effect was known, therefore, no substantial risk." (Source: EID107199) In 1979, DuPont became aware that studies of 3M workers found that their blood levels of C-8 had more than doubled, from the usual 10-20 ppm to more than 40 ppm. (The highest was 70 ppm.) (Source: EID080223) In 1979, DuPont was aware that blood test results of Washington Works employees in 1978 showed that organic fluoride was associated with increases in SGOT (an enzyme in the serum, which, Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 10 of 277 PAGEID #: 61011 8- - when increased suggests liver damage). The average SGOT level in the highest organic fluoride decile was 52, compared to the average SGOT level of 40 in the lower nine organic fluoride deciles combined. (Source: EID106689) By March 5, 1979, DuPont was aware that "compound-related effects" (effects related to FC-143, or C-8) were observed in both Rhesus monkeys and Charles River CD rats, but that "monkeys were more severely affected of the two." By that date, it also was aware that "the data on monkeys suggest increased incidences of chronic interstitial nephritis, hyperkeratosis in the skin and a slight increase in skeletal muscle atrophy.... Similarly, the data on rats suggest hepatocellular necrosis, sinusoidal liver congestion and the presence of yellow-brown pigment in the epithelium of the convoluted tubules in the kidney." (Source: EID123474-475 and Robert W. Rickard deposition, August 27, 2014, Exhibit 12) By September 4, 1979, DuPont was aware that in a 90-day oral study in Rhesus monkeys, FC-143 (C-8) had been administered at dosage levels of 0, 3, 10, 30, and 100 mg/kg/day. "The monkeys treated with a higher dose, (100/mg/kg/day) all died during weeks 2 through 5 of the study. At the 30 mg/kg/day dosage level, three monkeys died during weeks 7-12. They all showed signs of toxicity in the gastrointestinal tract (anorexia, emesis, sometimes brown in color, black stools), pale face and gums, swollen face and eyes, slight to severe decreased activity and prostration. The monkeys of the 30 and 100 mg/kg/day dosage level showed body weight losses from the first week of the study." (Source: EID123422 and Robert W. Rickard deposition, August 27, 2014, Exhibit 11) During his deposition, Dr. Rickard stated that he was not aware of any primate studies done or sponsored by DuPont on C-8 between 1979 and 1999. (Source: Robert W. Rickard deposition, August 27, 2014, p. 118, line 9 through p. 119, line 1) Starting in the late 1970s or the early 1980s, DuPont had internal committees for developing guidelines for carcinogens and developmental toxins, which met regularly. (Source: Gerald Kennedy deposition transcript, July 31, 2002, p. 64) DuPont first initiated an acceptable exposure level (AEL) committee review of C-8 in 1979. (Source: Robert W. Rickard deposition, August 27, 2014, p. 109, lines 18-21) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 11 of 277 PAGEID #: 61012 -9- 1980s By 1980, DuPont had internally confirmed that C-8 "is toxic," "people accumulate C-8," and "continued exposure is not tolerable." (Source: EID079399-418) However, DuPont stated that "...there is no conclusive evidence of an occupationally related health problem among workers exposed to C-8." (Source: EID102452) In 1980, DuPont knew that C-8 is absorbed through the skin. Studies demonstrated that, when C-8 is applied to the backs of rats in aqueous form, it penetrates the skin, thereby increasing blood organofluoride levels. (Source: EID924561) In 1980, DuPont was aware that the 16 highest organic fluoride levels among Teflon area workers at its Washington Works plant ranged from 4.97 to 21.69 ppm. (Source: EID102470) By 1980, DuPont was aware that at its Washington Works plant, between 1956 and 1973, there were 20 (first) acute myocardial infarctions in company foremen, compared to an expected number of 10.2. (Source: EID713127-135) In materials from a C-8 Communications Meeting, dated July 31, 1980, C.E. Steiner, a DuPont employee, stated: "After 25 years of handling C-8 we see no damage among the workers. However the potential is there -- C-8 has accumulated in the blood. Because of this accumulation we have decided to undertake programs to minimize accumulation of C-8 in the blood in the workers." (Source: EID079404 and Robert W. Rickard deposition, August 27, 2014, Exhibit 14) By August 1980, F.D. Griffith and J.E. Long of Toxicology Services, 3M Company, reported in a published paper entitled, "Animal toxicity studies with ammonium perfluorooctanoate," in the American Industrial Hygiene Association Journal: "In contrast to the rats and mice the major sites of toxicity in the Rhesus monkey appear to be the gastrointestinal tract and the reticuloendothelial system." (Source: ElD102398-405 and Robert W. Rickard deposition, August 27, 2014, Exhibit 13) (The reticuloendothelial system is part of the immune system.) In March 1981, 3M informed DuPont about a preliminary animal study that suggested that C-8 caused eye defects in unborn rats whose mothers had been fed C-8 during pregnancy. All female DuPont employees with potential C-8 exposure were promptly transferred to other plant areas. (Source: EID951571-580) (However, by March 1982, 3M reported to DuPont that repeat studies of pregnant rats exposed to C-8 did not find birth defects in their offspring, and C-8 was therefore thought not to be teratogenic. [Source: EID071705-706]) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 12 of 277 PAGEID #: 61013 In 1981, DuPont conducted a study of C-8 exposure and pregnancy outcome. It found that C-8 blood levels in six pregnant employees and one employee 1 month before pregnancy ranged from 0.48 to 2.5 ppm. Two of the seven children born from these pregnancies had craniofacial birth defects: A child with an (unconfirmed) eye and tear duct defect and another with a nose and eye defect. (Sources: EID090083 and EID079875) (Another pregnant woman later added to the study had a nondetectable C-8 blood level and a normal pregnancy outcome.) [Source: EID079375]) By 1981, DuPont was aware that C-8 in the blood of a pregnant woman could cross the placenta to the fetus. C-8 was found to be present in (a) the umbilical cord blood of the infant of an employee, and (b) the blood of an infant of another employee. In April 16, 1981, DuPont knew that C-8 caused toxic effects in multiple animal studies: 1. Fed to rats, it caused clinical signs of toxicity, including inactivity, red discharge around the nose, perineal discoloration, and weight loss. 2. Rats given non-lethal doses showed ptosis (eyelid drop), piloerection (erection of skin hair), hypoactivity, decreased limb tone, ataxia (inability to coordinate voluntary muscle movements), and corneal opacity. 3. Rats that had received intragastric doses developed enlarged livers and gastrointestinal irritation. 4. Male beagles that had been given a single dose of 450 mg/kg died within 48 hours. 5. Dogs that had received 200 mg/kg developed abnormally increased liver enzymes within 24 hours, deemed "indicative of cellular damage" in the liver. 6. C-8 caused, on rabbits' eyes, generalized moderate corneal opacity with a small area of severe opacity, intermittent moderate iritis, and moderate conjunctivitis. 7. Monkeys that had consumed it for 90 days developed anorexia (loss of appetite), emesis (vomiting), black stool, pale face and gums, swollen face and eyes, hypoactivity, and prostration. 8. Rats that had been dermally exposed to C-8 lost weight, showed slight reddening of the skin, developed salivation, had dose-related increases in liver enzymes, had liver damage, developed increased liver weight, and developed coagulative necrosis of the epidermis. (Source: EID924550-557) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 13 of 277 PAGEID #: 61014 -11 In the early 1980s, DuPont approached members of the Tennant family to explore the possibility of buying several hundred acres of their property to construct a landfill near the base of Dry Run Creek. DuPont promised them that no hazardous materials would ever be disposed of in the landfill. With this assurance and the promise that the Tennants would be permitted to have their cattle graze along the adjacent Dry Run Creek, they eventually agreed to sell a portion of their property to DuPont for construction of a "non-hazardous" landfill. DuPont received a permit to operate the unlined solid-waste landfill in 1982 and began operations there in 1984. (Sources: EID089743-745 and EID022224-225) In 1982, Dupont determined that approximately 40 percent of C-8 vapor that had been inhaled is retained in the blood of human males. (Source: EID079296) In 1982, DuPont knew that C-8 was in the Ohio River and could be present in drinking water that came from the Ohio River. This knowledge was reflected in an internal DuPont memo, dated October 19, 1982, which cited analyses and projections that estimated human C-8 exposure due to drinking Ohio River water in 1982 and 1987. (Source: EID079287-292) On November 23, 1982, DuPont's then Medical Director Dr. Bruce Karrh wrote in an internal memorandum: "Our knowledge of the product health effects from long term exposure to low levels of C-8 is quite limited. C-8 is retained in the blood for a long time, creating concern in other areas such as blood donations, etc. All employees, not just Teflon area workers, are exposed. There is obviously great potential for current or future exposure of members of the local community from emissions leaving the Plant perimeter." He recommended that all "available practical steps be taken to reduce this exposure." (Source: EID096449-450) In 1983, DuPont performed an update of the 1981 liver function study of Washington Works employees who had been exposed to C-8. It found that there were no statistically significant differences (between study groups and controls) in adverse effects on the liver, history of hypertension, or history of taking hypertensive drugs. (Source: EID106488-498) By June 14, 1984, DuPont was aware that, based on former Teflon division employees, the average biological half-life of C-8 in human blood is approximately 2.4 years and that it can vary significantly among individuals. (Source: EID080543-547) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 14 of 277 PAGEID #: 61015 -12 In 1984, DuPont was aware that there was the following Allegation of Significant Adverse Reaction (made in the context of Toxic Substances Control Act [TSCA] Section 8[c]): "Various male operators have complained about difficulty in having their wives conceive children after they have worked at the [Washington Works] plant for a few years. All operators worked in the Teflon area." (Source: EID523009-011) In 1984, the Hazardous and Solid Waste Amendments of the Resource Conservation and Recovery Act (RCRA) were enacted. Since these amendments required companies to report to the U.S. Environmental Protection Agency (EPA) if they created offsite waste releases, DuPont checked for offsite releases. It found C-8 in the Ohio River, downstream from its Washington Works facility. (Source: EID079271-272) By 1984, DuPont began a program of secretly collecting samples of tap water reported to be from public drinking water supplies near the Washington Works plant and determining their C-8 levels. DuPont found that C-8 was present in drinking water samples collected from locations supplied by public water sources in both Ohio and West Virginia. (Source: EID079096-100) DuPont was aware of technologies to further control C-8 emissions from its manufacturing sites and of potential replacement materials that could eliminate further C-8 emissions. (Sources: EID079740-754 and EID602999-603010) However, DuPont chose to continue its use of C-8, despite its risks, because discontinuation of its use would have jeopardized approximately $100-$200 million in annual business. (Source: Richard Anguillo deposition transcript, November 22, 2002, pp. 37-38) By June 1984, DuPont was aware that water supplied by the town of Little Hocking, Ohio, located "up-river" from the Washington Works plant, contained at least 0.5 ppb of C-8. (Source: EID103022) In addition, DuPont knew that its C-8 releases would continue and that C-8 levels in Little Hocking's wellfields and water distribution system would increase, given these ongoing releases and C-8's long-term persistence in the environment. However, DuPont did not inform Little Hocking about this contamination or its threat to the public. By 1985, DuPont was aware that C-8 was leaching into groundwater under three old, unlined anaerobic digestion ponds at the Washington Works plant that DuPont had previously used for disposing of thousands of tons of sludge soaked with C-8. (Sources: 105-2009-0009282 to 105-2009-0009299; EID007976; EID079258-259; EID079261; EID079269-270; EID079102; EID079685701; and EID087412) DuPont found that C-8 was migrating through Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 15 of 277 PAGEID #: 61016 the groundwater under the plant and into the public drinkingwater wells of the Lubeck Public Service District (LPSD), which were immediately adjacent. DuPont found C-8 levels in the community drinking water supply as high as 1.5 ppb. (Source: EID079271-272) (These levels increased to as high as 1.9 ppb in 1987 and as high as 2.2 ppb in 1988. [Sources: EID079091-094; EID079695; and EID079090]) The West Virginia Division of Environmental Protection gave DuPont permission to dispose of about 7,100 tons of the sludge into the unlined Dry Run Landfill, after DuPont submitted data to it claiming that the sludges were "non-hazardous" under RCRA. (Sources: EID076048-051; EID007534535/ and EID078867) (Sludge disposal into the landfill was completed by DuPont in 1988.) By 1986, DuPont was aware of a cancer morbidity study among its Washington Works employees that showed male wage workers had 8 deaths due to bladder cancer compared to 3.07 expected (standardized mortality ratio [SMR] = 2.61). (Source: 002-0002 0000900) By 1986, DuPont, which had found, by 1985, C-8 levels greater than 1 ppb in water supplied by the LPSD, was evaluating its possible purchase of the LPSD water wells. (Sources: EID079096100 and EID181074-076) By 1987, DuPont had conducted air modeling, which indicated that ambient levels of C-8 were escaping the fenceline of the Washington Works facility and moving into ambient air in the community. (Source: EID229345-348) On June 11, 1987, Dr. Karrh told DuPont officials that the Washington Works plant needed to give "highest priority" to issues associated with the presence of C-8 outside the boundaries of the plant. (Source: EID079682-684) By 1987, DuPont knew that research had demonstrated increases in deaths due to the following malignancies among its workers at its Chamber Works plant, where fluorochemicals were used: female breast cancer, bladder cancer, Hodgkin's disease, lung cancer, urinary cancers (in men), and cirrhosis of the liver (in women). (Sources: 002-0002-0000776 to 002-0002-0000782; and 002-0002 0000-809 to 002-0002-0000-812) DuPont's corporate representative, Dr. Rickard, when asked during his deposition: "By 1987, DuPont had taken additional samples of the Lubeck Public Service District water and had continued to find C-8 in those samples, correct?," he responded: "I'm not aware of the precise dates that they did that, but, yeah. I know Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 16 of 277 PAGEID #: 61017 -14- they continued to find that and subsequently dealt with Lubeck to purchase those wells and put in new wells." (Source: Robert W. Rickard deposition, August 27, 2014, p. 169, lines 9-17) On June 12, 1987, H.A. Smith, Safety, Energy & Environmental Affairs, Manufacturing Division of DuPont, made the following request of G.L. Kennedy, CR&D Department, Haskell Laboratory: "Ammonium perfluorooctanoate (C-8): Please establish an acceptable level for C-8 in blood, and an acceptable level for C8 in community drinking water." (Source: EID079034 and Robert W. Rickard deposition, August 27, 2014, Exhibit 18) In 1988, DuPont described C-8 as being associated with moderate acute toxicity, mild to moderate skin irritation, ocular effects, and liver abnormalities. (Source: 003-002-002460 to 003-002 002463) By March 8, 1988, DuPont was aware that research in rats had found that C-8 exposure was associated with increased rates of cancer, including testicular cancer. (Source: EID568827-830) On March 9, 1988, DuPont first recommended a CEG for C-8 in community drinking water of 1 pg/L (1 part per billion), which was based on the assumption that only 20 percent of the C-8 exposure was coming from drinking water. (Sources: Robert W. Rickard deposition, August 27, 2014, p. 168, lines 11-20 and Robert W. Rickard deposition, August 27, 2014, Exhibit 19) In the process of completing its RCRA Facility Investigation (RFI) Report for the Washington Works plant, DuPont was required to investigate (a) if any of its former solid waste management units were releasing wastes onto neighboring properties, and (b) if any wastes were exposing people to unreasonable health risks. DuPont sampled groundwater under the Washington Works site that it used for drinking water at the plant. DuPont also arranged for sampling of groundwater under a neighboring General Electric (GE) plastics plant. (Source: EID089310) DuPont found that the C-8 level in drinking water at the Washington Works plant was as high as 3.3 ppb, and as high as 0.71 ppb in the drinking water supply of the GE plant. (Sources: EID103379 and EID091591) DuPont also found C-8 levels as high as 0.8 ppb in the new LPSD drinking water wells, which were located about 2 miles further away from the Washington Works site. (Source: EID089310) Therefore, DuPont was aware that people residing in the area near its Washington Works facility, the Letart Landfill, and the Dry Run Landfill may have been exposed and may be continuing to be exposed to C-8 from DuPont due to ongoing, continuous releases of C-8. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 17 of 277 PAGEID #: 61018 In 1988, DuPont conducted an internal formal review of C-8 and classified it as a "c" carcinogen -- indicating that it had not ruled out its being a carcinogen. DuPont informed its employees that experiments on laboratory animals found that C-8 caused certain cancers in animals, but did not inform consumers of drinking water. (Source: EID107384-386) Dr. Rickard, in his deposition, when asked "After DuPont classified C-8 as a small C carcinogen in 1988 and updated its AELs for C-8, DuPont notified its employee of the cancer data, correct?," he replied: "Yes, through the hazard determination letter process. And that's a standard process that we would do for any chemical." (Source: Robert W. Rickard deposition, August 27, 2014, p. 169, lines 19-24 and p. 170, lines 1-2). During this period of time, DuPont started developing community exposure guidelines (CEGs), although it did not finalize any CEG for C-8 in water until 1991. (Sources: Gerald Kennedy deposition transcript, July 31, 2002, p. 78; and EID079034) In this process, DuPont did not seek any input from external scientists. In 1988, an internal DuPont memo summarized the basis for a CEG that was being developed for C-8 in drinking water, based on a study in rats that had been fed 30 mg/kg of C-8. Starting with an AEL of 0.01 mg/m', DuPont reduced the AEL to account for longer exposure period (24 hours for community residents, compared with 8 hours for workers), for the diverse population found in the community (including young, old, and sick people), and for the long half life of C-8 in blood. A CEG of 0.3 pg/rrt for C-8 in air was recommended. Exposure to C-8 at this level, it was thought, would result in a daily C-8 intake of 6 pg. Assuming (a) 20 percent of this could come from drinking water, and (b) a daily intake of 2 liters of water per day, a CEG of 1 pg/L for C-8 in water was recommended. (Source: EID568823-826) On June 13, 1989, in response to a request from the LPSD for assistance in replying to a request of the West Virginia Public Service Commission for groundwater analytical data that might be available from DuPont, DuPont mentioned to the LPSD that there was C-8 in the water in the old LPSD wellfields that DuPont was in the process of purchasing. DuPont's letter stated that "ammonium perfluorooctanoate (FC-143)" -- that is, C-8, was present in LPSD water taps from 1984 to 1988 and from well 27 in 1988 at concentrations from "1.0 to 2.2 micograms [micrograms] per liter (parts per billion)." However, DuPont did not reveal that it had had, since March 1988, a recommended community exposure guideline for water of 1 part per billion, which was exceeded in these results. (Source: James Cox deposition, March 30, 2004, p. 261, lines 12-24 and p. 262, lines 1-6, and James Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 18 of 277 PAGEID #: 61019 -16- Cox deposition, March 30, 2004, Exhibit 20) DuPont also did not tell consumers of the water about the presence of C-8 or that its acceptable exposure limit committee had recommended, in 1988, a community exposure guideline (CEG) for water, which had been exceeded in their water. In 1989, a study of Washington Works employees found that there was increased occurrence of leukemia (8 cases versus 4.2 expected). (Source: EID571347-357) In addition, DuPont was aware that there was increased occurrence of other cancers, including: 1. Buccal cavity and pharynx cancer among male wage employees (8 cases versus 2.6 expected) and among all employees 2. A statistically significant excess of kidney cancer and other urinary cancers among male salary employees (5 cases versus 1.8 expected) and among all male employees (8 cases versus 3.8 expected). 3. A statistically significant excess in bladder cancer among male wage employees (8 cases versus 4.0 expected). 4. A statistically significant increase in multiple myeloma among all male employees (4 cases observed versus 1.4 expected). (Source: EID521383) By 1989, DuPont was aware that, among its Chamber Works employees, there were increases in cancers, including pancreatic, lung, kidney, and bladder cancer as well as Hodgkin's disease. (Source: 002-0002-0000749 to 002-0002-0000751) In an internal DuPont memorandum, dated December 14, 1989, which was entitled "Washington Works: Cancer Incidence and Overall Mortality Rates," there were reported 4 cases of cancer of the testis versus 2.78 expected (observed/expected ratio = 1.44). (Source: EID521382-392 and Robert W. Rickard deposition, August 27, 2014, Exhibit 23) This same document also confirms that, by December 14, 1989, DuPont was aware that in studies of cancer incidence and overall mortality rates at the Washington Works plant, "There was a statistically significant excess of kidney and other urinary cancers among male salary (5 cases versus 1.8 expected) and all male employees (8 cases versus 3.8 expected)." (Source: EID521382-392 and Robert W. Rickard deposition, August 27, 2014, Exhibit 23) (In January 2003, Robin Leonard, corporate epidemiologist for DuPont was still asking DuPont to initiate a study of kidney cancer in the Washington Works plant -- over 13 years after this.) (Source: Robin Leonard deposition, Leach case, June 25, 2004, pp. 155-157, and Robin Leonard deposition, Leach case, June 25, 2004, Exhibit 5) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 19 of 277 PAGEID #: 61020 -17- 1990s In 1990, DuPont was aware that, among its Chamber Works employees: 1. There was a statistically significant excess of deaths due to urinary cancers, observed among both male wage and salary employees, with 115 deaths observed and 57.1 expected among all men. 2. Bladder cancer incidence was statistically significantly elevated among male wage and all male employees for the 1956-1989 period. 3. Among female salary employees, there was a statistically significant excess in mortality from cancer of the digestive organs (13 deaths versus 6.3 expected). 4. Cirrhosis of the liver continued to be statistically significantly increased among female salary roll employees (4 deaths observed versus 0.7 expected). (Source: 002-0002-0000752 to 002-0002-0000768) In 1990, based on an internal industrial hygiene data review, DuPont was aware that (a) there was a correlation, in humans, between blood and air C-8 levels; (b) C-8 exposure at the AEL of 0.56 ppb would result in a human blood level of about 3 ppm; (c) the "background" C-8 blood level for the Teflon area at the Washington Works plant was between 0.1 and 0.5 ppm; (d) dermal exposure to C-8 was the cause for higher blood levels; and (e) the half-life of C-8 in blood was about 4 to 5 years. (Source: GK001456-4 63) By April 1990, DuPont was aware that C-8 was leaching from its Dry Run Landfill (in which it had dumped more than 7,000 tons of sludge contaminated with C-8 that had originated from the Washington Works plant) and discharging into the Dry Run Creek at levels as high as 1.6 ppm -- more than 1,000 times DuPont's recommended CEG for drinking water (1 ppb). (Source: EID080167169) By April 12, 1990, DuPont was aware, based on the "Investigation of Hormonal Mechanisms for C-8 Induced Leydig Cell Adenoma," by Mark Hurtt and Jon Cook of DuPont's Haskell Laboratory, that in the two-year 3M feeding study of C-8, "a dose-dependent increase in Leydig cell adenomas (testicular tumors) was observed.... Specifically, the effect of C-8 treatment on the hormonal status was examined. The results of the study suggest that the induction of Leydig cell adenoma by C-8 is hormonally mediated. Although the data from the study was far from firm or commanding, the study scientists did feel it did not preclude a human route for testicular tumors." DuPont was aware that "This study is Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 20 of 277 PAGEID #: 61021 -18- supportive of the low level benign testicular tumors in the 3M study and supports our existing low AEL." (Source: EID924242-243 and Robert W. Rickard deposition, August 27, 2014, Exhibit 20) By October 30, 1990, DuPont was aware, based on information presented at the International C-8 Meeting, October 24-25, 1990, that C-8 induced a dose-related decrease in serum testosterone, which appeared to be a direct effect on the testes. (Source: EID924473 and Robert W. Rickard deposition, August 27, 2014, Exhibit 21) In 1991, an internal DuPont document indicated that C-8 had been detected by DuPont in the environment and people at the following levels: Washington Works Site Supernate pond area - Contaminated soil - 100 ppm - Groundwater (approximately 20 feet) - 100 ppm West end of site - Groundwater (approximately 75 feet) - 2 to 4 ppb Number 5 outfall - Discharged to Ohio River - 40 ppb Washington Works Employees 1991 (voluntary testing) - up to 5 ppm Drinking Water (Lubeck Public Service District) 1984 - 1989 - 0.7-2.2 ppb 1991 - 3.8* ppb Letart Landfill Surface water - Leachate pond overflow - 2-3 ppm Groundwater - Well samples - 0.05-0.7 ppm Dry Run Landfill Supernate sludge - 75-100 ppm Surface water - Upper pond - 2-3 ppm - Sedimentation basin - 2-3 ppm - Discharge stream at property line - 0.04-2 ppm Groundwater - Monitor wells - 2-5 ppb Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 21 of 277 PAGEID #: 61022 -19- In 1991, an internal DuPont document stated that CEGs are based on the best available information from industrial experience, animal toxicity studies, controlled human exposure studies, and epidemiological findings. However, it stated, because of the variability of sensitivities in members of the community compared with healthy workers, for whom acceptable exposure levels (AELs) had been developed, a larger uncertainty factor needs to be used when extrapolating AELs to CEGs. (Source: EID097177-185) By 1991, DuPont was aware that, among male employees at its Chamber Works facility, there were (a) significant increases in the incidence of total cancers, bladder cancer, Hodgkin's disease, and lung cancer; and (b) significant increases in mortality among employees there due to urinary cancers (in men), pneumonia (in women), and cirrhosis of the liver (in women). (Source: 038-0063-0000283) On March 15, 1991, Wayne H. Martin of Regulatory Affairs at DuPont sent a memo that reported on a meeting at which he and other DuPont employees made the following decisions: "A warning of potential C-8 hazards (especially from condensate) should be included in MSDSs for all products in which the C-8 concentration is 0.1% or more." "Other product literature which contains safety or health warnings should be revised to be consistent with the MSDS: Safe handling bulletin [and] Dispersion processing bulletins." (Source: EID112155 and Robert W. Rickard deposition, August 27, 2014, Exhibit 22) On June 4, 1991, DuPont officials met to address the Toxic Substances Control Act 8 (e) reporting criteria for C-8 contamination at the Washington Works site. Based on the following, DuPont determined that the EPA administrator had, at that time, "'knowledge' of the contamination" and that "No 8(e) notice is warranted at this time": "The toxicology of C-8 has been disclosed to the EPA (region and headguarters) by 3M and Du Pont. The presence of C-8 in ppb levels in the aquifer underlying the site and from which Lubeck draws its drinking water has been reported to EPA Region 3 (RCRA Corrective Action Investigation Plan, 2/90). These levels do not, in our judgement, present a substantial health risk. The discharge of C-8 into the Ohio River from the current process and from the Letart and Dry Run Landfills is regulated by NPDES permits. In addition the site confirmed the permitted discharge of C-8 with EPA Region 3 on 6/81." (Source: EID102770-771) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 22 of 277 PAGEID #: 61023 - 20- On June 11, 1991, DuPont adopted its provisional community exposure guideline for water (CEGW) of 1 pg/L. (Source: EID097177 and Robert W. Rickard deposition, August 27, 2014, Exhibit 16) In October 1991, DuPont rejected an internal proposal for a cross-sectional study of liver enzymes among Washington Works employees with potential exposure to C-8. (Source: EID107462-465) In notes from a meeting when this proposed study was considered, a DuPont employee wrote, in part: "Do the study after we are sued." (Source: EID951146) In 1991, DuPont found that C-8 levels in drinking water near the Washington Works plant were greater than its CEG of 1 ppb, but it did not inform people who drank the water. (Sources: EID103018 and EID103020) In November 1991, DuPont switched laboratories for determining the C-8 levels in water to a laboratory that used a method that had recovery rates that were approximately 60% of the C-8 that was actually present in the water; however, DuPont did not notify water suppliers, consumers of drinking water, government agencies, or others of this change, so others could not accurately interpret the levels of C-8 in drinking water. (Source: EID256133-137) This laboratory found that C-8 levels in drinking water were less than 1 ppb. (Source: EID195965-968) In January 1992, DuPont completed its purchase of the LPSD wellfield that was contaminated with C-8. DuPont therefore believed it was no longer required to sample the old wells in this wellfield since it was no longer a source of public drinking water. (Sources: EID182129 and James Cox deposition, March 31, 2004, Exhibit 25) (The LPSD had moved its public wellfield 2 miles "down-river." [Source: EID909790-809]) DuPont believed it did not need to include the old LPSD well within its RCRA facility investigation report because the Lubeck wells that were contaminated with C-8 were now onsite. However, when DuPont tested the new Lubeck wells, which were 2 miles further downstream, it found even higher levels of C-8 (as high as 2.4 ppb). (Source: EID909790-809) Although DuPont initially planned to disclose this information to residents drinking C-8contaminated water, it eventually chose not to release or disclose that information to community residents. (Source: EID079134-140) (In 2001, the West Virginia Division of Environmental Protection required sampling of river water near the facility, including further downriver, leading to the confirmation of C-8 in additional drinking water supplies. [Source: SPD01788-01836]) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 23 of 277 PAGEID #: 61024 -21 In early 1992, DuPont had completed its Verification Investigation, as required by its RCRA permit. (Source: EID083372-407) On March 23, 1992, DuPont mentioned to the LPSD that there was C-8 in the new wells, but DuPont did not disclose that it had a community exposure guideline (CEG) for water or that sampling in 1991 had found C-8 in those new wells exceeding this CEG. (Source: James Cox deposition, March 31, 2004, Exhibit 26) DuPont told the State of West Virginia that there should be no concern about the presence of C-8 in the new well because there were no health effects associated with C-8.(Source. EID083372-407) Once again, consumers of the water were not told about the presence of C-8 in the well water or that the level of C-8 had ever exceeded DuPont's own CEG. In 1993, an internal DuPont document indicated that, at 300 ppm, C-8 caused statistically significant increases in (a) adenomas, combined adenomas, and adenomas and carcinoma combined in the liver; (b) combined adenomas, adenoma/carcinoma combined, and acinar hyperplasia in the pancreas; and (c) Leydig cell adenomas in the testis. (Source: EID101658) Thus, by 1993, DuPont was aware of two animal studies that found that C-8 caused testicular cancer, and DuPont knew that C-8 caused cancer at three different anatomical sites among laboratory animals exposed to C-8. In 1993, DuPont was aware that a report had been published, indicating that prostate cancer mortality was elevated among 3M workers. (Source: Robert W. Rickard deposition, August 27, 2014, p. 206, lines 2-9) The study found that 10 years of employment in C-8-exposed jobs was associated with a 3.3-fold increase (95% Cl, 1.02-10.6) in prostate cancer mortality, as compared with no employment in C-8 production. (Source: Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. Journal of Occupational Medicine 1993; 35: 950-954.) In addition, DuPont was aware that there were more studies demonstrating that C-8 induced tumors in rats. (Sources: GK000665-666 and RCG000181-190) Nevertheless, DuPont maintained its internal "c" carcinogen classification for C-8. In 1993, the American Conference of Governmental Industrial Hygienists (ACGIH) determined that C-8 was an A3 animal carcinogen -- "of unknown relevance to humans -- different from ACGIH's A4 classification of not classifiable as a human carcinogen. (Source: EID584775-777) Dr. Rickard, when asked in his deposition, "In 1993, after receipt of a copy of the 3M mortality study that we have referred to that found that prostate cancer increase [and] the additional rat study that we had talked about, DuPont found that data sufficient enough to inform all of its employees exposed to C-8 about that data, correct?," he responded: "Again, I think there Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 24 of 277 PAGEID #: 61025 - 22- would have been a communication at the appropriate plant sites. (Source: Robert W. Rickard deposition, August 27, 2014, p. 229, line 24, and p. 230, lines 1-6, and 9-11) Dr. Rickard further stated: "Again, our process is, new information becomes available on the potential hazards or risks of a chemical and we try to keep our employees informed of those particular hazards. So that would be part of the normal process." (Source: Robert W. Rickard deposition, August 27, 2014, p. 231, lines 3-9) By September 23, 1993, DuPont was aware of a second study that had been done on rats exposed to C-8 with increased Leydig cell tumors of the testes as well as increases in hepatic and pancreatic tumors. (Sources: Robert W. Rickard deposition, August 27, 2014, p. 212, lines 20-24, and p. 213, lines 1-24, and Exhibit 26 [GK000665-666]) On June 17, 1994, DuPont still considered C-8 a "c" carcinogen and confirmed that, as of 1993, it still categorized it as a "c" carcinogen. (Source: WJB000014) According to DuPont s Carcinogen Classification System at that time, a "c" carcinogen was defined as "possible human carcinogen (weak animal carcinogen or limited evidence in animals)." (Source: WJB000005) At that time, DuPont's CEGa (community exposure guideline for air) for C-8 was 0.0003 mg/m3 (Source: WJB000070), and its CEGW (community exposure guideline for water) for C-8 was 1 pg/L (1 part per billion). (Source: WJB000071) (An additional source for all of the information in this paragraph: Robert W. Rickard deposition, August 27, 2014, Exhibit 27) As confirmed by a document of the American Conference of Governmental Industrial Hygienists (ACGIH) that was published in 2001, ACGIH proposed in 1993 that C-8 be designed as an "A3 Confirmed Animal Carcinogen with Unknown Relevance to Humans," and in 1994 adopted this designation. (This 2001 ACGIH document provides a history of TLVs for C-8: In 1986, a TLV-TWA of 0.1 mg/m3 was proposed for C-8 with a skin notation: This TLV was in effect from 1988 to 1993. In 1993, ACGIH proposed a a TLV-TWA of 0.01 mg/m3with a skin notation and the A3 carcinogen status; this TLV was adopted in 1994 and was still in effect in 2001.) (Source: EID584775-777 and Robert W. Rickard deposition, August 27, 2014, Exhibit 28) Dr. Rickard, when asked in his deposition "At any time between 1993 and the cancer mortality study that was published by DuPont in 2006, did DuPont generate any study looking at prostate cancer rates among employees exposed to C-8?," he responded: "Again, I Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 25 of 277 PAGEID #: 61026 -23 am not aware of any specific study on that particular endpoint. (Source: Robert W. Rickard deposition, August 27, 2014, p. 228, lines 5-13) On December 13, 1995, the West Virginia Division of Natural Resources contacted DuPont in response to a phone call from Earl Tennant concerning five deer that he alleged were poisoned by water flowing from the Dry Run Landfill. (Source: EID010289) Despite these reports, DuPont did not disclose to state government that it knew that C-8 was present in the Dry Run Creek at ppm levels. In 1996, as part of DuPont's Supervisor Information Manual, a memo to all employees on mortality and cancer incidence stated that DuPont employees were healthier than average Americans. (Source: 011-0002-0000204) In approximately 1997, Dr. Matt Bogdanffy, a manager of biochemical toxicology at the Haskell Laboratory of DuPont, made a proposal to conduct a General Human Health and Environmental Effects Risk Analysis on C-8. (Sources: EID080839-840 and Robert W. Rickard deposition, August 27, 2014, p. 236, lines 10-24, and Exhibit 30) As of January 1997, researchers at DuPont were aware of a hormonally-mediated mechanism for the Leydig cell tumors in rat testes. Lisa B. Biegel, Ph.D., Senior Research Toxicologist at the DuPont Haskell Laboratory wrote, in a document entitled, "Hazard Characterization for Human Health in C8 Exposure: CAS Registry No. 3825-26-1": The studies summarized below support a hormonally-mediated mechanism on Leydig cell tumorigenesis: C8 produces an increase in hepatic aromatase activity, which elevates serum estradiol concentrations, which in turn modulates growth factors in the testes, which results in tumor formation. (Source: EID171625 and Robert W. Rickard deposition, August 27, 2014, Exhibit 32) She further stated in that document: "The mechanism of tumorigenesis is not completely understood, and therefore relevance to humans can not be completely ruled out. However, it is known that non-genotoxic compounds (such as C8) produce Leydig cell tumors by altering the endocrine system. (Source: EID171629 and Robert W. Rickard deposition, August 27, 2014, Exhibit 32) In 1997, DuPont was aware of a published paper by Eric D. Clegg of the EPA, John C. Cook of DuPont, and others, who comprised an expert panel on the relevance of rat Leydig cell hyperplasia to humans. The paper concluded: "Occurrence of Leydig cell adenomas in test species is of potential concern as both a carcinogenic Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 26 of 277 PAGEID #: 61027 -24- and reproductive effect if this mode of induction and potential exposure cannot be ruled out as relevant for humans. The paper also stated: "...it should be assumed that humans are potentially susceptible." (Source: EID797573-587) In 1997, scientists at the DuPont Haskell Laboratory wrote a paper entitled "Hazard Characterization for Human Health C-8 Exposure." In the summary, it stated that C-8 was a nongenotoxic agent that posed little or no hepatocarcinogenic (liver cancer) hazard to humans because (a) the liver tumors induced in animals were due to peroxisome-proliferator-induced liver growth and subsequent development and growth of liver tumors; and (b) peroxisome proliferators in rodents were not relevant to humans. It further stated that the findings of Leydig cell tumors and pancreatic acinar cell tumors in laboratory animals likely posed little or no carcinogenic risk to humans. In addition, the document stated that programs monitoring the health of C-8exposed workers and retrospective cohort studies of workers exposed to C-8 "provide no evidence of an association between C-8 exposure and adverse human health effects." (Source: EID171605634) Yet, at this time in 1997, DuPont still considered C-8 a "c" carcinogen and could not rule out the results of the animal studies showing carcinogenicity as relevant to humans. By 1997, DuPont was aware that there had been, on May 22, 1997, notification of possible adverse health/environmental effects under the Toxic Substances Control Act Section 8(c), reporting 170 cattle deaths. This report stated that the site of discharge emission or effluent was leachate from the Washington Works Dry Run Landfill. (Source: EID523001) EPA investigated the cattle deaths and asked DuPont what chemicals it may have dumped in or near the Landfill. Subsequently, by October 1998, DuPont developed a new hazard characterization for C-8, although there had been no new data on which to base it. DuPont then, in October 1998, said that animal data were of no relevance to humans because rodents have peroxisome proliferator (PP) receptors and humans do not. DuPont made this statement not only for the liver tumors in animals, but also for Leydig cell testicular tumors and for pancreatic tumors, which, in animals, were not thought to be based on the PP mechanism for carcinogenicity. Despite there being no new data, DuPont issued new carcinogenic and developmental toxicity hazard determinations for C-8, reaching different conclusions than it had reached before. It now determined that C-8 was "not likely to be a human carcinogen and Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 27 of 277 PAGEID #: 61028 not likely to be a developmental toxin." DuPont cited the following: _ ,, Studies that found that rats fed diets containing C-8 had increased incidences of liver tumors and Leydig- cell testicular adenomas. A study that found that rats fed C-8 had increased incidences of benign tumors of the liver, pancreas, and testis. Several mechanistic studies that determined that C-8 is a peroxisome proliferator, a chemical known to produce the same types of benign tumors in animals (as noted above). It concluded that "these tumor types appear to have little or no biological significance to man." Retrospective mortality studies (Ubel et al., 1980; Gilliland, 1993; and Olsen, 1996), which it claimed showed no causal relationship between C-8 exposure and cancer. The American Conference of Governmental Industrial Hygienists categorization of C-8 as an A3 carcinogen, "An animal carcinogen with little or no relevance to man." (Source: EID086677-680) In December 1997, DuPont revised and reaffirmed a document entitled "Product Stewardship -- Characterization Risk Management for New and Existing Products." (Source: EID575362-381 and Robert W. Rickard deposition, August 27, 2014, Exhibit 31) However, Dr. Rickard, when asked in his deposition how far into the risk characterization/risk management process DuPont had gotten with regard to C-8, he responded that: "it would not necessarily go step by step on the product stewardship because it was never a product," even though DuPont did start manufacturing C-8 on its own. (Source: Robert W. Rickard deposition, August 27, 2014, p. 239, lines 23 and 24 and p. 240, line 1) As of 1998, DuPont possessed a published paper that suggested there might be estradiol-related effects in workers exposed to C-8. The paper by Geary W. Olsen, D.V.M., Ph.D., and colleagues entitled, "An Epidemiologic Investigation of Reproductive Hormones in Men with Occupational Exposure to Perfluorooctanoic Acid," reported on a study that found a 10% increase in mean estradiol levels among employees who had the highest levels of serum PFOA (although this association was confounded by body mass index). (Source: EID104969-977 and Robert W. Rickard deposition, August 27, 2014, Exhibit 33) On August 7, 1998, G.L. Kennedy, Jr., of DuPont and colleagues wrote a draft of a paper entitled, "Toxicology of Ammonium Perfluorooctanoate," which stated, in part, "Histopathological Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 28 of 277 PAGEID #: 61029 -26- evaluation revealed compound-related increases in liver, Leydig cell, and pancreatic acinar cell tumors in C-8 treated rats. Based on the data, the Leydig cell tumors appear to be due to the combination of elevated estradiol levels and reduced prolactin levels." (Sources: EID918337-397 and Robert W. Rickard deposition, August 27, 2014, p. 263, lines 11-17, and Exhibit 36) In a DuPont document entitled, "Carcinogenic and Developmental Toxicity Hazard Determinations, Ammonium Perfluorooctanoate," dated October 30, 1998, DuPont stated: "Based on the proceeding information, the DuPont AEL Committee has categorized C-8 as not likely to be a human carcinogen." (Source: EID086677-680 and Robert W. Rickard deposition, August 27, 2014, Exhibit 38) Dr. Rickard, when asked "What new scientific data had been generated since January 1997 with respect to C-8's ability to cause cancer in laboratory animals?" (Source: Robert W. Rickard deposition, August 27, 2014, p. 283, line 24, and p. 284, lines 1-3), responded: "This change wasn't driven by new data. Like I said, we made this change for every chemical that we had hazard determination letters on. So this was a process change[.] This had nothing to do with new data and this was not specific to PFOA." (Source: Robert W. Rickard deposition, August 27, 2014, p. 284, lines 8-14) When asked "What issues had arisen by October 1998 that persuaded DuPont that it needed to change this carcinogen evaluation process?" (Source: Robert W. Rickard deposition, August 27, 2014, p. 285, lines 14-17), Dr. Rickard responded: "I wouldn't say an issue existed. I would say in an effort to constantly improve the process, we do that for all processes.... It was really trying to improve the process and trying to improve the communication and I think it is much more informative than a little C, big C, which nobody on the outside really would have any idea what it means." (Source: Robert W. Rickard deposition, August 27, 2014, p. 285, line 18 through p. 296, line 9) By February 1999, DuPont was aware that, in an experiment on 22 monkeys exposed to C-8, a monkey that had been receiving the lowest dose of C-8 (3 mg/kg) had suffered severe health effects and had to be sacrificed. (Source: EID087006) By May 1999, DuPont knew that a second monkey had also suffered severe health effects and had to be sacrificed. (Source: CLI0304-308) The preliminary results of this study demonstrated that adverse liver effects occurred in all of the monkeys in the study, at all levels of exposure. (Sources: CLI0304-308 and EID101453-496) Therefore, this study did not determine a "no observable effects level" (NOEL) for C-8 in non-human primates. (Sources: EID087238-254 and EID101453-4 96) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 29 of 277 PAGEID #: 61030 -27- Dr. Rickard, during his deposition, when asked "What did DuPont do with respect to looking at C-8's effects in monkeys in the 1999 timeframe?," he stated: "A consortium of industry had a sixmonth study conducted and financed and that was not a DuPont study. DuPont was part of several companies that sponsored the study." (Source: Robert W. Rickard deposition, August 27, 2014, p. 309, lines 12-18) When asked "During the course of that study, one of the monkeys at the lowest dose level died, correct?," he responded: "One of the monkeys at the lowest level was sacrificed in extremis, actually." (Source: Robert W. Rickard deposition, August 27, 2014, p. 310, lines 1-5) When asked "And what has DuPont done since that monkey work was done to further investigate effects of C-8 on primates?," he responded: There hasn't been any additional primate studies done." (Source: Robert W. Rickard deposition, August 27, 2014, p. 310, lines 13-17) On November 12, 1999, DuPont reviewed its AEL for C-8: 0.01 mg/m', with a skin notation. This AEL was based on a 1 mg/m NOEL determined in a subchronic inhalation study, and a 30 ppm dietary NOEL determined in a 2-year feeding study. DuPont reviewed preliminary data from the subchronic oral study in monkeys (briefly described above). Groups of male Rhesus monkeys had been given 3, 10, or 30 mg/kg per day for up to 6 months. The high dose was reduced to 20 mg/kg on day 22 of this study and this dose was administered until the end of the study for 3 monkeys; two others had dosing discontinued from days 43 to 81; and one monkey died on day 29, with the cause of death unclear. Monkeys administered 30 mg/kg per day lost weight and had low food consumption. After reducing the dose to 20 mg/kg per day, these monkeys still ate less than controls, but the marked weight loss was not seen; however, the weight gain of these monkeys was less than that of the controls. Liver weights were increased in all of the dosed monkeys, but no pathological liver changes were seen. (Source: RCG000231-239) 2000s . By April 2000, DuPont rejected its occupational health official's recommendation for a comprehensive medical surveillance program for employees exposed to C-8, noting that establishing such a program "could have significant repercussions at any of our other sites that handle... similar products." (Sources: EID157030; Barbara J. Dawson deposition transcript, August 27, 2004, p. 123; and 054-0142-0004361) By May 2000, DuPont had learned that 3M, which manufactured the C-8 used at DuPont's Washington Works plant, had decided to stop manufacturing and selling C-8 because of its bio-persistence and toxicity. (Source: EID166245-247) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 30 of 277 PAGEID #: 61031 -2 8 - By February 2001, DuPont was aware of blood C-8 levels in Chamber Works plant employees who had recycled C-8 liquid wastes at the plant. Instead of comparing these levels with baseline levels from 1999 (when the average C-8 blood level was 30 ppb and the average blood level of organic fluorine was 270 ppb), DuPont told these employees that "all of the reported results [for C-8] were below 100 ppb" and that "all of the results in the follow up study [for organic fluorine] were less than the revised detection limit" of 500 ppb, making it impossible for these employees to know if their C-8 organic fluorine blood levels had increased or decreased after exposure to the C-8 wastes. (Sources: Barbara J. Dawson deposition transcript, August 27, 2004, pp. 132-133, and Exhibits 11 and 19) By the spring of 2001, DuPont installed a carbon absorption treatment system at its Washington Works plant to try to reduce the levels of C-8 discharged directly from the plant into the Ohio River. In August 2001, in a preliminary draft of a document entitled, "A Review of the Toxicology of Ammonium Perfluorooctanoate (PFOA )," prepared by ENVIRON International Corporation for the DuPont Corporation Legal Department, the authors of the document stated: "However, available evidence indicates that peroxisome proliferators do not elicit peroxisome proliferation in Leydig cells." (Source: EID483876-484019 and Robert W. Rickard deposition, August 27, 2014, Exhibit 37) In the same document, there is the statement: "Clinical experts participating in a workshop convened to review the available information on Leydig cell hyperplasia and neoplasia and to reach consensus about the relevance of animal results for human health risk assessment concluded that aromatase inhibition is one of the several hormonal modes of Leydig cell adenoma induction that are potentially relevant to human health." (Source: EID484009 and Robert W. Rickard deposition, August 27, 2014, Exhibit 37) By October 10, 2001, DuPont possessed a draft paper entitled "A Simple, Conservative Compartmental Model to Relate Ammonium Perfluorooctanoate (APFO) Exposure to Estimates of Perfluorooctanoate (PFO) Blood Levels in Humans," by Paul M. Hinderliter, Ph.D., and Gary W. Jepson, Ph.D., of the DuPont Haskell Laboratory, which described a blood model that DuPont had created to assess the level of C-8 likely to be present in humans exposed to certain levels of C-8 in environmental media, including drinking water, which showed that 1 part per billion of C-8 in drinking water translated to 300 parts per billion of C-8 in human blood. (Source: EID166599-608 and Robert W. Rickard deposition, August 27, 2014, Exhibit 40) Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 31 of 277 PAGEID #: 61032 -29- On January 24, 2002, ENVIRON, on contract to DuPont to write a "hazard narrative" for PFOA (C-8), concluded that the "RfD [maximal acceptable oral dose] derived from the monkey data (2 pg/kg/day), provides a reliable and relevant criteria for human health protection, and should be used to derive a drinking water limit. Using default assumptions for drinking water consumption and body weight, the RfD corresponds to a drinking water [sic] of 70 pg/L. If the contribution of PFOA in drinking water to the total intake of PFOA by all media is considered, then the final drinking water criterion would be adjusted accordingly using the EPA default of 20%, the resultant drinking water criterion would be 14 pg/L; however, using a more realistic contribution of 50% would result in a drinking water criterion of 35 pg/L." (Source: "A Hazard Narrative for Perfluorooctanoate [PFOA]: Final." Prepared by: ENVIRON International Corporation, January 24, 2002.) In January 2002, the Little Hocking Water Association first learned about the detection of C-8 up to 7.69 ppb (more than seven times DuPont's CEGJ in its wellfields during the previous month. (This testing had been done because Little Hocking had requested being included in the water sampling conducted under a West Virginia administrative order. [Sources: Little Hocking Water Associations News Release, January 23, 2002; EID193045-057; and Rowe006810-817]) (DuPont's internal CEG for water was not discovered until many years later, during litigation against DuPont.) By February 20, 2002, the U.S. Environmental Protection Agency completed a draft of a paper entitled "Hazard Assessment of Perfluorooctanoic Acid and Its Salts." (Source: Robert W. Rickard deposition, August 27, 2014, Exhibit 38) (This document was corrected on April 15, 2002.) This document, on page 5 states: "The mechanism(s) of APFO tumorigenesis is not clearly understood....As the mechanisms of carcinogenic action of APFO have not been fully elucidated, it is assumed that the tumors induced in rats are relevant to humans." (Source: Robert W. Rickard deposition, August 27, 2014, Exhibit 38) By March 15, 2002, DuPont told EPA and the West Virginia Division of Environmental Protection that it would only agree to provide clean drinking water where the level of C-8 exceeded 14 ppb, which had been determined by DuPont and its consultant, ENVIRON. DuPont stated: "In more than 50 years of C-8 use by DuPont and others, there have been no known adverse human health effects associated with the chemical." (Source: EID738989-990) On March 18, 2002, a DuPont website entitled, "C-8 INFORM," represented to the public: "In more than 50 years of C-8 use by DuPont and others, there have been no known adverse human health Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 32 of 277 PAGEID #: 61033 -30- effects associated with the chemical. 3M and DuPont studies, as well as extensive other scientific data, support the position of no known adverse human health effects associated with C-8. (Source: DRS002490 and Robert W. Rickard deposition, August 27, 2014, Exhibit 41) On March 19, 2002, Dr. Rickard, then Director of the DuPont Haskell Laboratory for Health & Environmental Sciences, wrote a letter to The Charleston Gazette, stating, in part: "It is important to emphasize that there is an extensive database on C-8, including employee health effects studies from DuPont and others, that indicate no known adverse human health impact associated with current or historic use of C-8." (Source: 003 0001-0019350 to 003-0001-0019352 and Robert W. Rickard deposition, August 27, 2014, Exhibit 42) On June 25, 2002, Barbara J. Dawson of DuPont, in an internal memorandum, stated: "Based on the current guidance, we are not going to have a medical surveillance program per se - we will have biological monitoring which will be flagged as a medical surveillance program in Medgate since this is our means of identifying the cohort....Please note that the blood monitoring method is not currently available." (Source: EID570740-750) Before 2003, only one commercial laboratory in the United States had the capacity to detect perfluorocarbons in blood. DuPont's contract with that laboratory prohibited it from testing PFCs for other entities without the consent of DuPont. (Source: May 1, 2003 Order Granting Injunctive Relief in Leach vs. DuPont) On March 18, 2003, DuPont Washington Works provided a "Media Update," in which it stated, in a chart entitled, "Analysis of C-8 Health Effects," that C-8 was biopersistent and an animal carcinogen, but it was not bioaccumulative, not a human carcinogen, not a developmental toxin, not a reproductive toxin, and not a genetic toxin. (Source: EID822842-867 and Robert W. Rickard deposition, August 27, 2014, Exhibit 43) On April 11, 2003, in a 2-page "Corporate News" statement entitled, "DuPont Refutes Allegations of Violating TSCA Act," Dr. Rickard of DuPont said: "There is no evidence or data that demonstrates PFOA causes adverse human health effects, including development or reproductive effects, in any segment of the human population." (Source: 015-0002-0001876 to 015-0002-0001877 and Robert W. Rickard deposition, August 27, 2014, Exhibit 44) A "Corporate News" statement from DuPont, dated May 7, 2003, entitled "DuPont to Appeal Court Order in Case Involving C-8," quoted Larry Janssen, Counsel for DuPont: "Nothing in DuPont's 50 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 33 of 277 PAGEID #: 61034 -31- years of experience with C-8 indicates it is a hazard and nothing in the toxicity testing for C-8 suggests the class members are at any risk whatsoever." (Source: Robert W. Rickard deposition, August 27, 2014, Exhibit 45) In 2004, Dr. Karrh, then DuPont's former medical director, stated in sworn deposition testimony that DuPont's duty to report potential health hazards from materials used at its plants extended to the communities where DuPont plants are located. He stated: "The company policy was, as stated, if we cannot manufacture a product without creating undue risk to our employees we will not manufacture it at all. That same applied to the communities surrounding us, surrounding the plant..." (Source: Deposition of Bruce W. Karrh, M.D., April 14, 2004, p. 75, lines 2-25, and p. 76, lines 1-4.) On May 5, 2004, in a DuPont press release entitled, "DuPont Reiterates Position on PFOA: Refutes Claim that PFOA Causes Human Health Effects," Dr. Rickard was quoted: "DuPont's position is very clear: PFOA is not a human carcinogen and there are no known health effects associated with PFOA. [Dr. James] Dahlgren's claims are inaccurate and inconsistent with published scientific studies. In fact, the more we study PFOA, the more confident we are in our conclusions that PFOA is safe." In the same press release, Dr. Robin Leonard, principal epidemiologist for DuPont, was quoted: "Based on what we have seen, we question the scientific validity of the conclusion in the Dahlgren report. It is clear from the abstract of the paper, and the methodology reported at a recent meeting in Europe, that the analyses do not represent the scientific approach used by epidemiologists. There is no indication that other factors impacting the health of populations were considered or analyzed. (Source: 083-0001 0005541 and Robert W. Rickard deposition, August 27, 2014, Exhibit 46) Recent Publication A recent publication in the public health literature is generally consistent with the facts detailed in this report. (Grandjean P, Clapp R. Changing interpretation of human health risks from perfluorinated compounds. Public Health Reports 2014; 129: 482 485.) Summary of Opinions I have compared DuPont's knowledge of the adverse health effects of C-8, at various points in time, with its actions (and inaction) based on that knowledge. In assessing the appropriateness of these actions (and inaction), I have compared DuPont's actions (and inaction) with (a) well-established Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 34 of 277 PAGEID #: 61035 -32- principles and standards of public health as well as occupational and environmental health, (b) codes of ethical conduct, and (c) duties and responsibilities affirmed by DuPont's own health officials. A. APPLICABLE STANDARDS OF CONDUCT 1. Principles and Standards of Public Health as Well as. Occupational and Environmental Health Well-established principles and standards include: Information about potentially hazardous exposures and potential health consequences of these exposures should be disclosed, with appropriate interpretation, to individuals and communities at risk of these exposures. (Hazard Communication) When initial studies yield results that may have relevance to human health and well-being, appropriate follow-up research investigations should be performed. When there is a demonstrated need for surveillance, or monitoring, of hazardous exposures and/or health outcomes, that surveillance should be continued unless there is evidence that the need for that surveillance no longer exists. The first of these principles and standards, concerning hazard communication, was affirmed by James Solyst, MS, Director of Risk Policy and Communication, Chemical Manufacturers Association in a symposium on "Communicating Risk in a Changing World" in 1996, when he said: "The members of the Chemical Manufacturers Association (CMA) are committed to providing the public with information to help them understand and assess the environmental, health, and safety performance of our products and activities. CMA is committed to working with government and the public to ensure that information is accurate, is responsive to concerns, provides useful context, and is easily accessible. (Solyst J. "Panelist Reaction: Right to Know" in Tinker TL, Pavlova MT, Gotsch AR, Arkin EB [eds.]. Communicating Risk in a Changing World. Solomon Island, MD, and Beverly Farms, MA: The Ramazzini Institute and OEM Press, 1998, pp. 159-160.) DuPont has been a member of the Chemical Manufacturers Association. In 1987, William B. Bunn, M.D., J.D., and Gary R. LeClercq, M.D., both then industry-based physicians, addressed hazard communication in an editorial in the Journal of Occupational Medicine, noting: "The Occupational Safety and Health Administration's (OSHA's) Federal Hazard Communication Standard, along with various state and local right-to-know laws,... require employers to inform workers and the community about the potential Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 35 of 277 PAGEID #: 61036 -33- health effects of thousands of chemicals." They further stated: "Companies and their personnel, including health professionals, are being held liable both civilly and criminally for failure to clearly communicate health risks to those who may be damaged by exposure." (Bunn WB III, LeClercq GR. Hazard communication and the occupational physician. [Editorial] Journal of Occupational Medicine 1987; 29 [3]: 262-263.) In regulating hazard communication in 1983, the United States government defined a "health hazard." It stated that a chemical is determined to be a "health hazard" if there is "statistically significant evidence based on at least one study conducted in accordance with established scientific principles that acute or chronic problems may occur in exposed employees." It further stated that both animal and human studies are to be considered in this type of assessment. (Hazard Communication: Final Rule. Federal Register 1983: 48: [Nov 25]:53347.) 2. Codes of Ethical Conduct In 1976, the American Occupational Medical Association (AOMA) developed a Code of Ethical Conduct for Physicians Practicing Occupational Medicine. The code consisted of "standards to guide physicians in their relationships with the individuals they serve, with employers' and workers' representatives, with colleagues in the health professions, and with the public." Two of these standards are directly related to hazard communication: "Physicians should...strive continually to improve medical knowledge, and should communicate information about health hazards in timely and effective fashion to individuals or groups potentially affected, and make appropriate reports to the scientific community; [and should] communicate understandably to those they serve any significant observations about their health, recommending further study, counsel or treatment when indicated." (Committee on Ethical Practice in Occupational Medicine, American Occupational Medical Association. Code of Ethical Conduct for Physicians Providing Occupational Medical Services. [Adopted by the Board of Directors of the American Occupational Medical Association, July 23, 1976.] Journal of Occupational Medicine, August 1978; Volume 18: Cover. Also cited in: Schuman BJ. Physicians and patients in the occupational setting: The rules of the game. [Commentary] Journal of the American Medical Association 1980; 244 [21]: 2417-2418.) In 1993, the Board of Directors of the American College of Occupational and Environmental Medicine (the new name for the former AOMA) approved the adoption of a new Code of Ethical Conduct. In describing the new code, Ronald Teichman, M.D., M.P.H., and Mary Sue Wester, M.D., the Chair and the Associate Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 36 of 277 PAGEID #: 61037 -34- Chair of the ACOEM Committee on Ethical Practice in Occupational Medicine, stated: "Ethical standards are necessary because, as opposed to laws, they do not vary according to temporal and regional standards and customs. Ethical standards involve higher issues than legal standards and deal with what is right." At least two of the seven parts of the new ACOEM Code of Ethical Conduct relate to hazard communication: "Physicians should...strive to expand and disseminate medical knowledge and participate in ethical research efforts as appropriate; [and]... communicate to individuals and/or groups any significant observations and recommendations concerning their health and safety." (Teichman R. Introduction to the new ACOEM Code of Ethical Conduct. Journal of Occupational Medicine 1994; 36 [1]: 27; and Teichman R, Wester MS. The new ACOEM Code of Ethical Conduct. Journal of Occupational Medicine 1994; 36 [1]: 27-30.) In 1996, the Association of Occupational and Environmental Clinics (AOEC), in a published position paper on the organization code for ethical conduct, identified seven broad categories of ethical principles, including "An obligation to advise and report." In the paper, it reviewed each of these seven categories of ethical principles to specific parts of the AOMA Code of Ethical Conduct (1976) and the ACOEM Code of Ethical Conduct (1993), both of which are described above, as well as the International Code of Ethics for Occupational Health Professionals (1992), the American Association of Occupational Health Nurses Code (1991), and the Industrial Hygienists Joint Code (1994). In relation to "An obligation to advise and report," it cited part of the International Code: "Occupational health professionals must be aware of their role in relation to the protection of the community and of the environment. They must initiate and participate, as appropriate, in identifying, assessing and advising on the prevention of environmental hazards arising or which may result from operations or processes in the enterprise." In relation to this obligation, it also cited part of the Industrial Hygienists Joint Code: "Counsel affected parties factually regarding potential health risks and precautions necessary to avoid adverse health effects." (Brodkin CA, Frumkin H, Kirkland KH, et al. AOEC Position Paper on the Organizational Code for Ethical Conduct. Journal of Occupational and Environmental Medicine 1996; 38 [9]: 869-881; International Commission on Occupational Health. International Code of Ethics for Occupational Health Professionals. Singapore: International Commission on Occupational Health, 1992. Also available in the Appendix to the chapter: Krantz A, Forst LS. "Ethics in Occupational Medicine" in Rosenstock L, Cullen MR, Brodkin CA, Redlich CA [eds.] Textbook of Clinical Occupational and Environmental Medicine [Second Edition]. Philadelphia: Elsevier Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 37 of 277 PAGEID #: 61038 -35- Saunders, 2005, pp. 1231-1236; and American Academy of Industrial Hygiene. Code of Ethics for Industrial Hygienists. American Academy of Industrial Hygiene Newsletter 1995; 1-2, also at: Code of Ethics for the Professional Practice of Industrial Hygiene [1995], available at: http://ethics.iit.edu/ecodes/?q=node/4275. Accessed on November 11, 2014.) 3. Duties and Responsibilities Affirmed by DuPont Health Officials Bruce W. Karrh, M.D., who served as Corporate Medical Director of the E.I. DuPont Corporation from 1977 to 1983, as Vice President for Safety, Health, and Environmental Affairs from 1984 to 1993, and as Vice President for Integrated Health Care from 1993 to 1996, affirmed DuPont's acceptance of, and commitment to, these public health and occupational and environmental health principles and standards and standards of ethical conduct in an article, entitled "A Company's Duty to Report Health Hazards," which was published in the Bulletin of the New York Academy of Medicine in September 1978 (cited above). In this article, he stated: "Yes, a company should disclose health-hazard information. It should be candid, and lay all the facts on the table. This is the only responsible and ethical way to go. This approach is the correct one, of course, and it is the way we try to proceed at Du Pont." In this article, Dr. Karrh cited the high incidence of bladder tumors among employees at DuPont's large Chamber Works plant in New Jersey starting in the 1930s and then stated: "But this incident, combined with our traditional concern for employee and public health and safety, has compelled us to formulate a number of basic principles. They are applied broadly, and they function as constants which are invoked whenever we consider the need to report hazards. Five principles are involved: knowledge, commitment, responsibility, compliance, and communications." Regarding knowledge, he stated: "Du Pont makes judgments based on the best available knowledge of health hazards and their consequences acquired both internally and from outside the company." Regarding commitment, he stated: "From our chairman of the board and the executive committee on down, Du Pont management is committed to make and to use products and chemicals safely, and to inform employees and others of possible health risks when they come to light." Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 38 of 277 PAGEID #: 61039 -3 6 - Regarding responsibility, he stated: "In our decentralized system of management, it is the duty of each of our industrial departments... to acquire adequate operating knowledge through testing and to disseminate this knowledge to all groups with a need to know." Regarding compliance, he stated: ''Where specific legal statutes exist...Du Pont policy is to meet or go beyond the requirements contained in these laws and implementing regulations." Regarding communications, he stated: Employees are told of health risks in the workplace and of how to deal with these hazards safely in their everyday work practices. Appropriate groups outside Du Pont, from customers to government agencies, are notified of potential hazards and actions taken by Du Pont to minimize their impact." Dr. Karrh also stated: "We also report health hazards to a number of other groups, depending on the circumstances. The main criteria for these communications efforts are: Will this information be useful to these groups? Will it serve to cause these organizations to take remedial action to protect people who might otherwise not be reached? Can these groups disseminate this health-hazard information on a wider scale to provide additional health and safety benefits? When it comes to our customers, other producers of the same material, and appropriate government agencies, the answer is almost invariably 'yes.' (Karrh BW. A company's duty to report health hazards. Bulletin of the New York Academy of Medicine 1978; 54 [8]: 782-788.) B- DUPONT'S BREACH OF APPLICABLE STANDARDS OF CONDUCT 1. DuPont Failed to Adequately Inform Its Employees and Consumers of Drinking Water About the Health Risks of C-8 As extensively documented in this report, DuPont has, for decades, been aware of substantial information concerning exposure of its employees and community residents to C-8 as well as multiple health risks posed by these exposures. Although DuPont provided some of this information to its employees, it provided little or no information to community residents, including those who drank water that DuPont had contaminated with C-8. As early as 1984, DuPont knew that: C-8 had toxic effects in laboratory animals, including primates. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 39 of 277 PAGEID #: 61040 -3 7 - c-8 accumulated in the blood of these laboratory animals as well as humans exposed to it, and C-8 remained in the blood of laboratory animals and humans for long periods of time. C-8 was present in public drinking water supplies near its Washington Works plant. In addition, by the end of 1988, DuPont also knew that: ^^ C-8 was an animal carcinogen and was considered a "c carcinogen under DuPont's own cancer guidelines. C-8 was present in the Ohio River several miles downstream from its Washington Works facility, including in public water wellfields, at levels that exceeded DuPont's recommended community exposure guideline for water. However, DuPont did not inform consumers of C-8-contaminated water of the presence of C-8 in the water, did not inform them of the existence of its recommended community guideline for water, and did not inform them that the concentration of C-8 in their drinking water exceeded this guideline. DuPont had a duty to inform people drinking water contaminated with C-8 that (a) C-8 accumulated in the blood, (b) C-8 was a potential carcinogen, and (c) C-8 was present at levels exceeding DuPont's recommended community exposure guideline for water, and failed to do so. By 1988, DuPont was also aware that C-8 was likely present in the air emissions from the Washington Works plant beyond the fence line of the plant. DuPont failed, however, to investigate the extent to which its C-8 releases were impacting nearby drinking water supplies, either in the path of its air emissions or downriver beyond the LPSD wells. These violations of duty were amplified in 1991-1992 when Dupont knew that C-8 was being found in drinking water supplies above its provisional and its final CEG for C-8 in water, including even the new LPSD wells approximately 2 miles further down the Ohio River from the Washington Works plant. In addition, these violations of duty were further exacerbated by 1994 when DuPont also knew that C-8 was an A3 animal carcinogen and had been linked to cancer in humans who had been exposed in the workplace. Not only is DuPont's failure to disclose and investigate the extent and impacts of its release and its failure to inform these community residents inconsistent with principles and standards of public health as well as occupational and environmental health and with codes of ethical conduct, it is also inconsistent with DuPont's duties and responsibilities, as affirmed by its own health officials. For example, DuPont's corporate medical director at the time, Dr. Bruce Karrh, affirmed that DuPont had a Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 40 of 277 PAGEID #: 61041 -38- responsibility to adequately inform community residents of exposures to C-8 and potential associated health impacts. DuPont acted in a manner that was inconsistent with this responsibility. Moreover, DuPont took steps to actively misrepresent and mislead those consuming C-8 in drinking water by omitting or misstating key information about C-8 risks in DuPont's communications. 2. DuPont Failed to Adequately Follow Up on Positive Findings from Animal Studies and Human Epidemiological Studies on C-8 Risks/Diseases Despite knowing, by at least 1982, that monkeys exposed to C-8 developed adverse health effects (including gastrointestinal and/or immunological effects), even at the lowest C-8 doses that were administered, DuPont neither performed nor sponsored monkey studies again until 1999. In addition, DuPont did not adequately follow up on rat studies that demonstrated increased occurrence of Leydig cell testicular tumors, liver tumors, and pancreatic acinar cell tumors. Furthermore, DuPont inappropriately asserted that Leydig cell testicular tumors in rats were caused by a mechanism (peroxisome proliferation) that had no relevance to testicular cancers in humans, despite the fact that it knew that it could not rule out this mechanism as relevant to humans. Although multiple epidemiologic studies that DuPont conducted on its employees demonstrated increased incidence and/or mortality rates due to specific types of cancer and other adverse health effects, DuPont did not adequately follow up on these findings and, in fact, ultimately ceased performing these studies. 3. DuPont Failed to Adequately Monitor Its Employees Who Were Exposed to C-8 for C-8 Risks/Diseases When faced with information concerning exposure of its own employees to C-8 and potential adverse health effects among them, DuPont repeatedly failed to follow up on these health effects and often discontinued the surveillance, monitoring, and research that identified exposures and potentially related health problems relevant to any person exposed to C-8, including, but not limited to, DuPont's own employees, such as in the following examples: When two offspring of eight female DuPont employees exhibited craniofacial birth defects, DuPont chose not to undertake any additional studies of outcomes of pregnancy among its employees. When studies demonstrated that DuPont employees exposed to C-8 had increased occurrence of abnormal liver function, DuPont ceased to perform adequate further research on this issue. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 41 of 277 PAGEID #: 61042 -39- DuPont failed to adequately follow up on its own studies or those of other investigators that showed increased rates of prostate cancer, kidney cancer, and other malignancies among its own employees or others exposed to C-8. 4. DuPont Misled Government Officials and the General Public About the Health and Safety of C-8 and Its Presence in Drinking Water Despite repeated findings of tumors in animals, increased rates of specific cancers among its own employees, craniofacial birth defects occurring among offspring of female DuPont employees exposed to C-8, and other information demonstrating the toxicity of C-8, DuPont repeatedly represented to government officials and to the public that no adverse health effects had been attributed to C-8 and that exposure to C-8 did not represent any health risk, and DuPont intentionally omitted and failed to disclose information about C-8 risks that should have been revealed. In addition, DuPont failed to adequately inform the U.S. Environmental Protection Agency and other federal and state governmental agencies about human exposures to C-8 and adverse health effects associated with C-8 of which it was aware. Conclusion For decades, DuPont's actions (and inaction) have not been compliant with principles and standards of public health as well as occupational and environmental health, ethical conduct, or even its own standards for reporting health risk information, thereby potentially placing those exposed to C-8 at an unnecessary increased risk of harm: DuPont failed to adequately inform its employees and consumers of drinking water about the health risks of C-8. DuPont failed to adequately follow up on positive findings from animal studies and human epidemiological studies on C-8 risks/diseases. DuPont failed to adequately monitor its employees who were exposed to C-8 for C-8 risks/diseases. DuPont misled government officials and the general public about the health and safety of C-8 and its presence in drinking water. I hold the opinions contained in this report to a reasonable degree of medical and scientific certainty. I reserve the right to amend or modify this report as further information may become available. Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 42 of 277 PAGEID #: 61043 Minor Changes in Report Changes should read as follows. Most of these changes are to correct typographical errors: Page 4, paragraph 1: An alternative Bates number for this document is EID603001, within the document Bates-numbered EID602999-603010. Page 4, paragraph 4, line 4, first word: (CeAPFC} Page 4, paragraph 4, line 7, first word: CeFDA Page 4, paragraph 5: Omit paragraph Page 5, paragraph 1: Add a second source: Pell S, D'Alonzo CA. Chronic disease morbidity and income level in an employed population. American Journal of Public Health 1970; 60: 116-129. Page 7, paragraph 1: Add the following additional source: EID080271-285 Page 10, paragraph 1, line 7, second source: EID079375 Page 13, paragraph 2: Change the beginning of the paragraph to: Based on data through 1986, Page 13, paragraph 6: Change the beginning of the paragraph to: Based on data through 1987, Page 14, paragraph 1, line 3: p. 163 Page 14, paragraph 4, line 3: tumors, including testicular tumors. Page 14, paragraph 5, first line: March 8 Page 14, paragraph 6: An alternative Bates number for the document Bates-numbered EID089310 is EID167558/HDR003004. Page 16, paragraph 3: Change beginning of paragraph to: Based on data through 1989, DuPont was aware by 1993 that... An additional source for this paragraph is the document Bates-numbered 038-0063-0000433 to 038-0063-0000474. Page 18, last paragraph ("Dry Run Landfill"), line 5: 0.04-0.2 ppm Page 21: Remove fourth paragraph (Similar information is on page 22, paragraph 4) Page 22 paragraph 4, line 8: a TLV-TWA (not 'a a TLV-TWA") Page 23 paragraph 5, line 6: "The studies... Page 24 middle of line 1 : if the mode Page 24 line 2: exposures Page 26 paragraph 2, bottom line: p. 286 Page 27 last paragraph, lines 3 and 4: omit "and toxicity" Page 28 paragraph 1 line "All (add open quotation mark) Page 28 paragraph 1 line Omit the open quotation mark before "all" Page 28, paragraph line 9: Omit the closed quotation mark after "limit" Page 29, paragraph 1, line 11: accordingly. Using the EPA default... (punctuation change) Page 31, paragraph 3, third line from the bottom: analyzed." Page 36, paragraph 3, line 1: "Employees Page 36, paragraph 4, line 10: invariably 'yes. LEVY Exhibit $ for I.D. Reporter: K.A. Smith Date: 3/5/15 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 43 of 277 PAGEID #: 61044 ATTACHMENT A BARRY S. LEVY, M.D M.P.H. Curriculum Vitae Barry S. Levy, M.D., M.P.H., P.C. 20 North Main Street, Suite 200 Post Office Box 1230 Sherborn, Massachusetts 01770 Telephone: (508) 650-1039 Fax: (508) 655-4811 Electronic Mail: BLEVY@IGC.ORG 1 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 44 of 277 PAGEID #: 61045 EDUCATION Undergraduate B.S. summa cum laude: Tufts College of Liberal Arts (1966) Graduate M.D.: Cornell University Medical College (1971) M.P.H.: Harvard School of Public Health (1970) POSTDOCTORAL TRAINING Internship and Residencies Internal Medicine: University Hospital, Boston (1971-1973) Preventive Medicine: Centers for Disease Control (1974-1976) Internal Medicine: Beth Israel Hospital, Boston (1976-1977) LICENSURE Massachusetts (#35399): 1973 to Present Connecticut (#035168): 1996 to Present BOARD CERTIFICATIONS American Board of Internal Medicine (1977) American Board of Preventive Medicine Occupational Medicine (1980) 2 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 45 of 277 PAGEID #: 61046 EMPLOYMENT Centers for Disease Control, 1973-1976: Medical Epidemiologist, Field Services Division, Bureau of Epidemiology (Epidemic Intelligence Service); Acting State Epidemiologist, Minnesota (1974-1976); Acting Director, Division of Personal (Preventive) Health Services, Minnesota Department of Health (1974-1976) Responsibilities included: ! Providing technical assistance and consultation to physicians and others working in public health in Minnesota ! Directing investigations of disease outbreaks and environmental exposures ! Developing and directing surveillance systems to monitor disease trends ! Developing and presenting professional and public education programs on disease prevention and control ! Developing and editing monthly Disease Control Newsletter ! Directing the largest division in the state health department (131 employees and an annual budget of $6 million), which included communicable and chronic disease control as well as maternal and child health programs. University of Massachusetts Medical School, 1977-1988: Assistant Professor (1977-1980), Associate Professor (1980 1985), and Professor (1985-1988) in the Department of Family and Community Medicine. Awarded tenure in 1983. Staff Physician, University of Massachusetts Hospital (1977-1987). On sabbatical 1987-1988. Responsibilities included: ! After founding the Occupational Health Program in 1981, directing it for 6 years during which the Program provided education to health professionals, students, workers, managers, and others ! Teaching occupational and environmental health to physicians, medical students, and others ! Providing consultative services related to occupational and environmental health, including providing expert testimony on many medicolegal cases ! Performing and supervising epidemiologic research in occupational and environmental health, on such topics as respiratory disease, cancer, cumulative trauma, and other subjects 3 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 46 of 277 PAGEID #: 61047 ! Writing and editing numerous publications, including two editions of the leading occupational health textbook in the United States, several chapters in other books, and many journal articles Kenya Medical Research Institute, 1987-1988: Visiting Research Scientist, Environmental and Occupational Health Research Programme, Medical Research Centre Responsibilities included: ! Assisting in development of overall research and educational program, as well as specific program components and projects, including writing a successful proposal for a three-nation, $850,000 grant for the establishment of the East Africa Regional Pesticide Network ! Co-directing project to assess and prioritize occupational health risks in Kenya ! Surveying occupational health services in Kenya, in a project sponsored by the Finnish Institute of Occupational Health ! Providing education for physicians, public health officers, graduate public health students, medical students, workers, and schoolchildren Global 2000, Carter Presidential Center, 1988-1989: Program Coordinator for Kenya (Half-time position) Responsibilities included: ! Coordinating development of a project to strengthen orthopedic workshops that produce braces and artificial limbs in Kenya ! Performing survey of needs of and resources for people with disabling conditions AIDSTECH, Family Health International, 1988-1989 Program Coordinator for Kenya (Half-time position) Responsibilities included: ! Providing overall coordination of AIDSTECH activities for AIDS prevention in Kenya ! Assisting in the development and implementation of projects to educate and provide condoms to prostitutes, long distance truck drivers, and others in high-risk groups ! Assisting in the development and implementation of projects to make the blood supply safe ! Coordinating workshop on AIDS prevention for family planning service providers 4 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 47 of 277 PAGEID #: 61048 Management Sciences for Health, 1989-1992 Director, Program for Environment and Health Responsibilities included: ! Developing and directing program to strengthen environmental and occupational health capabilities in developing countries and the nations of Central and Eastern Europe through training, providing technical assistance, and facilitating information exchange. ! Developing courses in policy development and program management in occupational and environmental health ! Providing technical assistance to programs in Botswana, Zimbabwe, and Indonesia ! Organizing symposia (and editing symposium proceedings) on environmental and occupational health in Central and Eastern Europe ! Directing inventory of 500 ongoing research projects in occupational health and environmental epidemiology in developing countries ! Editing two quarterly newsletters on environmental and occupational health for developing countries and the countries of Central and Eastern Europe ! Directing evaluation of the SENSOR occupational health surveillance system for the National Institute for Occupational Safety and Health ! Eliciting financial support for program activities from numerous national and international organizations ! Serving as a consultant to the World Bank, the Agency for International Development, and other organizations Tufts University School of Medicine, 1992 - Present 1992- 1993: Full-time faculty member and Director, Environmental and Occupational Health Program 1993- present: Adjunct Professor of Public Health (Formerly Adjunct Professor of Community Health), Department of Public Health and Community Medicine (Formerly Department of Family Medicine and Community Health) Responsibilities have included: ! Directing and teaching in Introduction to Environmental and Occupational Health course ! Presenting numerous lectures to students on topics in environmental and occupational health and in public health ! Assisting in developing university-wide environmental projects and programs 5 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 48 of 277 PAGEID #: 61049 ! Serving on interim executive committee that supervised the work of the major environmental center in the University ! Coordinating Fourth and Fifth Annual Symposia on Environmental and Occupational Health during Societal Transition in Central and Eastern Europe ! Directing lead poisoning prevention program in Hungary International Physicians for the Prevention of Nuclear War, 1993-1994 Executive Director Responsibilities included: ! Serving as Chief Executive Officer for an international federation of physicians' organizations in 83 countries ! Supervising a staff of 15 people in federation headquarters ! Establishing governance procedures and improving intra- and extra-organizational relationships ! Establishing new program initiatives ! Coordinating presentation of federation's 11th World Congress in Mexico City for over 1,000 participants ! Identifying priority needs of the federation Consultant, 1994 - Present Director, Barry S. Levy Associates, 1994-2002 Barry S. Levy, M.D., M.P.H., P.C., 2002-Present ! Providing consultative services in environmental and occupational health CONSULTANCIES (Partial List) National Institute for Occupational Safety and Health Occupational Safety and Health Administration Environmental Protection Agency National Academy of Sciences Pregnancy Environmental Hotline, National Birth Defects Center United States Agency for International Development Harvard Institute for International Development The World Bank World Health Organization Several corporations 6 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 49 of 277 PAGEID #: 61050 ACADEMIC APPOINTMENTS Primary (Full--time) Appointments 1977-1988 Assistant Professor, Associate Professor, and Professor (with Tenure); Director, Occupational Health Program Department of Family and Community Medicine University of Massachusetts Medical School 1992-1993 Director, Environmental and Occupational Health Program, Department of Community Health Tufts University School of Medicine Adjunct Appointments 1975-1976 Lecturer University of Minnesota School of Public Health 1980-1981 Adjunct Assistant Professor Boston University School of Public Health 1982-1988, 1991 Adjunct Assistant Professor, Adjunct Professor University of Massachusetts (Amherst) 1983-1987, 1994-2003 2005 Visiting Lecturer/Visiting Scientist Harvard School of Public Health 1987-present Adjunct Professor University of Massachusetts Lowell 1988-1989 Lecturer University of Nairobi Faculty of Medicine 1991-1998 Adjunct Professor University of Hawaii School of Public Health 1993-present Adjunct Professor of Public Health (Previously: Adjunct Professor of Community Health) Tufts University School of Medicine 1977-1987 HOSPITAL APPOINTMENTS Physician, University of Massachusetts Hospital 7 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 50 of 277 PAGEID #: 61051 INTERNATIONAL EXPERIENCE Puerto Rico (1 week, 1970) ! Studied maternal and child health system Jamaica (2 months, 1971) ! Provided medical care and public health services in rural clinic; helped to develop young child nutrition program Thailand (6 weeks, 1980) ! Provided medical care and taught public health course in Cambodian refugee camp China (6 weeks, 1984) ! As visiting professor in occupational health to Shanghai First Medical College, gave 14 lectures, visited many worksites, and reviewed occupational health research Soviet Union (1 week, 1986, 1987, 1988) ! As citizen ambassador in World Runners, promoted Soviet- American partnership to end world hunger Western Europe (2 weeks, 1987) ! Visited and lectured at occupational health programs in Sweden, Denmark, Switzerland, and Italy Kenya (2 years, 1987-1989) ! See page 3 Uganda and Tanzania (several visits, 1988-1991) ! Visited to help establish the East Africa Pesticide Network Botswana and Zimbabwe (2 weeks, 1989) ! Visited individuals and organizations concerned with occupational and environmental health that laid the foundation for project in 1990 to assess occupational health training needs of trade union federations in these countries Indonesia (1 week, 1990) ! Provided consultation to nongovernmental organization establishing an occupational health program 8 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 51 of 277 PAGEID #: 61052 Hungary, Poland, Czechoslovakia, Romania, Ukraine (numerous visits, 1990-1995) ! Organized courses and conferences ! Consulted on environmental and occupational health ! Co-directed lead poisoning prevention project in Hungary Egypt (1 week, 1993) ! Organized Middle East Environmental Health Conference Russia (2 weeks, 1993) ! Participated in Tufts University School of Medicine visit to establish health project in Pskov Region and St. Petersburg ! Participated in Executive Committee meeting of the International Physicians for the Prevention of Nuclear War (IPPNW) and visits with Russian government officials Ivory Coast (5 days, 1994) ! Participated in investigation of pesticide exposure Mexico (1 week, 1994) ! Participated in investigation of lead smelter The Philippines (5 days, 1994) ! Participated in investigation of pesticide exposure South Africa (4 days, 1997) ! Met with public health practitioners, educators, and researchers ! Presented APHA Presidential Citation to President Nelson R. Mandela Cuba (3 days, 1999) ! Presented keynote address at and participated in 3-day workshop on assessment and prevention of lead poisoning India (1 week, 2001) ! Presented four lectures and met with faculty members and government officials in environmental and occupational health Croatia (4 days, 2001) ! Presented keynote address on "Health and Peace" to forum of ministers of health from South East European countries ! Made presentation on landmines at "Andrija Stampar" School of Public Health in Zagreb 9 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 52 of 277 PAGEID #: 61053 AWARDS AND HONORS 2010 2005 2004 2002 2001 2000 1998 1998 1998 1996 1996 1991 1987 1984 1983 1980 1976 1966 1966 1966 1965 Arthur Frank Keynote Address, University of Texas Health Science Center Sedgwick Memorial Medal, American Public Health Association Inducted into Bayonne (N.J.) High School Hall of Fame Special Recognition Award, American College of Preventive Medicine Second Annual James P. Keogh Memorial Lecture, University of Maryland School of Medicine Alfred S. Evans Memorial Lecture, 35th Graduate Summer Session in Epidemiology, University of Michigan School of Public Health McDonald-Merrill-Ketcham Memorial Award and Lecture, Indiana University School of Law - Indianapolis and Indiana University School of Medicine for furthering greater understanding and exchange of opinions between the professions of law and medicine John P. Lamb, Jr., Memorial Lecture, College of Public and Allied Health, East Tennessee State University Duncan Clark Award, Association of Teachers of Preventive Medicine Harriet Hardy Award, New England College of Occupational and Environmental Medicine Speaker, Scientific Program, Cornell University Medical College, Class of 1971 25th Annual Reunion Class Orator, Tufts College of Liberal Arts, Class of 1966 25th Annual Reunion Senior Honor Society Induction Ceremony Speaker, Bayonne (New Jersey) High School, on 25th Anniversary of Graduation Joseph Healey Endowment Award for study of occupational health in China Book of the Year Award, Community Health, of the American Journal of Nursing for co-editing Occupational Health: Recognizing and Preventing Work-related Disease Second Prize, Boston Globe Color Photography Contest for "Being Alive," photograph of Cambodian refugee children; Honorable Mention, Kodak International Newspaper Snapshot Award Contest Commendation Medal, United States Public Health Service Graduated summa cum laude, Tufts College of Liberal Arts Class Poet, Tufts College of Liberal Arts, Class of 1966 Student Leadership Award, Tufts University Alumni Association Phi Beta Kappa 10 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 53 of 277 PAGEID #: 61054 1964 1962 1962 1962 1961 Society of Scholars (top three members in class-1966 academically), Tufts College of Liberal Arts Academic Salutatorian, Class of 1962, Bayonne (New Jersey) High School (BHS) Bausch and Lomb Science Award and Student Activities Award, Class of 1962, BHS Senior Honor Society, BHS Junior Honor Society, BHS PREVIOUS COMMITTEE SERVICE Tufts University School of Medicine Member, Curriculum Committee Member, Interim Executive Committee, Center for Environmental Management Coordinator, Task Force for MPH Program Expansion Member, International Health Committee Member, Advisory Board, Master of Public Health Program University of Massachusetts Medical School Member, Faculty Council Member, Student Promotions Board Member, Curriculum Committee Chairman, University of Massachusetts Medical Center Safety Committee Member, Personnel Action Committee Member, several tenure review committees Member, Search Committee for Chairperson of Department of Family and Community Medicine Member, Search Committee for Safety Officer, University of Massachusetts Medical Center Member, Review Committee, Biomedical Research Support Grant Program Member, Steering Committee, Environmental Health Sciences Program Other Major Committee Assignments: National, Regional, and Local Member, Pesticide Board, Department of Agriculture, Commonwealth of Massachusetts Chairman, Scientific Advisory Council, Center for Health Promotion and Environmental Disease Prevention, Department of Public Health, Commonwealth of Massachusetts Member, Surveillance Committee, National Institute for Occupational Safety and Health Member, Foundation Steering Committee, MetroWest Health, Inc. 11 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 54 of 277 PAGEID #: 61055 Member and Vice-Chairman, Board of Trustees, and Chairperson, Distribution Committee, MetroWest Community Healthcare Foundation Member, Scientific Review Board, Horizon Solutions Site Member, Advisory Council to the Center for Children's Health and the Environment, Mount Sinai School of Medicine Co-founder and Former Co-director of the Africa Project, Former Member of the Board of Directors, and Member and Former Chairperson of the Advisory Board, Global Partners for Development (formerly World Runners International Foundation) TEACHING RESPONSIBILITIES Department of Public Health and Community Medicine (Formerly Department of Family Medicine and Community Health), Tufts University School of Medicine Combined MD/DVM/MPH Program 1993-present Introduction to Environmental and Occupational Health (Course Director) 1995 War, Refugees, and Health (Course Director) Department of Family and Community Medicine, University of Massachusetts Medical School Undergraduate Teaching Program 1977-1987 Preventive Medicine (Course Director) Epidemiology (Group Leader) Community Medicine Clerkship (Group Leader) Family Medicine Clerkship (Director of Occupational Health Segment) New England Occupational Health and Safety Institute 1987 Communicating about Toxic Exposures to Workers and Community Residents (Course Director) Division of Public Health, University of Massachusetts (Amherst) MPH Program 1982-1984 Occupational Epidemiology (Course Director) Clark University Master of Health Administration Program 1981 Introduction to Epidemiology (Course Director) School of Public Health, Boston University MPH Program 1980 Occupational Health (Course Director) 12 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 55 of 277 PAGEID #: 61056 Management Sciences for Health Program for Environment and Health 1991 Environmental Health: Strengthening Policies and Programs (Courses in the United States and Hungary) (Course Director) PROFESSIONAL ORGANIZATIONS American Public Health Association President (1997) Immediate Past President (1998) President-Elect (1996) Chairperson, Executive Board (1993) Member, Executive Board (1988, 1990-1993, and 1996-1998) Chairperson (1983), Program Chairperson (1982), and Member of Alice Hamilton Award Committee, Occupational Health and Safety Section Chairperson, Development Campaign Cabinet (1998-2001) Chairperson, Committee on Constitution and Bylaws (2000-2003) Member, Governing Council (1985-1986, 1988, 1990-1993, 1996-1998) Chairperson, Action Board (1988) Co-chairperson, Joint Policy Committee (1988) Chairperson, Nominating Committee (1988) Member, Program Planning Committee (1999-2000, 2002-2003, 2009-2010) Member, Strategic Planning Committee (1995-1996) Member, Awards Committee (1997, 2008-2009, 2013) Member, Executive Director Search Committee (1996) Member, Task Force on Association Improvement and Reorganization (2004-2005) Alliance to End Childhood Lead Poisoning Former Member, Board of Directors; Former Chairperson, Nominating Committee American College of Epidemiology Fellow American College of Occupational and Environmental Medicine Editor, Occupational Medicine Self-Assessment Program (Exam and Syllabus), Three Editions; Former Member, Environmental Medicine Curriculum Committee 13 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 56 of 277 PAGEID #: 61057 PROFESSIONAL ORGANIZATIONS (Continued) Association for Prevention Teaching and Research (formerly, Association of Teachers of Preventive Medicine) Member; Former Member, Board of Directors and Occupational Health Committee Collegium Ramazzini Emeritus Member Council on Education for Public Health Member, Board of Councilors (2001-2004) Site Visitor and Chairman of Site Visits Harriet Hardy Institute Former Member Harvard School of Public Health Alumni Association Member, Alumni Council (1999-2006) President-Elect (2001-2003) President (2003-2005) Immediate Past President (2005-2006) International Commission on Occupational Health Member; Former Member, Board of Directors International Epidemiology Association Member Massachusetts Medical Society Member Massachusetts Public Health Association Member National Council for International Health Member, Planning Committee, 1993 International Health Conference New England College of Occupational and Environmental Medicine Member; Former Member, Board of Directors Physicians for Social Responsibility Member Society for Epidemiologic Research Member 14 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 57 of 277 PAGEID #: 61058 SELECTED GRANTS AND CONTRACTS (PROJECT DIRECTOR OR PRINCIPAL INVESTIGATOR) Environmental Health Program Development: Education, Research, Policy, and Outreach U.S. Environmental Protection Agency via the Tufts University Center for Environmental Management, approximately $60,000, 1992-1994 Facilitating a Multi-sectoral Approach for Environmental Health Policy and Program Development: Application to Lead Poisoning in Hungary U.S. Environmental Protection Agency via the Tufts University Center for Environmental Management, $120,000, 1993-1994 Environmental Health Conference for the Middle East Region Fogarty International Center, National Institutes of Health, $55,000, 1992-1993 Evaluation of the Sentinel Event Notification System for Occupational Risks (SENSOR) National Institute for Occupational Safety and Health, $85,000, 1991-1992 Assessment of Occupational Health Training Needs of National Trade Union Federations in Zimbabwe and Botswana African-American Labor Center, $6,000, 1990 Occupational Health and Environmental Epidemiology Research in Developing Countries World Health Organization and International Development Research Centre, $12,000, 1990 East Africa Pesticide Network International Development Research Centre (wrote grant proposal for the Kenya Medical Research Centre; not project director), $800,000, 1989-1992 Occupational Health Services in Kenya Finnish Institute of Occupational Health $10,000, 1987-1988 Development of a Systematic Approach for the Investigation of Health Problems of Suspected Environmental Origin Massachusetts Department of Public Health $15,000, 1986-1987 15 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 58 of 277 PAGEID #: 61059 Physician-based Surveillance of Occupational Disease Massachusetts Department of Public Health approximately $20,000, 1985-1987 A Model Occupational Health Program W. K. Kellogg Foundation $400,000, 1985-1987 A Back Injury Prevention Program for Hospital Nurses Blue Cross - Massachusetts Hospital Association Fund for Cooperative Innovation approximately $70,000, 1985-1987 Occupational Health Research Based on Experience in an Occupational Health Clinic University of Massachusetts Medical Center Biomedical Research Support Grant approximately $10,000, 1982-1983 Occupational Health Community Education Programs Central Massachusetts Areawide Health Education Center (AHEC) Program Five grants totaling approximately $25,000, 1982-1987 Occupational Health Curriculum Development Grant Health Resources Administration, U. S. Department of Health and Human Services approximately $200,000, 1979-1981 Occupational Cancer in the Greater Worcester Area University of Massachusetts Medical Center American Cancer Society Institutional Grant approximately $5,000, 1978-1979 PUBLICATIONS Books Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease. Boston: Little, Brown and Company, 1983. Levy BS, Susott DC (Editors). Years of Horror, Days of Hope: Responding to the Cambodian Refugee Crisis. New York: Associated Faculty Press, 1986. 16 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 59 of 277 PAGEID #: 61060 Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Second Edition. Boston: Little, Brown and Company, 1988. Weeks J, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991. Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Third Edition). Boston: Little, Brown and Company, 1995. Shahi G, Levy BS, Binger A, Kjellstrom T, Lawrence R (Editors). International Perspectives in Environment, Development, and Health: Toward a Sustainable World. New York: Springer, 1997. Levy BS, Sidel VW (Editors). War and Public Health. New York: Oxford University Press (in cooperation with the American Public Health Association), 1997; updated edition, Washington, DC: American Public Health Association, 2000. Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease and Injury (Fourth Edition). Philadelphia: Lippincott Williams & Wilkins, 2000. Levy BS, Sidel VW (Editors). Terrorism and Public Health: A Balanced Approach to Strengthening Systems and Protecting People. New York: Oxford University Press (in cooperation with the American Public Health Association), 2003; paperback edition, 2007. Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005. Levy BS, Sidel VW (Editors). Social Injustice and Public Health. New York, Oxford University Press, 2006; paperback edition, 2009. Levy BS, Wegman DH, Baron SL, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Fifth Edition). Philadelphia: Lippincott Williams & Wilkins, 2006. Levy BS, Sidel VW (Editors). War and Public Health (Second Edition). New York: Oxford University Press, 2008. 17 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 60 of 277 PAGEID #: 61061 Levy BS, Wegman DH, Baron SL, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Sixth Edition). New York: Oxford University Press, 2011. Levy BS, Gaufin JR (Editors). Mastering Public Health: Essential Skills for Effective Practice. New York: Oxford University Press, 2012. Levy BS, Sidel VW (Editors). Terrorism and Public Health: A Balanced Approach to Strengthening Systems and Protecting People (Second Edition). New York: Oxford University Press, 2012. Levy BS, Sidel VW (Editors). Social Injustice and Public Health (Second Edition). New York: Oxford University Press, 2013. Monographs Levy BS, Levenstein C (Editors). Environment and Health in Eastern Europe. Boston: Management Sciences for Health, 1990. Levy BS, Kjellstrom T, Forget G, Pollier L, Jones MRD. Inventory of Ongoing Research in Occupational Health and Environmental Epidemiology in Developing Countries. Geneva: World Health Organization, 1991. Levy BS (Editor). Air Pollution in Central and Eastern Europe: Health and Public Policy. Boston: Management Sciences for Health, 1991. Levy BS, Levenstein C (Editors). Environment and Health in Central and Eastern Europe: Policies, Programs, and Public Participation. Boston: Management Sciences for Health, 1993. Levy BS, Levenstein C, Fzesi Z (Editors). Restructuring Public Health Systems: Implications for Environmental and Occupational Health. Boston: Tufts University School of Medicine, 1995. Lovei M, Levy BS (Editors), based on contributions from Ori I, Rudnai P, Gorynski P, and Bainova A. Lead Exposure and Health in Central and Eastern Europe: The Impact on Children: Evidence from Hungary, Poland, and Bulgaria. Washington, DC: The World Bank, 1995. Fzesi Z, Levy BS, Levenstein C (Editors). From Science to Action: The Lead Hazard in Hungary. Pcs, Hungary: The Fact Foundation, 1996. 18 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 61 of 277 PAGEID #: 61062 Special Journal Issues and Sections Edited Wegman DH, Christiani DC, Quinn MM, Levenstein C, Levy BS (Editors). Problems of Modernization and Occupational Health in the People's Republic of China. Scandinavian Journal of Work, Environment and Health. Supplement, February 1986. LaDou J, Levy BS (Editors). International Issues in Occupational Health. International Journal of Occupational and Environmental Health. 1 (2), April-June 1995. Levy BS, Levin JL, Teitelbaum DT (Editors). Symposium: DBCPInduced Sterility and Reduced Fertility among Men in Developing Countries: A Case Study of the Export of a Known Hazard. International Journal of Occupational and Environmental Health. 5 (2), April-June 1999, pp. 115-153. Book Chapters Levy BS, Wegman DH. "Environmental and Occupational Hazards" in LJ Schneiderman (Editor) The Practice of Preventive Health Care. Menlo Park, California: Addison-Wesley, 1981, pp. 124-155. Levy BS. "Preventive and Occupational Medicine" in Catlin RJO (Editor). Family Practice: PreTest Self-Assessment and Review. New York: McGraw-Hill Book Company, 1981, pp. 155-175. Levy BS. "Occupational Health" in Stein J (Editor). Internal Medicine. Boston: Little, Brown and Company, 1981 (First Edition), pp. 1919-1925; 1987 (Second Edition), pp. 2265-2272; and 1990 (Third Edition), pp. 2385-2392. Levy BS. "Occupational Health" in Barker W. (Editor). Teaching Preventive Medicine in Primary Care. New York: Springer Publishing Company, 1983, pp. 195-201. Levy BS. "Occupational Health in the United States" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (First Edition) . Boston: Little, Brown and Company, 1983, pp. 3-13. Levy BS, Wegman DH. "Recognizing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (First Edition) . Boston: Little, Brown and Company, 1983, pp. 29-39. 19 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 62 of 277 PAGEID #: 61063 Levy BS, Wegman DH. "Preventing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (First Edition). Boston: Little, Brown and Company, 1983, pp. 41-49. Levy BS. "Screening for Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (First Edition) . Boston: Little, Brown and Company, 1983, pp. 69-80. Frumkin H, Levy BS. "Carcinogens" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Workrelated Disease (First Edition) . Boston: Little, Brown and Company, 1983, pp. 145-175. Levy BS, Susott DC. "Historical Context and Brief Overview of the Relief Operation" in Levy BS, Susott DC (Editors). Years of Horror, Days of Hope: Responding to the Cambodian Refugee Crisis. New York: Associated Faculty Press, 1986, pp. xix-xxii. Levy BS. "Working at Khao I Dang: A Physician's Experience" in Levy BS, Susott DC (Editors). Years of Horror, Days of Hope: Responding to the Cambodian Refugee Crisis. New York: Associated Faculty Press, 1986, pp. 107-115. Levy BS, Wegman DH. "Occupational Health" in Noble J (Editor). Textbook of General Medicine and Primary Care. Boston: Little, Brown and Company, 1987, pp. 85-111. Levy BS, Wegman DH. "Occupational Health in the United States" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Second Edition). Boston: Little, Brown and Company, 1988, pp. 3-14. Levy BS, Wegman DH. "Recognizing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Second Edition) . Boston: Little, Brown and Company, 1988, pp. 29-43. Levy BS, Wegman DH. "Preventing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Second Edition) . Boston: Little, Brown and Company, 1988, pp. 45-54. 20 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 63 of 277 PAGEID #: 61064 Levy BS, Halperin WE. "Screening for Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Second Edition). Boston: Little, Brown and Company, 1988, pp. 75-86. Frumkin H, Levy BS. "Carcinogens" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Workrelated Disease (Second Edition) . Boston: Little, Brown and Company, 1988, pp. 215-229. Levy BS, Choudhry AW. "Challenges in Developing an Epidemiologic Research Program in Occupational Health in a Developing Country" in Hogstedt C, Reuterwell C (Editors). Progress in Epidemiology. Amsterdam: Excerpta 1989, pp. 351-354. Levy BS. "Brain Cancer" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 164-166. Hodgson M, Levy BS. "Hepatitis A Virus (HAV) Infection" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 292-294. Levy BS, Alter MJ. "Hepatitis B Virus (HBV) Infection" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 294-299. Levy BS, Alter MJ. "Hepatitis, Non-A, Non-B" in JL Weeks, BS Levy, GR Wagner (Editors) Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 300-301. Levy BS. "Mercury Poisoning" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 416-419. Levy BS. "Nasal (or Sinonasal) Cancer" Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 436-438. 21 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 64 of 277 PAGEID #: 61065 Levy BS, Widess E. "Pesticide Poisoning" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 462-477. Levy BS. "Solvents, Organic, Adverse Effects" in Weeks JL, Levy BS, Wagner GR (Editors). Preventing Occupational Disease and Injury. Washington, DC: American Public Health Association, 1991, pp. 541-544. Levy BS, Choudhry AW. "Endemic Diseases" in Jeyaratnam J (Editor). Occupational Health in Developing Countries. London: Oxford University Press, 1992, pp. 314-325. Levy BS, Hertzman C. "Environment and Health in Central Europe" in Livernash R (Editor). World Resources: 1992-93. Washington, DC: World Resources Institute, 1992, pp. 62-63. Levy BS, Wegman DH. "Occupational Health in the Global Context: An American Perspective" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Third Edition). Boston: Little, Brown and Company, 1995, pp. 3-24. Wegman DH, Levy BS, Halperin WE. "Recognizing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Third Edition). Boston: Little, Brown and Company, 1995, pp. 57-82. Wegman DH, Levy BS. "Preventing Occupational Disease" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease (Third Edition). Boston: Little, Brown and Company, 1995, pp. 83-101. Shahi GS, Levy BS, Louis GE, et al. "The EnvironmentDevelopment-Health Interface" in Shahi GS, Levy BS, Binger A, Kjellstrom T, Lawrence RS (Editors). International Perspectives in Environment, Development, and Health: Toward a Sustainable World. New York: Springer, 1997, pp. 3-20. Shahi GS, Chen L, Levy BS, et al. "A Historical Perspective" in Shahi GS, Levy BS, Binger A, Kjellstrom T, Lawrence RS (Editors). International Perspectives in Environment, Development, and Health: Toward a Sustainable World. New York: Springer, 1997, pp. 21-47. 22 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 65 of 277 PAGEID #: 61066 Brantly E, Hetes R, Levy BS, et al. "Comparative Health Risk Assessment: A Method for Setting Priorities in Environmental Health" in Shahi GS, Levy BS, Binger A, Kjellstrom T, Lawrence RS (Editors). International Perspectives in Environment, Development, and Health: Toward a Sustainable World. New York: Springer, 1997, pp. 388-409. Levy BS, Rest KM. "Policies to Protect and Promote Workers' Health Are Necessary for Sustainable Human Development" in Shahi GS, Levy BS, Binger A, Kjellstrom T, Lawrence RS (Editors). International Perspectives in Environment, Development, and Health: Toward a Sustainable World. New York: Springer, 1997, pp. 486-496. Levy BS. "Hazards in the International Setting: General Issues" in Fleming LE, Herzstein JA, Bunn WB III (Editors). Issues in International Occupational and Environmental Medicine. Beverly, MA: OEM Press, pp. 105-114, 1997. Hyde JN, Levy BS. "Public Health and the Environment" in Mengel MB, Holleman WA (Editors). Fundamentals of Clinical Practice: A Textbook on the Patient, Doctor, and Society. New York: Plenum Medical Book Company, 1997, pp. 185-207. Levy BS, Shahi GS, Lee C. "The Environmental Consequences of War" in Levy BS, Sidel VW (Editors). War and Public Health. New York: Oxford University Press (in cooperation with the American Public Health Association), 1997, pp. 51-62. Levy BS, Sidel VW. "Impact of Military Activities on Civilian Populations" in Levy BS, Sidel VW (Editors). War and Public Health. New York: Oxford University Press (in cooperation with the American Public Health Association), 1997, pp. 149-167. Levy BS, Sidel VW. "Preventing War and Its Health Consequences: Roles of Public Health Professionals" in Levy BS, Sidel VW (Editors). War and Public Health. New York: Oxford University Press (in cooperation with the American Public Health Association), 1997, pp. 388-393. Lovei M, Levy BS (Editors). "Lead Exposure and Health in Central and Eastern Europe: Evidence from Hungary, Poland, and Bulgaria" in Lovei M (Editor) Phasing Out Lead from Gasoline in Central and Eastern Europe: Health Issues, Feasibility, and Policies. Washington, DC: The World Bank, 1997, pp. 35-48. 23 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 66 of 277 PAGEID #: 61067 Sidel VW, Levy BS. "Epilogue" in Levy BS, Sidel VW (Editors). War and Public Health (Updated Edition). Washington, DC: American Public Health Association, 2000, pp. 397-422. Levy BS, Wegman DH. "Occupational Health: An Overview" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease and Injury (Fourth Edition). Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 3-25. Levy BS, Wegman DH, Halperin WE. "Recognizing Occupational Disease and Injury" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease and Injury (Fourth Edition). Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 99-122. Levy BS, Wegman DH. "Preventing Occupational Disease and Injury" in Levy BS, Wegman DH (Editors). Occupational Health: Recognizing and Preventing Work-related Disease and Injury (Fourth Edition). Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 123-141. Hyde JN, Levy BS. "Public Health and the Environment" in Mengel MB, Holleman WA, Fields SA (Editors). Fundamentals of Clinical Practice (Second Edition). New York: Kluwer Academic/Plenum Publishers, 2002, pp. 493-512. Sidel VW, Levy BS. "The Health and Social Consequences of Diversion of Economic Resources to War and Preparation for War" in Taipale I with Makela PH, Juva K, Taipale V, et al. (Editorial Board). War or Health? A Reader. Dhaka: University Press (and other publishers) in association with Physicians for Social Responsibility (Finland) and International Physicians for the Prevention of Nuclear War, 2002, pp. 208-221. Sidel VW, Levy BS. "War" in Breslow L (Editor-in-Chief), Encyclopedia of Public Health (Vol. IV). New York: Macmillan, 2002, pp. 1301-1304. Levy BS, Sidel VW. "Challenges That Terrorism Poses for Public Health" in Levy BS, Sidel VW (Editors). Terrorism and Public Health: A Balanced Approach to Strengthening Systems and Protecting People. New York: Oxford University Press (in cooperation with the American Public Health Association), 2003. 24 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 67 of 277 PAGEID #: 61068 Sidel VW, Levy BS. "Biological Weapons" in Levy BS, Sidel VW (Editors). Terrorism and Public Health: A Balanced Approach to Strengthening Systems and Protecting People. New York: Oxford University Press (in cooperation with the American Public Health Association), 2003. Sidel VW, Levy BS. "Physician-Soldier: A Moral Dilemma?" In: Beam TE, Sparacino LR, specialty editors. Military Medical Ethics: Volume 1 (Textbooks of Military Medicine). Falls Church, VA: Office of the Surgeon General, United States Army; Washington, DC: Borden Institute, Walter Reed Army Medical Center; and Bethesda, MD: Uniformed Services University of the Health Sciences; 2003, pp. 293-312. Levy BS, Sidel VW. "War" in Frumkin H (Editor). Environmental Health: From Local to Global. San Francisco: Jossey-Bass/ Pfeiffer, 2005, pp. 269-287. Weeks J, Wagner GR, Rest KM, Levy BS. "A Public Health Approach to Preventing Occupational Diseases and Injuries" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 11-37. Levy BS. "Brain Cancer" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 129-131. Levy BS, Wegman DH. "Hard Metal Interstitial Disease" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 216-218. Levy BS, Hajjeh RA. "Histoplasmosis" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 250-253. Petsonk L, Levy BS. "Latex Allergy" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 298-301. 25 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 68 of 277 PAGEID #: 61069 Keogh J, Levy BS. "Lead Poisoning" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 301-310. Levy BS. "Lung Cancer" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 320-325. Levy BS, Wegman DH. "Respiratory Tract Irritation" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 442-444. Levy BS. "Solvents, Organic, Adverse Effects" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 459-462. Levy BS, Goldman RH. "Taking an Occupational History" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 527-535. Levy BS, Rest KM, Fingerhut MA. "Preventing Occupational Disease and Injury in Developing Countries" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 555-558. Levy BS. "Resources for Disaster Preparedness" in BS Levy, GR Wagner, KM Rest, J Weeks (Eds.). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 559-561. Levy BS. "Other Sources of Information: Organizations and Websites" in Levy BS, Wagner GR, Rest KM, Weeks J (Editors). Preventing Occupational Disease and Injury (Second Edition). Washington, DC: American Public Health Association, 2005, pp. 563-577. Sidel VW, Levy BS. "The Nature of Social Injustice and Its Impact on Public Health" in Levy BS, Sidel VW (Editors). Social Injustice and Public Health. New York, Oxford University Press, 2006, pp. 5-21. 26 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 69 of 277 PAGEID #: 61070 Levy BS, Sidel VW. "International Health" in Levy BS, Sidel VW (Editors). Social Injustice and Public Health. New York, Oxford University Press, 2006, pp. 378-402. Levy BS, Wegman DH, Baron SL, Sokas RK. "Occupational and Environmental Health: An Overview" in Levy BS, Wegman DH, Baron SL, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Fifth Edition). Philadelphia: Lippincott Williams & Wilkins, 2006, pp. 3-20. Levy BS, Wegman DH, Halperin WE, et al. "Recognizing Occupational and Environmental Disease and Injury" in Levy BS, Wegman DH, Baron SL, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Fifth Edition). Philadelphia: Lippincott Williams & Wilkins, 2006, pp. 131-147. Sokas RK, Levy BS, Wegman DH, Baron SL. "Preventing Occupational and Environmental Disease and Injury" in Levy BS, Wegman DH, Baron SL, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Fifth Edition). Philadelphia: Lippincott Williams & Wilkins, 2006, pp. 148-171. Levy BS, Sidel VW. "Epilogue" in Levy BS, Sidel VW (Editors). Terrorism and Public Health (Paperback Edition). New York: Oxford University Press, 2007, pp. 361-372. Sidel VW, Levy BS. "War" in Boslaugh S (Editor). Encyclopedia of Epidemiology (Volume 2). Thousand Oaks, CA: Sage Publications, 2008, pp. 1091-1093. Levy BS, Sidel VW. "War and Public Health: An Overview" in Levy BS, Sidel VW (Editors). War and Public Health (Second Edition). New York: Oxford University Press, 2008, pp. 3-20. Levy BS, Sidel VW. "Biological Weapons" in Levy BS, Sidel VW (Editors). War and Public Health (Second Edition). New York: Oxford University Press, 2008, pp. 135-151. Levy BS, Sidel VW. "The Iraq War" in Levy BS, Sidel VW (Editors). War and Public Health (Second Edition). New York: Oxford University Press, 2008, pp. 243-263. 27 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 70 of 277 PAGEID #: 61071 Sidel VW, Levy BS. "Roles and Ethics Dilemmas for Military Medical Care Workers" in Levy BS, Sidel VW (Editors). War and Public Health (Second Edition). New York: Oxford University Press, 2008, pp. 393-408. Sidel VW, Levy BS. "The Health Effects of War" in Arya N, Santa Barbara J (Editors). Peace Through Health. Bloomfield, CT: Kumarian Press, 2008, pp. 49-66. Sidel VW, Levy BS. "Collective Violence: Health Impact and Prevention" in Scott KA (Rapporteur). Violence Prevention in Low- and Middle-Income Countries: Finding a Place on the Global Agenda. Washington, DC: The National Academies Press, 2008, pp. 171-199. Levy BS, Sidel VW. "Terrorism" in Heggenhougen HK, Quah SR (Editors). International Encyclopedia of Public Health (Volume 6). Oxford: Elsevier, 2008, pp. 303-309. Sidel VW, Levy BS. "Weapons of Mass Destruction in Heggenhougen HK, Quah SR (Editors). International Encyclopedia of Public Health (Volume 6). Oxford: Elsevier, 2008, pp. 564-570. Sidel VW, Levy BS. "Collective Violence: War" in Detels R, Beaglehole R, Lansang MA, Gulliford M (Editors). Oxford Textbook of Public Health, 5th Edition. Oxford: Oxford University Press, 2009, pp. 1367-1375. Sidel VW, Levy BS, Slutzman JE. "Prevention of War and Its Environmental Consequences" in Kassim TA, Barcelo D (Editors). Environmental Consequences of War and Aftermath. Volume in The Handbook of Environmental Chemistry. Heidelberg, Germany: Springer-Verlag Berlin Heidelberg, 2009, pp. 21-39. Levy BS, Sidel VW. "Epilogue" in Levy BS, Sidel VW (Editors). Social Injustice and Public Health (Paperback Edition). New York: Oxford University Press, 2008, pp. 508-518. Levy BS. "Armed Conflict and Infectious Disease" in Relman DA, Choffnes ER, Mack A (Rapporteurs). Infectious Disease Movement in a Borderless World: Workshop Summary. Washington, DC: National Academies Press, 2010, pp. 104-109. 28 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 71 of 277 PAGEID #: 61072 Levy BS, Wegman DH, Baron SL, Sokas RK, "Occupational and Environmental Health: Twenty-First Century Challenges and Opportunities" in BS Levy, DH Wegman, SL Baron, RK Sokas (Editors). Occupational Health: Recognizing and Preventing Disease and Injury (Sixth Edition). New York: Oxford University Press, 2011, pp. 3-22. Sokas RK, Levy BS, Wegman DH, Baron SL. "Recognizing and Preventing Occupational and Environmental Disease and Injury" in BS Levy, DH Wegman, SL Baron, Sokas RK (Editors). Occupational and Environmental Health: Recognizing and Preventing Disease and Injury (Sixth Edition). New York: Oxford University Press, 2011, pp. 23-54. Levy BS, Sidel VW. "Biological Agents and Infectious Diseases in War and Terrorism" in Nriagu JO (Editor). Encyclopedia of Environmental Health. Burlington, MA: Elsevier, 2011, Volume 1, pp. 363-370. Gaufin JR, Levy BS. "Making a Presentation" in Levy BS, Gaufin JR (Editors). Mastering Public Health: Essential Skills for Effective Practice. New York: Oxford University Press, 2012, pp. 60-70. Lawrence RS, Levy BS. "Creating a Vision and Inspiring Others in Levy BS, Gaufin JR (Editors). Mastering Public Health: Essential Skills for Effective Practice. New York: Oxford University Press, 2012, pp. 241-255. Levy BS, Sidel VW. "Water and War: Averting Armed Conflict and Protecting Human Rights" in Selendy JMH (Editor). Water and Sanitation-Related Diseases and the Environment: Challenges, Interventions, and Preventive Measures. Hoboken, NJ: John Wiley Sons, Inc., 2011, pp. 41-44. Levy BS, Sidel VW. "Challenges That Terrorism Poses to Public Health" in Levy BS, Sidel VW (Editors). Terrorism and Public Health (Second Edition). New York: Oxford University Press, 2012, pp. 5-22. Sidel VW, Levy BS. "Biological Weapons" in Levy BS, Sidel VW (Editors). Terrorism and Public Health (Second Edition). New York: Oxford University Press, 2012, pp. 203-224. 29 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 72 of 277 PAGEID #: 61073 Levy BS, Sidel VW. "Public Health Consequences of the Wars in Afghanistan and Iraq" in Levy BS, Sidel VW (Editors). Terrorism and Public Health (Second Edition). New York: Oxford University Press, 2012, pp. 266-283. Sidel VW, Levy BS. "Addendum to Warfare I: Introduction" and "Chemical and Biological Weapons" in Post SG (Editor). Encyclopedia of Bioethics (4th Edition). Macmillan Reference, press. in Levy BS, Sidel VW. "The Nature of Social Injustice and Its Impact on Public Health" in Levy BS, Sidel VW (Editors). Social Injustice and Public Health (Second Edition). New York: Oxford University Press, 2013, pp. 3-18. Levy BS, Sidel VW. "International and Global Health" in Levy BS, Sidel VW (Editors). Social Injustice and Public Health (Second Edition). New York: Oxford University Press, 2013, pp. 379-404. Levy BS, Sidel VW. "War, Terrorism, and Children's Health" in Landrigan PJ, Etzel RA (Editors). Textbook of Children's Environmental Health. New York: Oxford University Press, 2014, pp. 537-545. Levy BS, Sidel VW. "Collective Violence: War" in Beaglehole R, Lansang MA, Gulliford M (Editors). Oxford Textbook of Public Health (6th Edition). New York: Oxford University Press, in press. Journal Articles Levy BS, Wilkinson FS, Marine WM. Reducing neonatal mortality rate with nurse-midwives. American Journal of Obstetrics and Gynecology. 1971; 109-50-58. (Reprinted in Journal of Midwifery and Women's Health 2005; 50: e10-e18.) Levy BS. Five years after: A follow-up of 50 narcotic addicts. American Journal of Psychiatry. 1972; 128: 868-872. Alderman MH, Husted J, Levy BS, et al. A young-child nutrition programme in rural Jamaica. Lancet 1973; 1: 1166-1169. Levy BS, McIntire W. The economic impact of a food-borne salmonellosis outbreak. Journal of the American Medical Association 1974; 230: 1281-1282. (Reprinted in Journal of Environmental Health 1975; 37: 467-469.) 30 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 73 of 277 PAGEID #: 61074 Hutton JT, Levy BS, Hosfield W. Reye's syndrome. American Family Physician 1975; 11: 146-150. Levy BS, Weissman JB, Edwards T. Epidemic shigellosis in Minnesota: 1972. Minnesota Medicine 1975; 58: 405-412. Levy BS, McIntire W, Damsky L, et al. The Middleton outbreak: 125 cases of salmonellosis associated with food served at a picnic and smorgasbord. American Journal of Epidemiology 1975; 101: 502-511. Levy BS, Fontaine RE, Smith CA, et al. A large food-borne outbreak of hepatitis A: Possible transmission via oropharyngeal secretions. Journal of the American Medical Association 1975; 234: 289-294. Levy BS, Sigurdson EE, Mandel J, et al. Investigating possible effects of asbestos in city water: Surveillance of gastrointestinal cancer in Duluth. American Journal of Epidemiology 1976; 103: 362-368. Bruhl HH, Bauer H, Levy BS, et al. Hepatitis-B surface antigen among residents of an institution for the mentally retarded. Minnesota Medicine 1976; 59: 263-267. Levy BS, Mature J, Washburn JW. Intensive hepatitis surveillance in Minnesota: Methods and results. American Journal of Epidemiology 1977; 105: 127-134. Winegar DA, Levy BS, Andrews JS, Landrigan P. Chronic occupa tional exposure to lead: An evaluation of the health of smelter workers. Journal of Occupational Medicine 1977; 19: 603-606. Levy BS, Harris JC, Smith JL, et al. Hepatitis B in ward and clinical laboratory employees of a general hospital. American Journal of Epidemiology 1977; 106: 330-335. Weiss HB, Winegar DA, Levy BS, et al. Giardiasis in Minnesota, 1971-1975. Minnesota Medicine 1977; 60: 815-820. Levy BS, von Reyn CF, Arbeit RD, et al. More on Streptococcus bovis endocarditis and bowel carcinoma (Letter to the editor). New England Journal of Medicine 1978; 298: 572-573. 31 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 74 of 277 PAGEID #: 61075 Peterson D, Andrews JS Jr, Levy BS, et al. An effective schoolbased influenza surveillance system. Public Health Reports 1979; 94: 88-92. Peterson MR, Levy BS. Misconceptions about possibly rabid animals that have bitten humans. Minnesota Medicine 1979; 62: 266-268. Gerber SD, Levy BS, Come P, et al. A diagnostic strategy for myocardial infarction. Journal of Family Practice 1979; 9: 207-218. Levy BS. The teaching of occupational health in American medical schools. Journal of Medical Education 1980; 5: 18-22. (reprinted in Occupational Health and Safety 1981; 50: 6-9.) Bennett D, Levy BS. Smoking policies and smoking cessation programs of large employers in Massachusetts. American Journal of Public Health 1980; 70: 629-631. von Reyn CF, Levy BS, Arbeit RD, et al. Infective endocarditis: An analysis based on strict case definitions. Annals of Internal Medicine 1981; 94 (Part I): 505-518. Sigurdson EE, Levy BS, Mandel J, et al. Cancer morbidity investigations: Lessons from the Duluth study of possible effects of asbestos in drinking water. Environmental Research 1981; 25: 50-61. Levy BS. Working in a camp for Cambodian refugees (Special report). New England Journal of Medicine 1981; 104: 1440-1444. Levy BS. How to recognize occupational disease. The New Physician 1981; 30: 41-42. Levy BS. How to prevent occupational disease. The New Physician 1981; 30: 37-38. Levy BS. A malady of micturition. The New Physician 1981; 30:41-42. Levy BS. Faults in "no fault" workers' compensation. The New Physician 1982; 31: 33-34. Levy BS. Toxic chemical exposure: Recognizing and preventing hazards in the workplace. Consultant November 1983, pp. 63-78. 32 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 75 of 277 PAGEID #: 61076 Friedland G, von Reyn CF, Levy BS, et al. Nosocomial endocarditis. Infection Control 1984; 5: 284-288. Levy BS, Goldberg R, Rippe J, et al. A regular exercise program for medical students: Learning about prevention through participation. Journal of Medical Education 1984; 59: 596-598. Levy BS, Hoffman L, Gottsegen S. Boilermakers' bronchitis: Respiratory tract irritation presumably due to vanadium pentoxide during oil-to-coal conversion of a power plant. Journal of Occupational Medicine 1984; 26: 567-570. Levy BS. The teaching of occupational health in United States medical schools: Five-year follow-up of an initial study. American Journal of Public Health 1985; 75: 79-80. Levy BS, Davis F, Johnson B. Respiratory symptoms among glass bottle makers exposed to stannic chloride solution and other potentially hazardous substances. Journal of Occupational Medicine 1985; 27: 277-282. Levy BS, Wegman DH, Quinn MM, et al. Occupational health and safety training in the United States. Chinese Journal of Industrial Hygiene and Occupational Diseases 1985; 3: 297-302. Levy BS. Workers and doctors. The New Physician 1985; 34: 36, 45. Levy BS. Occupational medicine: Defining your role as a part time medical consultant. Consultant 1985; 25: 135-144. Levy BS. Measures for increasing the teaching of occupational health in medical schools (Letter to the Editor). Journal of Occupational Medicine 1985; 27: 791. Levy BS. Trauma to the occupational health vocabulary (Letter to the Editor). American Journal of Industrial Medicine 1986; 9: 577-578. Himmelstein J, Levy BS. Environmental health aspects of the microelectronics industry. State of the Art Reviews: Occupational Medicine 1986; 1: 175-194. Levy BS, Wegman DH. The occupational history in medical practice: What questions to ask and when to ask them. Postgraduate Medicine 1986; 79: 301-311. 33 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 76 of 277 PAGEID #: 61077 Griffin TW, Smith TW, Levy BS, et al. Synchronous occurrence of glioblastoma multiforme in a husband and wife. Journal of Neurooncology 1986; 4: 75-78. Leone FH, Levy BS, Johnson BP. Effective use of advisory councils in occupational health programs. American Journal of Public Health 1986; 76: 817. Maynard L, Goldberg R, Ockene J, Levy BS, Howe J, Dalen J: Cigarette smoking and alcohol consumption behaviors and attitudes among medical students. Journal of Medical Education 1986; 61: 921-922. Fontus HM, Levy BS. Physician-based surveillance of occupational disease: Developing a methodology. Journal of Occupational Medicine 1987; 29: 688-691. Levy BS. Lessons learned from operating an academic occupational health program (Editorial). Journal of Occupational Medicine 1987; 27: 769-770. Levy BS. Acute toxic inhalations: Beyond treatment (Editorial). Journal of Intensive Care Medicine 1987; 2: 239-240. Levy BS. Risk assessment and standard setting. Advances in Occupational Health (China) 1987, pp. 28-34. Levy BS. Focus on prevention is key factor in Chinese occupational health, safety. Occupational Health and Safety News Digest 1987; 3 (9): 1, 2, 10. Choudhry AW, Levy BS. Medical research priorities in environmental and occupational health in Kenya: Role of the clinician. Medicus May 1988, pp. 6-8. Levy BS, Choudhry AW. Occupational pesticide poisoning in Kenya: The role of the physician in the diagnosis, treatment and prevention. Medicus May 1988, pp. 10-11. Levy BS, Choudhry AW. A proposal for addressing occupational cancer in Kenya. Proceedings of the 1988 Annual Medical Scientific Conference. Nairobi: Kenya Medical Research Institute, 1988. (Reprinted in the East African Newsletter on Occupational Health and Safety, November 30, 1989, pp. 16-19.) 34 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 77 of 277 PAGEID #: 61078 Choudhry AW, Levy BS. Estimating the morbidity and economic impact of selected occupational illnesses and injuries in Kenya. Proceedings of the 1988 Annual Medical Scientific Conference. Nairobi: Kenya Medical Research Institute, 1988. Levy BS. Short overview of pesticide hazards. Introduction to epidemiological concepts. Environmental monitoring, biological monitoring, and surveillance of health effects. East African Newsletter on Occupational Health and Safety (Supplement 2), 1989, pp. 64-65, 73-74, and 75-76. Levy BS, Choudhry AW. Using in-patient hospital records as an approach for surveillance of occupational diseases and injuries. Proceedings of the 1989 Annual Medical Scientific Conference. Nairobi: Kenya Medical Research Institute, 1989. Fontus H, Levy BS, Davis LK. Physician-based surveillance of occupational disease: Part II: Experience with a broader range of diagnoses and physicians. Journal of Occupational Medicine 1989; 31: 929-932. Levy BS. Working in occupational health in Kenya. Occupational and Environmental Medicine Report 1990; 4: 5-8. Levy BS. The environmental health crisis in Eastern Europe. Occupational and Environmental Medicine Report 1990; 4: 53-56. Levy BS, Levenstein C, Spangler E. Environment and health in Eastern Europe. New Solutions: A Journal of Occupational and Environmental Health Policy 1991; 1: 19-27. Frumkin H, Levy BS, Levenstein C. Occupational and environmental health in Eastern Europe: Challenges and opportunities (Comment ary). American Journal of Industrial Medicine 1991; 20:265-270. Levy BS, Kjellstrom T, Forget G, et al. Ongoing research in occupational health and environmental epidemiology in developing countries. Archives of Environmental Health 1992; 47: 231-235 Levy BS, Seplow A. Asbestos-related hazards in developing countries. Environmental Research 1992; 59: 167-174. Levy BS. Occupational health policy issues in Kenya: Considera tions for other less developed countries. New Solutions: A Journal of Occupational and Environmental Health Policy 1992; 3: 55-60. 35 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 78 of 277 PAGEID #: 61079 Levy BS, Levenstein C, Rest K. Air pollution and health in Central and Eastern Europe. New Solutions: A Journal of Occupational and Environmental Health Policy 1993; 3: 37-43. Burstein J, Levy BS. The teaching of occupational health in U.S. medical schools: Little improvement in 9 years. American Journal of Public Health 1994; 84: 846-849. Levy BS, Wegman DH. Hearing loss (Letter to the editor). New England Journal of Medicine 1994; 330: 715. Levy BS. Occupational health policy issues in developing countries: The experience in Kenya. International Journal of Occupational and Environmental Health 1995; 1: 79-85. Levy BS. Health and social effects of worldwide economic transformation: Focus on occupational and environmental health. Social Justice 1995; 22: 77-84. Sidel VW, Levy BS, Johnson B. Environmental injustice: What must be done? (Commentary). Health & Environment Digest 1996; 9:79 80. Levy BS. Toward a holistic approach to public health surveillance (Editorial). American Journal of Public Health 1996; 86: 624-625. Levy BS. Global occupational health issues: Working in partnership to prevent illness and injury. AAOHN Journal: Official Journal of the American Association of Occupational Health Nurses 1996; 44: 244-247. Levy BS. Putting the public back in public health (President's column). The Nation's Health, December 1996, p. 2. Levy BS. Communicating public health: A "top 10" list (President's column). The Nation's Health, January 1997, p. 2. Fuzesi Z, Levy BS, Levenstein C, et al. A multisectoral approach to prevention of lead poisoning in Hungary: Lessons learned and potential for replicability elsewhere. International Journal of Occupational and Environmental Health 1997; 3: 60-67. Levy BS. Public health requires both science and advocacy (President's column). The Nation's Health, February 1997, p. 2. 36 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 79 of 277 PAGEID #: 61080 Levy BS. PH Leadership 301: A case study for the year 2072 (President's column). The Nation's Health, March 1997, p. 2. Levy BS. Conditions in which people can be healthy (President's column). The Nation's Health, April 1997, p. 2. Levy BS. Keeping up with societal trends and public health (President's column). The Nation's Health, May/June 1997, p 2. Levy BS. Attacks on proposed clean-air standards offer lessons for all (President's column). The Nation's Health, July 1997, p. 2. Levy BS. Local public health dies of multiple causes (President's column). The Nation's Health, August 1997, p. 2. Levy BS. Eliminating pollution of the mind (President's column). The Nation's Health, September 1997, p. 2. Levy BS. Public health: What we do together as a global society (President's column). The Nation's Health, October 1997, p. 2. Levy BS. Public health in America, 1997 (President's column). The Nation's Health, November 1997, p. 2. Levy BS. Putting the public back in public health: Vision, partnership, and leadership. TPHA (Texas Public Health Association) Journal 1997; 40: 9-14. Levy BS. Creating the future of public health: Values, vision, and leadership: 1997 American Public Health Association Presidential Address. American Journal of Public Health 1998; 88: 188-192. Forrow L, Blair BG, Helfand I, Lewis G, Postol T, Sidel V, Levy BS, Abrams H, Cassel C. Accidental Nuclear War -- A Post Cold War Assessment. New England Journal of Medicine 1998; 338: 1326-1331. Levy BS. What is public health? Healthcare Review 1998; 11(7): 4. Levy BS. The future of occupational health. Occupational and Environmental Medicine Report 1998; 12: 97-99. 37 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 80 of 277 PAGEID #: 61081 Castleman B, Dement J, Frank AL, Frumkin H, Giannasi F, Gochfeld M, Goldstein BS, Grandjean P, Greenberg M, LaDou J, Lemen RA, Levy BS, Maltoni C, McDiarmid M, Silbergeld EK, Teitelbaum DT, Thebaud-Mony A, Upton AC, Wegman DH. Open letter to the editor of Salud Ocupacional. International Journal of Occupational and Environmental Health 1998; 4: 131-133. Slutsky M, Levin JL, Levy BS. Azoospermia and oligospermia among a large cohort of DBCP applicators in 12 countries. International Journal of Occupational and Environmental Health 1999; 5: 116-122. Levy BS. Preventive medicine in the 21st century: Challenges and opportunities (The 1998 Duncan Clark Lecture). American Journal of Preventive Medicine 1999; 16: 363-366. Ryan D, Levy BS, Pollack S, Walker B Jr. Protecting children from lead poisoning and building healthy communities (Editorial). American Journal of Public Health 1999; 89: 822-824. Levy BS. Twenty-first century challenges for law and public health. Indiana Law Review 1999; 32: 1149-1160. Levy BS. Public health and health geographics: Challenges and opportunities for the 21st century. In: Khan OA, Skinner WF (Eds.) Proceedings of the First International Health Geographics Conference, Baltimore, MD, 16-18 October 1998. Infectious Disease Review 1999; 2 (suppl.). Levy BS. A tribute to Myron Allukian, Jr., D.D.S., M.P.H. Journal of Public Health Dentistry 1999; 59: 111-112. Levy BS. The future of environment and health: A global perspective. International Journal of Occupational and Environmental Health 1999; 5: 299-303. Willis BM, Levy BS. Recognizing the public health impact of genocide (Commentary). Journal of the American Medical Association 2000; 284: 612-614. Levy BS. Introduction to "Children and War" (photo essay by D Parker). Public Health Reports 2000; 115: 320. Levy BS. Occupational health: Challenges and opportunities for the 21st century. Indian Journal of Physiology and Allied Sciences 2001; 55: 128-132. 38 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 81 of 277 PAGEID #: 61082 Levy BS. Health and peace (Guest editorial). Croatia Medical Journal 2002; 43: 114-116. Willis BM, Levy BS. Child prostitution: Global health burden, research needs, and interventions. The Lancet 2002; 359: 1417-1422. Levy BS. Commentary: The continuing rise of occupational medicine. American Journal of Preventive Medicine 2002; 22: 326-327. Levy BS. Models for obtaining and sharing information: Lessons learned from Central and Eastern Europe (Letter to the editor). International Journal of Occupational and Environmental Health 2002; 8: 287. Willis B, Levy BS, Wharf C. Child prostitution: Public health and clinical issues. NHS Journal of Healthcare Professionals, September 2002, pp. 68-69. Sidel VW, Levy BS. Security and public health. Social Justice 2002; 29: 108-119. Levy BS, Nassetta WJ. Manganese: A review of neurological effects in humans. International Journal of Occupational and Environmental Health 2003; 9: 153-163. Sidel VW, Levy BS. War, terrorism, and public health. Journal of Law, Medicine, and Ethics 2003; 31: 516-523. Levy BS, LaGana GM. Repairing damaged care. Michigan Health and Hospitals 2003; 39: 52-53. Levy BS, Sidel VW. War and public health in the twenty-first century. New England Journal of Public Policy, Fall/Winter 2003 2004 (published in 2004); 167-178. Sidel VW, Levy BS. Terrorism "preparedness": diversion of resources and erosion of trust. Virtual Mentor 2004 May 1;6(5). Sidel VW, Levy BS. Commentary: Guard against war: an expanded role for public health. European Journal of Public Health 2006; 16: 232. Sidel VW, Levy BS. Proliferation of nuclear weapons: Opportunities for control and abolition. American Journal of Public Health 2007; 97: 1589-1594. 39 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 82 of 277 PAGEID #: 61083 Bailar JC III, Cicolella A, Harrison R, LaDou J, Levy BS, Rohm T, Teitelbaum DT, Wang YD, Watterson A, Yoshida F. IBM, Elsevier Science, and academic freedom. International Journal of Occupational and Environmental Health 2007; 13: 312-317. Levy BS. Graves' disease (Letter to the editor). New England Journal of Medicine 2008; 359: 1408. Sidel VW, Levy BS. The health impact of war. International Journal of Injury Control and Safety Promotion 2008; 15: 189-195. Levy BS, Sidel VW. Health effects of combat: A life-course perspective. Annual Review of Public Health 2009; 30: 123-136. Levy BS, Sidel VW. The economic crisis and public health (editorial). Social Medicine 2009; 4: 82-87. Sidel VW, Levy BS. Doctors and scientists call for an end to war: a tribute to Douglas Holdstock and Jack Piachaud (Tributes). Medicine, Conflict and Survival 2009; 25: 222-225. Levy BS, Sidel VW. How academic medicine can contribute to peace-building efforts worldwide. Academic Medicine 2009; 84: 1487. Sidel VW, Levy BS. The threat of nuclear war. The Journal of Cosmology 2009; 2: 309-315. Sidel VW, Levy BS. The health consequences of the diversion of resources to war and preparation for war. Social Medicine 2009; 4: 133-135. Sidel VW, Levy BS. Homage to Janus: looking backward and forward. Medicine, Conflict and Survival 2009; 25: 271-274. Levy BS. Look upstream to prevent border injuries (Commentary). American Journal of Preventive Medicine 2010; 38: 571-572. Levy BS, Sidel VW. Editorial: Water rights and water fights: Preventing and resolving conflicts before they boil over. American Journal of Public Health 2011; 101: 778-780. Levy BS, Sidel VW. Levy and Sidel respond (Letter to the editor). American Journal of Public Health 2011; 101: 1349 (In response to a letter to the editor by MO Harhay, who had responded to the above editorial.) 40 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 83 of 277 PAGEID #: 61084 Levy BS, Nassetta WJ. The adverse health effects of oil spills: A review of the literature and a framework for medically evaluating exposed individuals. International Journal of Occupational and Environmental Health 2011; 17: 161-167. Klare MT, Levy BS, Sidel VW. The public health implications of resource wars. American Journal of Public Health 2011; 101: 1615-1619. Levy BS, Sidel VW. Adverse health consequences of US Government responses to the 2001 terrorist attacks. Lancet 2011; 378: 944 952. Levy BS, Wegman DH. Commentary: Public health and preventive medicine: Proposing a transformed context for medical education and medical care. Academic Medicine, 2012, 87: 837-839. Levy BS. Lessons from Cuba's National Health System (letter). American Journal of Public Health 2012 Dec;102(12):e3. Levy BS, Sidel VW. Adverse health consequences of the Iraq War. Lancet 2013; 381: 949-958. Levy BS. Poverty, social injustice, and health (Festschrift in Honor of Dr. Victor Sidel). Social Medicine 2013; 7: 169-171. Levy BS. Mild asthma (Letter to the editor). New England Journal of Medicine 2013; 369: 2361. Levy BS, Sidel VW. Collective violence caused by climate change and how it threatens health and human rights. Health and Human Rights Journal 2014; 16: 32-40. Self-Assessment Examinations with Syllabi Givens A, Levy BS, Myers R, et al. (Editors) American Occupational Medical Association Self-Assessment Program in Occupational Medicine. 1st ed. Chicago: American Occupational Medical Association, 1984. Levy BS, Givens A, Myers R, et al. (Editors) American Occupational Medical Association Self-Assessment Program in Occupational Medicine. 2nd ed. Chicago: American Occupational Medical Association, 1988. 41 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 84 of 277 PAGEID #: 61085 Levy BS, McCunney R, Borak J, et al. (Editors) American College of Occupational and Environmental Medicine Self-Assessment Program in Occupational Medicine. 3rd ed. Chicago: American College of Occupational and Environmental Medicine, 1993. OTHER REPORTS Levy BS. Investigation of outbreak of health problems related to indoor air contamination at the Graduate Research Center of the University of Massachusetts (Amherst). Department of Family and Community Medicine, University of Massachusetts Medical School, Worcester, MA, 1978. Levy BS. Occupational Health Services in Kenya. Finnish Institute of Occupational Health, Helsinki, Finland, 1988. LaMontagne AD, Levy BS. Occupational health and safety in the Botswana Federation of Trade Unions: An assessment of needs and opportunities for donor involvement. Management Sciences for Health, Boston, 1990. Levy BS, Johnson A, Rest KM, Wegman DH, Sencer D. Evaluation of the Sentinel Event Notification System for Occupational Risks (SENSOR). Management Sciences for Health, Boston, 1992. Brantly E, Hetes R, Levy BS, Powell C, Whiteford L. Environmental health assessment: An integrated methodology for rating environmental health problems -- Description of assessment methodology. Water and Sanitation for Health (WASH) Project, Camp Dresser, and McKee, Arlington, VA, and Technologies for Primary Health Care (PRITECH) Project, Management Sciences for Health, Boston, 1993. Arcia G, Brantly E, Hetes R, Levy BS, Powell C, Suarez J, Whiteford L. Environmental health assessment: A case study conducted in the city of Quito and the county of Pedro Moncayo, Pichincha Province, Ecuador. Water and Sanitation for Health (WASH) Project, Camp Dresser, and McKee, Arlington, VA, and Technologies for Primary Health Care (PRITECH) Project, Management Sciences for Health, Boston, 1993. Levy BS (Editor). Data Enhancement Pilot Project: Meeting Report for the Occupational Safety and Health Administration. Barry S. Levy Associates, 1994. 42 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 85 of 277 PAGEID #: 61086 BLOG POSTS Levy BS, Sidel VW. "Social Injustice and Public Health in America." OUPblog.com, Oxford University Press, August 27, 2013. Levy BS, Sidel VW. "The Case Against Striking Syria." OUPblog.com, Oxford University Press, September 9, 2013. Levy BS, Sidel VW. "Poverty and Health in the United States." OUPblog.com, Oxford University Press, November 9, 2013. Levy BS, Sidel VW. "Celebrating the Life of Nelson Mandela, Continuing the Quest for Social Justice." OUPblog.com, Oxford University Press, December 11, 2013. Levy BS, Sidel VW. "Pete Seeger: The Power of Singing to Promote Social Justice." OUPblog.com, Oxford University Press, February 18, 2014. Levy BS, Sidel VW. "The Continuing Threat of Nuclear Weapons." OUPblog.com, Oxford University Press, April 19, 2014. Levy BS, Sidel VW. "Addressing the True Enemies of Humankind." OUPblog.com, Oxford University Press, September 12, 2014. EDITORIAL BOARD SERVICE AND EDITORIAL REVIEW WORK Member, Editorial and Advisory Boards of Journals International Journal of Occupational and Environmental Health International Journal of Occupational Medicine and Environmental Health Occupational and Environmental Health Report (Former Member) New Solutions: A Journal of Occupational and Environmental Health Policy Health & Environment Digest (Former Member) Journal of Public Health Policy (Former Member) Reviewer for Journals American Journal of Public Health International Journal of Occupational and Environmental Health American Journal of Industrial Medicine New Solutions: A Journal of Occupational and Environmental Health Policy Journal of the National Medical Association Academic Medicine Social Science & Medicine 43 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 86 of 277 PAGEID #: 61087 Environmental Health Environment International Journal of Epidemiology and Global Health Journal of Conflict Resolution Earth's Future Journal of Immigrant and Minority Health A list of selected presentations since 1990 is available on request. Rev. September 12, 2014 44 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 87 of 277 PAGEID #: ATT 61088T B Barry S. Levy, M.D., M.P.H. Deposition and Courtroom Testimony, 2010 - Present 2014 Gloria Gomez, et al. vs. Amcord, Inc., et al Superior Court, County of Los Angeles-Central Civil West, California, Deposition Vernon Fox and Mikki Fox vs. NuStar Logistics, L.P., and Valero Energy Corporation District Court, Galveston County, Texas, Deposition Wardell D. Norris, Sr. vs. Trinidad Drilling, L.P., et al. District Court, Parish of Lafayette, Louisiana, Deposition Randall A. Biddy, et al. vs. Citgo Petroleum Corporation, et al. District Court, Parish of Calcasieu, Louisiana, Trial Testimony Shannon Johnson, et al. v s . IGWT Investments, LLC, et al. District Court, Clark County, Nevada, Deposition Helen Hammonds, individually and as Survivor of Decedent William Hammonds vs. Monsanto Company, et al. Circuit Court, St. Louis County, Missouri, Deposition Earl Watson and Melba Rose Watson vs. Amchem Products, Inc., et al Superior Court, County of Los Angeles, California, Deposition MDL Litigation Regarding Texas City Refinery Ultracracker Emission Event Litigation District Court, Galveston County, Texas, Deposition and Trial Testimony Felicitas Salas, et al. vs. Agco Corp., et al. Superior Court, County of Los Angeles-Central Civil West, California, Deposition In the Matter of the Complaint of Bertucci Contracting Co., LLC, as Owner of the M/V Sharon Gail, for Exoneration from or Limitation of Liability U.S. District Court, Eastern District of Louisiana, Deposition 2013 Howard Brashear, et al. vs. Amcord, Inc., et al. Superior Court, County of Ventura, California, Deposition Mattie McFall, et al. vs. Amcord, Inc., et al. Superior Court, County of San Francisco, California, Deposition Donald Bell, et al. vs. Arvin Meritor, Inc., et al. U.S. District Court, Eastern District of Pennsylvania, Deposition MDL Litigation Regarding Texas City Refinery Ultracracker Emission Event Litigation District Court, Galveston County, Texas, Deposition and Trial Testimony Rick Rush, et al. vs. Amcord, Inc., et al. Superior Court, County of Los Angeles, California, Trial Testimony Sandi Mainwarring, et al. vs. Buffalo Pumps, Inc., et al. U.S. District Court, Central District of California, Deposition Darcy Justice, et al. v s . Ameron International Corporation, et al. Superior Court, County of Alameda, California, Deposition 2012 Charles Sunnycalb vs. CSX Transportation, Inc. U.S. District Court, Southern District of Ohio, Videotaped Trial Testimony, Hearing, Trial Livingston Hampton, et al. vs. Monsanto Co., et al.; Ruth Nishida, et al. vs. Pharmacia Corporation; and Edward Colella vs. Pharmacia Corporation Circuit Court, St. Louis County, Missouri, Deposition Joe and Loretta Oddo vs. Allied Packing & Supply, Inc., et al Superior Court, County of Alameda, California, Deposition Alnedia Anthony, et al. vs. Georgia Gulf, LLC District Court, Parish of Calcasieu, Louisiana, Trial Testimony Clyde Norris and Maida Norris vs. Amcord, Inc., et al Superior Court, County of Los Angeles, California, Deposition Dennis Ivanjack and Marsha Ivanjack vs. Amcord, Inc., et al. Superior Court, County of Los Angeles, California, Deposition Dawn Arnold, et al. vs. Raymond E. Palmer, et al. Superior Court, Addison Unit, State of Vermont, Deposition Linda Zacharias, et al. vs. RPM Wood Finishes Group, et al. Circuit Court, Cook County, Illinois, Deposition George Patterson and Sherley Patterson vs. Alta Building Materials Co., et al. Superior Court, County of San Francisco, California, Deposition Rick Rush, et al. vs. Amcord, Inc., et al. Superior Court, County of Los Angeles, California, Deposition James Lester David and Rebecca Lee David vs. Aladdin Heating Corporation, et al. Superior Court, County of Los Angeles, California, Deposition Virginia Scarcella, et al. vs. Amcord, Inc., et al. Superior Court, County of Los Angeles, California, Deposition Mary Ellen Kelly, et al. vs. Abco Mechanical Contractors, Inc., et al. Superior Court, County of San Francisco, California, Deposition Velio Mallozzi and Rosalie Mallozzi vs. EcoSmart Technologies, Inc. U.S. District Court, Eastern District of New York, Deposition Maurice Paul Billiot, et al. vs. Georgia Gulf Lake Charles, LLC District Court, Parish of Calcasieu, Louisiana, Trial Testimony Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 88 of 277 PAGEID #: 61089 2011 Kathy Blackwell vs. PPG Industries, Inc. Office of Workers' Compensation, State of Louisiana, Deposition Engle Progeny Cases Tobacco Litigation: Patricia Bowman, as Personal Representative of the Estate of Michael Bowman Circuit Court, Duval County, Florida, Deposition and Trial Testimony Tangela Brown, et al. vs. Georgia Gulf Lake Charles, LLC District Court, Parish of Calcasieu, Louisiana, Deposition and Trial Testimony Ralph Garcia vs. SmithKline Beecham Corporation d/b/a GlaxoSmithKline and Carmen Hoss District Court, County of Santa Fe, New Mexico, Deposition Vernest Hollowell vs. Amcord, Inc., et al. Superior Court, County of Los Angeles, California, Deposition William Patchen and Sharon Patchen vs. A.W. Chesterton Company, Inc., et al. Superior Court, County of Los Angeles, California, Deposition and Trial Testimony (2012) 2010 Nora Williams, et al. vs. City of Jacksonville, et al. Circuit Court, Duval County, Florida, Deposition Abarca, et al. vs. Merck & Co., Inc., et al. U.S. District Court, Eastern District of California, Deposition Debra Brown v. Citgo, et al., Gregory Henderson v. Citgo, et al., Mary Duhon v. Citgo, et al., Jody Dwayne Kopnicky v. et al., James Turner, Jr. v. et al., Bradley Charles Granger v. Citgo, et al. District Court, Parish of Calcasieu, Louisiana, Deposition Joyce Yonushewski v. Wyeth, et al. District Court, County of Hennepin, State of Minnesota, Deposition Carlis Faye Brown, et al. vs. NL Industries, Inc., et al Circuit Court, Wayne County, Michigan, Trial Testimony Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 89 of 277 PAGEID #: 61090 Attachment C List of Specific Materials and Documents Considered EID951571 EID077622 EID718828-829 HLAB000254 HLAB0002 61-27 4 EID122849-854 Robert W. Rickard deposition, August 27, 2014, Exhibit 6 EID193614-618 EID193614 Robert W. Rickard deposition, August 27, 2014, Exhibit 9 EID713244-270 EID072196-199 Robert W. Rickard deposition, August 27, 2014, Exhibit 8 EID916604-605 Robert W. Rickard deposition, August 27, 2014, Exhibit 10 EID951571 Robert W. Rickard deposition, August 27, 2014, p. 95, lines 17-20 Robert W. Rickard deposition, August 27, 2014, p. 97, lines 7-13 Karrh BW. A company's duty to report health hazards. The Bulletin of the New York Academy of Medicine 1978; 54: 782-788 EID107111-129 EID080233-234 RL001770 EID096511 EID2322 93-300 EID110523 EID924173-175 EID924170-172 EID107151-152 EID924 654 EID942335-336 EID107199 EID080223 EID106689 EID123474-475 Robert W. Rickard deposition, August 27, 2014, Exhibit 12 EID123422 Robert W. Rickard deposition, August 27, 2014, Exhibit 11 Robert W. Rickard deposition, August 27, 2014, p. 118, line 9 through p. 119, line 1 Gerald Kennedy deposition transcript, July 31, 2002, p.. 64 Robert W. Rickard deposition, August 27, 2014, p. 109, lines 18-21 EID079399-418 1- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 90 of 277 PAGEID #: 61091 EID102452 EID924561 EID102470 EID713127-135 EID079404 Robert W. Rickard deposition, August 27, 2014, Exhibit 14 EID102398-405 Robert W. Rickard deposition, August 27, 2014, Exhibit 13 EID951571-580 EID071705-706 EID090083 EID079875 EID079375 EID924550-557 EID089743-745 EID022224-225 EID07 92 96 EID079287-292 EID096449-450 EID106488-4 98 EID080543-547 EID523009-011 EID079271-272 EID07 9096-100 EID079740-754 EID602999-603010 Richard Anguillo deposition transcript, November 22, 2002, pp. 37-38 EID103022 105-2009-0009282 to 105-2009-0009299 EID007976 EID07 9258-259 EID07 9261 EID079269-270 EID07 9102 EID07 9685-701 EID087412 EID079091-094 EID079695 EID079090 EID076048-051 EID007534-535 EID078867 002-0002-0000900 EID079096-100 EID181074-076 EID229345-348 EID079682-684 2- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 91 of 277 PAGEID #: 61092 002-0002-0000776 to 002-0002-0000782 002- 0002-0000-809 to 002-0002-0000-812 Robert W. Rickard deposition, August 27, 2014, p. 169, lines 9-17 EID079034 Robert W. Rickard deposition, August 27, 2014, Exhibit 18 003- 002-002460 to 003-002-002463 EID568827-830 Robert W. Rickard deposition, August 27, 2014, p. 168, lines 11-20 Robert W. Rickard deposition, August 27, 2014, Exhibit 19 EID089310 EID103379 EID091591 EID107384-386 Robert W. Rickard deposition, August 27, 2014, p. 169, lines 19-24 and p. 170, lines 1-2 Gerald Kennedy deposition transcript, July 31, 2002, p. 78 EID079034 EID568823-826 James Cox deposition, March 30, 2004, p. 261, lines 12-24 and p. 262, lines 1-6 James Cox deposition, March 30, 2004, Exhibit 20 EID571347-357 EID521383 002-0002-0000749 to 002-0002-0000751 EID521382-392 Robert W. Rickard deposition, August 27, 2014, Exhibit 23 Robin Leonard deposition, Leach case, June 25, 2004, pp. 155-157 Robin Leonard deposition, Leach case, June 25, 2004, Exhibit 5 002-0002-0000752 to 002-0002-0000768 GK001456-4 63 EID080167-169 EID924242-243 Robert W. Rickard deposition, August 27, 2014, Exhibit 20 EID924473 Robert W. Rickard deposition, August 27, 2014, Exhibit 21 EID951586 EID097177-185 038-0063-0000283 EID112155 Robert W. Rickard deposition, August 27, 2014, Exhibit 22 EID102770-771 EID097177 Robert W. Rickard deposition, August 27, 2014, Exhibit 16 EID107462-465 EID951146 EID103018 EID103020 3- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 92 of 277 PAGEID #: 61093 EID256133-137 EID195965-968 EID182129 James Cox deposition, March 31, 2004, Exhibit 25 EID909790-809 EID079134-140 SPD01788-01836 EID083372-407 James Cox deposition, March 31, 2004, Exhibit 26 EID101658 Robert W. Rickard deposition, August 27, 2014, p. 206, lines 2-9 Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. Journal of Occupational Medicine 1993; 35: 950-954 GK000665-666 RCG000181-190 EID584775-777 r- CM Robert W. Rickard deposition, August 2014, p. 229, line 24, and p. 230, lines 1-6, and 9-11 Robert W. Rickard deposition, August 27, 2014, p. 231, lines 3-9 Robert W. Rickard deposition, August 27, 2014, p. 212, lines 20-24 and p. 213, lines 1-24, and Exhibit 26 GK000665-666 WJB000014 WJB000005 WJB000070 WJB000071 Robert W. Rickard deposition, August 27, 2014, Exhibit 27 EID584775-777 Robert W. Rickard deposition, August 27, 2014, Exhibit 28 Robert W. Rickard deposition, August 27, 2014, p. 228, lines 5-13 EID010289 011-0002-0000204 EID080839-840 Robert W. Rickard deposition, August 27, 2014, p. 236, lines 10-24 and Exhibit 30 EID171625 Robert W. Rickard deposition, August 27, 2014, Exhibit 32 EID17162 9 EID797573-587 EID171605-634 EID523001 EID086677-680 EID575362-381 Robert W. Rickard deposition, August 27, 2014, Exhibit 31 Robert W. Rickard deposition, August 27, 2014, p. 239, lines 23 and 24 and p. 240, line 1 4- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 93 of 277 PAGEID #: 61094 EID104 969 -977 Robert W. Rickard deposition, August 27, 2014, Exhibit 33 EID918337 -397 Robert W. Rickard deposition, August 27, 2014, p . 263, lines 11-17, and Exhibit 36 Robert W. Rickard deposition, August 27, 2014, Exhibit 38 Robert W. Rickard deposition, August 27, 2014, p. 283, line 24, and p . 284, lines 1-3 Robert W. Rickard deposition, August 27, 2014, p . 284, lines 8-14 Robert W. Rickard deposition, August 27, 2014, p. 285, lines 14-17 Robert W. Rickard deposition, August 27, 2014, p. 285, line 18 through p. 296, line 9 EID087006 CLI0304-308 EID101453-496 EID087238-254 Robert W. Rickard deposition, August 27, 2014, P- 309, lines 12-18 Robert W. Rickard deposition, August 27, 2014, P- 310, lines 1-5 Robert W. Rickard deposition, August 27, 2014, P- 310, lines 13-17 RCG000231-239 EID157030 Barbara J. Dawson deposition transcript, August 27, 2004, p. 123 054-0142-0004361 EID166245-247 Barbara J. Dawson deposition transcript, August 27, 2004, pp. 132-133, and Exhibits 11 and 19 EID483876-484019 Robert W. Rickard deposition, August 27, 2014, Exhibit 37 EID484009 EID166599-608 Robert W. Rickard deposition, August 27, 2014, Exhibit 40 "A Hazard Narrative for Perfluorooctanoate (PFOA): Final." Prepared by: ENVIRON International Corporation, January 24, 2002 Little Hocking Water Associations News Release, January 23, 2002 EID193045-057 Rowe006810-817 Robert W. Rickard deposition, August 27, 2014, Exhibit 38 EID738989-990 ' DRS0024 90 Robert W. Rickard deposition, August 27, 2014, Exhibit 41 003-0001-0019350 to 003-0001-0019352 Robert W. Rickard deposition, August 27, 2014, Exhibit 42 EID570740-750 May 1, 2003 Order Granting Injunctive Relief in Leach vs. DuPont 5- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 94 of 277 PAGEID #: 61095 EID822842-867 Robert W. Rickard deposition, August 27, 2014, Exhibit 43 015-0002-0001876 to 015-0002-0001877 Robert W. Rickard deposition, August 27, 2014, Exhibit 44 Robert W. Rickard deposition, August 27, 2014, Exhibit 45 Deposition of Bruce W. Karrh, M.D., p. 75, lines 9-22, and p. 76, line 4 083-0001-0005541 Robert W. Rickard deposition, August 27., 2014, Exhibit 46 Grandjean P, Clapp R. Changing interpretation of human health risks from perfluorinated compounds. Public Health Reports 2014; 129: 482-485. Solyst J. "Panelist Reaction: Right to Know" in Tinker TL, Pavlova MT, Gotsch AR, Arkin EB [eds.]. Communicating Risk in a Changing World. Solomon Island, MD, and Beverly Farms, MA: The Ramazzini Institute and OEM Press, 1998, pp. 159-160. Tinker TL, Pavlova MT, Gotsch AR, Arkin EB [eds.]. Communicating Risk in a Changing World. Solomon Island, MD, and Beverly Farms, MA: The Ramazzini Institute and OEM Press, 1998. Bunn WB III, LeClercq GR. Hazard communication and the occupational physician. [Editorial] Journal of Occupational Medicine 1987; 29 [3]: 262-263. Hazard Communication: Final Rule. Federal Register 1983: 48: [Nov 25]:53347. Committee on Ethical Practice in Occupational Medicine, American Occupational Medical Association. Code of Ethical Conduct for Physicians Providing Occupational Medical Services. [Adopted by the Board of Directors of the American Occupational Medical Association, July 23, 1976.] Journal of Occupational Medicine, August 1978; Volume 18: Cover. Also cited in: Schuman BJ. Physicians and patients in the occupational setting: The rules of the game. [Commentary] Journal of the American Medical Association 1980; 244 [21]: 2417-2418. Teichman R. Introduction to the new ACOEM Code of Ethical Conduct. Journal of Occupational Medicine 1994; 36 [1]: 27. Teichman R, Wester MS. The new ACOEM Code of Ethical Conduct. Journal of Occupational Medicine 1994; 36 [1]: 27-30. Brodkin CA, Frumkin H, Kirkland KH, et al. AOEC Position Paper on the Organizational Code for Ethical Conduct. Journal of Occupational and Environmental Medicine 1996; 38 [9]: 869-881. International Commission on Occupational Health. International Code of Ethics for Occupational Health Professionals. Singapore: International Commission on Occupational Health, 1992. (Reprinted as the Appendix to the chapter: Krantz A, Forst LS. "Ethics in Occupational Medicine" in Rosenstock L, Cullen MR, Brodkin CA, Redlich CA [eds.] Textbook of Clinical Occupational and Environmental Medicine [Second Edition]. Philadelphia: Elsevier Saunders, 2005, pp. 1231-1236.) 6- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 95 of 277 PAGEID #: 61096 Krantz A, Forst LS. "Ethics in Occupational Medicine" in Rosenstock L, Cullen MR, Brodkin CA, Redlich CA (eds.) Textbook of Clinical Occupational and Environmental Medicine (Second Edition). Philadelphia: Elsevier Saunders, 2005, pp. 1225-1236. American Academy of Industrial Hygiene. Code of Ethics for Industrial Hygienists. American Academy of Industrial Hygiene Newsletter 1995; 1-2. Code of Ethics for the Professional Practice of Industrial Hygiene (1995). Available at: http://ethics.iit.edu/ecodes/?q=node/4275. Accessed on November 11, 2014. Karrh BW. A company's duty to report health hazards. Bulletin of the New York Academy of Medicine 1978; 54 [8]: 782-788. American Association of Occupational Health Nurses. AAOHN Code of Ethics and Interpretive Statements. Atlanta: American Association of Occupational Health Nurses, 1991. Ropeik DP. "Risk Communication -- An Overlooked Tool for Improving Public Health" in Wallace RB (ed.). Wallace/MaxcyRosenau-Last Public Health & Preventive Medicine (Fifteenth Edition). New York: MacGraw Hill Medical, 2008, pp. 1029-1039. American College of Occupational and Environmental Medicine. The Seven Ethical Principles of Occupational and Environmental Medicine. Approved by the ACOEM Board of Directors, April 2010. American Occupational Medical Association. "Code of Ethical Conduct for Physicians Providing Occupational Medical Services." In McCunney RJ. Handbook of Occupational Medicine. Boston: Little Brown & Company, 1988. Ashford NA. Monitoring the worker and the community for chemical exposure and disease: Legal and ethical considerations in the US. Clinical Chemistry 1994; 40: 1426-1437. 7- - Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 96 of 277 PAGEID #: 61097 Materials Relied on, Reviewed and/or Considered by Expert Barry Levy All materials referenced and/or discussed within the report are incorporated. In addition to the materials within the report, the other materials relied on, reviewed, and/or considered in the preparation of the expert report are as follows: _______ Bates Numbered Documents_______ 000014 -000027; ROWE020338 -ROWE020351 000026 -000030; GHS006489 -GHS006493; EID722942 ___________ EID722946;AR226-1693___________ ______0003-0031-0002510 -003-0031-0002518_____ 000439 -000453; ROWE020370 -ROWE020384 _____ 001 -0001-0012178 -001 -0001-0012179_____ _____ 001-00001-0012174 -001-00001-0012175_____ ______ 001-0001-0002900 -001-0001-0002901______ ______ 001-0001-0002982 -001-0001-0002991______ _____________ 001-0001-0004961____________ ______ 001-0001-0005110 -001-0001-0005111______ _____________ 001-0001-0005123____________ ______ 001-0001-0008156 -001-0001-0008161______ ______ 001-0001-0008252 -001-0001-0008257______ ______ 001-0001-0008629 -001-0001-0008630______ ______ 001-0001-0009420 -001-0001-0009421______ ______ 001-0001-0009489 -001-0001-0009490______ ______ 001-0001-0012176 -001-0001-0012177______ ______ 001-0001-0012180 -001-0001-0012181______ ______ 001-0001-0012182 -001-0001-0012183______ _____________ 001-0001-0012184____________ ______ 001-0001-0012413 -001-0001-0012418______ ______ 001-0001-0013441 -001-0001-0013442______ ______ 001-0001-0014385 -001-0001-0014386______ ______ 001-0001-0015753 -001-0001-0015756______ ______ 001-0001-0019548-001-0001-0019557______ ______ 001-0001-0019611 -001-0001-0019612______ ______ 001-0001-0019652 -001-0001-0019662______ ______ 001-0001-0020279 -001-0001-0020280______ _____________ 001-0001-0024334____________ ______ 001-0001-0027752 -001-0001-0027753______ ______ 001-0001-0027754-001-0001-0027755______ ______ 001-0002-0001652 -001-0002-0001745______ ______ 001-0002-0003108-001-0002-0003109______ ______ 001-0002-0003128-001-0002-0003132______ ______ 001-0002-0003133 -001-0002-0003136______ 001-0002-0003554 -001-0002-0003560 Page 1 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 97 of 277 PAGEID #: 61098 Bates Numbered Documents 001-0004-0000098 -001-0004-0000121 001-0004-0000140 -001-0004-0000160 001-0004-0000237 -001-0004-0000266 001-0004-0000237 -001-0004-0000266 001-0004-0000395 -001-0004-0000405 001-0004-0002572 -001-0004-0002577 001-0018462 -001-0018463 001-0131-0002070 -001-0131-0002073 001-0131-0002156 -001-0131-0002162 _______ 001-0135-0001272_______ _______001-0135-0001373_______ 001-0135-0001400 -001-0135-0001403 _______001-0135-0001998_______ 001-0135-0004999 -001-0135-0005001 001-0135-0005080 -001-0135-0005082 _______ 001-0135-0005171_______ 001-0135-0011616 -001-0135-0011617 001-0135-0011618 -001-0135-0011619 _______ 001-0135-0011620_______ 001-0135-0011621 -001-0135-0011622 001-0229-0000578 -001-0229-0000580 001-0229-0000585 -001-0229-0000588 001-0235-0000125 -001-0235-0000131 001-0235-0000848 -001-0235-0000849 001-0235-0000973 -001-0235-0000985 001-0235-00011475 -001-0235-0001482 001-0235-0001484 -001-0235-0001485 001-0235-0002814 -001-0235-0002816 001-0235-0004379 -001-0235-0004394 001-0235-0006772 -001-0235-0006773 001-0235-0007004 -001-0235-0007141 001-0235-0008338 -001-0235-0008346 001-0235-0008391 -001-0235-0008407 001- 0344-0000001 -001-0344-0000113 002-0001-0000001; 002-0001-0000003 002-0001-0000004 -002-0001-0000049 002-0001-0000050 -002-0001-0000053 002-0001-0000054 -002-0001-0000056 _______002-0001-0000063_______ _______002-0001-0000064_______ _______002-0001-0000065_______ 002-0001-0000382 -002-0001-0000383 002-0001-0000384 -002-0001-0000394 002-0001-0000395 -002-0001-0000412 002-0001-0000442 -002-0001-0000463 Page 2 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 98 of 277 PAGEID #: 61099 Bates Numbered Documents 002-0001-0000464 -002-0001-0000471 002-0001-0000472 -002-0001-0000475 002-0001-0000476 -002-0001-0000480 002-0001-0000481 -002-0001-0000487 002-0001-0000483 -002-0001-0000487 002-0001-0000488 -002-0001-0000510 002-0001-0000490 -002-0001-0000510 002-0001-0000634 -002-0001-0000668 002-0001-0000671 -002-0001-0000672 ______ 002-0001-0000674______ 002-0001-0000721 -002-0001-0000722 002-0001-0000723 -002-0001-0000725 ______ 002-0001-0000742______ 002-0001-0000743 -002-0001-0000770 002-0001-0000743 -002-0001-0000770 002-0001-0000872 -002-0001-0000892 002-0001-0000893 -002-0001-0000894 002-0001-0000897 -002-0001-0000899 002-0001-0000900 -002-0001-0000908 002-0001-0000909 -002-0001-0000912 ______ 002-0001-0000913______ 002-0001-0000917 -002-0001-0000920 002-0001-0000921 -002-0001-0000928 002-0001-0000969 -0000976 002-0001-0000977 -002-0001-0000979 002-0001-0000983 -002-0001-0000991 002-0001-0000992 -002-0001-0001058 002-0001-0001245 -002-0001-0001248 002-0001-0001257 -002-0001-0001453 002-0001-0001454 -002-0001-0001480 ______ 002-0001-0001504______ 002-0001-0001505 -002-0001-0001569 002-0001-0001768 -002-0001-0001771 002-0001-0001772 -002-0001-0001774 002-0001-0001779 -002-0001-0001801 002-0001-0001983 -002-0001-0001986 ______ 002-0001-0001993______ 002-0001-0001994 -002-0001-0001995 ______ 002-0001-0001996______ ______ 002-0001-0001996______ 002-0001-0001997 -002-0001-0002000 002-0001-0002001 -002-0001-0002002 002-0001-0002003 -002-0001-0002016 ______ 002-0001-0002017______ 002-0001-0002023 Page 3 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 99 of 277 PAGEID #: 61100 _______ Bates Numbered Documents_______ ______ 002-0001-0002026 -002-0001-0002049______ ______ 002-0001-0002073 -002-0001-0002075______ ______ 002-0001-0002076 -002-0001-0002079______ ______ 002-0001-0002080 -002-0001-0002085______ ______ 002-0001-0002096 -002-0001-0002100______ _____________002-0001-0002101_____________ ______ 002-0001-0002103 -002-0001-0002125______ ______ 002-0001-0002127 -002-0001-0002128______ _____________002-0001-0002168_____________ ______ 002-0001-0002257 -002-0001-0002274______ ______ 002-0001-0002275 -002-0001-0002326______ _____________002-0001-0003896_____________ ______ 002-0001-0004854-002-0001-0004864______ ______ 002-0001-0004876 -002-0001-0004878______ ______ 002-0001-0004893 -002-0001-0004894______ ______ 002-0001-0004901 -002-0001-0004902______ _____________002-0001-0004903_____________ ______ 002-0001-0004904-002-0001-0004919______ ______ 002-0001-0004942 -002-0001-0004944______ _____________002-0001-0004948_____________ ______ 002-0001-0005008-002-0001-0005011______ ______ 002-0001-0005012 -002-0001-0005070______ ______ 002-0001-0005075 -002-0001-0005078______ ______ 002-0001-0005102 -002-0001-0005105______ ______ 002-0001-0005106 -002-0001-0005108______ ______ 002-0001-0005109 -002-0001-0005111______ ______ 002-0001-0005112 -002-0001-0005115______ ______ 002-0001-0005179 -002-0001-0005180______ ______ 002-0001-0005181 -002-0001-0005184______ ______ 002-0001-0005185 -002-0001-0005188______ _____________002-0001-0005196_____________ ______ 002-0001-0005296 -002-0001-0005308______ _____________002-0001-0005309_____________ ______ 002-0001-0005310 -002-0001-0005312______ ______ 002-0001-0005313 -002-0001-0005314______ 002-0001-0005392; 002-0001-0007119 -002-0001-0007171 002-0001-0005465 -002-0001-0005467 002-0001-0005468 -002-0001-0005469 002-0001-0005722 -002-0001-0005724 002-0001-0005729 -002-0001-0005747 002-0001-0005761 -002-0001-0005762 002-0001-0005764 -002-0001-0005855 002-0001-0005767 -002-0001-0005855 002-0001-0005861 -002-0001-0005863 Page 4 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 100 of 277 PAGEID #: 61101 Bates Numbered Documents 002-0001-0005868 -002-0001-0005870 002-0001-0005871 -002-0001-0005892 002-0001-0005893 -002-0001-0005906 002-0001-0005893 -002-0001-0005907 002-0001-0005920 -002-0001-0005923 002-0001-0005921 -002-0001-0005923 ______ 002-0001-0005928______ 002-0001-0005936 -002-0001-0005938 002-0001-0005939 -002-0001-0005953 ______ 002-0001-0005960______ ______ 002-0001-0005961______ ______ 002-0001-0005962______ 002-0001-0006007 -002-0001-0006009 ______ 002-0001-0006466______ 002-0001-0006644 -002-0001-0006669 002-0001-0006838 -002-0001-0006874 002-0001-0006913 -002-0001-0006914 002-0001-0007119 -002-0001-0007171 ______ 002-0001-0007895______ 002-0001-0008039 -002-0001-0008061 002-0001-0008039 -002-0001-0008061 002-0001-0008085 -002-0001-0008087 002-0001-0009136 -002-0001-0009138 ______ 002-0001-0009178______ 002-0001-0009179 -002-0001-0009225 002-0001-0009226 -002-0001-0009306 002-0001-0009307 -002-0001-0009406 002-0001-0009407 -002-0001-0009504 002-0001-0009602 -002-0001-0009629 ______ 002-0001-0009630______ 002-0001-0010541 -002-0001-0010563 002-0001-0010564 -002-0001-0010577 002-0001-0010960 -002-0001-0010995 002-0001-0011035 -002-0001-0011091 ______ 002-0001-0011116______ 002-0001-0011117 -002-0001-0011180 002-0001-0011181 -002-0001-0011236 002-0001-0011237 -002-0001-0011299 ______ 002-0001-0011387______ ______ 002-0001-0011395______ 002-0001-0011400 -002-0001-0011402 002-0001-0011416 -002-0001-0011417 ______ 002-0001-0011427______ 002-0001-0011429 -002-0001-0011430 002-0001-0011437 Page 5 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 101 of 277 PAGEID #: 61102 Bates Numbered Documents 002-0001-0011446 -002-0001-0011448 002-0001-0011449 -002-0001-0011451 002-0001-0011469 -002-0001-0011470 002-0001-0011471 -002-0001-0011472 ______ 002-0001-0011476______ 002-0001-0011484 -002-0001-0011486 002-0001-0011487 -002-0001-0011490 002-0001-0011493 -002-0001-0011496 002-0001-0011497 -002-0001-0011498 ______ 002-0001-0011645______ 002-0001-0011816 -002-0001-0011818 002-0001-0011846 -002-0001-0011849 ______ 002-0001-0011898______ 002-0001-0011925 -002-0001-0011930 002-0001-0012035 -002-0001-0012036 _______002-0001-005965_______ _______002-0001-011438_______ _______002-0001-011440_______ 002-0001-011836 -002-0001-0011839 ______ 002-0002-0000027______ 002-0002-0000206 -002-0002-0000208 002-0002-0000213 -002-0002-0000218 002-0002-0000219 -002-0002-0000223 002-0002-0000224 -002-0002-0000237 002-0002-0000254 -002-0002-0000255 002-0002-0000338 -002-0002-0000354 002-0002-0000407 -002-0002-0000439 ______ 002-0002-0000644______ 002-0002-0000647 -002-0002-0000655 ______ 002-0002-0000656______ 002-0002-0000657 -002-0002-0000658 ______ 002-0002-0000659______ 002-0002-0000660 -002-0002-0000659 002-0002-0000661 -002-0002-0000662 002-0002-0000664 -002-0002-0000668 002-0002-0000698 -002-0002-0000701 002-0002-0000706 -002-0002-0000715 002-0002-0000749 -002-0002-0000751 002-0002-0000752 -002-0002-0000768 ______ 002-0002-0000773______ ______ 002-0002-0000774______ ______ 002-0002-0000775______ 002-0002-0000776 -002-0002-0000782 002-0002-0000783 -002-0002-0000786 002-0002-0000809 -002-0002-0000812 Page 6 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 102 of 277 PAGEID #: 61103 Bates Numbered Documents ______ 002-0002-0000817______ ______ 002-0002-0000845______ ______ 002-0002-0000862______ ______ 002-0002-0000899______ 002-0002-0000900 -002-0002-0000901 002-0002-0000903 -002-0002-0000904 ______ 002-0002-0000905______ ______ 002-0002-0000906______ 002-0002-0000908 -002-0002-0000909 002-0002-0000910 -002-0002-0000911 002-0002-0000912 -002-0002-0000918 002-0002-0000924 -002-0002-0000925 ______ 002-0002-0001000______ 002-0002-000809 -002-0002-000812 002-0007-0000033 -002-0007-0000037 002-0007-0000038 -002-0007-0000092 002-0007-0000111 -002-0007-0000114 002-0007-0000120 -002-0007-0000132 002-0007-0000188 -002-0007-0000192 002-0007-0000198 -002-0007-0000200 002-0007-0000224 -002-0007-0000226 002-0007-0000230 -002-0007-0000290 ______ 002-0007-0000298______ 002-0007-0000299 -002-0007-0000315 002-0007-0000305 -002-0007-0000308 002-0007-0000309 -002-0007-0000315 002-0007-0000316 -002-0007-0000383 002-0007-0000384 -002-0007-0000405 002-0007-0000406 -002-0007-0000411 002-0007-0000493 -002-0007-0000547 ______ 002-0007-0000561______ 002-0007-0001060 -002-0007-0001132 002-0007-0001341 -002-0007-0001349 ______ 002-0007-0001350______ 002-0007-0001351 -002-0007-0001353 ______ 002-0007-0001376______ ______ 002-0007-0001377______ 002-0007-0001378 -002-0007-0001381 ______ 002-0007-0001382______ 002-0007-0001389 -002-0007-0001405 002-0007-0001406 -002-0007-0001408 002-0007-0001409 -002-0007-0001410 002-0007-0001411 -002-0007-0001414 002-0007-0001509 -002-0007-0001510 002-0007-0002167 -002-0007-0002184 Page 7 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 103 of 277 PAGEID #: 61104 Bates Numbered Documents _______002-004-0000794_______ _______002-004-0000956_______ 002-0047-0001678 -022-0047-0001682 ______ 002-0131-0000006______ 002-0131-0000008 -002-0131-0000021 002-0131-0000008 -002-0131-0000026 002-0131-0000032 -002-0131-0000066 002-0131-0000067 -002-0131-0000068 002-0131-0000069 -002-0131-0000092 002-0131-0000182 -002-0131-0000185 002-0131-0000186 -002-0131-0000198 002-0131-0000212 -002-0131-0000226 002-0131-0000227 -002-0131-0000241 002-0131-0000242 -002-0131-0000256 002-0131-0000257 -002-0131-0000272 002-0131-0000273 -002-0131-0000284 002-0131-0000285 -002-0131-0000296 002-0131-0000297 -002-0131-0000311 002-0131-0000312 -002-0131-0000324 002-0131-0000325 -002-0131-0000337 002-0131-0000354 -002-0131-0000378 002-0131-0000379 -002-0131-0000401 002-0131-0000423 -002-0131-0000441 002-0131-0000465 -002-0131-0000466 002-0131-0000487 -002-0131-0000488 002-0131-0000640 -002-0131-0000653 002-0131-0000654 -002-0131-0000658 002-0131-0000794 -002-0131-0000813 002-0131-0000814 -002-0131-0000833 002-0131-0000834 -002-0131-0000836 002-0131-0000837 -002-0131-0000879 ______ 002-0131-0000921______ 002-0131-0000922 -002-0134-0000928 002-0131-0000929 -002-0131-0000938 002-0131-0000939 -002-0131-0000966 002-0131-0000967 -002-0131-0000972 002-0131-0000973 -002-0131-0000975 002-0131-0000976 -002-0131-0000980 ______ 002-0131-0000981______ 002-0131-0001029 -002-0131-0001042 002-0131-0001043 -002-0131-0001065 002-0131-0001066 -002-0131-0001068 002-0131-0001069 -002-0131-0001070 002-0131-0001071 -002-0131-0001079 002-0131-0001080 -002-0131-0001083 Page 8 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 104 of 277 PAGEID #: 61105 Bates Numbered Documents ______ 002-0131-0001084______ 002-0131-0001085 -002-0131-0001088 002-0131-0001089 -002-0131-0001090 002-0131-0001262 -002-0131-0001282 002-0131-0001283 -002-0131-0001297 002-0131-0001298 -002-0131-0001300 002-0131-0001305 -002-0131-0001322 002-0131-0002682 -002-0131-0002685 002-0131-0002749 -002-0131-0002822 ______ 002-0131-0002824______ ______ 002-0131-0002826______ 002-0131-0002847; 002-0131-0000049 002-0131-0002935 -002-0131-0002939 002-0131-0002940 -002-0131-0002942 ______ 002-0131-0004237______ 002-0131-0004932 -002-0131-0004937 002-0131-0004936 -002-0131-0004937 ______ 002-0131-0004939______ 002-0131-0004964 -002-0131-0004965 002-0131-0005117 -002-0131-0005134 002-0131-0005913 -002-0131-0005915 002-0131-0005990 -002-0131-0005991 002-0131-0005992 -002-0131-0005993 002-0131-0006008 -002-0131-0006010 002-0131-0006011 -002-0131-0006012 002-0131-0006455 -002-0131-0006484 002-0131-0006485 -002-0131-0006527 002-0131-0006528 -002-0131-0006529 002-0131-0006528 -002-0131-0006547 002-0131-0006530 -002-0131-0006547 002-0131-0006618 -002-0131-0006629 ______ 002-0131-0006729______ ______ 002-0131-0006730______ 002-0131-0006779 -002-0131-0006781 002-0131-0006779 -002-0131-0006781 002-0131-0006801 -002-0131-0006821 002-0131-0006822 -002-0131-0006838 002-0131-0006843 -002-0131-0006867 ______ 002-0131-0006929______ 002-0131-0006945 -002-0131-0006991 002-0131-0006992 -002-0131-0007031 ______ 002-0131-0007072______ 002-0131-0007073 -002-0131-0007094 002-0131-0007095 -002-0131-0007115 002-0131-0007116 -002-0131-0007155 Page 9 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 105 of 277 PAGEID #: 61106 Bates Numbered Documents 002-0131-0007178 -002-0131-0007180 002-0131-0007182 -002-0131-0007184 002-0131-0007185 -002-0131-0007193 002-0131-0007297 -002-0131-0007314 002-0131-0007355 -002-0131-0007401 ______ 002-0131-0007849______ ______ 002-0131-0007849______ ______ 002-0131-0007850______ 002-0131-0007851 -002-0131-0007886 002-0131-0007932 -002-0131-0007937 002-0131-0007939 -002-0131-0007940 002-0131-0007941 -002-0131-0007988 ______ 002-0131-0008037______ ______ 002-0131-0008131______ 002-0131-0008141 -002-0131-0008146 002-0131-0008162 -002-0131-0008163 002-0131-0008164 -002-0131-0008172 002-0131-0008834 -002-0131-0008835 ______ 002-0131-0008836______ ______ 002-0131-0008837______ 002-0131-0008861 -002-0131-0008862 002-0131-0008863 -002-0131-0008864 002-0131-0009087 -002-0131-0009088 002-0131-0009283 -002-0131-0009296 002-0131-0009297 -002-0131-0009298 002-0131-0009756 -002-0131-0009762 002-0131-0010136 -002-0131-0010146 ______ 002-0131-0010355______ 002-0131-0010355 -002-0131-0010356 ______ 002-0131-0010356______ ______ 002-0131-0010628______ ______ 002-0131-0010628______ 002-0131-0010629 -002-0131-0010630 002-0131-0010629 -002-0131-0010630 002-0131-0010631 -002-0131-0010660 002-0131-0010680 -002-0131-0010683 002-0131-0010684 -002-0131-0010688 002-0131-0010684 -002-0131-0010688 002-0131-0010701 -002-0131-0010704 002-0131-0010864 -002-0131-0010889 002-0131-0010890 -002-0131-0010927 002-0131-0011455 -002-0131-0011456 002-0131-0011485 -002-0131-0011486 002-0131-0013419 -002-0131-0013427 002-0131-0013419 -002-0131-013427 Page 10 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 106 of 277 PAGEID #: 61107 Bates Numbered Documents ______ 002-0131-0013816______ ______ 002-0131-0013817______ 002-0131-0013818 -002-0131-0013820 002-0131-0013998 -002-0131-0014000 002-0131-0014005 -002-0131-0014015 002-0131-0014016 -002-0131-0014018 002-0131-0014019 -002-0131-0014029 002-0131-0014058 -002-0131-0014060 002-0131-0014122 -002-0131-0014142 002-0131-0015351 -002-0131-0015355 ______ 002-0131-0015455______ ______ 002-0131-0015456______ 002-0131-0015534 -002-0131-0015536 002-0131-0015537 -002-0131-0015539 002-0131-0015620 -002-0131-0015620 002-0131-0015630 -002-0131-0015635 ______ 002-0131-0015650______ 002-0131-0015681 -002-0131-0015693 002-0131-0015694 -002-0131-0015696 002-0131-0015697 -002-0131-0015703 002-0131-0015704 -002-0131-0015708 002-0131-0015715 -002-0131-0015716 002-0131-0015717 -002-0131-0015722 ______ 002-0131-0015723______ 002-0131-0015742 -002-0131-0015743 002-0131-0015937 -002-0131-0015938 002-0131-0016016 -002-0131-0016018 002-0131-0016412 -002-0131-0016424 002-0131-0016425 -002-0131-0016427 002-0131-0016496 -002-0131-0016538 ______ 002-0131-0019925______ ______ 002-0131-0020080______ ______ 002-0131-0020094______ 002-0131-0020094 -002-0131-0020100 002-0131-0020560 -002-0131-0020562 002-0131-0020563 -002-0131-0020567 002-0131-0023460 -002-0131-0023461 ______ 002-0131-0023462______ 002-0131-0023503 -002-0131-0023518 ______ 002-0131-0023537______ ______ 002-0131-0023547______ ______ 002-0131-0023557______ 002-0131-0023568 -002-0131-0023570 ______ 002-0131-0023574______ 002-0132-0003156 -002-0132-0003183 Page 11 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 107 of 277 PAGEID #: 61108 Bates Numbered Documents _______002-0132-0004265_______ 002-0132-0004268 -002-0132-0004269 _______002-0132-0004470_______ 002-0132-0004475 -002-0132-0004476 _______ 002-0132-0004842_______ 002-0132-0007296 -002-0132-0007297 002-0132-0007299 -002-0132-0007300 002-0132-0007408 -002-0132-0007422 _______ 002-0132-0008371_______ _______002-0132-0010048_______ 002-0132-0010119 -002-0132-0010137 002-0132-0010301 -002-0132-0010379 002-0132-0010380 -002-0132-0010383 002-0132-0010380 -002-0132-0010383 _______002-0132-0010384_______ _______002-0132-0010385_______ _______ 002-0132-0010386_______ 002-0134-0000027 -002-0134-00028 _______002-0134-0000044_______ _______002-0134-0000103_______ _______ 002-0134-0000192_______ 002-0134-0000194 -002-0134-0000195 _______002-0134-0000243_______ _______002-0134-0000244_______ 002-0134-0000301 -002-0134-0000305 002-0135-0000192 -002-0135-0000194 002-0135-0000201 -002-0135-0000215 002-0135-0000788 -002-0135-0000791 002-0135-0001696 -002-0135-0001706 002-0135-0001707 -002-00135-0001708 002-0135-0002507 -002-0135-0002514 002-0166-0000001 -00-0166-0000018 002-0166-0000019 -002-0166-0000053 002-0166-0000019 -002-0166-0000053 002-0166-0000054 -002-0166-0000082 002-0166-0000054 -002-0166-0000082 002-0166-0000054 -002-0166-0000082 002-0214-0004534 -002-0214-0004537 002-0214-0001336 -002-0214-0001337 002-0214-0001350 -002-0214-0001357 002-0214-0001369 -002-0214-0001371 002-0214-0002652 -002-0214-0002654 002-0214-0004114 -002-0214-0004124 002-0214-0004165 -002-0214-0004167 002-0214-0004168 -002-0214-0004169 Page 12 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 108 of 277 PAGEID #: 61109 Bates Numbered Documents 002-0214-0004228 -002-0214-0004236 002-0214-0004328 -002-0214-0004331 002-0214-0004427 -002-0214-0004429 _______ 002-0214-0004430_______ 002-0214-0004775 -002-0214-0004778 002-0214-0004789 -02-0214-0004790 002-0214-0004791 -002-0214-0004794 002-0214-0004806 -002-0214-0004810 002-0214-0004811 -002-0214-0004829 _______ 002-0218-0000001_______ 002-0218-0000022 -002-0218-0000023 002-0218-0001394 -002-0218-0001396 002-0218-0001880 -002-0218-0001887 _______ 002-0218-0002110_______ _______ 002-0218-0002277_______ _______ 002-0218-0002438_______ _______ 002-0235-0000001_______ _______ 002-0235-0000003_______ 002-0235-0000042 -002-0235-0000046 002-0235-0000158 -002-0235-0000171 _______ 002-0235-0000288_______ _______ 002-0235-0000373_______ 002-0235-0000603 -002-0235-0000604 002-0235-0000620 -002-0235-0000627 002-0235-0000722 -002-0235-0000724 _______ 002-0235-0001181_______ _______ 002-0235-0001182_______ 002-0235-0001308 -002-0235-0001310 002-0235-0001633 -002-0235-0001656 002-0235-0001657 -002-0235-0001658 002-0235-0001659 -002-0235-0001663 002-0235-0002073 -002-0235-0002078 002-0235-0002079 -002-0235-0002081 002-0235-0002342 -002-0235-0002343 002-0235-0002924 -002-0235-0002926 002-0235-0002975 -002-0235-0003002 002-0235-0007592 -002-0235-0007594 002-0235-0008097 -002-0235-0008098 002- 0235-0008112 -002-0235-0008113 _______ 002-132-0010048_______ 003- 0001-0000167 -003-0001-0000186 003-0001-0000537 -003-0001-0000557 003-0001-00011908 -003-0001-00011910 003-0001-0001903 -003-0001-0001920 003-0001-0002377 -003-0001-0002380 Page 13 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 109 of 277 PAGEID #: 61110 Bates Numbered Documents 003-0001-0002540 -003-0001-0002542 ______ 003-0001-0002640______ 003-0001-0002884 -003-0001-0002884 ______ 003-0001-0002908______ 003-0001-0002926 -003-0001-0002929 ______ 003-0001-0002948______ 003-0001-0003237 -003-0001-0003238 003-0001-0004205 -003-001-0004206 003-0001-0005208 -003-0001-0005209 003-0001-0005499 -003-0001-0005500 ______ 003-0001-0005633______ ______ 003-0001-0005793______ 003-0001-0005809 -003-0001-0005810 003-0001-0005827 -003-0001-0005828 003-0001-0005837 -003-0001-0005838 003-0001-0005842 -003-0001-0005843 003-0001-0005927 -003-0001-0005949 003-0001-0006086 -003-0001-0006087 ______ 003-0001-0006088______ 003-0001-0006173 -003-0001-0006175 003-0001-0008601 -003-0001-0008602 ______ 003-0001-0010508______ 003-0001-0010635 -003-0001-0010636 ______ 003-0001-0010637______ 003-0001-0010641 -003-0001-0010643 003-0001-0010695 -003-0001-0010697 ______ 003-0001-0011319______ 003-0001-0012306 -003-0001-0012307 003-0001-0014292 -003-0001-0014345 ______ 003-0001-0014829______ ______ 003-0001-0017691______ ______ 003-0001-0017719______ 003-0001-0017792 -003-0001-0017794 ______ 003-0001-0018397______ 003-0001-0019316 -003-0001-0019318 ______ 003-0001-0019345______ 003-0001-0019350 -003-0001-0019352 003-0001-0019691 -003-0001-0019693 003-0001-0019694 -003-0001-0019697 ______ 003-0001-0019742______ ______ 003-0001-0019787______ ______ 003-0001-0019790______ 003-0001-0024705 -003-0001-0024707 003-0001-0024710 -003-0001-0024722 003-0001-0024725 -003-0001-0024751 Page 14 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 110 of 277 PAGEID #: 61111 Bates Numbered Documents 003-0001-0024823 -003-0001-0024826 003-0001-0024871 -003-0001-0024880 003-0001-0025116 -003-0001-0025118 003-0001-0025116 -003-0001-0025118 003-0001-0025121 -003-0001-0025122 ______ 003-0001-0025132______ ______ 003-0001-0025132______ ______ 003-0001-0025133______ ______ 003-0001-0025133______ ______ 003-0001-0025154______ ______ 003-0001-0025154______ ______ 003-0001-0025155______ ______ 003-0001-0025155______ 003-0001-0025158 -003-0001-0025159 003-0001-0025158 -003-0001-0025159 003-0001-0025158 -003-0001-0025159 003-0001-0025244 -003-0001-0025247 003-0001-0025501 -003-0001-0025505 003-0001-0025837 -003-0001-0025840 003-0001-0026862 -003-0001-0026863 003-0001-0028261 -003-0001-0028262 ______ 003-0001-0028763______ ______ 003-0001-0028764______ 003-0001-0028885 -003-0001-0028886 003-0001-0030158 -003-0001-0030159 ______ 003-0001-0030170______ ______ 003-0002-0002222______ ______ 003-0002-0002266______ 003-0002-0002460 -003-0002-0002463 003-0002-0002460 -003-0002-0002463 003-0002-0002591 -003-0002-0002609 ______ 003-0002-0004226______ 003-0002-0004228 -003-0002-0004237 003-0002-0004242 -003-0002-0004251 ______ 003-0002-0004315______ ______ 003-0002-0004820______ ______ 003-0002-0005875______ 003-0029-0000034 -003-0029-0000037 003-0029-0000671 -003-0029-0000672 003-0029-0000676 -003-0029-0000681 003-0029-0000808 -003-0029-0000826 ______ 003-0029-0001239______ 003-0029-0001263 -003-0029-0001285 003-0029-0001325 -003-0029-0001326 003-0029-0001327 -003-0029-0001329 Page 15 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 111 of 277 PAGEID #: 61112 ______Bates Numbered Documents_____ ____ 003-0029-0001331 -003-0029-0001350____ ____ 003-0029-0001394-003-0029-0001395____ ____ 003-0029-0001396 -003-0029-0001398____ ____ 003-0029-0001538-003-0029-0001539____ ____ 003-0029-0001538-003-0029-0001539____ ____ 003-0029-0001538-003-0029-0001539____ ____ 003-0029-0001546 -003-0029-0001548____ ____ 003-0029-0001549 -003-0029-0001553____ 003-0029-0001554-003-0029-0001555; CULLEN02066 ____ 003-0029-0001556 -003-0029-0001557____ ____ 003-0029-0001556 -003-0029-0001557____ ____ 003-0029-0002035 -003-0029-0002036____ ____ 003-0029-0002390 -003-0029-0002391____ ____ 003-0029-0002399 -003-0029-0002400____ ____ 003-0029-0002592 -003-0029-0002600____ ___________ 003-0029-0002601___________ ___________ 003-0029-0002613___________ ____ 003-0029-0002677 -003-0029-0002679____ ___________ 003-0030-0000056___________ ____ 003-0030-0000057 -003-0030-0000122____ ____ 003-0030-0000148-003-0030-0000151____ ___________ 003-0030-0000327___________ ____ 003-0030-0000395 -003-0030-0000396____ ____ 003-0030-0000403 -003-0030-0000409____ ____ 003-0030-0001740 -003-0030-0001743____ ___________ 003-0030-0001787___________ ___________ 003-0030-0002344___________ ____ 003-0030-0002380 -003-0030-0002383____ ____ 003-0030-0002531 -003-0030-0002534____ ____ 003-0030-0002535 -003-0030-0002536____ ___________ 003-0030-0002558___________ ___________ 003-0030-0002559___________ ____ 003-0030-0002968-003-0030-0002970____ ____ 003-0030-0002971 -003-0030-0002984____ _____ 003-0030-0003232 -003-0030-000309_____ ___________ 003-0030-0003436___________ ___________ 003-0030-0003452___________ ___________ 003-0030-0003455___________ ___________ 003-0030-0003523___________ ___________ 003-0030-0003526___________ ____ 003-0030-0003527 -003-0030-0003528____ ___________ 003-0030-0003541___________ ___________ 003-0030-0003544___________ ___________ 003-0030-0003544___________ 003-0030-0003545 Page 16 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 112 of 277 PAGEID #: 61113 Bates Numbered Documents _______003-0030-0003545_______ 003-0030-0003575 -003-0030-0003582 003-0031-0000003 -003-0031-0000005 _______ 003-0031-0000026_______ 003-0031-0000063 -003-0031-0000064 _______ 003-0031-0000152_______ 003-0031-0000171 -003-0031-0000188 003-0031-0000447 -0003-0031-0000448 003-0031-0000939 -003-0031-0000940 003-0031-0001354 -003-0031-0001357 003-0031-0001404 -003-0031-0001405 _______ 003-0031-0001412_______ 003-0031-0001777 -003-0031-0001865 003-0031-0002147 -003-0031-0002149 003-0031-0002150 -003-0031-0002151 003-0031-0002505 -003-0031-00002507 003-0031-0002535 -003-0031-00025337 003-0031-0002543 -003-0031-0002546 _______ 003-0031-0002550_______ _______003-0131-0000004_______ 003-0131-0000811 -003-0131-0000827 _______003-0131-0000903_______ _______003-0131-0000903_______ _______003-0131-0001054_______ _______003-0131-0001054_______ 003-0131-0001129 -003-0131-0001131 003-0131-0001129 -003-0131-0001131 003-0131-0001285 -003-0131-0001299 003-0131-0001608 -003-0131-0001611 003-0131-0002917 -003-0131-0002918 003-0131-0003281 -003-0131-0003309 _______ 003-0131-0003321_______ 003-0131-0003322 -003-0131-0003326 003-0131-0003327 -003-0131-0003333 003-0131-0003412 -003-0131-0003433 _______ 003-0131-0003610_______ 003-0131-0003679 -003-0131-0003681 003-0131-0004982 -003-0131-0005005 003-0131-0005247 -003-0131-0005269 003-0131-0005329 -003-0131-0005331 003-0131-0006115 -003-0131-0006118 003-0131-0006625 -003-0131-0006628 003-0131-0006726 -003-0131-0006727 003-0131-0006807 -003-0131-0006809 003-0131-0007086 -003-0131-0007108 Page 17 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 113 of 277 PAGEID #: 61114 Bates Numbered Documents 003-0131-0007172 -003-0131-0007173 003-0134-0000082 -003-0134-0000082 _______ 003-0134-0000106_______ 003-0134-0000129 -003-0134-0001134 _______ 003-0134-0000135_______ 003-0134-0000279 -003-0134-0000280 _______ 003-0135-0002315_______ 003-0218-0002845 -003-0218-0002848 _______ 003-0218-0003630_______ _______ 003-0218-0003631_______ _______ 003-0218-0004416_______ 003-0218-0004760 -003-0218-0004761 003-0230-0000062 -003-0230-0000066 _______ 003-0230-0000614_______ 003-0230-0000723 -003-0230-0000735 003-0236-0000644 -003-0236-0000646 _______ 003-0236-0000911_______ _______ 003-0236-0002245_______ 003-0236-0002326 -003-0236-0002340 003-0236-0003679 -003-0236-0003683 003-0236-0004480 -003-0236-0004490 003-0236-0005115 -003-0236-0005120 003-0236-0005121 -003-0236-0005122 _______ 003-0236-0005137_______ _______ 003-0236-0005139_______ _______ 003-0236-0005201_______ _______ 003-0236-0005957_______ 003-0366-0000007 -003-0366-0000008 003-0366-0000009 -003-0366-0000010 003-0383-0000001 -003-0383-0000026 003-0385-0000001 -003-0385-0000053 _______ 003-0391-0000029_______ 003-0391-0000030 -003-0391-0000035 003-0391-0000036 -003-0391-0000041 003-0391-0000042 -003-0391-0000049 _______ 003-0394-0000001_______ _______ 003-0394-0000002_______ 003-0394-0000004 -003-0394-0000005 003-0394-0000006 -003-0394-0000007 _______ 003-0399-0000001_______ 003-0399-00000117 -003-0399-00000119 _______ 003-0399-0000120_______ ________ 003114-003116________ 003119 -003125; EID072034-EID072045 003126-003141 Page 18 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 114 of 277 PAGEID #: 61115 _______Bates Numbered Documents______ _____________003142-003165_____________ 003168 -003172; 058-0280-0000019 -058-0280-0000023 ________ 003173 -003466;T4171 -T4199________ 003485 -003509; WVDEP13300 -WVDEP13324 _____ 003577 -003599; EID668369 -EID668391_____ _____________003581-003583_____________ _____________003590-003595_____________ _____________003596-003599_____________ _____ 004-0003-0000016 -004-0003-0000024_____ _____ 004-0003-0000030 -004-0003-0000037_____ _____ 004-0003-0000038-004-0003-0000040_____ ____________ 004-0003-0000830____________ ____________ 004-0003-0000837____________ _____ 004-0003-0000841 -004-0003-0000842_____ _____ 004-0003-0000869 -004-0003-0000872_____ _____ 004-0003-0000884-004-0003-0000885_____ _____ 004-0003-0000886 -004-0003-0000888_____ _____ 004-0003-0000960 -004-0003-0000964_____ ____________ 004-0003-0000975____________ _____ 004-0003-0000976 -004-0003-0000977_____ _____ 004-0003-0000978-004-0003-0001000_____ _____ 004-0003-0001053 -004-0003-0001074_____ _____ 004-0003-0001193 -004-0003-0001196_____ _____ 004-0003-0001201 -004-0003-0001205_____ _____ 004-0003-0001279 -004-00003-0001349_____ _____ 004-0003-0001350 -004-0003-0001422_____ _____ 004-0003-0001423 -004-0003-0001498_____ _____ 004-0003-0001499 -004-0003-0001544_____ _____ 004-0131-0000857 -004-0131-0000881_____ _____ 004-0131-0001080 -004-0131-0001122_____ _____ 004-0131-0001138-004-0131-0001159_____ _____ 004-0131-0001160 -004-0131-0001163_____ ____________ 004-0134-0000046____________ ____________ 004-0134-0000049____________ ____________ 004-0134-0000050____________ _____ 004-0134-0000056 -004-0134-0000057_____ ____________ 004-0134-0000117____________ _____ 004-0134-0000228-004-0134-0000233_____ _____ 004-0134-0000247 -004-0134-0000249_____ _____ 004-0134-0000275 -004-0134-0000278_____ ____________ 004-0134-0000515____________ _____ 004-0134-0000531 -004-0134-0000535_____ _____ 004-0134-0000536 -004-0134-0000537_____ ______ 004-0134-0000538 -004-0134-000542______ 004-0134-0000546 -004-0134-0000548 Page 19 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 115 of 277 PAGEID #: 61116 Bates Numbered Documents ______ 004-0134-0000549______ ______ 004-0134-0000557______ 004-0134-0000608 -004-0134-0000621 ______ 004-0134-0000626______ ______ 004-0134-0000626______ ______ 004-0134-0000627______ 004-0134-0000638 -004-0134-0000639 004-0134-0000638 -004-0134-0000639 004-0134-0000701 -004-0134-0000702 004-0134-0000747 -004-0134-0000749 004-0134-0000747 -004-0134-0000749 ______ 004-0134-0000908______ ______ 004-0134-0000909______ 004-0134-0000942 -004-0134-0000943 ______ 004-0134-0001006______ 004-0134-0001013 -004-0134-0001015 004-0134-0001022 -004-0134-0001023 004-0134-0001173 -004-0134-0001174 004-0134-0001175 -004-0134-0001176 ______ 004-0134-0001179______ 004-0134-0001180 -004-0134-0001182 ______ 004-0134-0001190______ ______ 004-0134-0001199______ 004-0134-0001200 -004-0134-0001201 004-0134-0001200 -004-0134-0001201 ______ 004-0134-0001211______ ______ 004-0134-0001259______ 004-0134-0001260 -004-0134-0001261 004-0134-0001437 -004-0134-0001439 004-0134-0001442 -004-0134-0001443 ______ 004-0134-0001579______ ______ 004-0134-0001618______ 004-0134-0001660 -004-0134-0001662 ______ 004-0134-0001667______ 004-0134-0001729 -004-0134-0001730 004-0134-0001731 -004-0134-0001732 004-0134-0001733 -004-0134-0001737 004-0134-0001738 -004-0134-0001741 004-0134-0001742 -004-0134-0001745 004-0134-0001750 -004-0134-0001751 004-0134-0001764 -004-0134-0001766 004-0134-0001794 -004-0134-0001795 ______ 004-0134-0001807______ ______ 004-0134-0001855______ 004-0134-0001951 Page 20 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 116 of 277 PAGEID #: 61117 ________Bates Numbered Documents________ _____________ 004-0134-0002011_____________ _____________ 004-0134-0002012_____________ _____________ 004-0134-0002015_____________ ______ 004-0134-0002016 -004-0134-0002017______ ______ 004-0134-0002018-004-0134-0002019______ ______ 004-0134-0002070 -004-0134-0002072______ ______ 004-0134-0002070 -004-0134-0002072______ ______ 004-0134-0002077 -004-0134-0002079______ ______ 004-0134-0002086 -004-0134-0002088______ ______ 004-0134-0002130 -004-0134-0002133_______ _____________ 004-0134-0002151_____________ _____________004-0134-00022025_____________ ______ 004-0134-0002209 -004-0134-0002228______ _____________ 004-0134-0002229_____________ ______ 004-0134-0002230 -004-0134-0002231______ ______ 004-0134-0002259 -004-0134-0002262______ ______ 004-0134-0002289 -004-0134-0002300______ _______ 004-0134-0002290 004-0134-0002300_______ ______ 004-0134-0002326 -004-0134-0002330______ ______ 004-0134-0002377 -004-0134-0002407______ ______ 004-0134-0002605 -004-0134-0002607______ _____________ 004-0134-0002684_____________ ______ 004-0134-0002685 -004-0134-0002692______ _____________ 004-0193-0001417_____________ _____________ 004-0193-0002119_____________ _____________ 004-0193-0002119_____________ 004-0193-0002194; 003-0001-0022952; WEGMAN00891 ______ 004-0193-0002535 -004-0193-0002538______ 004-0193-0002782 -004-0193-0002783; 002-0001-0000064 _____________ 002-0001-0000082_____________ ______ 004-0193-0002904-004-0193-0002905_______ ______ 004-0193-0002904-004-0193-0002905_______ ______ 004-0219-0001597 -004-0219-0001599______ ______ 004-0219-0001726 -004-0219-0001736______ _______ 004-0219-0001748 -004-219-0001753_______ _______ 004-0219-0001795 -004-219-0001800_______ ______ 004-0219-0002217 -004-0219-0002219______ ______ 004-0219-0002229 -004-0219-0002230______ _____________ 004-0219-0002242_____________ _______004-0219-0002505 -004-0219-0002513_______ ______ 004-0219-0002692 -004-0219-0002694______ ______ 004-0219-0003270 -004-0219-0003272______ ______ 004-0219-0003664-004-0219-0003674______ ______ 004-0219-0003702 -004-0219-0003709______ 004-0219-0003712 -004-0219-0003759 Page 21 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 117 of 277 PAGEID #: 61118 Bates Numbered Documents 004-0219-0003779 -004-0219-0003808 004-0219-0004880 -004-0219-0004886 ______ 004-0219-0004887______ 004-0219-0004888 -004-0219-0004894 004-0219-0004895 -004-0219-0004897 004-0219-0004898 -004-0219-0004909 004-0219-0004910 -004-0219-0004915 004-0219-0004924 -004-0219-0004931 ______ 004-0219-0004941______ 004-0219-0005557 -004-0219-0005579 004-0219-0005688 -004-0219-0005689 004-0219-0005699 -004-0219-0005701 004-0219-0005705 -004-0219-0005708 004-0219-0005709 -004-0219-0005712 004-0219-0005723 -004-0219-0005725 004-0219-0005818 -004-0219-0005820 004-0219-0005822 -004-0219-0005862 004-0219-0005863 -004-0219-0005868 004-0219-0005869 -004-0219-0005874 004-0219-0005875 -004-0219-0005880 004-0219-0005897 -004-0219-0005901 004-0219-0005902 -004-0219-0005916 004-0219-0005917 -004-0219-0005936 004-0219-0005937 -004-0219-0005939 004-0219-0005940 -004-0219-0005946 004-0219-0005947 -004-0219-0005948 004-0219-0005949 -004-0219-0005974 ______ 004-0219-0005975______ 004-0219-0006006 -004-0219-0006028 004-0219-0006029 -004-0219-0006031 004-0219-0006035 -004-0219-0006037 004-0219-0006038 -004-0219-0006040 004-0219-0006041 -004-0219-0006043 004-0219-0006044 -004-0219-0006047 ______ 004-0219-0006048______ 004-0219-0006052 -004-0219-0006054 004-0219-0006120 -004-0219-0006123 004-0219-0006124 -004-0219-0006127 004-0219-0006128 -004-0219-0006130 004-0219-0006134 -004-0219-0006148 004-0219-0006179 -004-0219-0006181 004-0219-0006182 -004-0219-0006201 004-0219-0006217 -004-0219-0006219 004-0219-0006297 -004-0219-0006300 004-0219-0006301 -004-0219-0006303 Page 22 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 118 of 277 PAGEID #: 61119 Bates Numbered Documents 004-0219-0006304 -004-0219-0006308 004-0219-0006463 -004-0219-0006466 ______ 004-0219-0006495______ 004-0219-0006500 -004-0219-0006506 004-0219-0006533 -004-0219-0006537 004-0219-0006592 -004-0219-0006598 004-0219-0006599 -004-0219-0006605 004-0219-0006606 -004-0219-0006613 004-0219-0006736 -004-0219-0006758 004-0219-0006768 -004-0219-0006773 ______ 004-0219-0006774______ 004-0219-0006781 -004-0219-0006805 004-0219-0006908 -004-0219-0006928 004-0219-0006929 -004-0219-0006935 004-0219-0006936 -004-0219-0006937 ______ 004-0219-0007093______ 004-0219-0007094 -004-0219-0007118 004-0219-0007119 -004-0219-0007161 004-0219-0007186 -004-0219-0007205 ______ 004-0219-0007220______ ______ 004-0236-0000043______ 004-0236-0000136 -004-0236-0000137 004-0236-0000143 -004-0236-0000171 004-0236-0000249 -004-0236-0000325 ______ 004-0236-0000330______ 004-0236-0000332 -004-0236-0000337 ______ 004-0236-0000365______ 004-0236-0000412 -004-0236-0000414 004-0236-0000441 -004-0236-0000443 004-0236-0000532 -004-0236-0000540 004-0236-0000541 -004-0236-0000542 004-0236-0000551 -004-0236-0000564 004-0236-0000595 -004-0236-0000610 004-0236-0000611 -004-0236-0000617 004-0236-0002865 -004-0236-0002930 ______ 004-0236-0005572______ ______ 004-0236-0005648______ 004-0236-0005706 -004-0236-0005716 004-0236-0005717 -004-0236-0005780 ______ 004-0236-0005932______ 004-0236-0006134 -004-0236-0006135 004-0236-0006200 -004-0236-0006201 004-0236-0006365 -004-0236-0006371 _______ 004150 -004183_______ 004191 -004193 Page 23 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 119 of 277 PAGEID #: 61120 Bates Numbered Documents 004- 219-0006614 -004-0219-0006635 _______ 004262 -004276_______ 0045-0003-0001350 -004-0003-0001422 005- 0002-0000773 -005-0002-0000782 005-0385-0000122 -005-0385-0000146 005-0388-0000001 -005-0388-0000024 005- 0396-0000002 -005-0396-0000008 _______ 005899-005901_______ 006- 0002-0000007 -006-0002-0000008 006-0002-0000263 -006-0002-0000265 006-0002-0001093 -006-0002-0001094 006-0002-0002208 -006-0002-0002219 006-0002-0003204 -006-0002-0003219 006-0002-0003383 -006-0002-0003387 006-0002-0003958 -006-0002-0003971 006-0002-0004166 -006-0002-0004178 006-0002-0004206 -006-0002-0004207 006-0002-0006137 -006-0002-0006138 006-0002-0006137 -006-0002-0006138 006-0002-0006147 -006-0002-0006148 006-0002-0006149 -006-0002-00051 006-0002-0006156 -006-0002-0006158 006-0002-0006199 -006-0002-0006201 006-0002-0006208 -006-0002-0006209 006-0002-0006230 -006-0002-0006231 006-0002-0006620 -006-0002-0006623 006-0002-0006626 -006-0002-0006627 006-0002-0006630 -006-0002-0006633 _______006-0002-0006634_______ 006-0002-0006636 -006-0002-0006637 006-0002-0006638 -006-0002-0006639 006-0002-002220 -006-0002-002224 006-0008-0000321 -006-0008-0000323 006-0008-0001275 -006-0008-0001318 006-0008-0001328 -006-0008-0001343 006-0008-0002632 -006-0008-0002633 006-0009-0001200 -006-0009-0001205 _______006-0009-0001390_______ 006-0009-0001978 -006-0009-0001980 006-0009-0002043 -006-0009-0002046 006-0009-0002047 -006-0009-0002052 006-0009-0002390 -006-0009-0002395 006-0009-0002548 --006-0009-0002549 006-0010-0000622 -006-0010-0000625 006-0010-0000702 Page 24 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 120 of 277 PAGEID #: 61121 Bates Numbered Documents 006-0010-0001407 -006-0010-0001408 006-0010-0001409 -006-0010-0001410 006-0010-0001409 -006-0010-0001410 006-0010-0001441 -006-0010-0001442 006-0010-0001444 -006-0010-0001446 006-0010-0001450 -006-0010-0001458 006-0131-0001042 -006-0131-00010425 006-0131-0004364 -006-0131-0004365 006-0131-0004643 -006-0131-0004644 006-0131-0007121 -006-0131-0007123 006-0131-0008724 -006-0131-0008730 006-0131-0011049 -006-0131-0011050 006-0133-0003433 -006-0133-0003463 006-0133-0006307 -006-0133-0006308 006-0133-0006322 -006-0133-0006323 006-0133-0010707 -006-0133-0010717 006-0133-0010718 -006-0133-0010719 ______ 006-0133-00113414______ 006-0133-0018206 -006-0133-0018208 006-0133-0018374 -006-0133-0018386 006-0133-0018457 -006-0133-0018459 006-0133-0018857 -006-0133-0018872 _______006-0133-0019538_______ 006-0133-0021990 -006-0133-0021991 _______ 006-0133-0026156_______ _______ 006-0133-0027081_______ _______ 006-0133-0027599_______ _______ 006-0133-0028346_______ 006-0133-0029157 -006-0133-0029158 _______ 006-0133-0029171_______ 006-0133-0029292 -006-0133-0029296 006-0133-0029730 -006-0133-0029731 006-0133-0030806 -006-0133-0030852 _______006-0133-0032093_______ _______ 006-0133-0032322_______ 006-0133-0032378 -006-0133-0032379 006-0133-0032680 -006-0133-0032682 _______ 006-0133-0033126_______ _______006-0133-0033194_______ 006-0133-0033747 -006-0133-0033751 _______006-0133-0034208_______ _______006-0133-0035428_______ _______ 006-0133-0036331_______ 006-0133-0036347 -006-0133-0036348 006-0133-0036576 Page 25 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 121 of 277 PAGEID #: 61122 Bates Numbered Documents _______006-0133-0038585_______ 006-0133-0038948 -006-0133-0038991 006-0133-0038992 -006-0133-0038993 _______006-0133-0040405_______ 006-0133-0040921 -006-0133-0040922 _______ 006-0133-0041377_______ 006-0133-0041684 -006-0133-0041685 _______006-0133-0042683_______ _______ 006-0133-0042687_______ _______ 006-0133-0042897_______ _______ 006-0133-0044387_______ 006-0133-0044441 -006-0133-0044442 006-0133-0044772 -006-0133-0044773 006-0133-0048711 -006-0133-0048713 _______006-0133-0048805_______ 006-0133-0048905 -006-0133-0048906 006-0133-0049232 -006-0133-0049235 006-0133-0054251 -006-0133-0054318 006-0133-0055648 -006-0133-0055653 006-0133-0056442 -006-0133-0056443 006-0133-0056447 -006-0133-0056448 _______006-0133-0056514_______ _______ 006-0133-0058901_______ _______006-0133-0059404_______ 006-0133-0059766 -006-0133-0059767 006-0133-0060092 -006-0133-0060094 006-0133-0060206 -006-0133-0060208 006-0133-0060213 -006-0133-0060215 006-0133-0060526 -006-0133-0060528 006-0133-0061142 -006-0133-0061142 006-0133-0061386 -006-0133-0061388 006-0133-0061830 -006-0133-0061830 006-0133-0061834 -006-0133-0061837 006-0133-0061954 -006-0133-0061955 006-0133-0062619 -006-0133-0062624 006-0133-0062746 -006-0133-0062747 006-0133-0062791 -006-0133-0062794 006-0133-0062791 -006-0133-0062794 006-0133-0064570 -006-0133-0064571 006-0133-0065444 -006-01033-0065446 006-0133-0066117 -006-0133-0086120 006-0133-0067279 -006-0133-0067330 _______006-0133-0067336_______ 006-0133-0069708 -006-0133-0069709 006-0133-00699445 -006-0133-0069946 Page 26 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 122 of 277 PAGEID #: 61123 Bates Numbered Documents _______ 006-0133-0070179_______ 006-0133-0070184 -006-0133-0070185 _______ 006-0133-0071712_______ _______006-0133-0073388_______ 006-0133-0073624 -006-0133-0073625 006-0133-0074278 -006-0133-0074281 _______ 006-0133-0076242_______ 006-0133-0076266 -006-0133-0076267 _______006-0133-0076308_______ 006-0133-0077692 -0077694 006-0133-00777692 -006-0133-0077794 006-0133-0078559 -006-0133-0078560 006-0133-0078747 -006-0133-0078748 006-0133-0078791 -006-0133-0078799 006-0133-0079073 -006-0133-0079076 _______ 006-0133-0079597_______ 006-0133-0080051 -006-0133-0080052 006-0133-0080114 -006-0133-0080118 006-0133-0081531 -006-0133-0081532 006-0133-0082997 -006-0133-0082998 006-0133-0082997 -006-0133-0082998 _______006-0133-0083555_______ _______006-0133-0083555_______ 006-0133-0083664 -006-0133-0083665 _______ 006-0133-0083772_______ 006-0133-0084066 -006-0133-0084067 006-0133-0084189 -006-0133-0084190 006-0133-0084189 -006-0133-0084190 006-0133-0084196 -006-0133-0084197 006-0133-0084219 -006-0133-0084220 006-0133-0084219 -006-0133-0084220 006-0133-0084223 -006-0133-0084224 006-0133-0084223 -006-0133-0084224 006-0133-0084421 -006-0133-0084422 006-0133-0085077 -006-0133-0085079 006-0133-0085420 -006-0133-0085421 _______006-0133-0085479_______ 006-0133-0085733 -006-0133-0085734 006-0133-0085869 -006-0133-0085883 006-0133-0086130 -006-0133-0086131 006-0133-0086134 -006-0133-0086136 006-0133-0086309 -006-0133-0086312 006-0133-0086757 -006-0133-0086758 _______006-0133-0086939_______ 006-0133-0087024 -006-0133-0087029 Page 27 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 123 of 277 PAGEID #: 61124 Bates Numbered Documents 006-0133-0087072 -006-0133-0087073 ______ 006-0133-0087085______ ______ 006-0133-0087085______ 006-0133-0087093 -006-0133-0087094 006-0133-0088108 -006-0133-0088113 006-0133-0088139 -006-0133-0088141 006-0133-0088146 -006-0133-0088151 006-0133-0088168 -006-0133-0088175 ______ 006-0133-0088762______ 006-0133-0088888 -006-0133-0088889 006-0133-0089168 -006-0133-0089182 006-0133-0089637 -006-0133-0089639 006-0133-0090099 -006-0133-0090100 006-0133-0090109 -006-0133-0090110 ______ 006-0133-0090499______ ______ 006-0133-0090878______ 006-0133-0091622 -006-0133-0091623 006-0133-0091679 -006-0133-0091687 006-0133-0091738 -006-0133-0091739 006-0133-0091815 -006-0133-0091817 006-0133-0091815 -006-0133-0091823 ______ 006-0133-0091832______ ______ 006-0133-0091857______ ______ 006-0133-0092274______ 006-0133-0092780 -006-0133-0092781 ______ 006-0133-0092782______ ______ 006-0133-0093882______ 006-0133-0094043 -006-0133-0094061 006-0133-0094532 -006-0133-0094535 006-0133-0094718 -006-0133-0094720 006-0133-0095403 -006-0133-0095409 006-0133-0095476 -009-0133-0095478 006-0133-0095479 -006-0133-0095483 006-0133-0095514 -006-0133-0095519 006-0133-0095514 -006-0133-0095519 006-0133-0096695 -006-0133-0096704 ______ 006-0133-0096710______ 006-0133-0097862 -006-0133-0097875 ______ 006-0133-0098797______ 006-0133-0100153 -006-0133-0100154 006-0133-0100748 -006-0133-0100756 006-0133-0100858 -006-0133-0100859 006-0133-0101429 -006-0133-0101431 006-0133-0101493 -006-0133-0101506 006-0133-0101622 -006-0133-0101635 Page 28 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 124 of 277 PAGEID #: 61125 Bates Numbered Documents 006-0133-0105256 -006-0133-0105258 006-0133-0105256 -006-0133-0105258 006-0133-0105477 -006-0133-0105495 006-0133-0105477 -006-0133-0105495 006-0133-0105849 -006-0133-0105850 ______ 006-0133-0105882______ 006-0133-0105889 -006-0133-0105890 ______ 006-0133-0108123______ 006-0133-0108233 -006-0133-0108234 006-0133-0108584 -006-0133-0108585 006-0133-0108754 -006-0133-0108757 ______ 006-0133-0108770______ 006-0133-0108841-006-0133-0108846 006-0133-0109021 -006-0133-0109023 ______ 006-0133-0109464______ ______ 006-0133-0110420______ 006-0133-0111563 -006-0133-0111564 ______ 006-0133-0112817______ 006-0133-0113485 -006-0133-0113486 006-0133-0113911 -006-0133-0113915 ______ 006-0133-0113943______ 006-0133-0114118 -006-0133-0114119 006-0133-0114956 -006-0133-0114957 006-0133-0115098 -006-0133-0115124 006-0133-0115521 -006-0133-0115523 ______ 006-0133-0115637______ ______ 006-0133-0119725______ 006-0133-0119730 -006-0133-0119733 006-0133-0120154 -006-0133-0120155 006-0133-0120325 -006-0133-0120326 006-0133-0121130 -006-0133-0121131 ______ 006-0133-0122229______ 006-0133-0123812 -006-0133-0123815 006-0133-0124091 -006-0133-0124099 006-0133-0128079 -006-0133-0128080 006-0133-0128457 -006-0133-0128503 006-0133-0128666 -006-0133-0128668 006-0133-0128831 -006-0133-0128842 006-0133-0128843 -006-0133-0128844 006-0133-0129174 -006-0133-0129182 006-0133-0129526 -006-0133-0129528 006-0133-0129529 -006-0133-0129530 006-0133-0129657 -006-0133-0129678 006-0133-0130567 -006-0133-0130580 006-0133-0130689 -006-0133-0130692 Page 29 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 125 of 277 PAGEID #: 61126 Bates Numbered Documents ________ 006-0133-0131539________ 006-0133-0132771 -006-0133-0132773 ________ 006-0133-0132878________ ________ 006-0133-0132878________ 006-0133-0133-0143928 -006-0133-0143930 006-0133-0133060 -006-0133-0133062 006-0133-0133674 -006-0133-0133675 ________ 006-0133-013414________ ________ 006-0133-0134539________ 006-0133-0135477 -006-0133-0135479 006-0133-0135532 -006-0133-0135535 ________ 006-0133-0137412________ 006-0133-0137468 -006-0133-0137469 006-0133-0138440 -006-0133-0138442 ________ 006-0133-0140274________ ________ 006-0133-0140275________ ________ 006-0133-0140278________ 006-0133-0140310 -006-0133-0140314 006-0133-0140658 -006-0133-0140664 006-0133-0140963 -006-0133-0140966 006-0133-0141269 -006-0133-0141270 ________ 006-0133-0141283________ 006-0133-0142377 -006-0133-0142378 006-0133-0142849 -006-0133-0142851 006-0133-0142849 -006-0133-0142851 006-0133-0143092 -006-0133-0143094 006-0133-0143095 -006-0133-0143097 006-0133-0143099 -006-0133-0143102 006-0133-0143099 -006-0133-0143103 ________ 006-0133-0143101________ 006-0133-0143139 -006-0133-0143141 006-0133-0143139 -006-0133-0143141 006-0133-0143139 -006-0133-0143141 ________ 006-0133-0143415________ 006-0133-0146157 -006-0133-0146159 006-0133-0146855 -006-0133-0146864 006-0133-0146959 -006-0133-0146962 006-0133-0147203 -006-0133-0147205 006-0133-0147437 -006-0133-0147441 006-0133-0148088 -006-0133-0148089 006-0133-0148090 -006-0133-0148091 006-0133-0148092 -006-0133-0148093 ________ 006-0133-0148100________ 006-0208-0000039 -006-0208-0000042 006-0213-0000481 Page 30 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 126 of 277 PAGEID #: 61127 _______ Bates Numbered Documents_______ _____________006-0213-0000545_____________ _____________006-0213-0000546_____________ ______ 006-0231-0000398-006-0231-0000406______ ______ 006-0231-0000517 -006-0231-0000518______ ______ 006-0231-0000917 -006-0231-0000920______ ______ 006-0231-0001892 -006-0231-0001926______ ______ 006-0231-0001933 -006-0231-0001934______ ______ 006-0231-0001933 -006-0231-0001934______ ______ 006-0231-0001935 -006-0231-0001936______ ______ 006-0231-0001935 -006-0231-0001936______ ______ 006-0231-0001937 -006-0231-0001938______ ______ 006-0231-0001937 -006-0231-0001938______ ______ 006-0231-0001939 -006-0231-0001955______ _____________006-0232-0001704_____________ ______ 006-0236-0000080 -006-0236-0000082______ ______ 006-0236-0000701 -006-0236-0000706______ ______ 006-0236-0000872 -006-0236-0000874______ _____________006-0236-0004618_____________ ______ 006-0236-0006564-006-0236-0006566______ ______ 006-0236-0006715 -006-0236-0006717______ ______ 006-0236-0006885 -006-0236-0006888______ ______ 006-0236-0009407 -006-0236-0009423______ ______ 006-0236-0009848-006-0236-0009849______ _____________006-0236-0010007_____________ _____________006-0236-0013254_____________ _____________006-0236-0016030_____________ ______ 006-0236-0019605 -006-0236-0020023______ _____________006-0339-0000016_____________ _____________006-0339-0000019_____________ ______ 006-0342-0000001 -006-0342-0000002______ ______ 006-0357-0000004; 024-0357-0000004______ ______ 006-0357-0000005 -006-0357-0000012______ 006-0374-0000001; 006-0376-0000339 -006-0376-0000350 006-0374-0000005; 006-0376-0000036 -006-0376-0000072 006-0374-0000006; 006-0376-0000073 -006-0376-0000120 006-0374-0000007; 006-0376-0000121 -006-0376-0000175 006-0374-0000008; 006-0376-0000176 -006-0376-0000203 006-0374-0000010; 006-0376-0000245 -006-0376-0000278 Page 31 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 127 of 277 PAGEID #: 61128 _______ Bates Numbered Documents_______ 006-0376-0000009; 006-0376-0000204-006-0376-0000244 006-0376-0000305 -006-0376-0000338 006-0376-0000351 -006-0376-0000496 ______ 006-0380-0000009______ 006-0385-0000001 -006-0385-0000003 ______ 006-0385-0000018______ ______ 006-0385-0000022______ 006-0385-0000023 -006-0385-0000024 006-0386-0000020 -006-0386-0000021 ______ 006-0391-0000013______ 006-0391-0000024 -006-0391-0000025 006-0391-0000026 -006-0391-0000027 006-0391-0000029 -006-0391-0000031 006-0394-0000001 -006-0394-0000002 006-0394-0000003 -006-0394-0000004 006-0394-0000038 -006-0394-0000044 006-0394-0000046 -006-0394-0000053 006-0394-0000054 -006-0394-0000057 006-0394-0000058 -006-0394-0000064 006-0396-0000028 -00-0396-0000034 006-0396-0000035; 006-0394-0000045 006-0396-0000036 -006-0396-0000043 006-0396-0000044 -006-0396-0000047 ______ 006-0396-0000051______ 006-0396-0000052 -006-0396-0000053 006-0399-0000053 -006-0399-0000057 006-0399-0000074 -006-0399-0000107 006-0399-0000108 -006-0399-0000112 006-0399-0000121 -006-0399-0000124 006-0399-0000125 -006-0399-0000127 006-0399-0000128 -006-0399-0000158 ______ 006-0399-0000159______ 006-0399-0000160 -006-0399-0000165 006-0399-0000166 -006-0399-0000170 006-0399-0000171 -006-0399-0000172 006-0401-0000001 -006-401-0000004 006-0401-0000005 -006-0401-0000007 006-0401-0000017 -006-0401-0000019 006-0401-0000020 -006-0401-0000022 006-0401-0000023 -006-0401-0000024 ______ 006-0401-0000025______ 006-0401-0000026; 173-0401-0000021 ______ 006-0403-0000015______ 006-0403-0000016 -006-0403-0000017 Page 32 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 128 of 277 PAGEID #: 61129 Bates Numbered Documents 006-0440-0000001 -006-0440-0000004 008-0020-0000421 -008-0020-0000424 008-0020-0000421 -008-0020-0000424 ______ 008-0020-0000426______ 008-0020-0000426 -008-0020-0000427 ______ 008-0020-0000427______ 008-0020-0000428 -008-0020-0000431 008-0020-0000428 -008-0020-0000431 008-0131-0004274 -008-0131-0004280 ______ 008-0135-0000186______ ______ 008-0135-0002578______ 008-0237-0009632 -008-0237-0009633 ______ 008-0339-0000016______ 008- 0357-0000004 -008-0357-0000008 _______008-0357-000006_______ _______008-0357-000006_______ ______ 008-0366-0000004______ ______ 008-0366-0000005______ ______ 009-0070-0000010______ ______ 009-0070-0000011______ 009- 0070-0000014 -009-0070-0000018 009-0070-0000024 -009-0070-0000025 009-0070-0000024 -009-0070-0000025 009-0070-0000026 -009-0070-0000029 ______ 009-0070-0000031______ 009-0139-0006511 -009-0139-0006516 009-0139-0008990 -009-0139-0008991 009-0139-0008990 -009-0139-0008991 009-0139-0008990 -009-0139-0008991 009-0139-0009715 -009-0139-009718 ______ 009-0237-0001887______ ______ 009-0237-0002475______ ______ 009-0237-0007556______ ______ 009-0237-0008826______ 009- 0237-0012450 -009-0237-0012511 010-0065500 -010-0065503 010- 0343-0000001 -010-0343-0000027 ______ 010-0343-0000028______ ______ 010-0343-0000029______ ______ 010-0343-0000030______ ______ 010-0343-0000031______ ______ 010-0343-0000032______ _______01-0235-0000001_______ ______ 011-0001-0003496______ 011-0001-0003811 Page 33 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 129 of 277 PAGEID #: 61130 _______ Bates Numbered Documents_______ _____________ 011-0001-0003811_____________ ______ 011-0058-0000012 -011-0058-0000013______ ______ 011-0058-0000036 -011-0058-0000037______ ______ 011-0161-0000326 -011-0161-0000327______ ______ 011-0161-0001460 -011-0161-0001461______ ______ 013-0002-0001044-013-0002-0001045______ _____________ 014-0002-0016817_____________ _____________ 014-0002-0019141_____________ _____________ 014-0343-0000011_____________ ______ 015-0002-0001876 -015-0002-0001877______ ______ 015-0002-0001922 -015-0002-0001930______ ______ 015-0002-0003114-015-0002-0003117______ ______ 015-0002-0004215 -015-0002-0004218______ _____________ 016-000-0005698_____________ ______ 016-0002-0001314 -016-0002-0001336______ ______ 016-0002-0001783 -016-0002-0001784______ ______ 016-0002-0006573 -016-0002-0006577______ ______ 016-0002-0007570 -016-0002-0007594______ ______ 016-0002-0007970 -016-0002-0007988______ ______ 016-0002-0010750 -016-0002-0010766______ _____________ 016-0038-0000567_____________ ______ 016-0146-0038440 -016-0146-0038441______ _____________ 016-0339-0000001_____________ _____________ 016-0339-0000001_____________ ______ 016-0376-0000001 -016-0376-0000023______ _____________ 016-0376-0000024_____________ ______ 016-0385-0000005 -016-0385-0000006______ ______ 016-0388-0000001 -016-0388-0000009______ ______ 016-0388-0000010 -016-0388-0000018______ ______ 016-0388-0000019 -016-0388-0000021______ ______ 016-0388-0000022 -016-0388-0000023______ _____________ 016-0388-0000024_____________ _____________ 016-0388-0000027_____________ 019-0351-0000002 -013-0351-0000003; 024-0353-0000003; ____________ EID256133-EID256137____________ _____________ 019-0351-0000007_____________ _____________ 019-0351-0000008_____________ _____________ 019-0353-0000002_____________ _____________ 019-0357-0000004_____________ _____________ 019-0388-0000001_____________ _____________ 019-0388-0000002_____________ ______ 019-0401-0000001 -019-0401-0000005______ __________ 020-0000052 -020-0000053__________ ______ 022-0044-0000109 -022-0044-0000143______ 022-0044-0000146 -022-0044-0000149 Page 34 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 130 of 277 PAGEID #: 61131 Bates Numbered Documents 022-0044-0000248 -022-0044-0000291 ______ 022-0044-0000465______ ______ 022-0044-0000466______ ______ 022-0044-0000467______ ______ 022-0044-0000467______ ______ 022-0044-0000468______ ______ 022-0044-0000576______ 022-0044-0000797 -022-0044-0000798 022-0044-0001003 -022-0044-0001005 022-0044-0001006 -022-0044-0001008 022-0044-0001086 -022-0044-0001088 022-0044-0001129 -022-0044-0001135 022-0044-0001201 -022-0044-0001230 022-0044-0001277 -022-0044-0001288 ______ 022-0044-0001289______ 022-0044-0001290 -022-0044-0001293 022-0044-0001294 -022-0044-0001297 ______ 022-0044-0001466______ ______ 022-0044-0001467______ 022-0044-0001503 -022-0044-0001511 022-0044-0001512 -022-0044-0001515 ______ 022-0044-0001516______ 022-0044-0002358 -022-0044-0002361 ______ 022-0044-0002409______ 022-0044-0002457 -022-0044-0002459 022-0045-0000026 -022-0045-0000032 022-0045-0000186 -022-0045-0000213 022-0045-0000411 -022-0045-0000417 022-0045-0000418 -022-0045-0000432 022-0045-0000440 -022-0045-0000444 022-0045-0000445 -022-0045-0000446 ______ 022-0045-0000894______ ______ 022-0045-0001129______ 022-0045-0001364 -022-0045-0001379 ______ 022-0045-0001401______ ______ 022-0045-0001403______ 022-0045-0001560 -022-0045-0001577 022-0045-0002058 -022-0045-0002060 022-0045-0002285 -022-0045-0002287 022-0046-0000177 -022-0046-0000178 022-0046-0000179 -022-0046-0000182 022-0046-0000191 -022-0046-0000192 ______ 022-0046-0000209______ ______ 022-0046-0000211______ 022-0046-0000212 Page 35 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 131 of 277 PAGEID #: 61132 Bates Numbered Documents 022-0046-0000213 -022-0046-0000214 022-0046-0000536 -022-0046-0000538 022-0046-0000563 -022-0046-0000564 022-0046-0000565 -022-0046-0000567 ______ 022-0046-0000568______ 022-0046-0000727 -022-0046-0000728 ______ 022-0046-0000765______ 022-0046-0001353 -022-0046-0001354 022-0046-0001490 -022-0046-0001495 022-0046-0001500 -022-0046-0001501 022-0046-0001506 -022-0046-0001507 ______ 022-0046-0001508______ 022-0046-0002006 -022-0046-0002013 ______ 022-0046-0002067______ ______ 022-0046-0002068______ 022-0046-0002069 -022-0046-0002075 ______ 022-0046-0002076______ ______ 022-0046-0002077______ _______022-0046-000216_______ 022-0046-0002367 -022-0046-0002369 022-0046-0002458 -022-0046-0002459 022-0047-0001035 -022-0047-0001037 ______ 022-0047-0001084______ 022-0047-0001085 -022-0047-0001088 022-0047-0001112 -022-0047-0001119 ______ 022-0047-0001122______ 022-0047-0001141 -022-0047-0001151 022-0047-0001152 -022-0047-0001156 022-0047-0001678 -022-0047-0001679 022-0047-0001683 -022-0047-0001685 022-0047-0001686 -022-0047-0001688 022-0047-0001695 -022-0047-0001696 022-0047-0001705 -022-0047-0001724 022-0047-0001786 -022-0047-0001789 _______022-0047-001785_______ 022-0048-0001522 -022-0048-0001524 ______ 022-0048-0001525______ 022-0048-0002196 -022-0048-0002201 022-0049-0000098 -022-0049-0000101 ______ 022-0049-0001310______ ______ 022-0134-0014179______ ______ 022-0134-0014179______ 022-0134-0014273 -022-0134-0014275 ______ 022-0233-0001331______ 022-0233-0001409 -022-0233-0001415 Page 36 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 132 of 277 PAGEID #: 61133 Bates Numbered Documents 022-0233-0003856 -022-0233-0003857 022-0233-0004269 -022-0233-0004274 022-0233-0004687 -022-0233-0004688 022-0233-0006102 -022-0233-0006103 ______ 022-0233-0007348______ ______ 022-0233-0008336______ ______ 022-0339-0000043______ ______ 022-0345-00000008______ ______ 022-0353-0000001______ ______ 022-0353-0000001______ 022- 0357-0000001; 022-0357-0000002 ______ 022-0357-0000002______ ______ 022-0357-0000004______ 023- 0135-0015957 -023-0135-0015960 023-0242-0000045 -023-0242-0000046 023- 0242-0015448 -023-0242-0015452 024- 0104-0001349 -024-0104-0001350 ______ 024-0104-0001353______ 024-0104-0001360 -024-0104-0001363 ______ 024-0104-0001374______ 024-0134-0063051 -024-0134-0063089 024-0200-0000584 -024-0200-0000622 024-0245-0005193 -024-0245-0005195 024-0245-0005312 -024-0245-0005314 024-0245-0008484 -024-0245-0008485 024-0245-0011078 -024-0245-0011079 024-0245-0011231 -024-0245-0011234 ______ 024-0330-0000014______ ______ 024-0339-0000013______ ______ 024-0339-0000017______ ______ 024-0339-0000018______ ______ 024-0339-0000019______ ______ 024-0339-0000020______ ______ 024-0339-0000022______ ______ 024-0339-0000024______ ______ 024-0339-0000026______ ______ 024-0339-0000027______ ______ 024-0339-0000028______ ______ 024-0339-0000029______ ______ 024-0339-0000030______ ______ 024-0339-0000032______ ______ 024-0339-0000035______ ______ 024-0342-0000005______ ______ 024-0345-0000007______ 024-0357-0000002 Page 37 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 133 of 277 PAGEID #: 61134 _______ Bates Numbered Documents_______ ______ 024-0359-0000004; 024-0359-0000005______ 024-0359-0000006; 024-0359-0000008; 024-0359-0000012 ______ 024-0359-0000015 -024-0359-0000022______ ____________ 024-0388-0000001____________ ______ 024-0394-0000001 -024-0394-0000003______ ______ 024-0399-0000001 -024-0399-0000001______ ____________ 024-0399-0000003____________ ______ 024-0399-0000004 -024-0399-0000006______ _____________ 026-061-0000053_____________ _________ 029-0061491 -029-0061492_________ ______________ 029-0104090______________ ____________ 030-0002-0002438____________ ______ 030-0002-0002439 -030-0002-0002440______ ____________ 030-0162-0012279____________ ____________ 030-0275-0000095____________ ____________ 030-0275-0000095____________ ____________ 031-0001-0002002____________ ______ 031-0074-0000033 -031-0074-0000041______ ______ 032-0151-0002154 -032-0151-0002155______ _________ 034-0006629 -034-0006631_________ ______ 035-0002-0000231 -035-0002-0000233______ ______ 038-0063-0000283 -038-0063-0000296______ ______ 038-0063-0000297 -038-0063-0000300______ ______ 038-0063-0000301 -038-0063-0000307______ ______ 038-0063-0000308 -038-0063-0000316______ ______ 038-0063-0000317 -038-0063-0000318______ ______ 038-0063-0000319 -038-0063-0000322______ ______ 038-0063-0000323 -038-0063-0000324______ ______ 038-0063-0000356 -038-0063-0000377______ ______ 038-0063-0000433 -038-0063-0000490______ ____________ 038-0063-0000673____________ ____________ 038-0063-0000679____________ ______ 038-0236-0000029 -038-0236-0000030______ ______ 038-0236-0000037 -038-0236-0000041______ _________ 040-0013871 -040-0013875_________ _________ 045-0122821 -045-0122822_________ ______________ 045-0122828______________ ______________ 047-0002621______________ ______ 052-0121-0000167 -052-0121-0000175______ ______ 053-0001-0000001 -053-0001-0000002______ ______ 053-0001-0000729 -053-0001-0000733______ ______ 053-0001-0000903 -053-0001-0000904______ ____________ 053-0001-0001076____________ ____________ 053-0001-0001109____________ 053-0001-0001110 Page 38 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 134 of 277 PAGEID #: 61135 Bates Numbered Documents _______ 053-0001-0001197_______ 053-0001-0001409 -053-0001-0001410 053-0001-0002586 -053-0001-0002587 053-0001-0003039 -053-0001-0003040 053-0001-0003061 -053-0001-0003065 053-0001-0003070 -053-0001-0003072 053-0001-0003079 -053-0001-0003085 _______ 053-0001-0005085_______ 053-0001-0005391 -053-0001-0005393 _______ 053-0001-0005472_______ 053-0001-0006778 -053-001-0006779 053-0001-0012164 -053-0001-0012166 053-0001-0012216 -053-0001-0012218 053-0001-0018569 -053-0001-0018585 053-0001-0018569 -053-0001-0018585 _______ 053-0001-0018921_______ 053-0001-0019206 -053-0001-0019207 053-0001-0019206 -053-0001-0019207 _______ 053-0001-0019235_______ 053-0001-0019280 -053-0001-0019281 053-0001-0019735 -053-0001-001819758 053-0001-0019735 -053-0001-0019758 _______ 053-0001-0026757_______ _______ 053-0001-0026758_______ _______ 053-0001-0026758_______ 053-001-0019259 -053-0001-0019260 053-0145-0000008 -053-0145-0000015 053-0169-0000788 -053-0169-0000789 053- 0169-0000788 -053-0169-0000789 _______ 053-0215-0005779_______ 054- 0001-0000203 -054-0001-0000205 054-0001-0000203 -054-0001-0000205 054-0001-0000228 -054-0001-0000230 054-0001-0000332 -054-0001-0000334 054-0001-0000341 -054-0001-0000342 054-0001-0000346 -054-0001-0000347 _______ 054-0001-0000517_______ _______ 054-0001-0000777_______ 054-0001-0001747 -054-0001-0001750 054-0001-0001891 -054-0001-0001904 054-0001-0012821 -054-0001-0012822 _______ 054-0001-0012907_______ _______ 054-0001-0013860_______ 054-0002-0000046 -054-0002-0000049 054-0002-0000534 -054-0002-0000544 Page 39 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 135 of 277 PAGEID #: 61136 Bates Numbered Documents 054-0002-0000545 -054-0002-0000604 054-0002-0000605 -054-0002-0000616 054-0002-000073 -054-0002-000082 054-0033-0000137 -054-0033-0000154 054-0033-0000298 -054-0033-0000332 054-0033-0001110 -054-0033-0001124 054-0033-0001127 -054-0033-0001129 054-0033-0001140 -054-0033-0001142 054-0033-0001243 -054-0033-0001250 054-0034-0000102 -054-0034-0000110 ______ 054-0142-0004361______ 054-0142-0006067 -054-0142-0006068 054-0169-0003269 -054-0169-0003273 054-0169-0003290 -054-0169-0003305 054-0169-0003320 -054-0169-0003342 054-0169-0004850 -054-0169-0004853 054-0169-0005603 -054-0169-0005606 054-0169-0005817 -054-0169-0005819 054-0169-0007105 -054-0169-0007161 054-0169-0008578 -054-0169-0008580 054-0169-0010489 -054-0169-0010495 054-0214-0000130 -054-0214-0000137 054-0214-0000215 -054-0214-0000215 054-0215-0002024 -054-0215-0002027 ______ 054-0353-0000001______ ______ 054-0353-0000017______ 054-0380-0000001 -054-0380-0000015 ______ 054-0388-0000001______ ______ 054-0392-0000001______ 058-0078-0000103 -058-0078-0000107 060-0001-0004483 -060-0001-0004485 ______ 060-0001-0009293______ 060-0001-0009707 -060-0001-0009708 060-0001-0014287 -060-0001-0014289 060-0001-0017421 -060-001-0017422 ______ 060-0001-0021541______ 060-0001-0022196 -060-0001-0022198 ______ 060-0001-0022735______ 060-0001-0022737 -060-0001-0022744 060-0001-0022824 -060-0001-0022828 060-0001-0022960 -060-0001-0022963 060-0001-0023000 -060-0001-0023001 060-0001-0023732 -060-0001-0023734 060-0001-0023760 -060-0001-0023762 060-0001-0023817 Page 40 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 136 of 277 PAGEID #: 61137 Bates Numbered Documents 060-0001-0024060 -060-0001-0024066 060-0001-0024203 -060-0001-0024205 060-0001-0024210 -060-0001-0024211 060-0001-0024283 -060-0001-0024284 060-0001-0032316 -060-0001-0032317 060-0001-0050334 -060-0001-0050338 060-0001-0050353 -060-0001-0050359 ______ 060-0001-0050599______ ______ 060-0001-0050626______ ______ 060-0001-0050626______ ______ 060-0001-0050636______ ______ 060-0002-00006153______ 060-0002-0001522 -060-0002-0001525 060-0002-0002180 -060-0002-0002218 ______ 060-0002-0006009______ ______ 060-0002-0006069______ 060-0002-0006306 -060-0002-0006308 ______ 060-0002-0011438______ 060-0002-0012843 -060-0002-0012848 060-0002-0012849 -060-0002-0012862 060-0002-0012876 -060-0002-0012878 060-0149-0003330 -060-0149-0003349 060-0149-0003331 -060-0149-000337 060-0149-0003338 -060-0149-0003349 060-0208-0000004 -060-0208-0000005 ______ 060-0208-0000006______ ______ 060-0208-0000007______ ______ 060-0208-0000008______ ______ 060-0208-0000009______ 060-0208-0000011; BJR000849 ______ 060-0208-0000012______ 060-0208-0000013; BJR000851 060-0208-0000014; BJR000852 ______ 060-0208-0000015______ ______ 060-0208-0000016______ ______ 060-0208-0000017______ 060-0208-0000018, BJR000856 060-0208-0000019; BJR000857 060-0208-0000020; BJR000858 060-0208-0000021; BJR000859 ______ 060-0219-0002884______ 060-0219-0002884; OEPA9150 060-0219-0002885 -060-0219-0002886 060-0219-0004494 -060-0219-0004496 060-0219-0004495 -060-0219-0004496 Page 41 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 137 of 277 PAGEID #: 61138 ________Bates Numbered Documents________ ______ 060-0219-0004769 -060-0219-0004771______ _____________ 060-0219-0005670_____________ _____________ 060-0235-0001656_____________ _____________ 060-0345-0000001_____________ _____________ 061-0001-0000011_____________ ______ 061-0001-0000012 -061-0001-0000013_______ ______ 061-0001-0000026 -061-0001-0000090______ ______ 061-0001-0000187 -061-0001-0000191______ ______ 061-0001-0000294-061-0001-0000295_______ ______ 061-0001-0000445 -061-0001-0000447______ ______ 061-0001-0000706 -061-0001-0000707______ _____________ 061-0001-0000712_____________ _____________ 061-0001-0001300_____________ _____________ 061-0001-0001393_____________ ______ 061-0001-0001509 -061-0001-0001513_______ ______ 061-0001-0002368-061-0001-0002369______ ______ 061-0001-0002368-061-0001-0002369______ ______ 061-0001-0002694-061-0001-0002701______ ______ 061-0001-0003522 -061-0001-0003523_______ ______ 061-0001-0004040 -061-0001-0004042______ ______ 061-0001-0004122 -061-0001-0004125_______ ______ 061-0001-0004275 -061-0001-0004276______ _____________ 061-00010004672_____________ _____________ 061-0001-0004748_____________ ______ 061-0001-0004765 -061-0001-0004768______ ______ 061-0001-0006508-061-0001-0006509______ ______ 061-0001-0007040 -061-0001-0007041______ ______ 061-0001-0007543 -061-0001-0007544______ _______ 061-0001-0007543-061-0001-0007544_______ ______ 061-0001-0007550 -061-0001-0007551______ ______ 061-0001-0007550 -061-0001-0007551______ _____________ 061-0001-0007611_____________ ______ 061-0001-0007831 -061-0001-0007833_______ ______ 061-0001-0007855 -061-0001-0007856______ ______ 061-0001-0007904-061-0001-0007905_______ ______ 061-0001-0007904-061-0001-0007905_______ ______ 061-0002-0000510 -061-0002-0000512______ ______ 061-0002-0000852 -061-0002-0000854______ ______ 061-0002-0000855 -061-0002-0000864______ ______ 061-0002-0001053 -061-0002-0001054______ ______ 061-0002-0001640 -061-0002-0001650______ 061-0002-0001982 -061-0002-0001984; 054-0001-0000228 _____________ 054-0001-0000230_____________ ______ 061-0082-0000274-061-0082-0000278______ 061-0158-0000237 Page 42 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 138 of 277 PAGEID #: 61139 Bates Numbered Documents 061- 0158-0001975 -061-0158-0001976 ______ 061-0236-0001223______ ______ 062-0001-0001000______ ______ 062-0001-0001001______ ______ 062-0001-0001004______ 062- 0001-0001015 -062-0001-0001016 062-0001-0001190 -062-0001-0001192 062-0001-0001193 -062-0001-0001194 062-0001-0001195 -062-0001-0001196 062-0074-0000363 -062-0074-0000367 ______ 062-0074-0000366______ 062-0074-0000392 -062-0074-0000402 062-0074-0001113 -062-0074-0001128 ______ 062-0149-0000325______ 062-0149-0000536 -062-0149-0000537 062-0149-0000755 -062-0149-0000757 062-0149-0000902 -062-0149-0000904 062-0149-0001062 -062-0149-0001063 ______ 062-0149-0002578______ ______ 062-0149-0002578______ ______ 062-0150-0000021______ ______ 062-0150-0000021______ ______ 062-0150-0000022______ 062-0150-0000050 -062-0150-0000056 062-0150-0000137 -062-0150-0000139 062-0169-0002666 -062-0169-0002665 062-0169-0002666 -062-0169-0002667 062-0169-0002680 -062-0169-0002684 062-0169-0002680 -062-0169-0002684 062-0169-0003085 -062-0169-0003088 ______ 062-0169-0003091______ 062-0169-0003092 -062-0169-0003095 062-0169-0005075 -062-0169-0005083 062-0215-0000403 -062-0215-0000404 ______ 062-0215-0000890______ ______ 062-0215-0001001______ ______ 062-0215-0001340______ ______ 062-0215-0004294______ 062- 0215-0004403 -062-0215-0004465 063- 0001-0000482 -063-0001-0000488 063-0001-0000489 -063-0001-0000490 ______ 063-0001-0001128______ ______ 063-0001-0001154______ 063-0001-0001270 -063-0001-0001273 Page 43 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 139 of 277 PAGEID #: 61140 ________Bates Numbered Documents________ 063-0001-0001410 -063-0001-0001411; 063-0001-0001331 _____________ 063-0001-0001332_____________ ______ 063-0001-0001942 -063-0001-0001943_______ ______ 063-0001-0002710 -063-0001-0002712_______ ______ 063-0001-0002829 -063-0001-0002830_______ ______ 063-0001-0002831 -063-0001-0002842_______ ______ 063-0001-0003117 -063-0001-0003118______ ______ 063-0001-0003740 -063-0001-0003746_______ ______ 063-0001-0003808-063-0001-0003809_______ _____________ 063-0001-0004306_____________ ______ 063-0001-0004465 -063-0001-0004467_______ ______ 063-0001-0004500 -063-0001-0004501_______ ______ 063-0001-0004906 -063-0001-0004919_______ ______ 063-0001-0004939 -063-0001-0004941_______ ______ 063-0001-0004942 -063-0001-0004945_______ ______ 063-0001-0004985 -063-0001-0004986_______ ______ 063-0001-0005112 -063-0001-0005116_______ ______ 063-0001-0005831 -063-0001-0005832_______ _____________ 063-0001-0005834_____________ _____________ 063-0001-0005835_____________ ______ 063-0001-0005880 -063-0001-0005892_______ ______ 063-0001-0006163 -063-0001-0006164______ ______ 063-0001-0006429 -063-0001-0006430_______ ______ 063-0001-0007062 -063-0001-0007064______ _____________ 063-0001-0007073_____________ ______ 063-0001-0007660 -063-0001-0007661_______ ______ 063-0001-0007974-063-0001-0007975_______ ______ 063-0001-0008075 -063-0001-0008076_______ ______ 063-0001-0008222 -063-0001-0008223_______ _______063-0001-0008403 -0630001-0008404_______ ______ 063-0001-0008869 -063-0001-0008871_______ ______ 063-0001-0009102 -063-0001-0009103_______ ______ 063-0001-0009190 -063-0001-0009197_______ ______ 063-0001-0009892 -063-0001-0009895______ ______ 063-0001-0010259 -063-0001-0010260_______ _____________ 063-0001-0010268_____________ 063-0001-0010269; 003-0001-0025133; 003-0001-0025132; _____________ 063-0001-0010268_____________ ______ 063-0002-0000009 -063-0002-0000011_______ _____________ 063-0002-0000659_____________ ______ 063-0002-0000682 -063-0002-0000730_______ ______ 063-0002-0000844-063-0002-0000850_______ ______ 063-0151-0002259 -063-0151-0002260_______ ______063-0151-00041402 -063-0151-00041403______ 063-0151-0005555 -063-0151-0005556 Page 44 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 140 of 277 PAGEID #: 61141 Bates Numbered Documents ______ 063-0151-0007708______ ______ 063-0151-0009648______ 063-0151-0010259 -063-0151-0010260 063-0151-0013718 -063-051-0013731 063-0151-0015726 -063-0151-0015727 063-0151-0015743 -063-0151-0015744 063-0151-0017153 -063-0151-0017188 ______ 063-0151-0024786______ ______ 063-0151-0025370______ ______ 063-0151-0025371______ 063-0151-0025372 -063-0151-0025375 ______ 063-0151-0027486______ 063-0151-0029672 -063-0151-0029673 ______ 063-0151-0029677______ ______ 063-0151-0029861______ ______ 063-0151-0030002______ ______ 063-0151-0030070______ 063-0151-0030394 -063-0151-0030395 063-0151-0032724 -063-0151-0032725 ______ 063-0151-0032978______ ______ 063-0151-0032979______ 063-0151-0032980 -063-0151-0032982 ______ 063-0151-0034126______ ______ 063-0151-0034769______ 063-0151-0034770 -063-0151-0034791 063-0151-0034770 -063-0151-0034791 063-0151-0034792 -063-0151-0034804 063-0151-0034851 -063-0151-0034866 063-0151-0036930 -063-0151-0036931 063-0151-0037345 -063-0151-0037346 063-0151-0037439 -063-0151-0037440 ______ 063-0151-0038411______ 063-0151-0038659 -063-0151-0038660 ______ 063-0151-0038661______ 063-0151-0038717 -063-0151-0038718 063-0151-0038719 -063-0151-0038720 ______ 063-0151-0038721______ 063-0151-0038782 -063-0151-0038783 063-0151-0038896 -063-0151-0038897 ______ 063-0151-0039781______ 063-0151-0039788 -063-0151-0039789 ______ 063-0151-0040674______ ______ 063-0151-0040677______ ______ 063-0151-0040899______ 063-0151-0041804 -063-0151-0041807 Page 45 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 141 of 277 PAGEID #: 61142 _____ Bates Numbered Documents_____ 063-0151-0042163 -063-0151-0042165 __________ 063-0151-0042875___________ __________ 063-0151-0045212__________ __________ 063-0151-0045638__________ __________ 063-0151-0045640__________ __________ 063-0151-0046057__________ __________ 063-0151-0046956__________ __________ 063-0151-0046957__________ 063-0151-0046958 -063-0151-0046964 063-0151-0046958 -063-0151-0046964 __________ 063-0151-0046965___________ 063-0151-0046968 -063-0151-0046970 063-0151-0046968 -063-0151-0046970 __________ 063-0151-0048144__________ 063-0151-0048450 -063-0151-0048451 __________ 063-0151-0048995___________ __________ 063-0151-0049167__________ __________ 063-0151-0049168__________ __________ 063-0151-0049284__________ __________ 063-0151-0049388__________ 063-0151-0049660 -063-0151-0049661 __________ 063-0151-0049767__________ 063-0151-0050722 -063-0151-0050723 __________ 063-0151-0050871__________ __________ 063-0151-0051581__________ 063-0151-0051965 -063-0151-0051969 063-0151-0052556 -063-0151-0052560 063-0169-0001256 -063-0169-0001279 063-0169-0005487 -063-0169-0005489; EID522970 ______ EID522972; SL001069 -SL001071______ __________ 066-0002-0000001__________ 066-0002-0000095 -066-0002-0000097 066-0002-0000528 -066-0002-0000535 __________ 066-0002-0001652__________ 066-0002-0001851 -066-0002-0001852 __________ 066-0002-0001853___________ 066-0002-0001860 -066-0002-0001863 066-0002-0002267 -066-0002-0002269 066-0002-0002417 -066-0002-0002420 066- 0002-0002955 -066-0002-0002957 067-0141-0017198 -067-0141-0017199 067-0141-0019219 -067-0141-0019221 067-0141-0029363 -067-0141-0029366 067-0237-0000134 -067-0237-0000136 067-0237-0000695 Page 46 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 142 of 277 PAGEID #: 61143 Bates Numbered Documents 070-0002-0000257 -070-0002-0000258 070-0002-0000276 -070-0002-0000282 070-0002-0000283 -070-0002-0000284 070-0002-0000451 -070-0002-0000453 ______ 070-0002-0000733______ ______ 070-0002-0000752______ ______ 070-0002-0001045______ ______ 070-0002-0001046______ 070-0002-0001180 -070-0002-0001202 070-0002-0001284 -070-0002-0001287 070-0002-0001288 -070-0002-0001289 070-0002-0001297 -070-0002-0001305 070-0002-0001629 -070-0002-0001632 070-0002-0001725 -070-0002-0001728 070-0002-0001803 -070-0002-0001828 070-0002-0001803 -070-0002-0001828 070-0002-0001897 -070-0002-0001899 070-0106-0000001 -070-0106-0000021 ________ 070-0140978________ ________ 070-0140978________ 075-0126-0000344 -075-0126-0000346 075-0144-0000052 -075-0144-0000054 075-0144-0000067 -075-0144-0000075 ______ 075-0144-0000357______ 075-0144-0000598 -075-0144-0000599 075-0144-0001848 -075-0144-0001850 075-0144-0002837 -075-0144-0002838 075-0144-0003072 -075-0144-0003073 ______ 075-0144-0003074______ ______ 075-0144-0004825______ 075-0144-0005163 -075-0144-0005164 ______ 075-0144-0005214______ ______ 075-0144-0006515______ ______ 075-0144-0008330______ ______ 075-0144-0008330______ ______ 075-0144-0008344______ 075-0144-0008355 -075-0144-0008357 ______ 075-0144-0008753______ 075-0144-0009744-075-0144-0009745 075-0144-0010634 -075-0144-0010636 ______ 075-0144-0010992______ 075-0144-0010993 -075-0144-0010994 ______ 075-0144-0011119______ ______ 075-0144-0011120______ 075-0144-0011158 Page 47 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 143 of 277 PAGEID #: 61144 Bates Numbered Documents 075-0144-0011163 -075-0144-0011164 ______ 075-0144-0011165______ ______ 075-0144-0011570______ 075-0144-0012180 -075-0144-0012182 075-0144-0013008 -075-0144-0013140 ______ 075-0144-0013431______ 075-0144-0013943 -075-0144-0013945 075-0144-0014202 -075-0144-0014203 ______ 075-0215-0001168______ ______ 075-0215-0001176______ ______ 075-0215-0001177______ 075-0215-0001178 -075-0215-0001179 075-0215-0001180 -075-0215-0001181 ______ 075-0237-0000665______ ______ 076-0154-0000513______ 080-0002-0000208 -080-0002-0000211 ______ 082-0002-0000009______ ______ 083-0001-0005541______ 083-0002-0000004 -083-0002-0000005 083-0002-0000004 -083-0002-0000005 083-0002-0000067 -083-0002-0000068 ______ 083-0002-0000075______ ______ 083-0002-0000076______ 083-0002-0000098 -083-0002-0000114 083-0002-0000116 -083-0002-0000117 083-0002-0000197 -083-0002-0000199 083-0002-0000203 -083-0002-0000204 083-0002-0000297 -083-0002-0000299 083-0159-0010731 -083-0159-0010735 083-0159-0011528 -083-0159-0011530 ______ 083-0159-0012405______ 083-0169-0002097 -083-0169-0002099 085-0243-0000059 -085-0243-0000060 087-0002-0000004 -087-0002-0000006 ______ 087-0112-0000002______ 087-0122-0000062 -087-0122-0000075 087-0164-0000678 -087-0164-0000679 ______ 087-0164-0001704______ ______ 087-0164-0002029______ 087-0171-0000511 -087-0171-0000512 ______ 087-0216-0000284______ ______ 087-0236-0000878______ 092-0163-0006584 -092-0163-0006585 092-0163-0006810 -092-0163-0006812 092-0163-0007334 -092-0163-0007335 Page 48 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 144 of 277 PAGEID #: 61145 Bates Numbered Documents 092-0163-0078439 -092-0163-0078441 092-0163-0090701 -092-0163-0090717 _______092-0245-029844_______ 104- 0107-0000482 -104-0107-0000484 105- 2009-0009282 -105-2009-0009299 108- 0317-0000368 -108-0317-0000395 109- 0001-0004854 -109-0001-0004856 109-0001-0004896 -109-0001-0004900 109-0162-0000212 -109-0162-0000214 ______ 109-0162-0000559______ 109-0162-0000564 -109-0162-0000565 109-0162-0000569 -109-0162-0000571 ______ 109-0162-0000651______ 109-0162-0000657 -109-0162-0000663 109-0162-0000657 -109-0162-0000663 109-0162-0000664 -109-0162-0000666 109-0162-0000850 -109-0162-0000853 ______ 109-0162-0000864______ 109-0162-0000868 -109-0162-0000869 ______ 109-0162-0000870______ 109-0162-0000871 -109-0162-0000872 109-0162-0000981 -109-0162-0000982 109-0162-0001160 -109-0162-0001161 109-0162-0001160 -109-0162-0001161 118-0000328 -118-0000336 118-0000611 -118-0000615 ________ 118-0000616________ 124-0226-0001644 -124-0226-0001673 139-0279-0000646 -139-0279-0000653 ______ 139-0346-0000004______ ______ 139-0346-0000006______ ______ 139-0352-0000002______ ______ 139-0354-0000003______ ______ 139-0358-0000001______ ______ 139-0358-0000001______ ______ 139-0358-0000002______ ______ 139-0358-0000004______ 139-0358-0000026 -139-0358-0000027 139-0358-0000027 -139-0358-0000035 139-0360-0000002 -139-0360-0000004 139-0360-0000005 -139-0360-0000006 ______ 139-0376-0000001______ ______ 139-0376-0000002______ 139-0381-0000001 -139-0381-0000037 139-0386-0000001 -139-0386-0000003 Page 49 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 145 of 277 PAGEID #: 61146 Bates Numbered Documents ______ 139-0389-0000001______ 139-0392-0000001 -139-0392-0000002 ______ 139-0395-0000001______ ______ 139-0397-0000001______ 139-0402-0000001 -139-0402-0000052 ______ 139-0404-0000001______ ______ 161-0339-0000005______ ______ 161-0339-0000006______ ______ 161-0339-0000009______ 161-0342-0000001 -161-0342-0000023 161-0348-0000004 -161-0348-0000006 161-0352-0000008 -161-0352-0000025 ______ 161-0353-0000002______ ______ 161-0353-0000005______ ______ 161-0353-0000006______ ______ 161-0353-0000007______ _______ 161-0353-000001_______ ______ 161-0353-0000042______ ______ 161-0353-0000047______ ______ 161-0353-0000048______ ______ 161-0353-0000050______ ______ 161-0357-0000001______ 161-0357-0000004 161-0357-0000005 161-0361-0000005 -161-0361-0000006 161-0390-0000008 -161-0390-0000010 161-0390-000001 -161-0390-000007 ______ 161-0390-0000011______ ______ 161-0390-0000012______ 161-0394-0000001 -161-0394-0000002 161-0394-0000010 -161-0394-0000013 161-0394-0000019 -161-0394-0000020 161-0399-0000025 -161-0399-0000026 161-0399-0000032 -161-0399-0000033 161-0399-0000036 -161-0399-0000053 ______ 161-0399-0000055______ ______ 161-0399-0000063______ 161-0399-0000067 -161-0399-0000068 161-0401-0000003 -161-0401-0000073 161-0403-0000001 -161-0403-0000004 161-0403-0000011 -161-0403-0000014 161-0403-0000015 -161-0403-0000016 161-0403-0000021 -161-0403-0000025 ______ 161-0403-0000047______ 161-0403-0000048 -161-0403-0000049 161-0403-0000128 -161-0403-0000133 Page 50 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 146 of 277 PAGEID #: 61147 Bates Numbered Documents ______ 169-0401-0000003______ 173-0394-0000010 -173-0394-0000023 ______ 173-0401-0000020______ 173-0403-0000001 -173-0403-0000002 173-0403-0000004 -173-0403-0000007 173-0403-0000008 -173-0403-0000013 _________ 176 -178_________ 196-2023-0000001 -196-2023-0000006 196-2023-0000007 -196-2023-0000010 196-2023-0000011 -196-2023-0000017 196-2023-0000018 -196-2023-0000024 196-2023-0000025 -196-2023-0000031 196-2023-0000032 -196-2023-0000037 196-2023-0000038 -196-2023-0000042 196-2023-0000043 -196-2023-0000047 196-2023-0000048 -196-2023-0000049 196-2023-0000050 -196-2023-0000055 196-2023-0000056 -196-2023-0000062 196-2023-0000063 -196-2023-0000068 196-2023-0000073 -196-2023-0000079 196-2023-0000080 -196-2023-0000085 196-2023-0000086 -196-2023-0000094 196-2023-0000095 -196-2023-0000101 196-2023-0000102 -196-2023-0000103 196-2023-0000104 -196-2023-0000112 196-2023-0000113 -196-2023-0000122 196-2023-0000123 -196-2023-0000130 196-2023-0000131 -196-2023-0000137 196-2023-0000138 -196-2023-0000152 196-2023-0000153 -196-2023-0000163 196-2023-0000164 -196-2023-0000176 ______ 196-2024-0000004______ ______ 196-2024-0000016______ 196-2024-0000017 -196-2024-0000042 196-2024-0000043 -196-2024-0000045 ______ 196-2024-0000051______ ______ 196-2024-0000052______ 196-2024-0000078 -196-2024-0000126 196-2024-0000128 -196-2024-0000132 ______ 196-2024-0000133______ ______ 196-2024-0000137______ 196-2024-0000138 -196-2024-0000158 196-2024-0000159 -196-2024-0000160 196-2024-0000161 -196-2024-0000167 196-2024-0000168 -196-2024-0000172 Page 51 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 147 of 277 PAGEID #: 61148 ________Bates Numbered Documents_______ _______ 196-20240000173 -196-20240000178_______ ______ 196-2024-0000179 -196-2024-0000182______ ______ 196-2024-0000183 -196-2024-0000186______ ______ 196-2024-0000187 -196-2024-0000211______ ______ 196-2024-0000212 -196-2024-0000308______ ______ 196-2024-0000309 -196-2024-0000323______ ______ 196-2024-0000324-196-2024-0000325______ ______ 196-2024-0000326 -196-2024-0000327______ _______ 196-2024-000048 -196-2024-0000050_______ ______ 196-2025-0000001 -196-2025-0000004______ ______ 196-2025-0000005 -196-2025-0000006______ ______ 196-2025-0000007 -196-2025-0000008______ ______ 196-2025-0000009 -196-2025-0000011______ ______ 196-2025-0000012 -196-2025-0000013______ _____________ 196-2025-0000014_____________ ______ 196-2025-0000016 -196-2025-0000017______ ______ 196-2025-0000018-196-2025-0000019______ ______ 196-2025-0000020 -196-2025-0000022______ ______ 196-2025-0000023 -196-2025-0000024______ ______ 196-2025-0000025 -196-2025-0000027______ ______ 196-2025-0000028-196-2025-0000031______ ______ 196-2026-0000001 - 196-2026-0000004______ ______ 196-2026-0000005 -196-2026-0000006______ ______ 196-2026-0000007 -196-2026-0000008______ _____________ 196-2026-0000009_____________ _____________ 196-2026-0000010_____________ ______ 196-2026-0000011 -196-2026-0000012______ ______ 196-2026-0000013 -196-2026-0000016______ 207 -211;GHS008474 -GHS008478; EID724910 -EID724914 3MA00405138 -3MA00405151; ROWE005095 -ROWE005108 3MA00405152 -3MA00405169; ROWE004954 -ROWE004971 3MA00405152 -3MA00405169; ROWE004972 -ROWE004989 3MA00749384 -3MA00749681; ROWE010543 -ROWE010840 3MA10067228 -3MA10067230; ROWE010540 -ROWE010542 ________ AC009647 -AC009653________ AEL000349 -AEL00067; EID716602 -EID716620 AEL000386 -AEL000391; EID16639 -EID16644 AEL000399 -AEL000407; EID716652 -EID716660 AEL000417 -AEL000420; EID716670 -EID716673 Page 52 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 148 of 277 PAGEID #: 61149 ________ Bates Numbered Documents________ AEL000436 -AEL000442; EID716689 - EID716695 AEL000523 -AEL0000553; EID716776 -EID716806 ____________ AJP001628; EID924233 AJP002394 -AJP002395; USEPA8842 -USEPA884 ____________ AJP003042-AJP003047 AJP005297 -AJP005303; EID117492 -EID117498 AJP009997 -AJP010005; EID521393 -EID521401 AJP009997 -AJP010005; EID521393 -EID521401 AJP010006 -AJP010007; EID521402 -EID521403 AJP010006 -AJP010007; EID521402 -EID521403 AJP010008 -AJP010009; EID521404-EID521405 AJP010008 -AJP010009; EID521404-EID521405 AJP010008 -AJP010009; EID521404-EID521405 ____________ AJP010232; EID603747 AJP010251 -AJP010255; EID603766 -EID603770 AJP010259 -AJP010260; EID603774-EID603775 AJP010285 -AJP010286; EID603800 -EID603801 ____________ AJP010344-AJP010345 ____________ AJP010351-AJP010352 AR226-1865-1867; AR226-1869; AR226-1899; 279325; MR279024; EID713127 -EID713135; EID584159 -EID584186 EID584204; EID080233 -EID080233;AJP001418 -AJP001419; GK000378 -GK000379; EID080214-EID080215;AJP001399 AJP001400; EID102509 -EID102534;WEF000076 WEF000101; LE5954 -LE5957; SL001108 -SL001120; EID523009 -EID523021; EID106191 -EID106205;WEF000116 WEF000130; EID090076 -EID090085;AJP002917 -AJP002923; AJP002926 -AJP002928; EID079371 -EID079375;AJP002509 AJP002511; EID871401 -EID871410; EID166599 -EID166608 ASH010156; ASH010159 -ASH010161 -ASH010164; ________ USEPA14989 -USEPA14994________ ASH014657 -ASH014660; EID192527 -EID192530 _____________ASH016201_____________ _________AVM000426; EID918750_________ AVM010257 -AVM010259; EID717936 -EID717938 AVM010433 -AVM010440; EID718110 -EID718117 AVM011080 -AVM011081; EID718742 -EID718743 AVM011149 -AVM011171; EID7188805 -EID718827 AVM011183 -AVM011186; EID718838 -EID718841 AVM011207 -AVM011208; EID718862 -EID718863 BEAUCHAMP000020 -BEAUCHAMP000021 __________ BEAUCHAMP000031__________ BEAUCHAMP000038 -BEAUCHAMP000042 Page 53 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 149 of 277 PAGEID #: 61150 ____ Bates Numbered Documents _________ BEAUCHAMP000072_________ BLD000087 -BLD000089; EID209529 -EID209531 BLD003307 -BLD003315; EID521998 -EID522006 BLD003332 -BLD003333; EID522023 -EID522024 BLH000021 -BLH000023; EID603879 -EID603881 ________ BLH000034 -BLH000035________ CAB000300 -CAB000308; EID719372 -EID719380 CF018853 -CF018856; EID181068-EID181071 _________ CF036835 -CF036878_________ _________ CF037249 -CF037250_________ CHK000001 -CHK000006; EID604186 -EID604191 ________ CMB000459; EID215645________ CS000737 -CS000764; EID089043 -EID089070 DDJ001712 -DDJ001719; EID510244-EID510251 ____________ DDJ006904____________ ________ DDJ008103 -DDJ008108________ ________ DDJ009041; EID604811_________ ________ DDJ009397; EID720342_________ ________ DDJ009398; EID720343_________ ________ DDJ009408 -DDJ009409________ DDJ009432 -DDJ009433; EID720377 -EID720378 _________ DE000274;EID909818_________ DFA006722 -DFA006723; EID720457 -EID720458 ________ DFA006725;EID720460________ DMR018545 -DMR018552; EID720690 -EID720697 DMR019635 -DMR019662; EID721776 -EID721803 _______ DMR020403 -DMR020408_______ ________ DMR034127; EID794564________ DMR034508 -DMR034509; EID794914 -EID794915 DPL000017 -DPL000019; EID713572 -EID713574 _________DPL000042; EID713597________ _________ DPL000043; EID13598_________ DPL000156 -DPL000165; EID713700 -EID713709 DPL000206 -DPL000210; EID713750 -EID713754 DPL000211 -DPL000213; EID713755 -EID713757 _________DPL000219; EID713763_________ DPL000226- DPL000231; EID713770 -EID713775 DPL000250 -DPL000258; EID713793 -EID713801 DPL000250 -DPL000258; EID713793 -EID713801 DPL000260 -DPL000272; EID713802 -EID713814 _______ DPZ0332640 -DPZ0332650_______ DPZ033265; DPZ0332652 -DPZ0332653 _______ DPZ0332751 -DPZ0332789_______ _______ DPZ0332751 -DPZ0332789_______ DPZ0338890 -DPZ0338896 Page 54 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 150 of 277 PAGEID #: 61151 _______Bates Numbered Documents_______ __________ DUP000987; EID123133__________ DUP000989 -DUP000991; EID071855 -EID071857 DWS1036528 -DWS1036529; HLAB003912 -HLAB003913; ___________EID123463 -EID123464___________ DWS1036530 -DWS1036532; EID071855 -EID071857; __________ DUP000989 -DUP000991__________ _________ EDD0013043 -EDD0013044_________ _________ EDD0013496 -EDD0013497_________ _________ EDD0013498 -EDD0013499_________ _________ EDD0017605 -EDD0017647_________ ______________ EDD0017672______________ _________ EDD0017685 -EDD0017729_________ ______________ EDD0018037______________ ______________ EDD0020382______________ ______________ EDD0023058______________ _________ EDD0025578 -EDD0025603_________ _________ EDD0025633 -EDD0025635_________ ______________ EDD0025666______________ _________ EDD0025696 -EDD0025717_________ ______________ EDD0025754______________ ______________ EDD0025792______________ _________ EDD0025794 -EDD0025795_________ ______________ EDD0025805______________ _________ EDD0029187 -EDD0029188_________ ______________ EDD0029352______________ _________ EDD0029457 -EDD0029461_________ _________ EDD0029531 -EDD0029533_________ ______________ EDD0029719______________ ______________ EDD0029720______________ _________ EDD0030720 -EDD0030723_________ _________ EDD0030832 -EDD0030836_________ _________ EDD0031057 -EDD0031134_________ _________ EDD0032428 -EDD0032437_________ ______________ EDD0032459______________ ______________ EDD0032530______________ _________ EDD0034838; EDD0053985_________ ______________ EDD0036870______________ _________ EDD0037501 -EDD0037502_________ ______________ EDD0038069______________ ______________ EDD0038481______________ _________ EDD0039236 -EDD0039259_________ _________ EDD0040293 -EDD0040294_________ ______________ EDD0040516______________ _________ EDD0040583 -EDD0040584_________ EDD0040817 -EDD0040818 Page 55 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 151 of 277 PAGEID #: 61152 Bates Numbered Documents _______ EDD0040935_______ EDD0041002 -EDD0041003 _______ EDD0041115_______ _______ EDD0041201_______ _______ EDD0041202_______ _______ EDD0041203_______ EDD0041296 -EDD0041297 EDD0041303 -EDD0041304 EDD0041340 -EDD0041341 _______ EDD0047524_______ EDD0048763 -EDD48764 _______ EDD0052262_______ EDD0052575 -EDD0052576 _______ EDD0053400_______ _______ EDD0053811_______ _______ EDD0053985_______ EDD0054275 -EDD0054312 _______ EDD0058879_______ EDD0059977 -EDD0059978 EDD0064077 -EDD0064096 EDD0064573 -EDD0064617 EDD0064618 -EDD0064665 EDD0065093 -EDD0065124 EDD0065933 -EDD0065936 EDD0066018 -EDD0066026 EDD0069422 -EDD0069424 _______ EDD0069533_______ _______ EDD0069702_______ EDD0069863 -EDD0069864 _______ EDD0070085_______ _______ EDD0070264_______ EDD0070290 -EDD0070294 _______ EDD0070679_______ _______ EDD0070715_______ _______ EDD0071319_______ _______ EDD0071329_______ EDD0071408 -EDD0071409 _______ EDD0071711_______ EDD0071765 -EDD0071767 EDD0071768 -EDD0071769 EDD0071832 -EDD0071833 EDD0072219 -EDD0072220 _______ EDD0072286_______ _______ EDD0072289_______ EDD0072377 -EDD0072378 Page 56 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 152 of 277 PAGEID #: 61153 ______ Bates Numbered Documents______ _________ EDD0072486 -EDD0072489_________ _________ EDD0072506 -EDD0072508_________ EDD0072617 -EDD0072622; EDD0072648 -EDD0072649 _____________ EDD0072900_____________ _________ EDD0072939 -EDD0072951_________ _____________ EDD0073329_____________ _________ EDD0073366 -EDD0073368_________ _____________ EDD0073522_____________ _____________ EDD0073854_____________ _____________ EDD0073854_____________ _____________ EDD0073970_____________ _____________ EDD0073970_____________ _____________ EDD0074006_____________ _____________ EDD0075341_____________ _________ EDD0075365 -EDD0075370_________ _________ EDD0075378 -EDD0075391_________ _________ EDD0075677 -EDD0075695_________ _________ EDD0076050 -EDD0076051_________ _________ EDD0076050 -EDD0076051_________ _________ EDD0076180 -EDD0076185_________ _________ EDD0076245 -EDD0076247_________ _________ EDD0076245 -EDD0076247_________ _____________ EDD0076288_____________ _____________ EDD0076288_____________ _____________ EDD0076288_____________ _____________ EDD0076369_____________ _____________ EDD0076369_____________ _________ EDD0076385 -EDD0076386_________ _____________ EDD0076388_____________ _________ EDD0076442 -EDD0076445_________ _____________ EDD0076605_____________ _____________ EDD0076764_____________ _____________ EDD0076791_____________ _____________ EDD0076804_____________ _____________ EDD0076808_____________ _____________ EDD0076808_____________ _____________ EDD0076831_____________ _____________ EDD0076839_____________ _____________ EDD0076852_____________ _____________ EDD0076876_____________ _____________ EDD0076877_____________ _____________ EDD0076880_____________ _____________ EDD0076881_____________ _____________ EDD0076883_____________ EDD0076995 Page 57 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 153 of 277 PAGEID #: 61154 Bates Numbered Documents _______ EDD0077002_______ EDD0077229 -EDD0077234 _______ EDD0077316_______ EDD0077455 -EDD0077465 _______ EDD0077485_______ _______ EDD0077485_______ _______ EDD0077532_______ EDD0078223 -EDD0078224 EDD0078223 -EDD0078224 _______ EDD0078225_______ _______ EDD0078228_______ _______ EDD0078308_______ _______ EDD0078308_______ _______ EDD0078308_______ EDD0078312 -EDD0078313 _______ EDD0078793_______ _______ EDD0078793_______ _______ EDD00788225_______ _______ EDD0078997_______ _______ EDD0078997_______ EDD0079155 -EDD0079157 EDD0079158 -EDD0079159 _______ EDD0079181_______ _______ EDD0079181_______ EDD0079199 -EDD0079200 _______ EDD0079253_______ _______ EDD0079253_______ EDD0079559 -EDD0079585 EDD0079587 -EDD0079619 EDD0079587 -EDD0079619 EDD0079620 -EDD0079651 EDD0079620 -EDD0079651 EDD0080020 -EDD0080063 EDD0080020 -EDD0080063 _______ EDD0080154_______ _______ EDD0080154_______ EDD0080907 -EDD0080949 EDD0081245 -EDD0081419 _______ EDD0081421_______ EDD0081423 -EDD0081631 EDD0081768 -EDD0081798 EDD0081768 -EID0081798 EDD0081935 -EDD0082144 EDD0091226 -EDD0091268 EDD0091548 -EDD0091557 Page 58 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 154 of 277 PAGEID #: 61155 ________ Bates Numbered Documents________ ____________EDD303759 -EID303760 _______________ EDD397484 ____________ EID007534-EID007535 _______________ EID0077532 ________________ EID007976 EID009818-EID009823; RLR001835 -RLR001840 ________________ EID010289 ____________ EID010448; RLR000536 EID017446 -EID017447; RLR001040 -RLR001041 EID017452 -EID017454; RLR001006 -RLR001008 EID017457 -EID017457; RLR000818 -RLR000819 EID018445 -EID018446; LKI000066 -LKI000067; ENV0006163 _______________ ENV0006164 ____________ EID022224-EID022225 EID071353 -EID071357;JMM002365 -JMM002369 ____________EID071527; DUP000598 EID071660 -EID071675; DUP000729 -DUP000743 EID071660; DUP000729; EID071662; DUP000730; EID071663; DUP000731; EID071664; DUP000732; EID071665; DUP000733; EID071666; DUP000734; EID071667; DUP000735; EID071668; DUP000736; EID071669; DUP000737; EID071670; DUP000738; EID071671; DUP000739; EID071672; DUP000740; EID071673; DUP000741; EID071674; DUP000742; EID071675; _______________ DUP000743; ____________EID071704; DUP000772 EID071705 -EID071706; DUP000773 -DUP000774 EID071705 -EID071706; DUP000773 -DUP000774 EID071705 -EID071706; DUP000773 -DUP000774 EID071705 -EID071706; DUP000773 -DUP000774 ____________EID071707; DUP000775 EID071712 -EID071713; DUP000779 -DUP000780 EID071712 -EID071713; DUP000779 -DUP000780 ____________EID071717; DUP000814 ____________EID071734; DUP000860 ________________ EID071865 ____________ EID071866 -EID071905 ____________ EID071934; EID071935 ____________ EID072032 -EID072033 ____________ EID072046 -EID072051 ________________ EID072052 EID072164 -EID072166; DUP000574 -DUP000576 ____________EID072167; DUP000578 EID072168 -EID072176; DUP000579 -DUP000587 ____________EID072183; DUP000783 Page 59 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 155 of 277 PAGEID #: 61156 ________Bates Numbered Documents________ ___________ EID072185; DUP000785____________ ___________ EID072185; DUP000785____________ ___________ EID072186; DUP000786____________ ___________ EID072186; DUP000786____________ EID072196 -EID072199; DUP001001 -DUP001004 ________________EID072214________________ ________________EID072215________________ ____________EID072216 -EID072233____________ ________________EID072234________________ ________________EID072240________________ EID072278-EID72281; RLR003002 -RLR003005 ________________EID072367________________ EID072378 -EID072380; GW007426 -GW0007428 ____________ EID072531;AJP000027____________ ____________ EID072968;AJP000563____________ ____________EID076048 -EID076051____________ ___________ EID076894; RLR002852____________ ____________EID076926; RLR002898____________ EID077233 -EID077236;AJP003805 -AJP003808 EID077237 -EID077262;AJP003809-AJP003834 EID077263 -EID077268;AJP003835 -AJP003840 EID077553 -EID077576;AJP003140 -AJP003163 EID077553 -EID077576;AJP003140 -AJP003163 EID077577 -EID077578;AJP003165 -AJP003166 EID077579 -EID077580;AJP003169 -AJP003170 EID077579 -EID077580;AJP003169 -AJP003170 ____________ EID077622;AJP003241____________ EID077623 -EID077624;AJP003242 -AJP003243 EID077625 -EID077646;AJP003244 -AJP003265 EID077676 -EID077680;AJP003406 -AJP003410 EID077720 -EID077733;AJP003452 -AJP003465 ____________EID077758; DFA000031____________ EID078567 -EID078571; RJZ004937 -RJZ004941 ____________ EID078581; RJZ004947____________ ____________ EID078689; RJZ005066____________ ____________ EID078719; RJZ005098____________ ____________ EID078719; RJZ005098____________ EID078738 -EID078739; RJZ005154-RJZ005155 ____________ EID078738; RJZ005154____________ ____________ EID078739; RJZ005155____________ EID078752 -EID078777; RJZ005372 -RJZ005397 EID078779 -EID078780; RJZ005408-RJZ005409 EID078781 -EID078784; RJZ005426 -RJZ005429 EID078781 -EID078784; RJZ005426 -RJZ005429; EID078784- EID078801; RJZ005445 -RJZ005446 Page 60 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 156 of 277 PAGEID #: 61157 Bates Numbered Documents EID078781 -EID078799; RJZ005426 -RJZ005444 EID078812 -EID078814; RJZ006502 -RJZ006504 ____________EID078867____________ EID078877 -EID078878; RJZ007143 -RJZ007146 ____________EID079034____________ ________ EID079036; RJZ009056________ EID079049 -EID079057; RJZ009070 -RJZ009078 ________ EID079066; RJZ009087________ ________ EID079084; RJZ009105________ ________ EID079089; RJZ009206________ ____________EID079090____________ EID079091 -EID079094; RJZ009208-RJZ009211 EID079096 -EID079100; RJZ009213 -RJZ009218 EID079099 -EID079100; RJZ009217 -RJZ009218 ____________EID079102____________ ________ EID079102; RJZ009220________ EID079107 -EID079108; RJZ009226 -RJZ009228 EID079110 -EID079118; RJZ009253 -RJZ009261 ____________EID079124____________ EID079134 -EID079140; RJZ009711 -RJZ009716 EID079154 -EID079158; RJZ009758-RJZ009762 EID079177 -EID079182; RJZ009794-RJZ009799 EID079183 -EID079189; RJZ009800 -RJZ009806 ________ EID079198; RJZ009815________ EID079200 -EID079202; RJZ009817 -RJZ009819 EID079212 -EID079218; RJZ009828-RJZ009834 ____________EID079219____________ EID079256 -EID079257; RJZ009901 -RJZ009902 EID079258-EID079259; EID079269 ____________EID079261____________ ________ EID079268; RJZ010046________ ________EID079269 -EID079270________ ________EID079271 -EID079272________ ____________EID079273____________ EID079274 -EID079276; AJP002397-AJP002399 EID079277 -EID079281;AJP002400 -AJP002404 EID079287 -EID079292;AJP002414 -AJP002419 EID079294 -EID079296; AJP002432-AJP002434 ________ EID079309;AJP002447________ EID079310;AJP002448; EID571588-EID571591 EID079349 -EID079352;AJP002487 -AJP002490 ________ EID079367;AJP002505________ EID079371 -EID079375;AJP002509-AJP002511 EID079371 -EID079375;AJP002509-AJP002511 EID079375 Page 61 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 157 of 277 PAGEID #: 61158 Bates Numbered Documents EID079375 EID079375 EID079375 EID079399 -EID079418; AJP002552 -AJP002571 EID079419 -EID079421; AJP002585 -AJP002587 EID079423 -EID079497; AJP002593 -AJP002667 EID079434-EID079438; AJP002604-AJP002608 EID079507 -EID079508; AJP002834-AJP002835 EID079519 -EID079521; AJP002847-AJP002849 EID079520; AJP002848 EID079521; AJP002849 EID079522 -EID079530; AJP002850-AJP002858 EID079531 -EID079539; AJP002859-AJP002867 EID079538-EID079539; AJP002866-AJP002867 EID079541; AJP002869 EID079544-EID079550; AJP002872-AJP002878 EID079547 -EID079550; AJP002875 -AJP002878 EID079554 -EID079563; RJZ009764 -RJZ009764-RJZ009773 EID079567 -EID079576; AJP002882-AJP002891 EID079603 -EID079606; AJP002940-AJP002943 EID079607 -EID079612; AJP002944-AJP002949 EID079613 -EID079626; AJP002950-AJP002963 EID079631 EID079633 EID079641 -EID079642; AJP002267-AJP002268 EID079682 -EID079684;AJP002312 -AJP002314 EID079685, EID079694, EID079695, EID079701 EID079735 -EID079736; AJP002366-AJP0079736 EID079740 -EID079754; AJP002371-AJP002385 EID079758-EID079759; AJP002389-AJP002390 EID079829 -EID079832; AJP002223 -AJP002248 EID079930; AJP001868 EID079945 -EID079954; AJP001886-AJP001895 EID080125 EID080127 -EID080128;AJP001522 EID080167 EID080169 EID080180 -EID080188; AJP001365 -AJP001373 EID080214-EID080215; AJP001399-AJP001400 EID080214-EID080217; AJP001399-AJP001402 EID080223 -EID080225; AJP001408-AJP001410 EID080229 -EID080231; AJP001414-AJP001416 EID080233 -EID080234; AJP001418-AJP001419 EID080233 -EID080234; AJP001418-AJP001419 EID080236 -EID080240; AJP001421-AJP001425 EID080241 -EID080246; AJP001426-AJP001431 Page 62 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 158 of 277 PAGEID #: 61159 Bates Numbered Documents EID080253 -EID080254;AJP001438 -AJP001439 ________ EID080266;AJP001451________ EID080267 -EID080270;AJP001452 -AJP001455 EID080271 -EID080285;AJP001456 -AJP001470 EID080531 -EID080533;AJP001131-AJP001133 EID080543 -EID080547;AJP001143 -AJP001147 EID080591 -EID080592;AJP001191 -AJP001192 EID080601 -EID080611;AJP001201 -AJP001211 EID080604-EID080611;AJP001204 -AJP001211 ________ EID080630;AJP001230________ ________ EID080632;AJP001232________ ________ EID080633;AJP001233________ EID080635 -EID080636;AJP001235 -AJP001236 EID080637 -EID080644;AJP001237 -AJP001244 ________ EID080657;AJP001257________ ________ EID080662;AJP001262________ EID080677 -EID080692;AJP001277 -AJP001292 ________ EID080693;AJP001293________ ________ EID080694;AJP001294________ EID080695 -EID080706;AJP001295 -AJP001306 EID080707 -EID080709;AJP001307 -AJP001309 EID080710 -EID080711;AJP001310 -AJP001311 EID080748-EID080756;AJP001347 -AJP001355 EID080757 -EID080764;AJP001356 -AJP001363 ________ EID080797 -EID080801________ EID080797 -EID080801; GW006836 -GW006840 ________ EID080803; LK1001393________ EID081573 -EID081598;JLO000305 -JLO000330 EID082037 -EID082047; RJZ015393 -RJZ0153403 EID082048 -EID082051; RJZ015405 -RJZ015407 ________ EID082077; RJZ015499________ EID082081 -EID082090; RJZ015511 -RJZ015521 ________EID0821132 -EID821136________ EID082729 -EID082731; BSD000199 -BSD000201 EID083053 -EID083064; RP000737 -RP000748 EID083053 -EID083064; RP000737 -RPP000748 ________ EID083372 -EID083407________ EID086275; RJZ013179 -EID086276; RJZ013180 EID086677 -EID086680; RCG000014 -RCG000017 EID086677 -EID086680; RCG000014 -RCG000017 EID086681 -EID086682; RCG000018 -RCG000019 EID086757 -EID086768; RCG000094 -RCG000105 EID086757 -EID086768; RCG000094 -RCG000105 EID086757 -EID086768; RCG000094 -RCG000105 EID086784-EID086796; RCG000121 -RCG000133 Page 63 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 159 of 277 PAGEID #: 61160 ______ Bates Numbered Documents______ EID086797 -EID086803; RCG000134 -RCG000140 EID086812 -EID086820; RCG000149 -RCG000157 EID086821 -EID086834; RCG000158 -RCG000171 ______________ EID087006______________ __________ EID087238-EID087254__________ ______________ EID087412______________ __________ EID087880; HDR001824__________ EID088521 -EID088528; RV000914 -RV000921 EID088672 -EID088696; GWJ000091 -GWJ000115 __________ EID088847; GWJ000305__________ ________________EID089________________ EID089300 -EID089303; DDJ001536 -DDJ001539 ______________ EID089310______________ ______________ EID089407______________ ______________ EID089418______________ ______________ EID089418______________ ______________ EID089421______________ EID089443 -EID089448; DDJ001701 -DDJ001706 EID089449 -EID089453; DDJ001707 -DDJ001711 EID089462 -EID089463; DDJ001720 -DDJ001721 __________ EID089464-EID089466__________ __________ EID089515; HDR001920__________ __________ EID089743 -EID089745__________ EID090073 -EID090075;AJP002935 -AJP002937 EID090076 -EID090085;AJP002917 -AJP002928 EID090076 -EID090085;AJP002917 -AJP002928 EID091316 -EID091317; RJZ026696 -RJZ026697 EID091340 -EID091354; RJZ026743 -RJZ026757 EID091378 -EID091402; RJZ02655 -RJZ02668; RJZ02670 ______________ RJZ026580______________ ___________EID091388; RJZ026565___________ ______________ EID091591______________ EID092770 -EID092810; RJZ021593 -RJZ021633 EID093140 -EID093147; RJZ020573 -RJZ020588 EID096399 -EID096406;AJP003848 -AJP003855 __________ EID096447; BWK000012__________ EID096449 -EID096450; BWK000014 -BWK000015 EID096449 -EID096450; BWK000014 -BWK000015 __________ EID096456; BWK000021__________ EID096458-EID096459; BWK000023 -BWK000024 __________ EID096464; BWK000104__________ EID096465 -EID096472; BWK000105 -BWK000112 EID096478-EID096480; BWK000118 -BWK000120 __________ EID096481; BWK000121__________ __________ EID096481; BWK000121__________ Page 64 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 160 of 277 PAGEID #: 61161 ________ Bates Numbered Documents________ EID096482 -EID096483; BWK000127 -BWK000128 ____________EID096486; BWK000131___________ EID096487 -EID096491; BWK000132 -BWK000136 ____________EID096492; BWK000137___________ EID096494-EID096495; BWK000139 -BWK000140 EID096494-EID096495; BWK000139 -BWK000140 EID096496 -EID096502; BWK000141 -BWK000147 ____________EID096503; BWK000148___________ EID096504-EID096508; BWK000150 -BWK000154 ________EID096510 -EID096511; BWK000157________ ________ EID096510; EID096511: BWK000157________ ____________EID096514; BWK000160___________ ____________EID096515; BWK000161___________ EID096516 -EID096519; BWK000162 -BWK000165 EID096523 -EID096525; BWK000172 -BWK000174 EID097177 -EID097185; RAM000001 -RAM000009 ____________EID097177; RAM000001___________ ____________ EID098719;JW000048____________ EID099433 -EID099434; BJR000090 -BJR000091 ____ EID099795 -EID099796; GK000521 -GK000522 ____________ EID101453 -EID101496____________ ____ EID101656 -EID101662; GK001607 -GK001613 ____ EID102117 -EID102121; GK002312 -GK002316 _____ EID102174-EID102175; GK002377 -GK2378_____ ____________ EID102437; BR000086____________ EID102439 -EID102471;WEF000002 -WEF000034 ____________ EID102477; WEF000044____________ EID102478-EID102507;WEF000045 -WEF000074 EID102508-EID102534;WEF000075 -WEF000101 EID102509 -EID102534;WEF000076 -WEF000101 EID102509; WEF000076; EID102510;WEF000077; EID102511; WEF000078; EID102512;WEF000079; EID102513; WEF000080;EID102514; WEF000081; EID102515; WEF000082; EID102516;WEF000083; EID102517; WEF000084; EID102518;WEF000085; EID102519; WEF000086; EID102520;WEF000087; EID102521; WEF000088;;EID102522;WEF000089; EID102523; WEF000090; EID102524;WEF000091; EID102525; WEF000092; EID102526;WEF000093; EID102527; WEF000094; EID102528;WEF000095; EID102529; WEF000096; EID102530;WEF000097; EID102531; WEF000098; EID102532;WEF000099; EID102533; _______ WEF000100; EID102534;WEF000101;_______ ____________ EID102539; RRS000004____________ EID102616 -EID102624; RRS000087 -RRS000095 Page 65 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 161 of 277 PAGEID #: 61162 ________ Bates Numbered Documents________ EID102770 -EID102771;AVM000200 -AVM000201 ___________ EID102770; AVM000200___________ EID102777 -EID102781;AVM000213 -AVM000217 EID102805 -102817; AVM000242 -AVM000254 ___________ EID102805; AVM000242___________ EID102806 -EID102817;AVM000243 -AVM000254 ____________ EID102984; ASH010015____________ ________________ EID103018________________ ____________ EID103020 -EID103023____________ EID103027 -EID103031; ASH010172 -ASH010177 EID103032 -EID103035; ASH010179 -ASH010182 ________________ EID103379________________ EID104354 -EID104356; ASH008956 -ASH008958 ____ EID104879 -EID104880; RL000133 - RL000134____ _____ EID104924 -EID104931; RL000191 RL000197_____ _____EID104960 -EID104968; RL000258 -RL000266_____ EID104960; RL000258; EID104961; RL000259; EID104962; RL000260; EID104963; RL000261; EID104964; RL000262; EID104965; RL000263; EID104966; RL000264; EID104967; _________ RL000265;EID104968; RL000266_________ _____EID104969 -EID104977; RL000267 -RL000275_____ EID104969; RL000267; EID104970; RL000268; EID104971; RL000269; EID104972; RL000270; EID104973; RL000271; EID104974; RL000272; EID104975; RL000273; EID104976; _________ RL000274;EID104977; RL000275_________ ____ EID106039 -EID106046; RB000010 -RB000017____ ____ EID106039 -EID106046; RB000010 -RB000017____ EID106191 -EID106195; WEF000116 -WEF000120; EID106180; EID106215;WEF000105; WEF000167 ____________ EID106191 -EID106205____________ EID106191; WEF000116; EID106192; WEF000117; EID106193; WEF000118; EID106194; WEF000119; EID106195; WEF000120; EID106196; WEF000121; EID106197; WEF000122; EID106198; WEF000123; EID106199; WEF000124; EID106200; WEF000125; EID106201; WEF000126; EID106202; WEF000127; EID106203; WEF000128; EID106204; WEF000129; EID106205; WEF000130; EID924540; AJP002916; EID924541;AJP002926; EID924542; AJP002927; EID924543; AJP002928; EID924544; AJP002929; EID924545; AJP002930; EID079375 EID106206 -EID106212;WEF000131 -WEF000137 EID106216 -EID106223;WEF000168 -WEF000175 EID106225 -EID106275;WEF000177 -WEF000227 EID106336 -EID106340;WEF000288 -WEF000292 Page 66 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 162 of 277 PAGEID #: 61163 ________ Bates Numbered Documents________ ____________EID106354; WEF000308____________ EID106418 -EID106428;WEF000372 -WEF000382 EID106418; WEF000372; EID106419; WEF000373; EID106420; WEF000374; EID106421; WEF000375; EID106422; WEF000376; EID106423; WEF000377; EID106424; WEF000378; EID106425; WEF000379; EID106426; WEF000380; EID106427; WEF000381; EID106428; _______________ WEF000382;_______________ EID106488 -EID106498;WEF000442 -WEF000452 ____________EID106594; WEF000549____________ ________ EID106596; EID106603 -EID106684________ EID106597 -EID106602;WEF000552 -WEF000557 ____________EID106598; WEF000553____________ ____________EID106599; WEF000554____________ ____________EID106600; WEF000555____________ ____________EID106601; WEF000556____________ EID106685 -EID106686;WEF000640 -WEF000641 EID106687 -EID106696;WEF000642 -WEF000651 _____EID106953; RL001264; EID769927 -EID769938____ _____EID107066 -EID107071; RL001483 -RL001488_____ EID107066; RL001483; EID107067; RL001484; EID107068; RL001485; EID107069; RL001486; EID107070; RL001487; ____________ EID107071; RL001488____________ _____EID107111 -EID107129; RL001539 -RL001557_____ _____EID107133 -EDI107154; RL001690 -RL001711_____ _____EID107155 -EID107156; RL001722-RL001723_____ ____________ EID107157; RL001724____________ _____EID107158 -EID107159; RL001725 -RL001726_____ _____EID107159 -EID107160; RL001725 -RL001727_____ _____EID107161 -EID107172; RL001728-RL001739_____ _____EID107173 -EID107175; RL001743 -RL001745_____ _____EID107173 -EID107175; RL001743 -RL001745_____ _____EID107176 -EID107182; RL001746 -RL001752_____ _____EID107192 -EID107193; RL001773 -RL001774_____ _____EID107194 -EID107195; RL001775 -RL001776_____ _____EID107194 -EID107195; RL001775 -RL001776_____ _____EID107194 -EID107195; RL001775 -RL001776_____ ____________ EID107196; RL001777____________ ____________ EID107196; RL001777____________ ____________ EID107196; RL001777____________ _____EID107198 -EID107200; RL001779 -RL001781_____ ____________ EID107201; RL001782____________ _____EID107347 -EID107348; RL001944 -RL001945_____ ____________ EID107349; RL001946____________ Page 67 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 163 of 277 PAGEID #: 61164 ________ Bates Numbered Documents________ EID107350 -EID107355; DWS1040708 -DWS1040713; ____________ RL001978 -RL001983____________ EID107350 -EID107355; DWS1040708 -DWS1040713; ____________ RL001978 -RL001983____________ EID107350 -EID107355; DWS1040708 -DWS1040713; ____________ RL001978 -RL001983____________ _____EID107356 -EID107363; RL001984 -RL001991_____ ____________ EID107357; RL001985____________ ____________ EID107358; RL001986____________ ____________ EID107358; RL001986____________ _____EID107384 -EID107386; RL002015 -RL002017_____ _____EID107384 -EID107386; RL002015 -RL002017_____ _____EID107384 -EID107386; RL002015 -RL002017_____ EID107462 -EID107465; RL002093 -RL002096; EID079268; ________________ RJZ010046________________ EID107462 -EID107465; RL002093 -RL002096; EID117451; ________________ RJZ016982________________ EID107654 -EID107657;WJB000344 -WJB000347 EID107654 -EID107657;WJB000344 -WJB000347 EID108184 -EID108186; LAB000047 -LAB000049 ____ EID108608 -EID108615; RP001967 -RP001974____ EID108802 -EID108819; GLK001121 -GLK001138 EID109493 -EID109525; GLK002502 -GLK002541 EID109642 -EID109643; GLK002614-GLK002615; EID109687 EID109768; GLK002659 -GLK002740; EID109781 -EID109784; GLK002753 -GLK002756; EID109786; GLK002758 EID109642 -EID109649; GLK002614 -GLK002621; EID109687 EID109698; GLK002659 -GLK002670; EID109782 -EID109786; ___________ GLK002754 -GLK002758 EID110113 -EID110115; ARF000015 -ARF000017 ____________ EID110142;JJP000006 ____ EID110260 -EID110261;JJP000202 -JJP000203 EID110517 -EID110521; BLD000009 -BLD000013 EID110522 -EID100526; BLD000014 -BLD000018 ____ EID110651 -EID110653; BLD00172 -BLD00174 EID110654 -EID110658; BLD000175 -BLD000179 EID111009 -EID111010; RJA000232 -RJA000233 EID111565 -EID111602; RJC000945 -RJC000982 EID112155 -EID112156; LWB000735 -LWB000736 EID112798 -EID112830; RJZ029978-RJZ030010 ____________ EID112971; DDJ001815 ____ EID114185 -EID114197; RP002056 -RP002068 EID118383 -EID118386; GIL000007 -GIL000010 EID118757 -EID118781; WAB000514 -WAB000538 Page 68 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 164 of 277 PAGEID #: 61165 _______ Bates Numbered Documents_______ EID118986 -EID118988; MEM000430 -MEM000432 EID120806 -EID120818; RP002159 -RPP002171 EID121879 -EID121894; RL002146-RL002161 ____________ EID121879; RL002146____________ EID121880 -EID121894; RL002147-RL002161 EID121895 -EID121898; GK003122 -GK003125 EID122022 -EID122031; RL000382-RL000391 EID123110 -EID123112; DWS1036517 -DWS1036519; ___________DUP000824 -DUP000826___________ ___________ EID123115; DUP000829___________ ___________ EID123132; DUP000973___________ EID123138 -EID123141; DUP001005 -DUP001008 EID123142 -EID123143; DUP001009 -DUP001010 ___________ EID123175; HLAB003624___________ ___________ EID123176; HLAB003625___________ EID123531 -EID123532; RLR003481 -RLR003482 EID123531 -EID123532; RLR003481 -RLR003482 EID123558 -EID123595; EWM000125 -EWM000162 EID143358 -EID143361; BSL000250 -BSL000253 ___________ EID147311; DDJ001807___________ EID147511 -EID147513; DDJ002286 -DDJ002288 EID147883 -EID147923; FS000010 -FS000050 EID147886 -EID147893; FS000013 -FS000020 EID147894 -EID147923;FS000021-FS000050 EID147927 -EID147931; FS000054 -FS000058 ____________ EID147954; FS000107____________ EID148048 -EID148052; FS000252 -FS000256 ____________ EID148070;FS000275____________ EID148274 -EID148275; GK003559 -GK003560 EID152790; STB000168; EID152751; STB000129; EID152756; ________ STB00134;EID152903; STB000281________ ___________ EID156076 -EID156080___________ ___________ EID156108 -EID156116___________ ___________ EID156165 -EID156166___________ _______________ EID156362_______________ _______________ EID156362_______________ _______________ EID156477_______________ ___________ EID156563 -EID156567___________ ___________ EID156808 -EID156809___________ ___________ EID156808 -EID156809___________ _______________ EID156870_______________ _______________ EID156889_______________ ___________ EID156891 -EID156892___________ _______________ EID156918_______________ EID157029 Page 69 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 165 of 277 PAGEID #: 61166 _____Bates Numbered Documents_____ _____________EID157030_____________ _________EID157284 -EID157287_________ _________EID157290 -EID157293_________ _________EID157578 -EID157583_________ _________ EID157631-EID157655_________ _________EID157785 -EID157790_________ _____________EID157940_____________ _____________EID157940_____________ _________EID157942 -EID157944_________ _____________EID157950_____________ _____________EID157950_____________ _____________EID158015_____________ _________EID158024 -EID158028_________ _________EID158029 -EID158030_________ _________EID158031 -EID158034_________ _________EID158041 -EID158042_________ _____________EID158046_____________ _________EID158076 -EID158078_________ _________EID158623 -EID158627_________ _________EID158830 -EID158834_________ _____________EID159344_____________ _________EID159350 -EID159359_________ _________EID160006 -EID160007_________ _________ EID160301-EID160304_________ EID161612 -EID161628; EID160320 -160321 _____________EID161692_____________ _________EID161725 -EID161727_________ _____________EID161775_____________ _________EID164389 -EID164390_________ _________EID165462; HDR002697_________ EID166245 -EID166247; DGW000038 -DGW000040 _________ EID166449; GK004600_________ EID166596 -EID166598; GK004794 -GK004796 EID166599 -EID166608; GK004797 -GK004806 EID166859 -EID166868; HDR002182 -HDR002191 EID166921 -EID166925; HDR002256 -HDR002260 EID166991 -EID166992; HDR002357 -HDR002358 EID167138; EID167286; HDR00235; HDR002700 _____EID167416; RLR002983; HDR002860_____ _____EID167437; RLR003302; HDR002881_____ EID167716 -EID167717;JHW000004 -JHW000005 EID167963 -EID167964;JJP000735 -JPP000736 _________EID168414; NSR000024_________ EID170094 -EID170096; GK003302 -GK003304 EID170703 -EID170712; KHF000032 -KHF000042 Page 70 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 166 of 277 PAGEID #: 61167 ________ Bates Numbered Documents________ ________________ EID170763________________ ____________ EID170795 -EID170798____________ EID170810 -EID170811; KHF000151 -KHF000152 _____EID171605 -EID171634; RK000567 -RK000596 ____________ EID173849 -EID173853____________ _____EID173958 -EID173967; RP006052 -RP006061 ____________ EID173968; RP006062____________ _____EID181074 -EID181076; CF018865 -CFO18867 ____________ EID182129; CF018868____________ EID189826 -EID189835; RJA000688 -RJA000698 EID189826 -EID189835; RJA000688 -RJA000698 ____________ EID190467; RJC003907____________ EID192481 -EID192482; ASH014611 -ASH014612 EID192523 -EID192524; ASH014653 -ASH014654 ____________ EID193045 -EID193057____________ _____ EID193608 -EID193610; CF020518 -CF020520____ _____ EID193611 -EID193612; CF020522 -CF020523____ ____________ EID193613; CF020524____________ _____ EID193614 -EID193618; CF020541 -CF020545____ EID194771 -EID194781; DDJ002371 -DDJ002381 EID194854 -EID194858; DDJ002454 -DDJ002458 EID195325 -EID195326; GAA000139 -GAA000140 ____________ EID195362; IAL000024____________ ____ EID195364 -EID195370; IAL000029 -IAL000035 ____ EID195387 -EID195394; IAL000087 -IAL000094 ____________ EID195965 -EID195968____________ EID196124 -EID196138; PJB000224 -PJB000238 EID196182 -EID196183; PJB000298 -PJB000299 EID196260 -EID196263; PJB000378 -PJB000381 ____________ EID196652 -EID196654____________ ____________ EID197765 -EID197768____________ ____________ EID197786 -EID197804____________ ____________ EID198132;TSB001599____________ ________________ EID209467________________ EID209550 -EID209561; BLD000180 -BLD000186; BLD000086 ________________ BLD000093_______________ ____________ EID209554; BR000086____________ ____________ EID215079; BJR000284____________ ____________ EID216812; LWB000249___________ EID217103 -EID217104; LWB000757 -LWB000758 EID217103 -EID217104; LWB000757 -LWB000758 ____________ EID217105; LWB000759___________ ____________ EID217109; LWB000766___________ ____________ EID217109; LWB000766___________ ____________EID217282; MAK001197___________ Page 71 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 167 of 277 PAGEID #: 61168 ______ Bates Numbered Documents______ __________ EID217291; MAK001208__________ __________ EID219491 -EID219492__________ ______________ EID221326______________ __________ EID221352 -EID221353__________ __________ EID221376 -EID221384__________ __________ EID221402 -EID221403__________ __________ EID221416 -EID221417__________ _______ EID221446; EID290786; EID570922_______ ___________EID221523; EID157411___________ __________ EID221589 -EID221591__________ __________ EID221744 -EID221750__________ ______________ EID221837______________ __________ EID221879 -EID221883__________ __________ EID221950 -EID221954__________ ______________ EID221967______________ __________ EID222474 -EID222485__________ __________ EID222474 -EID222485__________ ______________ EID222894______________ __________ EID223429 -EID223430__________ __________ EID223453 -EID223454__________ ______________ EID223479______________ __________ EID223496 -EID223497__________ ______________ EID223536______________ ______________ EID223546______________ ______________ EID223645______________ EID229345 -EID229348; CF025193 -CF025196 __________ EID230663; RCB000992__________ __________ EID230665; RCB000994__________ __________ EID230666; RCB000995__________ EID232293 -EID232300; RCB001012 -RCB001019 EID232452; RL002176; EID232453; RL002177; EID232454; _______ RL002178;EID232455; RL002179_______ ___________ EID232463; RL002187___________ EID252785 -EID252786; MAK002242 -MAK002243 __________ EID252791 - EID252799__________ ______ EID252815 -EID252816; MAK002280______ EID254620 -EID254621; MAK002216 -MAK002217 EID256133 -EID256137; RJZ007652 -RJZ007656 __________ EID262048 -EID262052__________ __________ EID262198 -EID262199__________ ___________EID262341; EID262343___________ ______________ EID267734______________ ______________ EID271549______________ __________ EID271679 -EID271680__________ EID271743 -EID271749 Page 72 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 168 of 277 PAGEID #: 61169 Bates Numbered Documents EID271817 -EID271818 EID272031 -EID272032 ________ EID272252________ EID272585 -EID272586 EID272877 -EID272912 EID273441 -EID273442 EID273505 -EID273507 EID277891 -EID277892 EID278951 -EID278953 ________ EID286119________ EID286132 -EID286134 EID286156 -EID286173 EID288787 -EID288820 ________ EID290336________ EID290349 -EID290350 EID292610 -EID292620 EID292650 -EID292652 EID292684 -EID292691 ________ EID292795________ EID292937 -EID292939 EID292994 -EID292995 EID294568;EID399527;EID398372 ________ EID302070________ EID302092 -EID302093 EID303541 -EID3033670 ________ EID303759________ EID303759 -EID303760 EID304435 -EID304441 ________ EID310516________ EID310517 -EID310519 ________ EID310520________ EID310521 -EID310522 ________ EID310523________ ________ EID310525________ EID314184; EID314204 ________ EID314710________ EID317203 -EID317204 ________ EID317726________ EID317730 -EID317731 EID317879 -EID317880 EID317937 -EID317939 EID317940 -EID317941 EID318050 -EID318051 ________ EID318066________ EID318097 -EID318098 Page 73 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 169 of 277 PAGEID #: 61170 Bates Numbered Documents ________ EID318140 -EID318143________ ____________ EID318753____________ ____________ EID318753____________ ________ EID324221 -EID324222________ ________ EID324243 -EID324245________ ________ EID324333 -EID324235________ ____________ EID392253____________ ________ EID392962 -EID392964________ ________ EID395145 -EID395147________ ____________ EID395370____________ ____________ EID397484____________ ____________ EID397484____________ ________ EID398288 -EID398324________ ____________ EID398372____________ ____________ EID398372____________ ________ EID416481 -EID416484________ ________ EID417693 -EID417694________ ____________ EID418715____________ ________ EID421854 -EID421859________ ________ EID434833 -EID434834________ ____________ EID434841____________ ________ EID434926 -EID434927________ ________ EID435272 -EID435273________ ________ EID435272 -EID435273________ ________ EID435508 -EID435510________ ____________ EID436286____________ ________ EID437504 -EID437507________ ________ EID437504 -EID437507________ _________ EID437504 EID437507_________ ________ EID437686 -EID437687________ ________ EID437686 -EID437687________ ________ EID443206 -EID443207________ ________ EID447531 -EID447532________ ________ EID451631 -EID451641________ ________ EID462825; DRS001591________ EID463553 -EID463555; FH000081 -FH000083 _________ EID463564; FH000100_________ ____________ EID463724____________ EID467393 -EID467401; GWJ013064 -GWJ013072 EID468890 -EID468892; LJB000015 -LJB000017 EID468899 -EID468900; LJB000024-LJB000025 EID476862 -EID476877; RP025834 -RP025849 EID476878 -EID476884; RP025850 -RP025856 ________ EID477097; RWR000804________ EID477100 -EID477105; RWR000807 -RWR000812 Page 74 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 170 of 277 PAGEID #: 61171 _______Bates Numbered Documents_______ EID477124 -EID477135; RWR000881 -RWR000892 ___________ EID477912; BJR000455___________ ___________ EID477912; BJR000455___________ EID483876 -EID484019; GWJ010275 -GWJ010418 ___________ EID488910; LJB000002___________ EID495285 -EID495286; RP026263 -RPO26264; GK001381 EID495811 -EID495821; RWR000584 -RWR000594 EID495822 -EID495828; RWR000595 -RWR000601 EID495829 -EID495875; RWR000602 -RWR000648 EID496070-EID496114; STB002285 - STB002329 EID497142 -EID497143; STB003454 -STB003455 ___________ EID497353; STB003769___________ ___________ EID497423; STB003839___________ EID497487-EID497488; STB003904 -STB003905 EID502722 -EID502723; DJM000563 -DJM000564 ___________ EID509412 -EID509414___________ ___________ EID509977 -EID510001___________ ___________ EID510188-EID510190___________ EID510221 -EID510226; DDJ001689 -DDJ001694 EID510227 -EID510232; DDJ001695 -DDJ001700 EID510258 -EID510260; DDJ001726 -DDJ001728 EID510258 -EID510260; DDJ001726 -DDJ001728 EID510258 -EID510260; DDJ001726 -DDJ001728 EID510261 -EID510263; DDJ001729 -DDJ001731 ___________ EID510279 -EID10289___________ ___________ EID510379 -EID510393___________ _______________ EID517471_______________ _______________ EID517538_______________ ___________ EID517551 -EID517565___________ _______________ EID517606_______________ EID521382 -EID521392;AJP009986-AJP009996 EID521382 -EID521392;AJP009986-AJP009996 EID523009; SL001108; EID523010; SL001109; EID523011; SL001110; EID523012; SL001111; EID523013; SL001112; EID523014; SL001113; EID523015; SL001114; EID523016; SL001115; EID523017; SL001116; EID523018; SL001117; EID523019; SL001118; EID523020; SL001119; EID523021; _______________ SL001120;_______________ ___________ EID531323 -EID531328___________ _______________ EID532321_______________ _______________ EID532423_______________ ___________ EID533200 -EID533201___________ ___________ EID534852 -EID534855___________ _______________ EID537534_______________ EID537535 Page 75 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 171 of 277 PAGEID #: 61172 Bates Numbered Documents EID545545 -EID545548 ________ EID545709________ ________ EID546942________ EID546974 -EID546980 EID553737 -EID553847 ________ EID555491________ ________ EID556286________ EID556287 -EID556289 EID556290 -EID556294 ________ EID556295________ EID556297 -EID556298 ________ EID556301________ ________ EID556308________ ________ EID556309________ ________ EID556310________ EID562917 -EID562927 EID566392 -EID566412 EID566536 -EID566553 EID566603 -EID566606 EID566704 -EID566708 ________ EID566717________ EID567066 -EID567071 EID567669 -EID567804 EID567805 -EID567970 EID568823 -EID568826 EID568827 -EID568830 ________ EID568932________ EID569962 -EID569966 EID569962 -EID569966 EID570740 -EID570750 EID570857 -EID570860 EID570880 -EID570881 EID570882 -EID570883 EID570884 -EID570892 EID570893 -EID570894 EID570895 -EID570913 EID570923 -EID570925 EID570926 -EID570928 EID570935 -EID570946 _____ EID570988 -EID0998_____ _____ EID570988 -EID0998_____ EID571080 -EID571101 ________ EID571103________ ________ EID571104________ EID571129 -EID571132 Page 76 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 172 of 277 PAGEID #: 61173 Bates Numbered Documents _______ EID571148 -EID571153_______ ___________ EID571154___________ ________EID571156 -EID71168________ _______ EID571181 -EID571232_______ _______ EID571233 -EID571295_______ _______ EID571347 -EID571357_______ _______ EID571572 -EID571573_______ _______ EID571576 - EID571577_______ _______ EID571578 -EID571579_______ _______ EID571594 -EID571595_______ _______ EID571598 -EID571599_______ _______ EID571600 -EID571601_______ _______ EID571633 -EID571635_______ ___________ EID572559___________ ___________ EID572607___________ ___________ EID573572___________ _______ EID573988 -EID573985_______ _______ EID573989 -EID573991_______ _______ EID574231; EID574233________ _______ EID574563 -EID574566_______ _______ EID575362 -EID575381_______ _______ EID575387 -EID575414_______ _______ EID575418 -EID575419_______ _______ EID575420 -EID575421_______ ________EID575426 -EID75429________ _______ EID579767 -EID579785_______ _______ EID581284 -EID581289_______ _______ EID582874 -EID582877_______ _______ EID583563 -EID583569_______ EID584137 -EID584152; EID192136;AJP007299 _______ EID584158 -EID584204_______ _______ EID584159 -EID584204_______ _______ EID584160 -EID584204_______ _______ EID584206 -EID584219_______ _______ EID584220 -EID584230_______ _______ EID584312 -EID584314_______ _______ EID584312 -EID584314_______ _______ EID584316 -EID584319_______ ___________ EID584333___________ _______ EID584341 -EID584350_______ ________EID584373 EID584374________ _______ EID584375 -EID584380_______ ___________ EID584381___________ _______ EID584775 -EID584777_______ EID586423 -EID586426 Page 77 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 173 of 277 PAGEID #: 61174 Bates Numbered Documents ________ EID586993 -EID586994________ ____________ EID587727____________ ____________ EID588162____________ ________ EID588601 -EID588602________ ____________ EID589366____________ ________ EID589567 -EID589569________ ________ EID597061 -EID597062________ ____________ EID598296____________ ________ EID599660 -EID599662________ ________ EID599668 -EID599670________ ________ EID599673 -EID599674________ ________ EID599757 -EID599759________ ________ EID600127 -EID600129________ ____________ EID600208____________ ____________ EID600954____________ ____________ EID600955____________ ____________ EID601077____________ ________ EID601234 -EID601236________ ________ EID601314 -EID601320________ ________ EID601427 -EID601428________ ____________ EID602210____________ ________ EID602956; RJZ009431________ ________ EID602989; RJZ009515________ EID602990 -EID602992; RJZ009957 -RJZ009959 EID602999 -EID603010; RJZ009986 -RJZ009997 ____________ EID603077____________ EID604383 -EID604386; DDJ008613 -DDJ008616 EID608981 -EID609012; GK011655 -GK011686 EID613593 -EID613594; PJB003901 -PJB003902 ________ EID657164 -EID657170________ ________ EID657660 -EID657667________ ________ EID665651 -EID665792________ ____________ EID666585____________ ____________ EID667449____________ ________ EID667472 -EID667474________ ________ EID667480 -EID667483________ EID667492; EID667494 -EID667498 ____________ EID667500____________ ____________ EID667508____________ ________ EID667523 -EID667524________ ________ EID667534-EID667537________ ____________ EID667550____________ ________ EID667557; EID667561________ _______ EID667578-EID6677579_______ EID667585 Page 78 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 174 of 277 PAGEID #: 61175 _____ Bates Numbered Documents_____ _________ EID667598-EID667599_________ _________ EID667627; EID667632_________ _________ EID667686 -EID667687_________ _____________ EID667743_____________ _________ EID667767 -EID667768_________ _________ EID667795 -EID667797_________ _________ EID668620 -EID668709_________ _________ EID668810 -EID668812_________ _________ EID668852 -EID668853_________ _________ EID673847 -EID673852_________ _________ EID673917 -EID673942_________ _________ EID675933 -EID675977_________ _________ EID692574-EID692583_________ _________ EID713127 -EID713135_________ _________ EID713127 -EID713135_________ _________ EID713136 -EID713143_________ EID713144 -EID713213; EID713215 -EID713234 _________ EID713244-EID713270_________ ______EID713307; AJP001412; EID80227______ EID713309 -EID713310; RL001773 -RL001774 EID713350 -EID713360; RL001729 -RL001739 EID713361 -WEID713369; WEF000643 -WEF000651 _____________ EID713388_____________ _____________ EID713389_____________ _________ EID713390 -EID713401_________ EID713536 -EID713557; CHW000011 -CHW00032 EID715277 -EID715289; SPR001406 -SPR001418 EID715945 -EID715948;AC011022 -AC011025 EID716645 -EID716649; AEL000392 -AEL000396 EID716929 -EID716930; AEL000676 -AEL000677 EID716931 -EID716932; AEL000678 -AEL000679 _________ EID71716; DUP000813_________ EID717723 -EID717735;AVM010040 -AVM010052 EID717795 -EID717796;AVM010113 -AVM010114 EID717855 -EID717857;AVM010174 -AVM010176 _________ EID718828-EID718829_________ EID718838 -EID718861;AVM011183 -AVM011206 _________ EID719068; BLH000367_________ EID720358 -EID720359; DDJ009413 -DDJ009414 EID723650 -EID723652; GHS007213 -GHS007215 EID723898 -EID723900; GHS007461 -GHS007463 EID723912 -EID723914; GHS007475 -GHS007477 EID723915 -EID723917; GHS007478 -GHS007480 EID723934 -EID723939; GHS007497 -GHS007502 _________ EID725332; GHS008965_________ Page 79 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 175 of 277 PAGEID #: 61176 Bates Numbered Documents EID726997 -EID727003; GK012104 -GK012110 EID727004 -EID727005; GK012111 -GK012112 EID729618 -EID729708; EID729897 -EID729905 EID738989 -EID738990; RWR004880 -RWR004881 EID742523 -EID742524;TSB002780-TSB002781 ____________ EID751241____________ ________ EID760361 -EID760371________ ________ EID761317 -EID761405________ ________ EID761533 -EID761624________ ____________ EID761785____________ ____________ EID761786____________ ____________ EID761787____________ ________ EID761788 -EID761878________ ________ EID761879 -EID761952________ ________ EID761953 -EID761971________ ________ EID762684 -EID762908________ ________ EID768106 -EID768107________ ____________ EID768298____________ ________ EID768299 -EID768306________ ________ EID768307 -EID768307________ ________ EID769106 -EID769127________ ________ EID769128 -EID769151________ ________ EID769159 -EID769162________ ________ EID769186 -EID769192________ ____________ EID769193____________ ________ EID769194 -EID769197________ ________ EID769198 -EID769204________ ________ EID769205 -EID769223________ ________ EID769227 -EID769229________ ____________ EID769230____________ ____________ EID769230____________ ________ EID769231 -EID769232________ ________ EID769233 -EID769234________ ________ EID769233 -EID769234________ ________ EID769235 -EID769237________ ________ EID769238 -EID769241________ ________ EID769242 -EID769243________ ________ EID769244 -EID769245________ ________ EID769246 -EID769253________ ________ EID769254 -EID769257________ ________ EID769254 -EID769257________ ____________ EID769258____________ ____________ EID769258____________ ____________ EID769259____________ EID769260 Page 80 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 176 of 277 PAGEID #: 61177 _______ Bates Numbered Documents_______ ___________ EID769318 -EID76938___________ ___________ EID769339 -EID769340___________ ___________ EID76979 -EID769185___________ ___________ EID769871 -EID769872___________ ___________ EID769882 -EID769884___________ ___________ EID769885 -EID769887___________ _______________ EID769889_______________ ___________ EID769894 -EID769901___________ _______________ EID769923_______________ ___________ EID769939 -EID769950___________ ___________ EID769958 -EID769959___________ ___________ EID769960 -EID769965___________ ___________ EID769960 -EID769965___________ EID769966; EID770067; EID769874; EID770065; EID770622; DFA006721; EID720456;AJP010154; EID603669 EID769967 -EID769968 EID769969 -EID769971 EID769972 -EID769976 EID770051 -EID770053 EID770054 -EID770064 EID770614 EID770628 -EID770631 EID770633 -EID770660 EID770683 EID770871 -EID770872 EID770873 -EID770876 EID771069 -EID771072 EID771256 -EID771257 EID771256 -EID771257 EID771431 -EID771435 EID771455 -EID771457 EID771458 -EID771483 EID771510-771512 EID772014 -EID772018 EID772101 -EID772103 EID772102 -EID772103 EID772127 -EID772139 EID772151 -EID772156 EID772354 -EID772360 EID772390 -EID772398 EID772449 -EID772456 EID772547 -EID772549 EID772550 EID772551 -EID77252 Page 81 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 177 of 277 PAGEID #: 61178 ____ Bates Numbered Documents____ ____________ EID772553____________ _____EID772745 -EID772757; EID713387_____ ________ EID774545 -EID774638________ ________ EID774639 -EID774752________ EID775225 -EID775242; GK031812 -GK031829 ________ EID775258 -EID775275_________ ____________ EID775276____________ ________ EID775276 -EID775277________ ________ EID775276 -EID775277________ ________ EID775278 -EID775400________ ________ EID775401 -EID775459________ ________ EID778797 -EID778889________ ________ EID778797 -EID778889________ EID778800 -EID778801;AJP010371 -AJP010372 ____________ EID781977____________ ____________ EID781980____________ ____________ EID781981____________ ____________ EID781982____________ ____________ EID781983____________ ____________ EID781983____________ ____________ EID781984____________ ____________ EID781985____________ ____________ EID781986____________ ____________ EID781987____________ ____________ EID781988____________ ____________ EID781988____________ ____________ EID781989____________ ____________ EID781990____________ ____________ EID781990____________ ____________ EID781991____________ ____________ EID781992____________ ____________ EID781992____________ ____________ EID781993____________ _________ EID78312 -EID78313_________ _________ EID79034; RJZ009054_________ _________ EID79506; AJP002833_________ ________ EID797573 -EID797587________ EID800056 -EID800057; MLR002326 -MLR002327 EID800823 -EID800833; PEG000032 -PEG000042 EID806588 -EID806593; UMC002262 -UMC002267 EID806995 -EID806996; UMC002692 -UMC002693 EID806998 -EID806999; UMC002695 -UMC002696 ________ EID811846 -EID811852________ ________ EID812420 -EID812447________ EID813781 -EID813804 Page 82 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 178 of 277 PAGEID #: 61179 Bates Numbered Documents _______ EID813781 -EID813804_______ _______ EID813781 -EID813804_______ _______ EID820883 -EID820886_______ _______ EID820894 -EID820896_______ _______ EID820897 -EID820899_______ _______ EID820976 -EID820977_______ EID820978 -EID820979; EID825366 -EID825367 _______ EID821019 -EID821020_______ _______ EID821088 -EID821089_______ _______ EID821115 -EID821116_______ ___________ EID821144___________ _______ EID821189 -EID821190_______ ___________ EID821192___________ _______ EID821237 -EID821239_______ _______ EID821266 -EID821268_______ ________EID821278 -EIS821281________ _______ EID821287 -EID821288_______ _______ EID821300 -EID821302_______ _______ EID821309 -EID821310_______ _______ EID821329 -EID821330_______ _______ EID821331 -EID821332_______ _______ EID821352 -EID821353_______ _______ EID821368 -EID821369_______ _______ EID821581 -EID821608_______ _______ EID821627 -EID821630_______ _______ EID821826 -EID821828_______ ___________ EID821906___________ _______ EID821907 -EID821908_______ _______ EID821977 -EID821991_______ _______ EID822000 -EID822007_______ _______ EID822052 -EID822054_______ _______ EID822171 -EID822175_______ _______ EID822283 -EID822284_______ ___________ EID822300___________ _______ EID822315 -EID822316_______ _______ EID822374 -EID822395_______ _______ EID822462 -EID822463_______ _______ EID822762 -EID822764_______ _______ EID822765 -EID822768_______ _______ EID822798 -EID822801_______ _______ EID822842 -EID822867_______ _______ EID822922 -EID822924_______ _______ EID823009 -EID823037_______ _______ EID823107 -EID823110_______ EID823209 -EID823211 Page 83 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 179 of 277 PAGEID #: 61180 Bates Numbered Documents ________ EID823323________ EID823324 -EID823325 EID823332 -EID823336 ________ EID823518________ ________ EID823519________ EID823605 -EID823614 EID823965 -EID823987 EID823994 -EID823996 ________ EID824042________ EID824421-EID824425 EID825031 -EID825042 ________ EID825043________ EID825044 -EID825045 EID825374 -EID825382 EID825815 -EID825816 ________ EID825984________ EID825985 -EID826082 EID826210 -EID826252 EID826313 -EID826316 ________ EID826333________ ________ EID826367________ EID826769 -EID826795 EID827405 -EID827408 EID827520 -EID827521 EID827863 -EID827874 EID828309 -EID828312 EID828309 -EID828312 EID828838 -EID828839 EID829452 -EID829468 EID830213 -EID830214 EID834586 -EID834587 ________ EID834695________ EID835953 -EID835955 EID836214 -EID836215 EID837186 -EID837187 EID837427 -EID837433 EID837496 -EID837499 EID837717 -EID837721 EID838278 -EID838322 EID838377 -EID838388 EID838390 -EID838391 EID838673 -EID838761 EID838823 -EID838911 EID841632 -EID841723 EID842229 -EID842234 Page 84 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 180 of 277 PAGEID #: 61181 Bates Numbered Documents ________ EID843813 -EID843843________ ________ EID845149 -EID845150________ ________ EID845341 -EID845381________ ________ EID845606 -EID845611________ ________ EID845612 -EID845705________ ________ EID845766 -EID845873________ ________ EID846104 -EID846212________ ________ EID861597 -EID861599________ ________ EID861634 -EID861639________ ____________ EID861641____________ ________ EID863858 -EID863860________ ________ EID863945 -EID863946________ ________ EID863948 -EID63952________ ________ EID864544 -EID864545________ ________ EID864684 -EID864710________ EID864732 -EID864733; 001-0135-0011615 ________ EID865305 -EID865306________ ________ EID865653 -EID865654________ ________ EID865695 -EID65698________ ________ EID865701 -EID865704________ ________ EID866512 -EID866514________ ________ EID866597 -EID866601________ ________ EID866597 -EID866601________ ________ EID866666 -EID866670________ ________ EID866666 -EID866670________ ____________ EID866989____________ ________ EID867041 -EID867043________ ________ EID867380 -EID867381________ ____________ EID867386____________ ________ EID867673 -EID867678________ ________ EID867688 -EID867689________ ____________ EID867733____________ ________ EID867733 -EID867840________ ________ EID867734 -EID867840________ ________ EID870204 -EID870206________ ________ EID871674 -EID871977________ EID900308 -EID900313; RJA000374 -RJA000379 EID900586 -EID900704;WJB000072 -WJB000190 EID903496 -EID903497; CF001391-CF001392 EID903496 -EID903497; CF001391-CF001392 EID909790 -EID909809; DE000245 -DE000264 EID909812 -EID909818; DE000268 -DE000268 ________ EID909865; DE000321________ EID914338 -EID914339; ASH010221 -ASH010222 EID914722 -EID914725; LKI001266 -LKI001269 Page 85 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 181 of 277 PAGEID #: 61182 ________ Bates Numbered Documents________ EID914730 -EID914733; LMK001319 -LMK001322 EID914744 -EID914745; LKI001338-LKI001339 EID914909 -EID914913; LKI001762 -LKI001766 ____________ EID914998; DDJ000386____________ ____________ EID914999; DDJ000388____________ EID915033 -EID915035; DDJ000667 -DDJ000669 EID915061 -EID915062; DDJ000701 -DDJ000702 EID915269 -EID915271; DDJ001043 -DDJ001048 EID915591 -EID915593; BWK000006 -BWK000008 EID915597 -EID915609; BWK000029 -BWK000041 EID915673 -EID915674; BWK000169 -BWK000170 ____________ EID916604 -EID916609____________ EID917493 -EID917494; MEM000452 -MEM000453 EID917773 -EID917774; GLK000037 -GLK000038 EID917954 -EID917959; GLK000699 -GLK000704 EID917954 -EID917959; GLK000699 -GLK000704 EID917954 -EID917959; GLK000699 -GLK000704 EID918337 -EID918397; GLK002093 -GLK002153 ____________ EID918667; GLK002513____________ EID918739 -EID918749;AVM000415 -AVM000425 EID920083 -EID920085;JMM000659 -JMM000661 ___________ EID920176;JMM001068___________ EID920663 -EID920668;JMM002528 -JMM002533 EID920673 -EID920674;JMM002667 -JMM002668 ________________ EID921553________________ EID921593 -EID921594;JMM008216 -JMM008217 EID921834 -EID921855;JCQC000060 -JCQC000081 EID921856 -EID921860;JCOC000082 -JCOC000086 ____ EID923989 -EID923990; RP002196 -RP002197_____ EID923989 -EID923990; RP002196 -RPP002197 ____ EID924014 -EID924016; RP002316 -RP002318____ EID924170 -EID924172;AJP001488 -AJP001490 EID924173 -EID924175;AJP001491 -AJP001493 EID924218 -EID924221;AJP001611 -AJP001614 EID924222 -EID924225;AJP001615 -AJP001618 ____________ EID924234;AJP001629____________ EID924240 -EID924259;AJP001659-AJP001663; AJP001669________________ AJP001683________________ EID924260- EID924265; AJP001689 -AJP001694 EID924268 -EID924273;AJP001698 -AJP001703 EID924274 -EID924275;AJP001704 -AJP001705 ________________ EID924294________________ EID924418 -EID924419;AJP002114 -AJP002115 ____________ EID924420;AJP002116____________ EID924421 -EID924426;AJP002117 -AJP002122 Page 86 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 182 of 277 PAGEID #: 61183 ________ Bates Numbered Documents________ EID924451 -EID924479;AJP002211 -AJP002214; AJP002216 ________ AJP002218;AJP002226 -AJP002247________ EID924458 -EID924460;AJP002226 -AJP002228 EID924509 -EID924512;AJP002548 -AJP002551 EID924513 -EID924521;AJP002572 -AJP002580 EID924526 -EID924538;AJP002672 -AJP002684 EID924540 -EID924545;AJP002916 -AJP002930 ________________ EID924546________________ EID924547 -EID924549;AJP002932 -AJP002934 EID924550 -EID924557;AJP002984 -AJP002991 ________ EID924558-EID924560; AJP002994________ ________ EID924561;AJP002995; EID924562________ ____________ EID924593 -EID924596____________ EID924636 -EID924638;AJP003076; EID924639;AJP003077; EID924640; AJP003078; EID924641; AJP003079 EID924642 -EID924644;AJP003080 -AJP003082 EID924645 -EID924646;AJP003083 -AJP003084 EID924654 -EID924655;AJP003092 -AJP003094 EID924674 -EID924675;AJP003111 -AJP003112 EID924676; EID924677;AJP003167; EID924678;AJP003168; _______________ EID924679_______________ EID924680; AJP003172; EID924681; AJP003173; EID924682; EID924683; AJP003174; EID924684; AJP003175; EID924685; AJP003176; EID924686 -EID924688;AJP003178 ________________ EID924689________________ ____________ EID924690;AJP003180____________ EID924691 -EID924694;AJP003181 -AJP003183 EID924697 -EID924712;AJP003266 -AJP003281 EID924744 -EID924747;AJP003357 -AJP003760 EID924766 -EID924768;AJP003468 -AJP003470 EID924769 -EID924775;AJP003471 -AJP003472; AJP003481 ________________ AJP003485________________ EID924790 -EID924791;AJP003535 -AJP003536 _____ EID925024 -EID925051;JS000097 -JS000124_____ EID925463 -EID925467;TAS000199 -TAS000203 EID926315 -EID926327; RLR000172 -RLR000184 EID926857 -EID926859; RLR001758 -RLR001760 ____________ EID927217; RLR002762____________ EID927281 -EID927284; RLR002919 -RLR002922 EID927380 -EID927381; HDR000317 -HDR000318 EID927410 -EID927414; HDR000485 -HDR000489 ____________EID927451; HDR001261____________ ____ EID927609 -EID927610; RV000480 -RV000481____ Page 87 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 183 of 277 PAGEID #: 61184 Bates Numbered Documents EID932089 -EID932090; RJZ004157 -RJZ004158 EID932730 -EID932731; RJZ004924-RJZ004927 ____________ EID932733____________ EID932735 -EID932742; RJZ005055 -RJZ005062 ____________ EID932971____________ EID933681 -EID933687; RJZ2007414 -RJZ007420 EID933689 -EID933690; RJZ007422 -RJZ007423 EID935007 -EID935009; RJZ008920 -RJZ008922 EID935007 -EID935009; RJZ008920 -RJZ008922 EID935010 -EID935011; RJZ008923 -RJZ008924 ________ EID935012; RJZ008925________ ________ EID935152 -EID935157________ EID935370 -EID935376; RJZ009653 -RJZ009659 EID935383 -EID935385; RJZ009666 -RJZ009667 ________ EID935451; RJZ009798________ ________ EID935452; RJZ009799________ EID935477 -EID935479; RJZ010010 -RJZ010012 EID935529 -EID935534; RJZ010077 -RJZ010082 EID935596 -EID935599; RJZ10146 -RJZ010149 EID935611 -EID935618; RJZ010161 -RJZ010168 ________ EID936770; RJZ011772________ ________ EID937562; RJZ013154________ ________ EID938073; RJZ014434________ EID942335 -EID942336; RJZ027075 -RJZ027076 ________ EID942337; RJZ027077________ EID943616 -EID943627; RJZ020387 -RJZ020398 ________ EID943631 -EID943690________ EID943691 -EID943717; RJZ020538-RJZ020564 ________ EID948790 -RAK004373________ EID948837 -EID948838; GPS000586 -GPS000587 EID948850 -EID948851; ASH000020 -ASH000021 EID948901 -EID948905; ASH000069 -ASH000073 EID948979 -EID948980; LKI001686 -LKI001687 EID949005 -EID949006; RP000177 -RP000178 _________EID949449; AC003618_________ EID949490 -EID949491; AC003590 -AC003591 _________EID949492; AC003592_________ ________ EID949713; WEF000041________ ________ EID949714; WEF000042________ ________ EID949715; WEF000043________ EID949716 -EID949721;WEF000542 -WEF000547 EID950217 -EID950218; GLK001289 -GLK001290 ________ EID950227; GLK001925________ EID950228 -EID950242; GLK002519 -GLK02533 ________ EID950250; GLK002575________ Page 88 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 184 of 277 PAGEID #: 61185 _______ Bates Numbered Documents_______ EID950267 -EID950271; RL001954 -RL001958 EID950527 -EID950530;AJP001983 -AJP001986 EID950543; BR000002; EID950544 -EID950549; BR000003 BR000008; EID950550 -EID950554; BR000009 -BR000013; EID950555; BR000014; EID950556 -EID950560; BR000015 BR000019; EID950561 -EID950575; BR000020 -BR000034; EID950576 -EID950580; BR000035 -BR000039; EID950581 EID950582 -BR000040 -BR000041; EID950583 -EID950584; BR000042 -BR000043; EID950585 -EID950596; BR000044 BR000055; EID950597 -EID950598; BR000056 -BR000057; ____________EID950599; BR000058____________ ___________ EID950616; HDR001952___________ ___________ EID951144; RJZ005413____________ ___________ EID951144; RJZ005413____________ EID951145 -EID951147; RJZ005416 -RJZ005418 EID951145 -EID951147; RJZ005416 -RJZ005418 EID951469 -EID951470; RJZ009513 -RJZ009514 EID951480 -EID951481; RJZ009525 -RJZ009526 EID951505 -EID951506; RJZ009903 -RJZ9904 EID951507 -EID951511; RJZ009905 -RJZ009909 ___________ EID951517; RJZ009916___________ EID951520 -EID951522; RJZ009919 -RJZ009921 EID951548 -EID951549; RJZ009949 -RJZ009950 EID951550 -EID951551; RJZ009951 -RJZ009952 EID951554 -EID951555; RJZ009955 -RJZ009955.01 ___________ EID951556; RJZ009956___________ EID951560 -EID951564; RJZ009974-RJZ009978 EID951565 -EID951567; RJZ009980 -RJZ009982 EID951568 -EID951570; RJZ009980 -RJZ009985 EID951571 -EID951580; RJZ009988-RJZ009997 EID951584 -EID951591; RJZ010002 -RJZ010009 EID951584 -EID951591; RJZ010002 -RJZ010009 ___________ EID951607; RJZ010454___________ EID951966 -EID951973; RJZ020580 -RJZ020587 EID952019 -EID952024; RJZ020668-RJZ020673 EID952076 -EID952084; RJZ020999 -RJZ021007 ______________ EID-CL0010415______________ ________ EID-CL-0010542-EID-CL-0010544________ ______________EID-CL-0037083______________ ________ EID-CL-0038046-EID-CL-0038048________ ________ EID-CL-003-8091-EID-CL-0038094________ ___________ EIE009891 -EIE009893___________ ___________ EIE009892 -EIE009893___________ ___________ EIE009893 -EIE009892___________ ____________EIE009893; EIE009892____________ Page 89 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 185 of 277 PAGEID #: 61186 ______ Bates Numbered Documents______ __________ EIE012637 -EIE012643__________ ___________EIE012653 -EIE12658___________ ______________ EIE012660______________ _________ ENV0004746 -ENV0004752_________ ENV0006601 -ENV0006606; T2459 -T2463 _____________ ENV0006632_____________ _____________ ENV0006650_____________ _____________ ENV0006682_____________ _____________ ENV0006685_____________ _____________ ENV0006686_____________ ENV001 -ENV027; ANA001 -ANA043; TOX001 -TOX025; ____________ RAP001 -RAP005____________ __________ EPA175; ROWE000982__________ EPL000040 -EPL000041; EID713595 -EID713596 __________ EXP017498-EXP017499__________ __________ EXP017506 -EXP017507__________ ______ EXP017508; EXP017501 -EXP017502______ __________ EXP017510 -EXP017518__________ __________ EXP018377-EXP018377__________ _______EXP019664.078 -EXP019664.0081_______ __________ EXP279539 -EXP279594__________ __________ EXP279595 -EXP279613__________ _________ GAA001596 -GAA001595_________ _________ GAA001684 -GAA001687_________ GHA012776 -GHS012777; EID796495 -EID796496 GHS005502 -GHS005504; EID605181 -EID605183 GHS006034 -GHS006036; EID605711 -EID605713 GHS006230 -GHS006234; EID605907 -EID605911 GHS006242 -GHS006244; EID605919 -EID605921 GHS006369 -GHS006371; EID722822 -EID722824 GHS006489 -GHS006493; EID722942 -EID722946 __________ GHS006509; EID722962__________ GHS006530 -GHS006531; EID722983 -EID722984 GHS006549 -GHS006551; EID723002 -EID723004 GHS006559 -GHS006561; EID723012 -EID723014 __________ GHS006562; EID723015__________ GHS006563 -GHS006564; EID723016 -EID723017 __________ GHS007162; EID723599__________ __________ GHS007489; EID723926__________ GHS008008 -GHS008019; EID724444 -EID724455 GHS008065 -GHS008072; EID724501 -EID724508 GHS008401 -GHS008402; EID724837 -EID724838 GHS008472 -GHS8478; EID724908 -EID724914 GHS008474 -GHS008477; EID724910- EID724913 GHS008513 -GHS008518; EID724949 -EID724954 Page 90 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 186 of 277 PAGEID #: 61187 ________ Bates Numbered Documents________ GHS008513 -GHS008518; EID724949 -EID724954 GHS008657 -GHS008658; EID725093 -EID725094 GHS008729 -GHS008731; EID725163 -EID725165 GHS008735 -GHS008738; EID725167 -EID725170 ____________ GHS008883; EID725257____________ GHS008952 -GHS008955; EID725323 -EID725326 GHS010510; GHS010513 -GHS010518; EID795156; EID795158 _______________ -EID795163_______________ GHS010554 -GHS010559; EID775988 -EID775993 GHS010565 -GHS010578; EID795204 -EID795217 GHS010565 -GHS010578; EID795204 -EID795217 GHS010595 -GHS010596; EID795234 -EID795235 GHS010597 -GHS010598; EID795236 -EID795237 ____________ GHS010599; EID795238____________ ____________ GHS010602; EID795241____________ ____________ GHS011109; EID795599____________ GHS012288 -GHS012290; EID796043 -EID796045 ____________ GHS012519; EID796243____________ GHS012576 -GHS012578; EID796298 -EID796300 GHS012607 -GHS012608; EID796327 -EID796328 GHS012779 -GHS012783; EID796498 -EID796502 ____________ GHS012790; EID796509____________ ____________ GHS012899; EID796585____________ GHS012900 -GHS012921; EID796586 -EID796607 GHS012922 -GHS012934; EID796608 -EID796620 GHS012922 -GHS012934; EID796608 -EID796620 GHS012936 -GHS 012937; EID796622 -EID796623 GHS013078 -GHS013080; EID796749 -EID796751 GHS013086 -GHS013089; EID796757 -EID796760 GHS013091 -GHS013092; EID796762 -EID796763 GHS013106 -GHS013107; EID796776 -EID796777 GHS013840 -GHS013846; EID797223 -EID797229 GHS013957 -GHS013958; EID797339 -EID797340 ____________ GHS013959; EID797341____________ __________ GK(p)000013 - GK(p)000015__________ __________ GK(P)000013 -GK(p)000015__________ __________ GK(p)000020 -GK(p)000021__________ __________ GK(p)000069 -GK(p)000070__________ __________ GK(P)000766 -GK(P)000769__________ _______________ GK(P)001193_______________ __________ GK(P)001256 -GK(P)001258__________ __________ GK(P)001256 -GK(P)001258__________ __________ GK(P)001276 -GK(P)001277__________ _______________ GK(P)001278_______________ __________ GK(P)001294 -GK(P)001295__________ Page 91 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 187 of 277 PAGEID #: 61188 Bates Numbered Documents __________ GK(P)001426__________ ______GK(p)002041 -GK(p)002084______ __________ GK(p)002121__________ ______GK(p)002122 -GK(p)002123______ ______ GK(p)002124 -GK(p)002135______ ______GK(p)002136 -GK(p)002139______ ______GK(p)002140 -GK(p)002143______ ______ GK(p)002144 -GK(p)002147______ ______ GK(p)002148 -GK(p)002152______ ______GK(p)002153 -GK(p)002168______ ______GK(p)002169 -GK(p)002175______ ______GK(p)002176 -GK(p)002178______ ______GK(p)002179 -GK(p)002180______ ______GK(p)002181 -GK(p)002193______ ______ GK(p)002194 -GK(p)002196______ ______ GK(P)002301-GK(P)002303______ _______ GK000378 -GK000379_______ _______ GK000378 -GK000385_______ ________GK000378; GK000379________ _______ GK000380 -GK000385_______ _______ GK000665 -GK000666_______ _______ GK001407 -GK001422_______ _______ GK001423 -GK001434_______ _______ GK001435 -GK001439_______ _______ GK001454 -GK001455_______ _______ GK001456 -GK001463_______ ___________ GK001533___________ _______ GK001540 -GK001541_______ _______ GK001600 -GK001601_______ _______ GK001607 -GK001613_______ _______ GK001607 -GK001613_______ _______ GK002007 -GK002009_______ _______ GK002017 -GK002018_______ _______ GK002049 -GK002067_______ ___________ GK002068___________ _______ GK002308 -GK002311_______ _______ GK002317 -GK002348_______ ___________ GK002829___________ GK003401 -GK003437; EID138315 -EID138351 _______ GK004724 -GK004743_______ ___________ GK005063___________ _______ GK009322; EID606681_______ _______ GK009323; EID606682_______ GK009401 -GK009436; EID606760 -EID606795 GK010681 -GK010721; EID608040 -EID608080 Page 92 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 188 of 277 PAGEID #: 61189 _______ Bates Numbered Documents_______ ________GK011233 -GK011234; EID608593________ GK011722 -GK011728; EID609048 -EID609055; HLG002298 GK012123 -GK012130; EID727016 -EID727023 GK012131 -GK012132; EID727024 -EID727025 GK012187 -GK012281; EID727080 -EID727174 GK012493 -GK012501; EID727386 -EID727394 GK012527 -GK012547; EID727420 -EID727440 GK012724 -GK012726; EID797428 -EID797430 ___________ GK012830; EID797532___________ GK012871 -GK012885; EID797573 -EID797587 GK012947 -GK012950; EID797649 -EID797652 GK013082 -GK013098; EID797784 -EID797800 GK013416 -GK013491; EID777095 -EID777170 GK013508 -GK013586; EID777171 -EID777249 GK014108 -GK014110; EID777467 -EID77469 GK014108 -GK014110; EID777467 -EID777469 ___________ GLK000325;EID917851___________ ______________ GQTTQ00070______________ ______________ GQTTQ00137______________ _________ GQTTQ00206 -GQTTQ00208_________ _________ GQTTQ00213 -GQTTQ00217_________ _________ GQTTQ00245 -GQTTQ00247_________ _________ GQTTQ00249 -GQTTQ00250_________ _________ GQTTQ00264 -GQTTQ00265_________ _________ GQTTQ00280 -GQTTQ00281_________ ______________ GQTTQ00592______________ _________ GQTTQ00601 -GQTTQ00626_________ __________ GQTTQ00676 -GQTTQ678__________ _________ GQTTQ00726 -GQTTQ00735_________ _________ GQTTQ00839 -GQTTQ00863_________ __________GQTTQ0251 -GQTTQ00253__________ GPS000629 -GPS000629; EID927504 -EID927505 GWS000106 -GWS000107; EID727976 -EID727977 GWS000169 -GWS000170; EID728039 -EID728040 GWS000263 -GWS000265; GHSGWS000270 -GWS000271; ___________ EID728112 -EID728116___________ HDR001193 -HDR001196; EID058072 -EID058075 HDR002553 -HDR002555; EID167154 -EID167156 HDR002553 -HDR002555; EID167154 -EID167156 HDR002553 -HDR002555; EID167154 -EID167156 __________ HDR005845 -HDR005846__________ _______________HDR005975_______________ __________ HDR006057 -HDR006060__________ HDR006205 -HDR006206 Page 93 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 189 of 277 PAGEID #: 61190 ________ Bates Numbered Documents_______ HDR006346 -HDR006355; EID522239 -EID522248 ____________ HDR006439; EID522332___________ HDR006440 -HDR006445; EID522333 -EID522338 ____________ HDR006763; EID522656___________ HDR007586 -HDR007588; EID728176 -EID728178 ___________HLAB005391 -HLAB005418__________ ___________ HOLT02895 -HOLT02901___________ _____IJZ003496-IJZ003499; EID728976 -EID728979 _______________ JAA0003494_______________ ___________ JAA0003497-JAA0003501___________ ___________ JAA0003497-JAA0003501___________ ___________ JAA0011475 -JAA0011514___________ ___________ JAA0016439-JAA0016441___________ _______________ JAA0027588_______________ ___________ JAA0027592-JAA0027599___________ ___________ JAA0027600-JAA0027601___________ ___________ JAA0027777-JAA0027781___________ ___________ JAA0037726-JAA037736___________ ___________ JAA0039242-JAA0039244___________ ___________ JAA0040855 -JAA0040858___________ JCOC002512 -JCOC002534; EID641460 -EID641482 JHH001274 -JHH001282; EID610077 -EID610085 JHH001476 -JHH001515; EID729771 -EID729810 JHH001539 -JHH001582; EID729834 -EID729877 JHH001669 -JHH001759; EID729964 -EID730054 JHW003306 -JHW003308; EID610137 -EID610139 JMM004049 -JMM004073; USEPA8669 -USEPA8693 JMM008015 -JMM008016; EID073298; EID073299 JMM008018 -JMM008020; EID073300 -EID073302 KEL000533 -KEL000537; EID730428 -EID730432 KEL000597 -KEL000598; EID730490 -EID730491 KEL000654 -KEL000660; KEL000664 -KEL000687; KEL000690 ________ KEL000694; EID730547 -EID730582________ ____________ KEL000695;EID730583____________ KEL000702 -KEL000727; EID730586 -EID730611 ______________ LE3858 -LE3887______________ ______________ LE1750-LE1751______________ ______________ LE1750-LE1751______________ ______________ LE1752 -LE1789______________ ______________ LE5954- LE5955______________ ______________ LE5956-LE5957______________ ___________ LE-EX04703 -LE-EX04703___________ LJB000116 -LJB000117; EID610228 -EID610229 ______LPSD137 -LPSD138; EID112971; DDJ001815_____ LPSD143 -LPSD144 Page 94 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 190 of 277 PAGEID #: 61191 _______ Bates Numbered Documents_______ ___________ LWB004968; EID635572___________ MAC001957 -MAC001963; EID731474 -EID731480 MAC002001 -MAC002025; EID731518 -EID731542 MAC002207- MAC002309, EID731724 a" EID731826 MAK008040 -MAK008042; EID610518 -EID610520 ___________MAK008126; EID610600___________ __________MEM014045 -MEM014056__________ MLR002254 -MLR002257; EID799992 -EID799995 MLR002317 -MLR002321; EID800051 -EID800055 MLR002340 -MLR002342; EID800070 -EID800072 MLR002340 -MLR002342; EID800070 -EID800072 MLR002357 -MLR002361; EID800087 -EID800091 MLR002732 -MLR002733; EID800441 -EID800442 __________ MNAG0001 -MNAG0030__________ ________ MOORE000017 -MOORE000019________ ________ MQQRE000028 -MQQRE000032________ _____________ MOORE000033______________ ________ MOORE000034 -MOORE000035________ ______________MOORE000036_____________ __________MOORE000037 -MOORE46__________ ______________MOORE000052_____________ ________ MOORE000089 -MOORE000096________ _____________ MOORE000114_____________ ________ MOORE000241 -MOORE000268________ __________ MOORE000288-MOORE__________ MPD000058 -MPD000059; EID613190 -EID613191 MR266876; GK013082 -GK013098; EID797784 -EID797800 MR314973; ROWE033130 -ROWE033189 MR314999; ROWE033099 -ROWE033129 MR325063; USEPA30567 -USEPA30623 NKT000001 -NKT000001; EID735221 -EID735222 NKT000003 -NKT000004; EID735223 -EID735224 ________ NKT000062; EID735282________ ________ NKT000063; EID735283________ NSR000300 -NSR000306; EID735328 -EID735334 NSR000307 -NSR000308; EID735335 -EID735336 NSR000309 -NSR000311; EID735337 -EID735339 ________PBJB003940; EID613632________ PEG000001 -PEG000009; EID800795 -EID800803 PEG000010 -PEG000017; EID800804 -EID800811 PEG000027 -PEG000028; EID800821 -EID800822 PEG000043 -PEG000051; EID800834 -EID800842 PEG000052 -PEG000059; EID800843 -EID800850 ________ PEG000099; EID800851________ Page 95 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 191 of 277 PAGEID #: 61192 ______ Bates Numbered Documents______ PEG000100 -PEG000107; EID800852 -EID800859 PJB000371 -PJB000374; EID196253 -EID196256 PJB000378 -PJB000381; EID196260 -EID196263 __________ PJB001934 -PJB001945__________ PJB003901 -PJB003902; EID613593 -EID613594 __________ PJB003937; EID613629__________ PJB003957 -PJB003967; EID613649 -EID613659 PJB004029 -PJB004043; EID685105 -EID685119 __________ PJB004082 -PJB004084__________ ___________PL000063 -PL000064___________ ______________ PL000065______________ PNC000053 -PNC000060; EID736556 -EID736563 PTDB000830 -PTDB000839; EID613678 -EID613687 RAK012623-RAK012624; EID736722-EID736723 __________ RCB000208;EID217843__________ RCB002272 -RCB002313; EID638342 -EID6383383 __________RCG000181 -RCG000190__________ __________ RCG000331; EID614317__________ RCG000345 -RCG000439; EID603194 -EID603288 ______________RCW002019______________ RGS000005 -RGS000007; EID217933 -EID217935 __________ RH009049; EDD0072900__________ RH009050 -RH009052; RGS000005 -RGS000007 RJA002101 -RJA002102; EID737588 -EID737589 __________ RJZ009207; USEPA8850__________ RJZ009208-RJZ009208; USEPA14965 -USEPA14966 RJZ009208-RJZ009211; USEPA14965 -USEPA14968 RL001580 -RL001582; EID107130 -EID107132 RL003145 -RL003163; EID645647 -EID645665 RLR001349 -RLR001449; EXP002362 -EXP002462 __________ RLR002787;EID927242__________ RLR002788 -RLR002792; EID927243 -EID927247 ________RLR002806; 011-0002-0000204________ RLR002807 -RLR002808; 011-0001-0000205 -011-0002 _______________ 0000206_______________ RLR002899 -RLR002902; EID076927 -EID076930 __________ RLR014826;EID614723__________ __________ RLR015746;EID737905__________ RLR016790 -RLR016792; EID802644 -EID802646 RLR016790 -RLR016792; EID802644 -EID802646 ________ ROWE 000467 -ROWE000468________ ________ R0WE000001 -R0WE000004________ _____________ R0WE000005_____________ _____________ R0WE000006_____________ R0WE000007 -R0WE000011 Page 96 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 192 of 277 PAGEID #: 61193 _______ Bates Numbered Documents_______ _________ ROWE000012 -ROWE000026_________ _________ ROWE000027 -ROWE000135_________ _________ ROWE000136 -ROWE000139_________ _________ RQWE000140 -ROWE000203_________ _________ ROWE000204 -ROWE000245_________ _________ ROWE000246 -ROWE000308_________ ROWE000309 -ROWE000385; WVDEP17747- WVDEP17754; USEPA18994 -USEPA18996; USEPA18931 -USEPA18993 ______________ ROWE0003777______________ ROWE000386 -ROWE000462; WVDEP17747 -WVDEP17754; USEPA18994 -USEPA18996; USEPA18931 -USEPA18993 ROWE000400 -ROWE000462 _____ROWE000463_____ ROWE000464 -ROWE000466 ROWE000469 -ROWE000487 ROWE000488 -ROWE000489 ROWE000490 -ROWE000501 ROWE000659 -ROWE000660 ROWE000661 -ROWE000662 ROWE000663 -ROWE000665 ROWE000666 -ROWE000677 ROWE000678 -ROWE000679 ROWE000682 -ROWE000683 ROWE000684 -ROWE000685 ROWE000686 -ROWE000687 ROWE000690 -ROWE000693 ROWE000694 -ROWE000695 ROWE000696 -ROWE000698 ROWE000699 -ROWE000700 ROWE000701 -ROWE000705 ROWE000706 -ROWE000712 ROWE000713 -ROWE000729 ROWE000730 -ROWE000731 ROWE000732 -ROWE000734 ROWE000735 -ROWE000741 ROWE000742 -ROWE000744 ROWE000745 -ROWE000768 _____ROWE000769_____ ROWE000770 -ROWE000813 ROWE000814 -ROWE000819 ROWE000820 -ROWE000821 ROWE000822 -ROWE000825 ROWE000826 Page 97 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 193 of 277 PAGEID #: 61194 Bates Numbered Documents ROWE000827 -ROWE000830 ROWE000831 -ROWE000836 ROWE000840 -ROWE000843 ROWE000844 -ROWE000847 ROWE000848 -ROWE000859 ROWE000860 -ROWE000882 ROWE000883 -ROWE000884 ROWE000885 -ROWE000886 ROWE000887 -ROWE000889 ROWE000890 -ROWE000891 ROWE000892 -ROWE000896 ROWE000897 -RQWE000901 ROWE000902 -ROWE000915 ROWE000916 -ROWE000919 ROWE000920 -ROWE000921 ROWE000922 -ROWE000923 ROWE000924 -ROWE000925 ROWE000926 -ROWE000956 _______ ROWE000957_______ ROWE000958 -ROWE000960 _______ ROWE000961_______ ROWE000962 -ROWE000972 ROWE000973 -ROWE000978 ROWE000979 -ROWE000981 ROWE000983 -ROWE001019 ROWE001020 -ROWE001021 _______ ROWE001022_______ ROWE001023 -ROWE001026 ROWE001027 -ROWE001041 _______ ROWE001042_______ ROWE001043 -ROWE001050 ROWE001051 -ROWE001052 ROWE001055 -ROWE001058 ROWE001059 -ROWE001060 ROWE001061 -ROWE001062 ROWE001063 -ROWE001101 ROWE001102 -ROWE001128 ROWE001129 -ROWE001130 ROWE001131 -ROWE001134 ROWE001135 -ROWE001145 ROWE001146 -ROWE001150 ROWE001151 -ROWE001152 ROWE001153 -ROWE001154 ROWE001155 -ROWE001156 ROWE001157 -ROWE001162 Page 98 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 194 of 277 PAGEID #: 61195 Bates Numbered Documents ROWE001163 -ROWE00001170 ROWE001171 -ROWE001172 ROWE001173 -ROWE001177 ROWE001178 -ROWE001179 ROWE001182 -ROWE001184 ROWE001185 -ROWE001186 ROWE001192 -ROWE001198 ROWE001199 -ROWE001237 ROWE001238 -ROWE001241 ROWE001242 -ROWE001245 _______ ROWE001246_______ ROWE001247 -ROWE001250 ROWE001251 -ROWE001256 _______ ROWE001257_______ ROWE001258 -ROWE001260 ROWE001261 -ROWE001264 ROWE001265 -ROWE001269 ROWE001270 -ROWE001332 ROWE001333 -ROWE001341 ROWE001342 -ROWE001467 ROWE001468 -ROWE001504 ROWE001508 -ROWE001510 ROWE001511 -ROWE001513 ROWE001514 -ROWE1525 ROWE001526 -ROWE001530 ROWE001531 -ROWE001546 ROWE001547 -ROWE001605 ROWE001606 -ROWE001612 ROWE001613 -ROWE001616 ROWE001617 -ROWE001618 ROWE003424 -ROWE003425 _______ ROWE003582_______ ROWE003583 -ROWE003590 ROWE003591 -ROWE003592 ROWE003593 -ROWE003594 ROWE003597 -ROWE003598 ROWE003612 -ROWE003613 ROWE003614 -ROWE003627 ROWE003661 -ROWE003662 _______ ROWE003663_______ _______ ROWE003664_______ ROWE003668 -ROWE003691 ROWE003692 -ROWE003693 ROWE003698 -ROWE003699 ROWE003700 -ROWE003701 Page 99 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 195 of 277 PAGEID #: 61196 Bates Numbered Documents ROWE003704 -ROWE003705 ROWE003706 -ROWE003709 ROWE003710 -ROWE003715 ROWE003716 -ROWE003753 ROWE003769 -ROWE003773 ROWE003778 -ROWE003779 ROWE003782 -ROWE003783 ROWE003784 -ROWE003785 ROWE003788 -ROWE003789 _______ ROWE003790_______ ROWE003791 -ROWE003792 ROWE003795 -ROWE003822 ROWE003826 -ROWE003827 _______ ROWE003828_______ ROWE003829 -ROWE003836 ROWE003837 -ROWE003838 ROWE003839 -ROWE003842 ROWE003843 -ROWE003844 ROWE003845 -ROWE003846 ROWE003847 -ROWE003848 ROWE003849 -ROWE003851 ROWE003852 -ROWE003853 ROWE003854 -ROWE003855 ROWE003856 -ROWE003861 ROWE003865 -ROWE003868 _______ ROWE003869_______ ROWE003874 -ROWE003877 _______ ROWE003878_______ ROWE003885 -ROWE003886 _______ ROWE003887_______ ROWE003888 -ROWE003907 _______ ROWE003909_______ ROWE003913 -ROWE003914 ROWE003926 -ROWE003927 _______ ROWE003929_______ _______ ROWE003930_______ _______ ROWE003933_______ ROWE003934 -ROWE003936 _______ ROWE003937_______ ROWE003938 -ROWE003939 RQWE003940-RQWE003942 _______ ROWE004000_______ _______ ROWE004027_______ _______ ROWE004028_______ ROWE004029 -ROWE004035 Page 100 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 196 of 277 PAGEID #: 61197 Bates Numbered Documents ROWE004036 -ROWE004045 ROWE004046 -ROWE004095 ROWE004096 -ROWE004097 ROWE004098 -ROWE004251 ROWE004252 ROWE004253 ROWE004943 -ROWE004953 _______ ROWE005061_______ _______ ROWE005062_______ ROWE005496 -ROWE005516 ROWE005517 -ROWE005519 ROWE005520 -ROWE005527 ROWE005528 ROWE005571 ROWE005572 -ROWE005573 ROWE005596 -ROWE005602 _______ ROWE005603_______ ROWE005604 -ROWE005606 ROWE005607 -ROWE005608 ROWE005659 -ROWE005663 ROWE005664 -ROWE005666 ROWE005667 -ROWE005671 ROWE005672 -ROWE005676 _______ ROWE005677_______ ROWE005678 -ROWE005681 ROWE005682 -ROWE005683 ROWE006115 -ROWE006117 ROWE006696 -ROWE006701 ROWE006810 -ROWE006817 _______ ROWE006831_______ _______ ROWE006846_______ ROWE007936 -ROWE007937 ROWE007938 -ROW007951 ROWE007952 -ROWE007964 ROWE007967 -ROWE007969 ROWE007970 -ROWE007978 ROWE007979 -ROWE007981 ROWE007982 -ROWE007985 _______ ROWE007986_______ ROWE007987 -ROWE007990 ROWE007991 -ROWE007996 ROWE007997 -ROWE007998 ROWE008008 -ROWE008010 ROWE008011 -ROWE008026 ROWE008027 -ROWE008149 ROWE008150 -ROWE008151 ROWE008152 -ROWE008157 Page 101 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 197 of 277 PAGEID #: 61198 Bates Numbered Documents ROWE008158 -ROWE008159 ROWE008167 -ROWE008169 ROWE008170 -ROWE008176 ROWE008177 -ROWE008179 _______ ROWE008181_______ ROWE008181 -ROWE008187 ROWE008181 -ROWE8182 _______ ROWE008183_______ ROWE008188 -ROWE008190 _______ ROWE008191_______ _______ROWE0081920_______ ROWE008194 -ROWE008195 ROWE008196 -ROWE008233 ROWE008234 -ROWE008235 ROWE008738 -ROWE008745 ROWE008746 -ROWE008750 ROWE008751 -ROWE008786 ROWE008787 -ROWE008829 ROWE008830 -ROWE008838 ROWE008839 -ROWE008847 ROWE008848 -ROWE008857 ROWE008858 -ROWE008876 ROWE008877 -ROWE008879 ROWE008880 -ROWE008890 ROWE008891 -ROWE008900 ROWE008901 -ROWE008910 ROWE008911 -ROWE008916 _______ ROWE008917_______ ROWE008918 -ROWE008920 ROWE008921 -ROWE008922 ROWE008923 -ROWE0089232 ROWE008953 -ROWE008956 ROWE008957 -ROWE008976 ROWE008977 -ROWE008995 ROWE009068 -ROWE0009069 ROWE010468 - ROWE010499 ROWE010501 -ROWE010524 ROWE010530 -ROWE010538 _______ ROWE010539_______ ROWE010842 -ROWE010877 ROWE010880 -ROWE010890 _______ ROWE010891_______ ROWE010892 -ROWE010893 _______ ROWE010894_______ ROWE010895 -ROWE010896 Page 102 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 198 of 277 PAGEID #: 61199 _______ Bates Numbered Documents_______ _________ ROWE010897 -ROWE010910_________ _________ ROWE010911 - ROWE010925_________ _________ ROWE010952 -ROWE010953_________ _________ ROWE010954 -ROWE010955_________ _________ ROWE011110 -ROWE011120_________ _________ ROWE011121 -ROWE011123_________ _________ ROWE011127 -ROWE011138_________ _________ ROWE011139 -ROWE011143_________ ______________ ROWE011144______________ ______________ ROWE011145______________ _________ ROWE011146 -ROWE011148_________ _________ ROWE011149 -ROWE011150_________ _________ ROWE011158 -ROWE011159_________ ______________ ROWE011160______________ _________ ROWE011163 -ROWE11171_________ ______________ ROWE011172______________ _________ ROWE011173 -ROWE011184_________ ROWE011173 -ROWE011184; LE5954 -LE5957; 003-0218 _______________ 0003631________________ ______________ ROWE011185______________ ______________ ROWE011186______________ _________ ROWE011187 -ROWE011187_________ _________ ROWE011195 -ROWE011271_________ _________ ROWE011272 -ROWE011274_________ _________ ROWE011275 -ROWE011276_________ _________ ROWE011277 -ROWE011279_________ _________ ROWE011288 -ROWE011289_________ _________ ROWE011290 -ROWE011299_________ _________ ROWE011300 -ROWE011342_________ _________ ROWE011345 -ROWE011346_________ _________ ROWE011348 -ROWE011349_________ _________ ROWE011350 -ROWE011371_________ ______________ ROWE011357______________ _________ ROWE011373 -ROWE011381_________ _________ ROWE011373 -ROWE011381_________ ______________ ROWE011382______________ _________ ROWE011383 -ROWE011894_________ _________ ROWE011395 -ROWE011396_________ ______________ ROWE011658______________ ______________ ROWE011661______________ _________ ROWE015303 -ROWE015334_________ ______________ ROWE016464______________ _________ ROWE016465 -ROWE016467_________ _________ ROWE016468 -ROWE016481_________ ROWE016482 -ROWE016486 Page 103 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 199 of 277 PAGEID #: 61200 _______ Bates Numbered Documents_______ _________ ROWE016487 -ROWE016505_________ _________ ROWE016535 -ROWE016536_________ ______________ ROWE01662______________ ______________ ROWE019704______________ ______________ ROWE019705______________ _________ ROWE019963 -ROWE019964_________ ______________ ROWE019965______________ _________ ROWE019995 -ROWE020000_________ _________ ROWE020036 -ROWE020079_________ ______________ ROWE020089______________ ______________ ROWE020603______________ _________ ROWE020612 -ROWE020613_________ _________ ROWE020614 -ROWE020615_________ _________ ROWE020718 -ROWE02730_________ _________ ROWE021058 -ROWE021059_________ _________ ROWE021294 -ROWE021300_________ ______________ ROWE021307______________ _________ ROWE021311 -ROWE021312_________ _________ ROWE021351 -ROWE023152_________ ______________ ROWE021790______________ _________ ROWE021826 -ROWE021828_________ ROWE021916 -ROWE021927; AR226-3743; AR226-3744 _________ ROWE022158 -ROWE022165_________ _________ ROWE022168 -ROWE022172_________ _________ ROWE022353 -ROWE022360_________ _________ ROWE022510 -ROWE022513_________ _________ ROWE022514 -ROWE022515_________ _________ ROWE022580 -ROWE022603_________ _________ ROWE022646 -ROWE022653_________ _________ ROWE022646 -ROWE022653_________ _________ ROWE022654 -ROWE022690_________ _________ ROWE022654 -ROWE022690_________ _________ ROWE022691 -ROWE022692_________ _________ ROWE022693 -ROWE022708_________ _________ ROWE022693 -ROWE022708_________ _________ ROWE022709 -ROWE022756_________ ______________ ROWE022760______________ _________ ROWE022773 -ROWE022868_________ _________ ROWE022869 -ROWE022991_________ _________ ROWE023197 -ROWE023229_________ _________ ROWE023230 -ROWE023248_________ _________ ROWE023249 -ROWE023267_________ _________ ROWE023536 -ROWE023537_________ ROWE023536 -ROWE02357; ROWE031925 -ROWE031926 Page 104 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 200 of 277 PAGEID #: 61201 Bates Numbered Documents ROWE023538 -ROWE023585 ROWE0235538 -ROWE023585 _______ ROWE023627_______ ROWE023729 -ROWE023730 ROWE023769 -ROWE023777 ROWE023778 -ROWE023779 ROWE023780 -ROWE023781 _______ ROWE023782_______ _______ ROWE023783_______ ROWE023784 -ROWE023801 ROWE023810 -ROWE023815 ROWE023815 -ROWE023822 ROWE023869 -ROWE023870 _______ ROWE024225_______ ROWE024231 -ROWE024232 ROWE024234 -ROWE024239 _______ ROWE024247_______ ROWE024337 -ROWE0024360 _______ ROWE024361_______ _______ ROWE024362_______ ROWE024363 -ROWE024374 _______ ROWE024540_______ _______ ROWE024541_______ ROWE024542 -ROWE024550 ROWE024551 -ROWE024561 ROWE024562 -ROWE024563 ROWE024564 -ROWE024574 ROWE024610 -ROWE024611 ROWE024612 -ROWE024613 ROWE024614 -ROWE024617 _______ ROWE024619_______ ROWE024620 -ROWE024621 ROWE024625 -ROWE024628 ROWE024629 -ROWE024630 ROWE024642 -ROWE024643 ROWE024644 -ROWE024651 ROWE024652 -ROWE024656 ROWE024796 -ROWE024820 ROWE024821 -ROWE024836 ROWE024837 -ROWE024838 ROWE024839 -ROWE024871 ROWE024887 -ROWE024891 ROWE024892 -ROWE024894 ROWE024946 -ROWE024952 ROWE024953 -ROWE024960 Page 105 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 201 of 277 PAGEID #: 61202 _____ Bates Numbered Documents_____ _______ ROWE024961 -ROWE024988_______ _______ ROWE024989 -ROWE024990_______ ____________ ROWE025558____________ ____________ ROWE025559____________ _______ ROWE026023 -ROWE026029_______ _______ ROWE026030 -ROWE026050_______ _______ ROWE026276 -ROWE026279_______ _______ ROWE026386 -ROWE026432_______ _______ ROWE026436 -ROWE026453_______ ____________ ROWE026488____________ ____________ ROWE026489____________ _______ ROWE026490 -ROWE026497_______ _______ ROWE026564 -ROWE026565_______ _______ ROWE026566 -ROWE026567_______ _______ ROWE026611 -ROWE026612_______ _______ ROWE026613 -ROWE026614_______ _______ ROWE026654 -ROWE026655_______ _______ ROWE026656 -ROWE026657_______ _______ ROWE026658 -ROWE026659_______ _______ ROWE027843 -ROWE027905_______ _______ ROWE029318 -ROWE029319_______ _______ ROWE029341 -ROWE029342_______ _______ ROWE029362 -ROWE029422_______ _______ ROWE029423 -ROWE029437_______ _______ ROWE029423 -ROWE029437_______ _______ ROWE029456 -ROWE029484_______ ____________ ROWE029819____________ ROWE029888 -ROWE029914; EID713244 -EID713270 _______ ROWE029965 -ROWE030011_______ _______ ROWE029985 -ROWE029887_______ _______ ROWE030064 -ROWE030075_______ _______ ROWE030076 -ROWE030080_______ ____________ RQWE030100____________ _______ ROWE030125 -ROWE030130_______ _______ ROWE030237 -ROWE030238_______ _______ ROWE030266 -ROWE030273_______ _______ ROWE030274 -ROWE030275_______ _______ ROWE030278 -ROWE030279_______ _______ ROWE030309 -ROWE030310_______ _______ ROWE030313 -ROWE030315_______ _______ ROWE030316 -ROWE030317_______ _______ ROWE030349 -ROWE030351_______ _______ ROWE030367 -ROWE030368_______ _______ ROWE030408 -ROWE030410_______ ROWE030411- ROWE030412 Page 106 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 202 of 277 PAGEID #: 61203 Bates Numbered Documents ROWE030419 -ROWE030421 ROWE030422 -ROWE030423 _______ ROWE030424_______ ROWE030425 -ROWE030427 ROWE030428 -ROWE030429 ROWE030445 -ROWE030446 ROWE030447 -ROWE030448 _______ ROWE030490_______ ROWE030491 -ROWE030492 _______ ROWE030493_______ _______ ROWE030494_______ _______ ROWE030495_______ ROWE030497 -ROWE030499 ROWE030503 -ROWE030507 _______ ROWE030508_______ ROWE030509 -ROWE030511 ROWE030512 -ROWE030513 ROWE030514 -ROWE030515 ROWE030607 -ROWE030608 ROWE030609 -ROWE030610 ROWE030754; 307271 ROWE030789 -ROWE030841 ROWE030862 -ROWE030869 ROWE030881 -ROWE030893 ROWE030894 -ROWE030925 ROWE030968 -ROWE030981 ROWE031166 -ROWE031169 ROWE031176 -ROWE031180 ROWE031363 -ROWE031365 ROWE031446 -ROWE031447 _______ ROWE031485_______ ROWE031486 -ROWE031487 ROWE031509 -ROWE031514 ROWE031515 -ROWE031559 ROWE031606 -ROWE031614 ROWE031615 -ROWE031656 ROWE031657 -ROWE031661 ROWE031662 -ROWE031664 ROWE031665 -ROWE031678 _______ ROWE031679_______ ROWE031875 -ROWE031876 ROWE031884 -ROWE031885 ROWE031895 -ROWE031896 _______ ROWE031924_______ ROWE031925 -ROWE031926 Page 107 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 203 of 277 PAGEID #: 61204 Bates Numbered Documents ROWE031942 -ROWE031943 ROWE031944 -ROWE031945 ROWE031946 -ROWE031955 ROWE031956 -ROWE032000 ROWE032001 -ROWE032010 ROWE032029 -ROWE032030 ROWE032071 -ROWE032077 ROWE032078 -ROWE032105 ROWE032106 -ROWE032148 ROWE032587 -ROWE032625 ROWE032703 -ROWE03705 ROWE032939 -ROWE033019 ROWE033020 -ROWE033031 ROWE033020 -ROWE033031 ROWE033040 -ROWE033053 ROWE033064 -ROWE033071 ROWE033075 -ROWE033076 ROWE033077 -ROWE033098 _______ ROWE033322_______ ROWE033329 -ROWE033330 ROWE033397 -ROWE033412 ROWE033465 -ROWE033497 ROWE033503 -ROWE033507 ROWE033503 -ROWE033507 _______ ROWE033508_______ ROWE033509 -ROWE033510 ROWE033530 -ROWE033565 ROWE033530 -ROWE033565 _______ ROWE033650_______ _______ ROWE033682_______ ROWE033683 -ROWE033686 ROWE033781 -ROWE033782 ROWE033786 -ROWE033788 ROWE034159 -ROWE034164 ROWE034165 -ROWE034166 _______ ROWE034167_______ ROWE034168 -ROWE034169 ROWE034170 -034171 ROWE034172 -ROWE034174 _______ ROWE034176_______ ROWE034177 -ROWE034182 ROWE034183 -ROWE034184 ROWE034185 -ROWE034199 _______ ROWE034645_______ ROWE034648 -ROWE034649 Page 108 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 204 of 277 PAGEID #: 61205 Bates Numbered Documents ROWE034673 -ROWE034674 _______ ROWE034694_______ ROWE034695 -ROWE034706 ROWE034715 -ROWE034795 ROWE035813 -ROWE035818 ROWE035864 -ROWE035873 ROWE035894 -ROWE035899 ROWE035900 -ROWE035906 ROWE035968 -ROWE036007 ROWE036140 -ROWE036143 ROWE036271 -ROWE036273 ROWE036342 -ROWE036355 ROWE036461 -ROWE036469 ROWE036470 -ROWE036478 ROWE036534 -ROWE036536 ROWE036560 -ROWE036586 ROWE036679 -ROWE036681 ROWE036682 -ROWE036686 ROWE036682 -ROWE036686 ROWE036687 -ROWE036703 _______ ROWE036735_______ _______ ROWE036738_______ ROWE037124 -ROWE037127 ROWE037128 -ROWE037129 _______ ROWE037135_______ ROWE037136 -ROWE037138 _______ ROWE037148_______ ROWE037149 -ROWE037152 ROWE037166 -ROWE037168 ROWE037169 -ROWE037171 ROWE037247 -ROWE037249 ROWE037254 -ROWE037256 ROWE037257 -ROWE037301 ROWE037332 -ROWE037334 ROWE037351 -ROWE037353 ROWE037356 -ROWE037361 ROWE037371 -ROWE037374 ROWE037411 -ROWE037416 ROWE037417 -ROWE037437 ROWE037457 -ROWE037459 ROWE037467 -ROWE037472 ROWE037473 -ROWE037476 ROWE037477 -ROWE037479 ROWE037483 -ROWE037512 ROWE037558 -ROWE037618 Page 109 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 205 of 277 PAGEID #: 61206 Bates Numbered Documents ROWE037626 -ROWE037681 ROWE037728 -ROWE037730 _______ ROWE037790_______ ROWE038025 -ROWE038033 ROWE038247 -ROWE038286 ROWE038289 -ROWE038315 ROWE038289 -ROWE038315 ROWE038341 -ROWE038342 ROWE038343 -ROWE038351 ROWE038393 -ROWE038394 ROWE038469 -ROWE038548 ROWE038549 -ROWE038553 ROWE038699 -ROWE038701 ROWE038720 -ROWE038727 ROWE038939 -ROWE038948 _______ ROWE038949_______ ROWE038978 -ROWE039005 ROWE039098 -ROWE039100 ROWE039164 -ROWE039174 ROWE039186 -ROWE039189 ROWE039253 -ROWE039255 _______ ROWE039260_______ ROWE039264 -ROWE039265 ROWE039266 -ROWE039274 ROWE039275 -ROWE039300 ROWE039321 -ROWE039324 ROWE039380 -ROWE039381 ROWE039382 -ROWE039393 _______ ROWE039418_______ ROWE039419 -ROWE039423 ROWE039425 -ROWE039427 ROWE039431 -ROWE039432 ROWE039431 -ROWE039432 ROWE039433 -ROWE039435 _______ ROWE039438_______ ROWE039591 -ROWE039593 _______ ROWE039594_______ ROWE039598 -ROWE039609 ROWE039637 -ROWE039639 ROWE039752 -ROWE039759 ROWE039752 -ROWE039759 ROWE040184 -ROWE040192 ROWE040305 -ROWE040306 ROWE040341 -ROWE040353 ROWE040354 Page 110 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 206 of 277 PAGEID #: 61207 _______ Bates Numbered Documents_______ _________ ROWE040363 -ROWE040366_________ _________ ROWE040367 -ROWE040379_________ _________ ROWE040388 -ROWE040389_________ _________ ROWE040476 -ROWE040477_________ ROWE040483 -ROWE040489; ROWE040491 -ROWE040499 ____ ROWE040483 -ROWE040499____ _________ ROWE040586_________ ____ ROWE040592 -ROWE040603____ ____ ROWE040604 -ROWE040624 ____ ROWE040707 -ROWE040708 ____ ROWE040725 -ROWE040726____ ____ ROWE040760 -ROWE040798 ____ ROWE040799 -ROWE040804 _________ ROWE040875_________ ____ ROWE040882 -ROWE040898 ____ ROWE040899 -ROWE040922____ _________ ROWE040970_________ ____ ROWE040994 -ROWE040995____ ROWE0409977 -ROWE040980 ____ ROWE041177 -ROWE041178 ____ ROWE041180 -ROWE041181____ _________ ROWE041191_________ ____ ROWE041201 -ROWE041233____ _________ ROWE041250_________ _________ ROWE041251_________ _________ ROWE041344_________ _________ ROWE041352_________ _________ ROWE041459_________ _________ ROWE041462_________ ROWE041469 -ROWE041471; ROWE041193 ____ ROWE041753 -ROWE041764 ____ ROWE041765 -ROWE041766____ _________ ROWE041791_________ ____ ROWE041924 -ROWE041926____ _________ ROWE041972_________ ____ ROWE042023 -ROWE042032____ ____ ROWE042023 -ROWE042032____ ____ ROWE042033 -ROWE042065____ _________ ROWE042106_________ _________ ROWE042107_________ _________ ROWE042205_________ _________ ROWE042206_________ _________ ROWE042207_________ ROWE042222 -ROWE042223 Page 111 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 207 of 277 PAGEID #: 61208 Bates Numbered Documents ROWE042224 -ROWE042289 ROWE042290 -ROWE042296 ROWE042297 -ROWE042302 ROWE042297 -ROWE042302 ROWE042336 -ROWE042353 _______ ROWE042354_______ _______ ROWE042355_______ ROWE042357 -ROWE042394 _______ ROWE042397_______ _______ ROWE042398_______ ROWE042405 -ROWE042417 _______ ROWE042418_______ ROWE042665 -ROWE042712 ROWE042742 -ROWE042748 ROWE042742 -ROWE042748 ROWE042763 -ROWE042765 ROWE042766 -ROWE042773 ROWE042803 -ROWE042804 ROWE042805 -ROWE042806 ROWE042836 -ROWE042848 ROWE042850 -ROWE042855 ROWE042856 -ROWE042863 ROWE042908 -ROWE042914 ROWE042947 -ROWE042992 _______ ROWE042993_______ ROWE043006 -ROWE043015 ROWE043018 -ROWE043024 ROWE043025 -ROWE043026 ROWE043042 -ROWE043097 _______ ROWE043268_______ ROWE043378 -ROWE043382 ROWE043378 -ROWE043382 ROWE043378 -ROWE043382 ROWE043530 -ROWE043531A _______ ROWE043532_______ _______ ROWE043534_______ _______ ROWE043539_______ ROWE043545 -ROWE043551 _______ ROWE043552_______ _______ ROWE043553_______ _______ ROWE043554_______ _______ ROWE043555_______ _______ ROWE043557_______ ROWE043598 -ROWE043599 ROWE043610 -ROWE043618 Page 112 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 208 of 277 PAGEID #: 61209 Bates Numbered Documents ROWE043610 -ROWE043618 ROWE043632 -ROWE043641 _______ ROWE043679_______ _______ ROWE043680_______ ROWE043889 -ROWE043896 ROWE043902 -ROWE043904 ROWE043905 -ROWE043923 ROWE043924 -ROWE043925 ROWE043926 -ROWE043928 ROWE043929 -ROWE043931 ROWE043932 -ROWE043933 ROWE043934 -ROWE043943 ROWE043944 -ROWE043947 ROWE043948 -ROWE043950 ROWE043951 -ROWE043953 ROWE043954 -ROWE043968 ROWE043969 -ROWE043970 ROWE043971 -ROWE043976 ROWE043977 -ROWE043978 _______ ROWE043979_______ ROWE043980 -ROWE043987 ROWE043988 -ROWE043990 ROWE043991 -ROWE043992 ROWE043993 -ROWE043994 ROWE043995 -ROWE043996 ROWE043997 -ROWE043999 ROWE044000 -ROWE044002 ROWE044003 -ROWE044006 ROWE044007 -ROWE044008 ROWE044009 -ROWE044016 ROWE044017 -ROWE044024 ROWE044025 -ROWE044028 ROWE044029 -ROWE044037 ROWE044038 -ROWE044041 ROWE044042 -ROWE044044 ROWE044045 -ROWE044047 ROWE044048 -ROWE044049 ROWE044050 -ROWE044051 ROWE044052 -ROWE044063 ROWE044064 -ROWE044066 ROWE044067 -ROWE044068 ROWE044069 -ROWE044070 ROWE044071 -ROWE044073 ROWE044074 -ROWE044077 ROWE044078 -ROWE044084 Page 113 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 209 of 277 PAGEID #: 61210 Bates Numbered Documents ROWE044085 -ROWE044086 ROWE044087 -ROWE044088 ROWE044100 -ROWE044107 ROWE044213 -ROWE044232 ROWE044609 -ROWE044664 ROWE044839 -ROWE044840 ROWE044841 -ROWE044842 ROWE044891 -ROWE044893 ROWE044894 -ROWE044902 ROWE044903 -ROWE044905 ROWE044907 -ROWE044920 _______ ROWE044921_______ ROWE044925 -ROWE044927 ROWE044931 -ROWE044933 ROWE045006 -ROWE045010 ROWE045011 -ROWE045020 ROWE045021 -ROWE045024 ROWE045027 -ROWE045052 ROWE045053 -ROWE045055 ROWE045056 -ROWE045139 ROWE045183 -ROWE045211 ROWE045183 -ROWE045211 ROWE045214 -ROWE045215 ROWE045216 -ROWE045218 ROWE045305 -ROWE045306 ROWE045307 -ROWE045314 ROWE045317 -ROWE045326 ROWE045317 -ROWE045326 ROWE045359 -ROWE045371 ROWE045410 -ROWE045426 ROWE045427 -ROWE045430 ROWE045431 -ROWE045433 ROWE045437 -ROWE045438 ROWE045464 -ROWE045465 ROWE045470 -ROWE045522 ROWE045534 -ROWE045535 ROWE045569 -ROWE045600 ROWE045608 -ROWE045612 _______ ROWE045661_______ ROWE045765 -ROWE045768 ROWE045769 -ROWE045773 ROWE045774 -ROWE045776 ROWE045777 -ROWE045811 _______ ROWE045812_______ ROWE045813 -ROWE045846 Page 114 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 210 of 277 PAGEID #: 61211 _______Bates Numbered Documents_______ _________ ROWE045847 -ROWE045849_________ _________ ROWE045850 -ROWE045859_________ _________ROWE045860 -ROWE0 45909_________ _________ ROWE045910 -ROWE045953_________ _________ ROWE045962 -ROWE045973_________ _________ ROWE045974 -ROWE046008_________ _________ ROWE046018 -ROWE046045_________ _________ ROWE046046 -ROWE046088_________ _________ ROWE046089 -ROWE046129_________ _________ ROWE046130 -ROWE046163_________ _________ ROWE046164 -ROWE046308_________ _________ ROWE046309 -ROWE046336_________ _________ ROWE046337 -ROWE046391_________ _________ ROWE046392 -ROWE046417_________ _________ ROWE046475 -ROWE046476_________ _________ ROWE046477 -ROWE046760_________ _________ ROWE046761 -ROWE046970_________ _________ ROWE046971 -ROWE046973_________ _________ ROWE046974 -ROWE046979_________ _________ ROWE046980 -ROWE046982_________ _________ ROWE047006 -ROWE047020_________ _________ ROWE047048 -ROWE047083_________ _________ ROWE047091 -ROWE047096_________ ______________ROWE047148______________ _________ ROWE047160 -ROWE047161_________ _________ ROWE047183 -ROWE047194_________ _________ ROWE047248 -ROWE047252_________ _________ ROWE047253 -ROWE047255_________ ______________ROWE047256______________ _________ ROWE047257 -ROWE047291_________ _________ ROWE047292 -ROWE047341_________ _________ ROWE047342 -ROWE047385_________ _________ ROWE047386 -ROWE047389_________ _________ ROWE047390 -ROWE047399_________ _________ ROWE047400 -ROWE047433_________ _________ ROWE047434 -ROWE047436_________ _________ ROWE047437 -ROWE047456_________ _________ ROWE047750 -ROWE047761_________ ROWE047787 -ROWE047789; USEPA23171 -USEPA23173 ROWE047790 -ROWE047791; USEPA23174 -USEPA23175 ROWE047792;USEPA23176 ROWE047793; USEPA23177 ROWE047794; USEPA23178 Page 115 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 211 of 277 PAGEID #: 61212 _______Bates Numbered Documents_______ ROWE047795 -ROWE047796; USEPA23179 -USEPA23180 ROWE047797 -ROWE047798; USEPA23181 -USEPA23182 ROWE047799 -ROWE047804; USEPA23183 -USEPA23188 _________ ROWE047805; USEPA23189_________ ROWE047806 -ROWE047808; USEPA23190 -USEPA23192 ROWE047809 -ROWE047811; USEPA23193 -USEPA23195 ROWE047812 -ROWE047815; USEPA23196 -USEPA23199 ROWE047816 -ROWE04819; USEPA23200 -USEPA23203 _________ ROWE047820; USEPA23204_________ ROWE047821 -ROWE047822; USEPA23205 -USEPA23206 ROWE047823 -ROWE047825; USEPA23207 -USEPA23209 _________ ROWE047826; USEPA23210_________ _________ ROWE047827; USEPA23211_________ _________ ROWE047828; USEPA23212_________ ROWE047829 -ROWE047830; USEPA23213 -USEPA23214 ROWE047831 -ROWE047832; USEPA23215 -USEPA23216 ROWE047833 -ROWE047834; USEPA23217 -USEPA23218 ROWE047835 -ROWE047836; USEPA23219 -USEPA23220 _________ ROWE047837; USEPA23221_________ _________ ROWE047838; USEPA23222_________ ROWE047839 -ROWE047841; USEPA23223 -USEPA23225 ROWE047842 -ROWE047843; USEPA23226 -USEPA23227 ROWE047844 -ROWE047846; USEPA23228 -USEPA23230 ROWE047847 -ROWE047848; USEPA23231 -USEPA23232 _________ ROWE047849; USEPA23233_________ _________ ROWE047850; USEPA23234_________ _________ ROWE047851; USEPA23235_________ ROWE047852 -ROWE047855; USEPA23236 -USEPA23239 Page 116 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 212 of 277 PAGEID #: 61213 _______Bates Numbered Documents_______ ROWE047856 -ROWE047859; USEPA23240 -USEPA23243 ROWE047860 -ROWE047864; USEPA23244 -USEPA23248 _________ ROWE047865; USEPA23249_________ _________ ROWE047867; USEPA23251_________ _________ ROWE047868; USEPA23252_________ _________ ROWE047869; USEPA23253_________ _________ ROWE047870; USEPA23254_________ _________ ROWE047871; USEPA23255_________ ROWE047872 -ROWE047873; USEPA23256 -USEPA23257 _________ ROWE047874; USEPA23258_________ _________ ROWE047875; USEPA23259_________ _________ ROWE047890 -ROWE047915_________ _________ ROWE047920 -ROWE047921_________ _________ ROWE047989 -ROWE047990_________ ______________ROWE048064______________ _________ ROWE048079 -ROWE048080_________ _________ ROWE048143 -ROWE048162_________ _________ ROWE048181 -ROWE048184_________ _________ ROWE048185 -ROWE048189_________ ______________ROWE048191______________ _________ ROWE048197 -ROWE048198_________ _________ ROWE048224 -ROWE048235_________ ______________ROWE048326______________ _________ ROWE048331 -ROWE048333_________ _________ ROWE048343 -ROWE048345_________ _________ ROWE048372 -ROWE048374_________ _________ ROWE048403 -ROWE048420_________ _________ ROWE048475 -ROWE048485_________ _________ ROWE048632 -ROWE048672_________ ROWE048673 -ROWE049140; USEPA23260 -USEPA23728 ROWE049299 -ROWE049301 ROWE049306 -ROWE049310 ROWE049312 -ROWE049314 _____ROWE049316_____ ROWE049318 -ROWE049352 ROWE049354 -ROWE049387 ROWE049389 -ROWE049392 ROWE049394 -ROWE049403 ROWE049405 -ROWE049407 ROWE049409 -ROWE049514 ROWE049516 -ROWE049551 Page 117 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 213 of 277 PAGEID #: 61214 Bates Numbered Documents ROWE049608 -ROWE049620 ROWE050065 -ROWE050068 ROWE050071 -ROWE050073 ROWE050074 -ROWE050077 ROWE050080 -ROWE050102 ROWE050151 -ROWE050152 ROWE050153 -ROWE050155 _______ ROWE050206_______ ROWE050207 -ROWE050209 ROWE050211 -ROWE050214 ROWE050215 -ROWE050223 ROWE050224 -ROWE050225 ROWE050227 -ROWE050228 ROWE050229 -ROWE050230 ROWE050231 -ROWE021825 ROWE050232; ROWE011372 _______ ROWE050233_______ ROWE050234 -ROWE050238 ROWE050300 -ROWE050301 ROWE050329 -ROWE050330 _______ ROWE050448_______ ROWE050516 -ROWE050526 _______ ROWE050554_______ ROWE050621 -ROWE050622 _______ ROWE050686_______ _______ ROWE050688_______ ROWE050690 -ROWE050691 ROWE050714 -ROWE050715 ROWE050716 -ROWE050758 ROWE050759 -ROWE050763 ROWE050851 -ROWE050887 ROWE051039 -ROWE051040 ROWE051041 -ROWE051042 ROWE051173 -ROWE051203 ROWE051285 -ROWE051297 ROWE051307 -ROWE051316 ROWE051333 -ROWE051338 ROWE051339 -ROWE051345 ROWE051346 -ROWE051353 ROWE051354 -ROWE051365 ROWE051438 -ROWE051441 ROWE051566 -ROWE051568 _______ ROWE051604_______ ROWE051634 -ROWE051642 ROWE051665 -ROWE051676 Page 118 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 214 of 277 PAGEID #: 61215 _______Bates Numbered Documents_______ _________ ROWE051688 -ROWE051695_________ _________ ROWE051696 -ROWE051701_________ _________ ROWE051702 -ROWE051705_________ _________ ROWE051706 -ROWE051710_________ _________ ROWE051711 -ROWE051714_________ _________ ROWE051715 -ROWE051719_________ _________ ROWE051720 -ROWE051731_________ _________ ROWE051732 -ROWE051734_________ _________ ROWE051735 -ROWE051743_________ _________ ROWE051744 -ROWE051749_________ _________ ROWE051750 -ROWE051756_________ _________ ROWE051773 -ROWE051774_________ _________ ROWE051776 -ROWE051786_________ _________ ROWE051788 -ROWE051791_________ _________ ROWE051793 -ROWE051795_________ _________ ROWE051797 -ROWE051799_________ _________ ROWE051801 -ROWE051803_________ _________ ROWE051812 -ROWE051860_________ _________ ROWE051814 -ROWE051852_________ _________ ROWE051863 -ROWE051901_________ _________ ROWE052035 -ROWE052042_________ _________ ROWE052050 -ROWE052088_________ _________ ROWE052330 -ROWE052364_________ _________ ROWE052442 -ROWE052449_________ _________ ROWE052450 -ROWE052460_________ _________ ROWE052461 -ROWE052469_________ _________ ROWE052471 -ROWE052489_________ _________ ROWE052490 -ROWE052498_________ ROWE052816 -ROWE052818; USEPA23817 -USEPA23819 ROWE052819 -ROWE052820; USEPA23820 -USEPA23821 _________ ROWE052821; USEPA23822_________ _________ ROWE052822; USEPA23823_________ _________ ROWE052823; USEPA23824_________ _________ ROWE052824; USEPA23825_________ ROWE052825 -ROWE052826; USEPA23826 -USEPA23827 _________ ROWE052827; USEPA23828_________ _________ ROWE052828; USEPA23829_________ _________ ROWE052829; USEPA23830_________ _________ ROWE052830; USEPA23831_________ ROWE052831 -ROWE052836; USEPA23832 -USEPA23837 Page 119 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 215 of 277 PAGEID #: 61216 _______Bates Numbered Documents_______ ROWE052837 -ROWE052838; USEPA23838 -USEPA23839 ROWE052839 -ROWE052841; USEPA23840 -USEPA23842 ROWE052842 -ROWE052843; USEPA23843 -USEPA23844 _________ ROWE052844; USEPA23845_________ ROWE052845 -ROWE052852; USEPA23846 -USEPA23853 ROWE053034 -ROWE053072 ROWE053196 -ROWE053197 _____ ROWE053210_____ ROWE053212 -ROWE053213 _____ ROWE053246_____ ROWE053260 -ROWE053283 ROWE053373 -ROWE053374 _____ ROWE053386_____ _____ ROWE053388_____ ROWE053396; ROWE053014 ROWE053401 -ROWE053407 ROWE053451 -ROWE053455 _____ ROWE053456_____ _____ ROWE053457_____ _____ ROWE053458_____ _____ ROWE053471_____ ROWE053476 -ROWE053483 _____ ROWE053484_____ ROWE053547 -ROWE053548 ROWE053553 -ROWE053556 ROWE053590 -ROWE053593 ROWE053674 -053680 ROWE053681 -ROWE053686 ROWE054176 -ROWE054157 ROWE054187 -ROWE054192A ROWE054202 -ROWE054203 ROWE054219 -ROWE054220 ROWE054263 -ROWE054266 ROWE054267 -ROWE054270 ROWE054271 -ROWE054280 ROWE054607 -ROWE054641 ROWE054607 -ROWE054641 ROWE054685 -ROWE054686 ROWE054687 -ROWE054756 _____ ROWE055065_____ ROWE055068 Page 120 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 216 of 277 PAGEID #: 61217 _______Bates Numbered Documents_______ ______________ROWE055069______________ _________ROWE055072 -ROWE055073_________ ______________ROWE055074______________ ______________ROWE055075______________ _________ROWE055133 -ROWE055133_________ ______________ROWE055140______________ _________ROWE055163 -ROWE055164_________ _________ROWE056419 -ROWE056420_________ _________ROWE056585 -ROWE056586_________ _________ROWE056601 -ROWE056606_________ _________ROWE056751 -ROWE056756_________ _________ROWE056766 -ROWE056778_________ _________ROWE056799 -ROWE056800_________ ______________ROWE056822______________ ______________ROWE056833______________ _________ROWE056845 -ROWE056853_________ _________ROWE056854 -ROWE056861_________ ______________ROWE056902______________ _________ROWE056903 -ROWE056904_________ ______________ROWE056908______________ ______________ROWE057294______________ ______________ROWE057295______________ _________ROWE057396 -ROWE057397_________ _________ROWE057404 -ROWE057472_________ _________ROWE057565 -ROWE057577_________ _________ROWE057581 -ROWE057582_________ ______________ROWE057744______________ _________ROWE057747 -ROWE057748_________ _________ROWE057758 -ROWE057759_________ _________ROWE057760 -ROWE057828_________ _________ROWE057891 -ROWE057935_________ ______________ROWE057968______________ ROWE057969 -ROWE057979; USEPA24014 -USEPA24024 ROWE057980 -ROWE058065; USEPA24025 -USEPA24110 _________ ROWE058066; USEPA24111_________ ROWE058067 -ROWE058079; USEPA24112 -USEPA24124 ROWE058080 -ROWE058113; USEPA24125 -USEPA24158 ROWE058114 -ROWE058157; USEPA24159 -USEPA24202 ROWE058158 -ROWE058187; USEPA24203 -USEPA24232 Page 121 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 217 of 277 PAGEID #: 61218 _______Bates Numbered Documents_______ ROWE058188 -ROWE058194; USEPA24233 -USEPA24239 ROWE058195 -ROWE058203; USEPA24240 -USEPA24248 ROWE058204 -ROWE058241; USEPA24249 -USEPA24286 ROWE058242 -ROWE058264; USEPA24287 -USEPA24309 ____________ ROWE058265____________ _______ ROWE058266 -ROWE058268_______ _______ ROWE058269 -ROWE058270_______ ____________ ROWE058271____________ RP027965 -RP027969; EID638384 -EID638388 ______ RTOWE000688 -ROWE000689______ RV000914 -RV000921; EID088521 -EID088528 RWR003982 -RWR003991; EID615440 - EID615449 ________ RWR003992; EID615450________ RWR004880 -RWR004881; EID738989 -EID738990 RWR004980 -RWR004988; EID739089 -EID739097 RWR005034 -RWR005036; EID739143 -EID739145 RWR005045 -RWR005137; EID744607 -EID744699 RWR005138 -RWR005145; EID744700 -EID744707 RWR010736 -RWR010738; EID802749 -EID802751 RWR010739 -RWR010741; EID802752 -EID802754 RWR010742 -RWR010744; EID802755 -EID802757 RWR010786 -RWR010788; EID802794 -EID802796 RWR010874 -RWR010875; EID802880 -EID802881 ________ RWR010877; EID802883________ RWR010957 -RWR010964; EID778059 -EID778066 RWR011044 -RWR011135; EID803042 -EID803133 RWR011136 -RWR011140; EID803134 -EID803138 RWR011142 -RWR011145; EID803139 -EID803142; _________PEG000325; EID801051_________ RWR011142 -RWR11145; EID803139 -EID803142 RWR011185 -RWR011186; EID803182 -EID803183 ________ RWR011360; EID803357________ _______ SAMET00053 -SAMET00057_______ _______ SAMET01846 -SAMET01848_______ _______ SAMET01846 -SAMET01848_______ _______ SAMET01849 -SAMET01850_______ ____________ SAMET02004____________ ____________ SAMET02005____________ SAPPHIRE-000079 -SAPPHIRE-000080 SAPPHIRE-000079 -SAPPHIRE-000080 SAPPHIRE-000081 -SAPPHIRE-000082 Page 122 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 218 of 277 PAGEID #: 61219 Bates Numbered Documents SAPPHIRE-000094 -SAPPHIRE-000095 SAPPHIRE-000122 -SAPPHIRE-000123 SAPPHIRE-000135 -SAPPHIRE-000136 SAPPHIRE-000139 -SAPPHIRE-000140 SAPPHIRE-000141 -SAPPHIRE-000142 SAPPHIRE-000143 -SAPPHIRE-000144 SAPPHIRE00137 -SAPPHIRE00138 SAPPHIRE-009799 -SAPPHIRE-009800 SAPPHIRE-010009 -SAPPHIRE-010078 SAPPHIRE-010361 -SAPPHIRE-010372 SAPPHIRE-010373 -SAPPHIRE-010390 SEIXAS00031 -SEIXAS00044 SEIXAS00048 -SEIXAS00061 SEIXAS00162 -SEIXAS00199 _______ SEIXAS00442________ SEIXAS00470 -SEIXAS00471 SEIXAS00473 -SEIXAS00474 SEIXAS00473 -SEIXAS00474 SEIXAS00495 -SEIXAS00508 SEIXAS00600 -SEIXAS00601 SEIXAS00602 -SEXIAS00604 SEIXAS00639 -SEIXAS00645 SEIXAS0065 -SEIXAS00071 SEIXAS00706 -SEIXAS0070 SEIXAS00855 -SEIXAS00860 _________ SEIXAS01006 -SEIXAS01008_________ ______________SEIXAS01033______________ ______________SEIXAS01035______________ ______________SEIXAS01036______________ _________ SEIXAS01177 -SEIXAS01189_________ _________ SEIXAS01212 -SEIXAS01213_________ _________ SEIXAS01354-SEIXAS01358_________ _________ SEIXAS01545 -SEIXAS01552_________ _________ SEIXAS01688-SEIXAS01691_________ ______________SEIXAS01692______________ ______________SEIXAS01693______________ _________ SEIXAS01699 -SEIXAS01706_________ _________ SEIXAS01720 -SEIXAS01723_________ _________ SEIXAS01724-SEIXAS01725_________ _________ SEIXAS01726 -SEIXAS01740_________ SHK000115 -SHK000117; EID152077 -EID152079 SL001069 -SL001071; EID522970 -EID522972; 063-0169 ________ 0005487 -063-0169-0005489________ SL001069 -SL001074; EID522970 -EID522975 Page 123 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 219 of 277 PAGEID #: 61220 _______ Bates Numbered Documents_______ SL001075 -SL001076; EID522976 -EID522977 SL001077 -SL001078; EID522978 -EID522979 SL001080 -SL001082; EID522981 -EID522983; BLD003353 _______________ BLD003360_______________ SL001091 -SL001095; EID522992 -EID522996 SL001096 -SL001098; EID522997 -EID522999;YLP000136 _______________ YLP000139_______________ SL001099 -SL001101; EID523000 -EID523002 ____________ SL001102;EID523003____________ _____ SL001103 -SL1104; EID523004 -EID523005_____ SL001105 -SL001106; EID523006 -EID523007 ____________SL001107; EID523008____________ SL001108 -SL001110; EID523009 -EID523011. SL001108 -SL001120; EID523009 -EID523021 SL001111 -SL001112; EID523012 -EID523013 SL001111 -SL001112; EID523012 -EID523013 SL001113 -SL001114; EID523014 -EID523015 ____________ SL001115;EID523016____________ ____________SL001116; EID523017____________ SL001117 -SL001120; EID523018 -EID523021 SMK002122 -SMK002129; EID741080 -EID741087 ___________ SPD002068-SP002154___________ _______________ SPD002326_______________ ___________SPD002327 -SPD002357___________ ____________SPD01534-SPD01540____________ ____________SPD01534-SPD01646____________ ____________ SPD01541SPD01646____________ SPD01788 -SPD01799; SPD01809 -SPD01810; SPD01837 _______________ SPD01838_______________ ____________SPD01788-SPD01930____________ SPR000232 -SPR000233; EID714149 -EID714150 SPR000237 -SPR000240; EID714154 -EID714157 SPR000310 -SPR000338; EID714222 -EID714250 SPR001359 -SPR001361; EID715230 -EID715232 SPR00297 -SPR000299; EID714209 -EID714211 ________________ T3758_________________ ________________ T3759_________________ ________________ T3760_________________ ________________ T3761_________________ ________________ T3762_________________ ________________ T3763_________________ ________________ T3764_________________ ______________ T3774 -T3777______________ ______________ T3778 -T3780______________ T3781 Page 124 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 220 of 277 PAGEID #: 61221 ______ Bates Numbered Documents______ TPM001824 -TPM001828; EID742473 -EID742477 TSB002753 -TSB002758; EID742496 -EID742501 TSB002899 -TSB002943; EID806348 -EID806392 TSB002899 -TSB002943; EID806348 -EID806392 TSB002944 -TSB002997; EID806393 -EID806446 TSB002944 -TSB002997; EID806393 -EID806446 UMC000169 -UMC000173; EID742829 -EID2833 UMC002541 -UMC002551; EID806844 -EID806854 UMC002644 -UMC002649; EID806947 -EID806952 UMC002659 -UMC002664; EID806962 -EID806967 USEPA14926 -USEPA14931; CF009524 -CF009529 USEPA15165 -USEPA15167; RL001770 -RL001772 _________ USEPA15189; BWK000016_________ _________ USEPA15189; BWK000026_________ _________ USEPA15190; BWK000027_________ USEPA15191 -USEPA15204; RCG000001 -RCG000002; __________ AJP002919-AJP002930__________ USEPA15205 -USEPA15207; RL000181 -RL000183 USEPA15609 -USEPA15616; RCG000141 -RCG000148 USEPA15609 -USEPA15616; RCG000141 -RCG000148 USEPA15640 -USEPA15648; RCG000172 -RCG000180 USEPA15649 -USEPA15658; RCG000181 -RCG000190 USEPA15649 -USEPA15658; RCG000181 -RCG000190 _________ USEPA15659; RCG000191_________ USEPA15699 -USEPA15707; RCG000231 -RCG000239 USEPA15699 -USEPA15707; RCG000231 -RCG000239 USEPA15743 -USEPA15812; WJB000002 -WJB000071 USEPA16148 -USEPA16191; HLAB000231 -HLAB000274 USEPA16690; GWJ000170; EID192138;AJP007301 USEPA16788 -USEPA16805; RL000910 -RL000927 USEPA16842 -USEPA16849; RKI000005 -RKI000011 USEPA16941 -USEPA16958; HLAB000003 -HLAB000020 ________USEPA8844-45; JRW000022-23________ ______ WEGMAN00110 -WEGMAN00114_______ ______ WEGMAN00294 -WEGMAN00302_______ ____________ WEGMAN00385____________ ____________ WEGMAN00386____________ ____________ WEGMAN00436____________ ____________ WEGMAN00437____________ ______ WEGMAN00438 -WEGMAN00444_______ ______ WEGMAN00456 -WEGMAN00478_______ ____________ WEGMAN00561____________ ______ WEGMAN00564 -WEGMAN00566_______ ______ WEGMAN00567 -WEGMAN00588_______ WEGMAN00589 -WEGMAN00592 Page 125 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 221 of 277 PAGEID #: 61222 _______ Bates Numbered Documents_______ ________ WEGMAN00593 -WEGMAN00735________ ________ WEGMAN00736 -WEGMAN00795________ WVDHHR000098 -WVDHHR000099; EID648314 -EID648315 WVDHHR000103; EID648319; WVDHHR000096; EID648312 WVDHHR000106 -WVDHHR000107; EID648322 -EID648323 WVDHHR000118 -WVDHHR000119; EID648334 -EID648335 __________WVDHHR000207; EID648423__________ WVDHHR000222 -WVDHHR000225; EID648438 -EID648441 WVDHHR000289; EID648505 YAA000030 -YAA000052 YAA000134 -YAA000142 YAA000389 -YAA000390 YAA000393 -YAA000394 YAA000423 -YAA000435 Page 126 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 222 of 277 PAGEID #: 61223 Descriptions of Documents Without Bates Numbers Amended ClassAction ComplaintfiledinJackLeach,etal.v.DuPonton 8/30/01 Second Amended ClassAction ComplaintfiledinWilliamRhodes,etal.v.DuPont on 1/8/09 FourthAmended CivilActionComplaint-ClassAction filedinRichardRowe, etal.,v.DuPonton 5/13/10 FirstAmended ComplaintfiledinThe LittleHocking WaterAssociationv.DuPont on 3/15/10 DuPont'sAnswertoAmended ClassActionComplaint intheLeach v.DuPont case,filedon 10/15/01 DuPont'sAnswertoAmended ComplaintintheRhodes v.DuPont case,filedon 7/5/06 DuPont'sAnswertoComplaint inthe Rowe v.DuPont case,filedon 5/31/06 DuPont'sAnswertoComplaintinTheLittleHocking WaterAssociationv.DuPont case,filedon 1/29/10 DuPont'sAnswersto Plaintiffs'FirstSetofRequestsforAdmissions inthe Leach v.DuPont case,served on DuPont'sAnswersto Plaintiffs'Second Setof RequestsforAdmissions intheLeach v.DuPont case,servedon DuPont'sAnswersto Plaintiffs'ThirdSetof RequestsforAdmissions inthe Leach v.DuPont case,served on DuPont's Responsesto Plaintiffs' FirstSetofInterrogatoriesinthe Leach v.DuPont case,served on 2/18/02 DuPont'sSupplemental Responseto Plaintiffs'Second SetofInterrogatoriesintheRhodes v.DuPont case, served on 7/11/07 DuPont's ResponsestoColesPlaintiffs'FirstSetof RequestsforAdmissions intheRowe v.DuPont case,served on 2/14/07 DuPont'sSupplemental Responsesto Rowe Plaintiffs' InterrogatoryNos.3-10 inthe Rowe v.DuPont case, served on 6/6/07 DuPont's Responsesto Plaintiffs'FirstSetof RequestsforAdmissionsinTheLittleHocking WaterAssociationv. DuPont case,servedon 1/4/13 DuPont's Responsesto Plaintiffs'Second RequestsforAdmissions inTheLittleHocking WaterAssociationv. DuPont case,servedon 1/9/13 DuPont's Responsesto Plaintiffs'InitialMasterSetsofRequestsforAdmissions, RequestsforProduction, Interrogatories,and RequestsforStipulations inthe DuPont/C-8 Personal InjuryMDL case, servedon 12/9/13 DuPont's Responsesto Plaintiffs'Fourth MasterSetofInterrogatories, Document Requestsand Requestsfor Admissionsinthe DuPont/C-8 Personal InjuryMDL case,servedon 3/5/2014 DuPont'sCounter-StatementofUndisputed Material FactsPursuantto Local Rule56.1,filedinthe Rowe v. DuPont caseon 9/24/10 DuPont's Counter-StatementtoPlaintiffs'JointSupplemental StatementofDisputed Material Facts,filedinthe Rowe v.DuPont case on 10/1/10 Book: Stain-Resistant,Nonstick,Waterproofand Lethal: The Hidden DangersofC-8,authored byCallieLyons Grandjean, P.,Clapp, R.,"Changing InterpretationofHuman Health Risksfrom PerfluorinatedCompounds", PublicHealth Reports,vol.129,482-485 Plaintiffs'Memorandum inSupportofMotion forpartialSummary Judgment under Rule56forDetermination of Issuesunder Rule16c,filedon 9/3/14 inthe DuPont C-8Personal InjuryLitigationMDL Defendant'sOppositionto Plaintiffs'MotionforPartialSummary Judgment under Rule56 orforDetermination ofIssuesunder Rule16C,filedon 9/29/14 inthe DuPont C-8Personal InjuryLitigationMDL Plaintiffs'ReplyinSupportofMotionforPartialSummary Judgment under Rule56 orforDeterminationofIssues under Rule16C,filedon 10/13/14 inthe DuPont C-8Personal InjuryLitigationMDL OrderGrantingInjunctiveReliefagainstDuPont, entered 5/1/03 inLeach v.DuPont case LittleHockingWater Association News Releaseand Statementdated 1/23/02 (2pages) (from LittleHocking Water Associationwebsite) Memo dated 5/19/99from Paul LiederofCovance LaboratoriestoAPFO Sub-Committee Re: APME transmitting attached preliminaryresultsforanimals(5pages) DuPont ExpertWitness DisclosureofMorton Corn, inthe Leach v.DuPont case Page 127 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 223 of 277 PAGEID #: 61224 Descriptions of Documents Without Bates Numbers April1981 articlesfrom variousnewspapers nationwide regardingDuPont reassigningfemale employees who worked with FC-143 atWashington Works plant(10pages) Extractedpagesfrom, "HearingsbeforetheSubcommittee on Investigationsand OversightoftheCommittee on ScienceandTechnology U.SHouse ofRepresentatives",NinetySeventh Congress FirstSession, Statementof Bruce Karrh, 10/14/1981 and 10/15/1981, No.53________________________________________ ParkersburgCommunity OpinionSurveydated December 1991 authored byStephen SchmidtofDuPont (39 pages) (from CharlesRyan & Associates'third-partyproduction inRowe/Rhodes cases) From United NationsEnvironment Program web page: Statementfrom Dr.PaulTebo, DuPontWorld Environment Day 1997, 6/5/1997 DuPont contractwithCharles Ryan Associatesdated 8/27/1998 (13pages) (from CharlesRyan & Associates' third-partyproduction inRowe/Rhodes cases) Letterfrom USEPAto Paul Bossert-DuPont, reRequestforInformation,7/24/2001 Fax,11/29/01to LarryWinterfrom EPA Region III,JanetE.Sharke,transmittingDuPont's Responseto Request for Information, 8/31/2001 Fax,11/29/01to LarryWinterfrom JanetSharke, EPA Region III,transmittingDuPont's FirstResponsetoJuly 24,2001 RequestforInformation,9/28/2001 Emaildated 1/1/2002from PatrickGallagherofCharlesRyantoCliftonWebb (1page)(fromCharlesRyan & Associates'third-partyproductioninRowe/Rhodes cases) DraftLetterofAgreement between Spilman,Thomas and Charles RyanAssociatesdated February2002 (2pages) (from CharlesRyan & Associates'third-partyproduction inRowe/Rhodes cases) DuPont PressRelease,"DuPont Statementon Ammonium Perfluorooctanoate(C-8)Human Health Protective Level",5/15/2002___________________________________________________________ 1/3/2003 Emailfrom Dawn D.Jackson, DuPont toAndrea Hannon, MariettaTimes, "Infofrom DuPont Washington Works",1/3/2003 DuPont news release: "DuPont Statementon December 20,2002 EnvironmentalWorking Group Articleon Past SurveillanceofC8 FaxtoAndrea Hannon from Dawn JacksontransmittingDuPont Statementon December 20,2002 Environmental Working Group Articleon PastSurveillanceofC8,1/3/2003 DuPont informationsheet:"DuPont Caution Regarding MedicalApplicationsofDuPont Materials,2/1/2003 CalendarEntryscreenshotforClifWebb, Re: News Journal Interviewrequestre:C8,2/27/2003 DuPont News Release,"DuPont RefutesHealth EffectsClaimsAbout PFOA ConfirmsSafetyofCookware Sold UnderTeflon Brand",3/31/2003 DuPont news release: "DuPont CountersAllegationson SafetyofTeflon,StainmasterCompany AffirmsSafety ofProducts",4/8/2003 Letterfrom EnvironmentalWorking GrouptoChristineTodd Whitman ofUSEPA reDuPont'sfailuretosubmit keyhealthstudiesunderthe requirementsofTSCA 8e, 4/11/2003 News Articlefrom Delawareonline News Journal:"DuPont chiefdefendsC-8", 5/1/2003 DuPont news release,"DuPonttoAppeal CourtOrderinCase InvolvingC-8",5/7/2003 AR226-1318______________________________________________________________ Letterfrom USEPAto KennethA.Cook,EWG re:EnvironmentalWorking Group concernsabout PFOA and possible DuPont violationsofreporting under Section 8 oftheToxicSubstance Control Act,5/28/203 AR226-1408; AR226-1409; AR226-1410; AR226-1411; AR226-1412; AR226-1413; AR226-1414____________ DuPont emailfrom G IrvinLipp,toChad Holliday,etal.,re: "NewsJournalCoverageofCPSC", 7/12/2003 WebsiteArticle,China, People'sDailyOnline,"DuPont non -stickcookware completelysafe: Interview" ,7/19/2004 Page 128 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 224 of 277 PAGEID #: 61225 Descriptions of Documents Without Bates Numbers PlasticNews Website Page,Opinion: "DuPont respectfulofhuman rights,desires",RichardJ.Angiulloof DuPont, 8/6/2003__________________________________________________________ EWG lettertoEPA Richard H.Heftner,re:DuPont'sfailuretosubmit keyhealthstudiesunderthe requirements ofTSCA 8e,,8/15/2003_______________________________________________________ WebsiteArticlerePFOAfrom PlasticsTechnology, "Hard Choices", Matt Naitove, Editor,9/2003 DuPont news release,"DuPont Statementon ABC "20/20Segment onTeflon", 12/8/2003 DuPont brochure: SocietalBenefitsofFluoropolymersand Fluorotelomers (notdated)(2pages) (fromthirdpartyproductionofDezenall Resources inRowe/Rhodes cases) Website page Earnings.com News, "DuPont ReportsSecond Quarter2004 Earnings",7/27/2004 DuPont SEC Report, Form 8-K, 7/27/2004 AR226-1879; AR226-1880_____________________________________________________ DuPont news release,"DuPont Reports FirstPhase ResultsofHealthStudy Examining PFOA Exposureon Washington Works Employees", 1/11/2005 Letterfrom Paul BossertofDuPonttoWashington Works Employees re:ResultsofPhase IPFOA healthsurvey, 1/11/2005_______________________________________________________________ DuPont PowerPoint PresentationgiventoUSEPA, "ProductStewardshipAdvancements and Direction",4/2005 DuPont DailyNews websitepage, "StudySaysConsumer Articleswith DuPont MaterialsareSafeforConsumer Use",4/21/2005___________________________________________________________ Website page, PFOAfacts.com: SPIStatementson PFOA, 11/21/2005 DuPont News Release,"DuPontSettlesWith USEPA on PFOA ReportingMatter, 12/14/2005 Website page,www.fibre2fashion.com:"USW warns carpetindustryon stainrepellentPFOA", 12/22/2005 DuPontwebsite PFOA page: PFOA ProductSafety,5/6/2005 DuPontwebsite PFOA page: Important FactsaboutTeflon, 11/4/2006 DuPontwebsite PFOA page: "About PFOA", 5/6/2005 DuPontwebsite PFOA page: "AboutTeflon",5/6/2005 DuPont News Release,"DuPont DisagreesWith ScienceAdvisoryBoard Drafton PFOA", 1/30/2006 DuPont Form 10-KSEC reportfor2005 fiscalyear,filedon 2/28/2006 DuPont emaildated4/25/05from SilvioDeCarlito DanielTurnerre: Communications Report(3pages)(from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). Emaildated4/27/06from DanielTurnerofDuPonttoCoreTeam re: Communications Report-Statementof Health Effects(1page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont SEC 10-Qreport,filed 5/4/2006forperiodupto 3/31/2006 Emaildated 7/21/06from Noah Seixasto Robin Leonard ofDuPont and DavidWegman re: Phase 1report (2 pages) (from DavidWegman's third-partyproduction inRowe/Rhodes cases). DuPont New Release,"DuPontConcludesWashington Works Employee PFOA Study", 10/17/2006 Emaildated 10/18/06from Tom Beauchampto DavidWegman andJonathanSamet re: PressRelease(3pages) (from DavidWegman's third-partyproduction inRowe/Rhodes cases). DuPont News Release,"DuPontSignsAgreement with USEPA on Interim DrinkingWater StandardforPFOA in West Virginiaand Ohio Communities", 11/21/2006 DuPont statement: DuPontActivitieson the ReductionofPFOA Emissions, Exposure, undated FactSheeton DuPontZonyl,undated DuPont News Release,"DuPont InstallsFinalTwo Water FiltrationSystems", 1/15/2009 DuPontwebsitepage, "About PFOA", undated Page 129 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 225 of 277 PAGEID #: 61226 Descriptions of Documents Without Bates Numbers The SapphireGroup news release, "New StudyFindsPFOA LevelsinDrinkingWaterAreSafe",3/3/2009 and SapphireGroup abstract: DerivationofaDrinkingWater EquivalentConcentrationand Maximum Contaminant LevelforPFOA" DuPont letterfrom William HopkinstoWashington Works employees re: EIBon C8 SciencePanelStatus Reports, 3/26/2009 Article,"TextileFluorochemicals,What Users Need to Know" byRobertC.Buckand Kai-VolkerSchubert,ATTC Review, pp.32-35, May 2009 ListofInformationforResidentsre:PFOA, undated USEPA emailfrom DanielGerasimowiczto Mathy Stanislaus,etal.,re: ,6/8/2009 ScheduleforLisaP.Jackson, 6/8/2009 InformationforDuPont Blog/Web responseon PFOA and BirthOutcomes, 8/7/2009 Letterfrom MichaelW. Steinberg,counselforDuPont, to DavidAltman,Esq. re:LittleHockingWater Association NoticeofIntenttoFileRCRA CitizenSuit,8/27/2009 Letterfrom DuPont to Bob Martin,Commissioner New JerseyDEP, Re:"NJDEPActionsRelatingto PerfluorooctanoicAcid (PFOA), 12/1/2010 DuPontWebsite Home page,Occupational & PublicHealth,undated DuPont news release: "DuPontStatementonJuly30,2012 Reports bytheC8 Science Panel",7/30/2012 DuPont letterfrom Andrea V.MalinowskiCorporateCounseltoUSEPA Document ProcessingCenter, Re:C-8 Science Panel,2/28/2013 Letterfrom RobertA.BilotttoPaula DurstGillis,Esq.Re:Wilbur E.Tennant, etal.v DuPont, re: C-8,8/15/2000 Letterfrom Lubeck PublicServiceDistrict,James Cox ManagertoPSD Customers re: C-8, 10/31/2000 DuPont calendarentryappointment, "Expect callfrom George Senklerre:C8 update",10/08/2001 Bernard Reillyemailto Bern re: drinkingwater results, 10/20/2001 The LittleHockingWaterAssociationnews releasereC-8, 1/15/2002 DuPont CalendarEntryAppointment ",Expectingacallfrom George Senklerre:C8",2/26/2002 DuPont emailfrom G IrvinLipp,toChad Holliday,etal., re:DailyCommunications Report,3/20/2002 WVDEP emailfrom Dave WatkinstoAllynTurner, Dee Ann Staatsre:EPA Laboratory,5/6/2002 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal., re:DailyCommunications Report, 5/13/2002 DuPont Emailfrom Anthony R.FarinatoChad Holliday,etal., re: DailyCommunications Report,5/16/2002 DuPont emailfrom CliftonWebb toChad Holliday,etal., re: DailyCommunications Report, 10/9/2002 DuPont emailfrom IrvLipptoChad Holliday,etal.,re:DailyCommunications Report, 10/11/2002 DuPont emailfrom G IrvinLipptoChad Holliday,etal.,re:DailyCommunications Report, 10/28/2002 Pagesfrom transcriptofGeorge H.SenklerinLeachv.DuPont case,11/21/2002 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal. reDailyCommunications Report, 12/20/2002 DuPont emailfrom CliftonWebb toChad Holliday,etal. re:Weekend Report Feb.16,2/16/2003 DuPont emailfrom Anthony R.FarinatoChad O. Holliday,etal.,Re:DailyCommunications Report, 2/26/2003 DuPont emailfrom CliftonWebb toChad Holliday,etal., re:DailyCommunications Report, 2/16/2003 DuPont emailfrom G IrvinLipptoChad Holliday,etal.re:DailyCommunications Report,3/17/2003 DuPont emailfrom G IrvinLipptoChad Holliday,etal., re:DailyCommunications Report,3/28/2003 DuPont emailfrom G IrvinLipptoChad Holliday,etal.,re:Storieson C8 Picked up acrossUS, 3/30/2003 DuPont emailfrom RCliftonWebb toChad Holliday,etal., re:DailyCommunications Report, 4/2/2003 April2003 DuPont informationre:USEPA releasedapreliminaryriskassessmentforC-8;alsoDuPont Calendar entry"Callfrom George SenklerreC8", 4/3/2003 DuPont emailfrom ScottF.NelsontoChad Holliday,etal. re:DailyCommunications Report,4/4/2003 DuPont emailfrom ScottF.Nelson toChad Holliday,etal., re: Weekend Communications Report,4/5/2003 Page 130 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 226 of 277 PAGEID #: 61227 Descriptions of Documents Without Bates Numbers DuPont emailfrom Anthony R.FarinatoChad Holliday,etal.,re: DailyCommunications Report,,4/7/2003 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal., reDailyCommunications Report, 4/8/2003 LettertoChristineTodd Whitman ofUSEPAfrom EWG re:DuPont'sfailuretosubmitkeyhealthstudiesunder the requirementsofTSCA 8e,15 U.S.C2607, 4/11/2003 EWG websitepages: PFCsGlobalContaminants -DuPont'sSpinAbout PFOA, undated DuPont emailfrom Chad Hollidayto RichardJ.Angiullo,re:DailyCommunications Report,4/11/2003 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal., Re:Weekend Communications Report,4/12/2003 DuPont emailfrom R.CliftonWebb toChad Holliday,etal., Re:DailyCommunications Report, 4/16/2003 DuPont CalendarEntryappointment: "George Senklerwillcall (C8),4/22/2003 Letterfrom "AConcerned Citizen"toChristineT.Whitman EPAAdministratorreDuPont,4/22/2003 DuPont emailfrom Chad Hollidayto Nandakumar Rao re: DailyCommunications Report, 4/28/2003 DuPont emailfrom Chad Hollidayto LoisJuliberre:ContactwithGore,4/29/2003 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal., re: DailyCommunications Report, 4/30/2003 OrderGranting Plaintiff'sSecond MotionforSanctionsAgainstDuPont, inLeachv.DuPont case,5/1/2003 DuPont emailfrom R.CliftonWebb toChad Holliday,etal. Re:DailyCommunications Report,5/8/2003 DuPont emailfrom Chad O. HollidaytoThomas M. Connelly, DuPont reWeekend Communications Report, 5/11/2003_______________________________________________________________ DuPont emailfrom Alexa LGirardito Donna Saundersforwarding DailyCommunications Report, 5/13/2003 AR226-1318______________________________________________________________ DuPont emailfrom Chad O. Hollidayto LouiseB.LancasterreAgendaforBoard Meeting,5/26/2003 From USEPA Docketswebsite: Document #OPPT-2003-0012-0124, dated6/20/2003 DuPont emailfrom G IrvinLipptoChad O. Holliday,etal. re;Weekend Communications Report,6/21/2003 Latham & Watkins presentationslides:"Chemicals inthe Body,"dated 6/24/03 (68pages) DuPont emailfrom Anthony FarinatoChad O. Holliday,etal., re:DailyCommunications Report, 6/25/2003 DuPont emailfrom Anthony R.FarinatoChadO. Holliday,etal., Re:DailyCommunications Report,7/7/2003 DuPont emailfrom Anthony R,FarinatoChadO. Holliday,etal., Re:DailyCommunications Report7/9/2003 DuPont emailfrom Anthony R.FarinatoChad O. Holliday,etal. re:DailyCommunications Report,7/10/2003 DuPont emailfrom G IrvinLipptoChad O. Holliday,etal. Re:News JournalCoverageofCPSC, 7/12/2003 DuPont emailfrom Anthony R.FarinatoChadO. Holliday,etal. Re:DailyCommunications Report,7/28/2003 DuPont emailfrom Anthony R.FarinatoChadO. Holliday,etal.,re: DailyCommunications Report, 7/29/2003 DuPont emailfrom CliftonWebb toChad Holliday,etal.,re:DailyCommunications Report, 8/6/2003 DuPont emailfrom Anthony R.FarinatoChad Holliday,etal.,re: DailyCommunications Report, 8/18/2003 DuPont emailfrom R.CliftonWebb toChad Holliday,etal., re;DailyCommunications Report, 8/22/2003 DuPont emailfrom R.CliftonWebb toChad O. Holliday,etal., re:Weekend Report,8/23/2003 DuPont emailfrom Anthony R.FarinatoChad O. Holliday,etal., re: DailyCommunications Report,9/23/2003 DuPont emailfrom G. IrwinLipptoChad O. Holliday,etal., re: DailyCommunication Report,9/30/2003 DuPont emailfrom Anthony R.FarinatoChad O. Holliday,etal., re:DailyCommunication Report, 10/24/2003 DuPont emailfrom G. IrwinLipptoChad Holliday,etal., Re: DailyCommunications Report,10/28/2003 DuPont emailfrom Catherine L.AndriadistoChad O. Holliday,etal., re:DailyCommunications Report, 10/31/2003______________________________________________________________ DuPont emailfrom Chad O. Hollidayto LoisJuliberforwarding Communication Report,11/15/2003 Emailfrom Louise B.LancasterofDuPonttoAlainBeldaofAlcoa,etal., reDuPont'stoStatementon ABC's 20/20 Segment, 11/15/2003____________________________________________________ DuPont emailfrom G IrvinLipptoChad O. Holliday,etal., reWeekend Communications Report, 11/16/2003 DuPont emailfrom RCliftonWebb toChad Holliday,etal., re:DailyCommunications Report, 11/22/2003 Page 131 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 227 of 277 PAGEID #: 61228 Descriptions of Documents Without Bates Numbers DuPont emailfrom RCliftonWebb toChad O. Holliday,etal., Re:Weekend Report-November 23, 11/23/2003 DuPont emailfrom G IrwinLipptoChad O Holliday,etal.,re: DailyCommunications Report, 11/24/2003 DuPont emailfrom G IrvinLipptoChad O. Holliday,etal., Re:DailyCommunications Report, 11/26/2003 DuPont Emailfrom Kathleen H.FortetoChad O. Holliday,etal., re:PossibleQuestionsandTopicsfor Community Leaders Meeting,12/2/2003 DuPont emailfrom ScottNelsontoChad Holliday,etal.,re: DailyCommunications Report, 12/5/2003 DuPont emailfrom ScottF.NelsontoChad O. Holliday,etal., re: Weekend Communications Report, 12/6/2003 DuPont emailfrom Chad O HollidaytoW DonaldJohnson,forwardingCommunications Report,1/3/2004 DuPont emailfrom LoriA.CaptaintoChad Holliday,etal., re: DailyCommunications Report, 1/6/2004 DuPont emailfrom Chad O. Hollidayto FrancineC.Shaw, re: 2003YrInReview, 1/10/2004 DuPont emailfrom Catherine L.AndriadistoChad Holliday,etal., re: DailyCommunications Report, 1/16/2004 DuPont emailfrom G. IrwinLipptoChad O. Holliday,etal., re: DailyCommunication Report, 2/11/2004 DuPont emailfrom G IrwinLipptoChad O. Holliday,etal., Re: DailyCommunications Report,2/14/2004 DuPont emailfrom Chad HolidaytoScotHolliday,etal.,forwarding DailyCommunications Report,2/12/2004 DuPont emailfrom Anthony R.FarinatoChad O. Holliday,etal.,re: DailyCommunications Report,2/27/2004 DuPont emailfrom G. IrvinLipptoChad Holliday,etal.,re: DailyCommunications Report,3/3/2004 DuPont emailfrom G. IrvinLipptoChad Holliday,etal., re:DailyCommunications Report,3/4/2004 Bullet-pointlistdated 3/15-3/16/05titled: Global RegulatoryMeeting (6pages)(from McCabe & Associates' third-partyproduction inRowe/Rhodes cases). Emaildated 2/22/2006from DavidWegman toTom Beauchamp re: questionsforERB retheCommunity Study (5pages) (from EllenEisen'sthird-partyproduction inRowe/Rhodes cases). DuPont emaildated 5/1/06from Susan Silencerto Robert Rickard,etal.,re: CoreTeam Meeting (1page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont emaildated 5/23/06from Susan Stalneckerto Robert Rickard,etal.,re: CoreTeam Meeting (1page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont emaildated 6/13/06from Susan Stalneckerto Robert Rickard,etal.,re: CoreTeam Meeting (1page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont emaildated 7/10/06from Susan Stalneckerto Robert Rickard,etal.,re: CoreTeam MeetingAgenda (1 page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont emaildated 7/18/06from Susan StalneckertoSusanStalnecker,with numerous copyholders, re: Agenda (3pages)(from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont emaildated 8/11/06from Susan Stalneckerto Robert Rickard,etal.,re: John Hopkins Update (1page) (from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). Emaildated 11/9/06from Michael McCabe toDavid Boothe, etal.,re: DaltonStudy(1page)(from McCabe & Associates'third-partyproduction inRowe/Rhodes cases). DuPont undated PowerPointslidestitled: Global RegulatoryStrategy. (4pages) (from McCabe & Associates' third-partyproduction inRowe/Rhodes cases). DuPont slides: "Clean Hardball",9/20/2007 Company Profiledated 12/11/01 authored byCharles RyanAssociates(40pages). (Fromthird-partyproduction ofCharlesRyan AssociatesinRowe/Rhodes cases.) CharlesRyan AssociatesJobCode Request Form dated 2/8/02 (1page). (Fromthird-partyproduction ofCharles RyanAssociatesinRowe/Rhodes cases.) Undated 2-pagedocument authored byCharles RyanAssociatestitled: Questions(Fromthird-partyproduction ofCharlesRyan AssociatesinRowe/Rhodes cases.) Page 132 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 228 of 277 PAGEID #: 61229 Descriptions of Documents Without Bates Numbers Memo dated9/18/03from JoeGollehon ofCharlesRyan Associatesto KelliKukura re: Regional PublicAffairs SpecialistPosition(2pages) (Fromthird-partyproductionofCharlesRyan AssociatesinRowe/Rhodes cases.) J. WesleyClayton,Jr.chapterfrom book: "FluorocarbonToxicityand BiologicalAction" Undated DuPont report: StudyofMyocardial InfarctionatWashington Works Plantauthored by Maureen T. O'Berg(8pages)(non-Bates numbered document produced by DuPont inthe Leach case) Don Fuqua, etal:"GeneticScreeningandthe HandlingofHigh-RiskGroups intheWorkplace", HearingsBefore theSubcommitte on Investigationsand OversightoftheCommittee on ScienceandTechnology U.S.House of Representatives, 10/14/1981 AR226-00467______________________________________________________________ 6/5/2001 Faxfrom RobinC.Leonardto R.W. RickardregardingEpidemiologySurveillanceatWashington Works Letterdated 9/16/03from Charles HollidayofDuPonttoAlanGreene, M.D. re: DuPont HealthAdvisory Board; attachesmeetingdetailsfor10/12-10/14/03 meeting (2pages)(from Dr.Greene'sthird-partyproduction in Rowe/Rhodes cases). DraftDuPont HealthAdvisoryBoard informationdated 10/3/03 (3pages)(from Dr.Greene'sthird-party production inRowe/Rhodes cases). Letterdated 10/12/03from CharlesHollidayofDuPonttoAlanGreene, M.D. reHealthAdvisoryBoard (1page) (from Dr.Greene'sthird-partyproduction inRowe/Rhodes cases). ListofDuPont HealthAdvisoryBoard Members attending10/12-10/14/03 meeting (11pages) (from Dr.Greene's third-partyproduction inRowe/Rhodes cases). Draftsummary ofDuPont HealthAdvisoryBoard meeting 10/12-10/14/03 (8pages) (from Dr.Greene'sthirdpartyproduction inRowe/Rhodes cases). Memo dated 12/12/03from DickBingham toJohanna Dwyer, EricaFrank,AlanGreene, DervillaMcCann, Donnica Moore and Mary Lake Polan reconferencecall;attaches11/6/03 leadershipprinciples(3pages) (from Dr.Greene'sthird-partyproduction inRowe/Rhodes cases). USEPA Dockets, Document Detail,"Suspected ScientificLinkBetween Enamel Degradation andthe Presenceof C8 inDrinkingWater" submitted by Debra Cochran, Citizen,2003 Undated proposed positionregardingchemicals inthe body prepared byJanesse Brewer ofThe KeystoneCenter (1page) (from Dr.Greene'sthird-partyproduction inRowe/Rhodes cases). Agenda ofDuPont HealthAdvisoryBoard meeting4/4-4/5/04withattached HealthAdvisory Board information and Overview (6pages) (from Dr.Greene'sthird-partyproduction inRowe/Rhodes cases). Draftsummary ofDuPont HealthAdvisoryBoard meeting4/4-4/5/04prepared byThe KeystoneCenter(6pages) (from Dr.Greene'sthird-partyproduction inRowe/Rhodes cases). Emaildated4/27/04from Robin Leonard ofDuPontto DavidWegman Re: Proposal;alsoemaildated4/25/04 from DavidWegman to Robin Leonard re: Proposal (2pages)(from DavidWegman's third-partyproduction in Rowe/Rhodes cases). 4/29/20047 DuPont Letterfrom Paul Bossert,toWashington Works Employees regardingWashington Works HealthSurveyby HaskellLaboratoryforHealthand Environmental Sciences 5/5/2004Statement IssuedregardingDuPont ReiteratesPositionPFOA, RefutesClaimthatPFOA Causes Human Health Effects Emaildated 5/18/04from Mark Cullento EllenEisenand Robin Leonard (1page) (from Mark Cullen'sthird-party production inRowe/Rhodes cases). Emaildated 5/25/04from Jonathan Sametto DavidWegman re: Statementon PFOA Study,inresponsetoemail on same pagedated 5/25/04from DavidWegman toAll(1page) (from DavidWegman's third-partyproduction inRowe/Rhodes cases). Page 133 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 229 of 277 PAGEID #: 61230 Descriptions of Documents Without Bates Numbers Reportprepared bySapphireGroup dated 6/2/04: Ammonium Perfluorooctanoate: Cross-SectionalSurveillance inaCommunity Sample ofClinicalMeasures ofGeneral HealthStatusRelatedtoaSerum BiomarkerofExposure: A Study Protocol(45pages) (Non-Batesnumbered document produced by DuPont inthe Leachcase). November 2003 ConfidentialGeneral HealthQuestionnaireprepared by Health Examinetics(12pages) (Non- Batesnumbered document produced by DuPont inthe Leachcase). Exygen Research report: Implementation Plan: May 1,2003 InjunctionOrder: Appendix No. 2--Study-Specific Standard Operating Procedure: Documentation, Accountabilityand Sample ChainofCustody Requirementsfor theShippingofSerum Samples (8pages) (non-Batesnumbered document produced by DuPont inthe Leach case). 6/23/2004 Letterfrom RobertA.Bilottto Laurence F.Janssen reLeach case,concerning DuPont proposed community study 7/20/2004 Letterfrom RobertA.Bilottto Laurence F.Janssen reJackW. Leach case,concerning DuPont proposed community study AR226-1869, AR226-1865, AR226-1866 ~ Emaildated 10/1/04from Robin Leonard ofDuPontto Mark Cullenre: An Opportunity/Requestinresponseto emailon same page dated 10/1/04from Mark Cullento Robin Leonard (2pages)(from Mark Cullen'sthird-party production inRowe/Rhodes cases). DuPont HealthAdvisory Board agendafor10/12-10/14/04 meeting (fromAlan Greene'sthird-partyproduction inRowe/Rhodes cases). DuPont HealthAdvisory Board meeting materialsfor10/17-10/18/04 meeting (6pages)(fromAlanGreene's third-partyproduction inRowe/Rhodes cases). 2/2/2005 USEPA Emailfrom Mary Dominiakto RobertA.BilottregardingDuPontWorker StudySlides Emaildated 1/3/05 from Robin LeonardtoThomas Beauchamp, DavidWegman, Jonathan Samet, Mark Cullen and Noah Seixasre: Your NoteofDecember 22,inresponsetoemailon same page dated 12/29/04from Jonathan Sametto Robin Leonard (from Mark Cullen'sthird-partyproduction inRowe/Rhodes cases). 1/8/2005 Emailfrom Kathleen FortetoRobertW. RickardregardingComment from LindaFisheron News Release-Need Input AR226-1899 ~ 1/11/2005 Letterfrom PaulJ.Bossert,Jr.,toWashington Works Employees regardingResultsofourPhase I PFOA HealthSurvey RobinC.Leonard, PhD: "ResultstoDatefrom the PFOA Worker Study,Ammonium Perfluorooctonoate:Cross SectionalSurveillanceofClinicalMeasures ofGeneral HealthStatusRelatedtoaSerum BiomarkerofExposure and RetrospectiveCohortAnalyses inaPolymer Production Plant",1/10/2005 1/11/2005 Release,"DuPont Reports First-PhaseResultsofHealthStudyExamining PFOA Exposure,To Date, No Human Health EffectsKnown tobeCaused by PFOA; SeveralStatisticalObservations Merit FurtherStudy" DuPont 1/11/2005 Slides,Resultsto Datefrom the PFOA Worker HealthStudy 1/14/2005 Emailfrom RobertW. Rickardto USEPA CharlesAuerand Oscar Hernandez regardingPresentation Emaildated 1/20/05from Noah Seixasto DavidWegman re:PFOA publicityand emaildated 1/19/05from David Wegman toNoah SeixasrePFOA publicity(fromthird-partyproduction by DavidWegman inthe Rhodes/Rowe cases Emaildated 2/8/05from Tom Beauchampto DavidWegman and EllenEisenre: Summary ofConferenceCall,in responsetoemailon same pagedated 2/4/05from DavidWegman to EllenEisenand Tom Beauchamp (from DavidWegman's third-partyproduction inRowe/Rhodes cases). Page 134 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 230 of 277 PAGEID #: 61231 Descriptions of Documents Without Bates Numbers Emaildated 5/23/05from Amelia KittredgetoThomas Beauchamp, DavidWegman, EllenEisen,Jonathan Samet, Mark Cullenand Noah Seixasre: U.S.Dept.ofJusticeGrand JurySubpoenato DuPont (from Mark Cullen'sthirdpartyproduction inRowe/Rhodes cases). AR226-3542______________________________________________________________ Emaildated 12/6/05from Jonathan Sametto Robin Leonard, EllenEisen,DavidWegman, Thomas Beauchamp, Mark Cullenand Noah Seixasre: Parkersburg Data Request(firstpageof7-pageemailstring). (From David Wegman's third-partyproduction inRowe/Rhodes cases). Emaildated 2/10/06from Jonathan Sametto DavidWegman re: IRBIssue(firstemail inemailstring)(4pages). (From DavidWegman's third-partyproduction inRowe/Rhodes cases). Letterdated 2/22/06from Robin Leonardto DavidWegman; alsoemaildated 2/22/06from Tom Beauchampto DavidWegman, JonSamet, Mark Cullen,Noah Seixasand EllenEisenre: TheWeinberg Proposal (3pages)(from EllenEisen'sthird-partyproduction inRowe/Rhodes cases). Letterdated 2/22/06from DuPont's EpidemiologyAdvisoryBoard (addresseenotlisted)re: comments on DuPont's research program on potentialhealthrisksofPFOA (3pages) (fromThomas Beauchamp'sthird-party production inRowe/Rhodes cases). Emaildated 2/22/06from Jonathan Sametto EllenEisenre: DraftLetter(topemail in2-pageemailstring). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases). Email (1page)dated 2/23/06from Mark CullentoCarineSakrre: Question, inresponsetoemail from Carine Sakrto Mark Cullenon thesame page. (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases). Memo dated 2/26/06from DuPont's Epidemiology Review Boardto Michael Kaplan re: comments on DuPont's research program on potentialhealthrisksofPFOA (2pages) (from EllenEisen'sthird-partyproduction in Rowe/Rhodes cases). Emaildated 2/27/06from Robin LeonardtoThomas Beauchamp, DavidWegman, EllenEisen,Jonathan Samet, Mark Cullenand Noah Seixasre: Memo (1page) (from Mark Cullen'sthird-partyproduction inRowe/Rhodes cases). Emaildated 3/8/06from CarineSakrto EllenEisenre: Cox DifferentExposures (topemail in2-pageemail string). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases). CurriculumVitaeofEricaFrank,M.D. dated4/17/06 (20pages)(from Mark Cullen'sthird-partyproduction in Rowe/Rhodes cases). CH Lee,etal:FatalAcute Pulmonary Oedema afterInhalationofFumes from Polytetrafluoroethylene(PTFE)", European RespiratoryJournal,Vol.10,pp.1408-11, 1997 Emaildated 5/3/06from Mark CullentoJonathanSamet Re: Regarding Erica(topemail in3-pageemailstring) (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases). Emaildated 5/4/06from Mark CullentoCarineSakrre: Update (1page) (from Mark Cullen'sthird-party production inRowe/Rhodes cases). AR226-3658, AR226-3659______________________________________________________ DuPont emaildated 5/18/06from Robin LeonardtoMike Kaplan re: Completed Data: What's Next? (topemail in2-pageemailstring)(From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 6/8/06from Noah Seixasto Kim Kreckmann ofDuPont re: Methods Section-Exposure (inresponse toemailon same pagefrom Kim Kreckmann) (2pages) (From EllenEisen'sthird-partyproduction in Rowe/Rhodes cases). Emaildated 6/9/06from Kim Kreckmann ofDuPonttoNoah Seixas(topemail in3-pageemailstring). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Page 135 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 231 of 277 PAGEID #: 61232 Descriptions of Documents Without Bates Numbers Emaildated 7/10/06from Robin Leonard ofDuPontto EllenEisen,DavidWegman, Thomas Beauchamp, Mark Cullen,Jonathan Samet and Noah Seixasre: SciencePanel Protocols.(1page) (From DavidWegman's third-party production inRowe/Rhodes cases.) Emaildated 7/17/06from Mark Cullento Robin Leonard, EllenEisen,Noah SeixasandThomas Beauchamp re: Protocols.(1page) (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 7/17/06from Mark Cullento Robin Leonard, EllenEisen,Noah SeixasandThomas Beauchamp re: Protocols.(1page) (From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 7/17/06from EllenEisentoRobin Leonard ofDuPont re: DifferentViews (inresponseto Robin Leonard's7/17/06 emailonthesame page).(From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 7/17/06from Robin Leonard ofDuPontto DavidWegman and EllenEisenre: DifferentViews. (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 7/20/06from Mark Cullento Robin Leonard, EllenEisen,DavidWegman, Thomas Beauchamp, Jonathan Samet and Noah Seixasre: ManuscriptinPreparation. (From EllenEisen'sthird-partyproduction in Rowe/Rhodes cases.) Emaildated 7/24/06from EllenEisentoDavidWegman re: DuPont (inresponseto7/24/06 emailfrom David Wegman on same page). (From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 8/1/06from Robin Leonard ofDuPonttoDavidWegman re: Diabetes Discussion.(From David Wegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 9/10/06from Noah Seixasto Robin Leonard re: Rate RatiosforCumulative Exposure (topemail in2page emailstring). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 9/10/06from Noah Seixasto Robin Leonard re: Rate RatiosforCumulative Exposure (topemail in2page emailstring). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) RobinC.Leonard, PhD: Study"Ammonium Perfluorooctanoate: Phase II.RetrospectiveCohort Mortality Analyses RelatedtoaSerum BiomarkerofExposure inaPolymer Production Plant",9/15/2006 Emaildated 9/20/06from Mark Cullento Robin Leonard, EllenEisenand DavidWegman re: New Table,in responseto9/20/06 emailfrom Robin Leonard (onthesame page). (From EllenEisen'sthird-partyproduction in Rowe/Rhodes cases.) Emaildated 9/21/06from Nancy SelzerofDuPonttoBarbara Dawson,Thomas Beauchamp, etal.re: Renaming ofERBto EABtopemail in2-pageemailstring). (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 9/21/06from Noah Seixasto DavidWegman reNew Table(topemail in3-pageemailstring). (From EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 9/26/06from Noah Seixasto Robin Leonard re: Input(inresponsetoemailon same pagefrom Robin Leonard). (From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Minutes of10/3/06 LipidReview Panel meeting (from Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) PowerPoint presentationslidesdated 10/3/06 reLRPteleconference headed "TeleconferenceAgenda" (from Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Emaildated 10/17/06from Jonathan SamettoDavidWegman re: PressRelease(topemail in2-pageemail string). (From DavidWegman's third-partyproduction inRowe/Rhodes cases.) Emaildated 11/8/06from EllenEisentoSolSax, etal.re: LettertoSciencePanel (from DavidWegman's thirdpartyproduction inRowe/Rhodes cases.) Emaildated 11/20/06from Robin Leonardto Kim Kreckmann,John Green, etal.re: FirstDraftofPhase I Manuscript (from DavidWegman's third-partyproduction inRowe/Rhodes cases.) Page 136 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 232 of 277 PAGEID #: 61233 Descriptions of Documents Without Bates Numbers Emaildated 12/6/06from EllenEisentoNoah Seixas,DavidWegman, Robin Leonard and Mark Cullenre: Firstof Two Phase IIManuscripts (topemail in2-pageemailstring). (From DavidWegman's third-partyproduction in Rowe/Rhodes cases.) Undated 1-pagedocumenttitled: Review ofFinalDraftofPhase IIReport(from EllenEisen'sthird-party production inRowe/Rhodes cases.) Undated 3-pagedocumenttitled: Review ofFinalDraftofPhase IIReport EllenEisen(from EllenEisen'sthirdpartyproduction inRowe/Rhodes cases.) Undated 3-pagedraftlettertoScienceAdvisory Panel (from EllenEisen'sthird-partyproduction inRowe/Rhodes cases.) Articlemanuscript: CarineSakr,MD, MPH, etal:"Twenty-fiveYearLongitudinalStudyofSerum Total Cholesterol RelatedtoaSerum BiomarkerofExposure (Serum PerfluorooctanoateorPFOA) inaPolymer Production Plant",Undated Undated 27-pagearticlefrom theAmericanJournalofEpidemiologytitled: Repeated Measures StudyofSerum Lipidsand LiverEnzymes inWorkerswith Occupational ExposuretoAmmonium Perfluorooctanoate(APFO). (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Undated 2-pagedraftdocument authored byJanesse BrewerofThe Keystone Centerheaded: FourPointBody Burden PositionProposed. (From AlanGreene'sthird-partyproduction inRowe/Rhodes cases.) 1/11/2007 Minutesfrom Dr.Emmett's LittleHockingC8 StudyCommunity Meeting Emaildated 1/19/07from Mark CullentoCarineSakrre:AJE-01232-2006 (Decision) Repeated Measures Study ofSerum Lipidsand LiverEnzymes inWorkers withOccupational ExposuretoAmmonium Perfluorooctanoate (APFO). (Topemailof4-page emailstring.) (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Email (2pages)dated 1/19/07from Nancy SelzerofDuPonttoBarbara Dawson, etal.re: Organization NoticeSolSax, forwardingemaildated 1/19/07from SolSax.(From Mark Cullen'sthird-partyproduction in Rowe/Rhodes cases.) Emaildated 2/27/07from J.Morel Symons toDavidWegman, Thomas Beauchamp, Mark Cullen,EllenEisen, Jonathan Samet and Noah Seixasre: DuPont EpiManuscriptforReview. (2pages) (From DavidWegman's thirdpartyproduction inRowe/Rhodes cases.) Email (1page)dated 3/30/07from SolSaxtoCarineSakr,EricaFrank,ErnstSchaefer, Mark Cullen,PeterGillies, Robert Rickardand Robin Leonard re:LipidReview Panel--Progress Report. (From Mark Cullen'sthird-party production inRowe/Rhodes cases.) Two-page document dated 3/22/07: Review ofmanuscript: RetrospectiveCohort MortalityStudyofWorkers inaPolymer Production PlantIncludingaReference PopulationofRegionalWorkers (from EllenEisen'sthirdpartyproduction inRowe/Rhodes cases.) Sidney Pell,PhD, etal:"Cancer EpidemiologicalSurveillanceinthe Du PontCompany", JournalofOccupational Medicine,Vol.20,No. 11,11/1978________________________________________________ BruceW. Karrh,M.D.: "ACompany's DutytoReport Health Hazards", Buff.NY Acad Med.,Vol.54,No.8, CJSakr,etal:"Cross-SectionalStudyofLipidsand LiverEnzymes RelatedtoaSerum BiomarkerofExposure (Ammonium PerfluorooctanoateorAPFO) asPartofaGeneral HealthSurveyinaCohortofOccupationally ExposedWorkers",JOEM (10),1086-96, Oct.2007_______________________________________ CarineJ.Sakr,MD, MPH, etal:"Cross-SectionalStudyofLipidsand LiverEnzymes RelatedtoaSerum Biomarker ofExposure(ammonium perfluorooctanoateorAPFO) asPartofaGeneral HealthSurveyinaCohortof OccupationallyExposed Workers",JOEM, Vol.49, No. 10,10/2007 Page 137 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 233 of 277 PAGEID #: 61234 Descriptions of Documents Without Bates Numbers CJSakr,etal:"Cross-SectionalStudyofLipidsand LiverEnzymes RelatedtoaSerum BiomarkerofExposure (Ammonium PerfluorooctanoateorAPFO) asPartofaGeneral HealthSurveyinaCohortofOccupationally ExposedWorkers", PubMed, 10/2007 4/6/2009 Letterfrom BarbaraJ.Dawson to Michael S.Morgan, ScD,CIH,regardingJOEH 149 Revision Kim H.Kreckmann, etal:"EstimationandValidationofBiomarker-Based ExposuresforHistoricalAmmonium Perfluorooctanoate",JournalofOccupational and Enviromental Hygiene,doi:10.1080/15459620903025483, 9/2009__________________________________________________________________ Presentationabstract: J.Morel Symons, etal:"Resultsfrom SequentialAnalysisofThyroid Hormone and DiseaseMeasuresfrom the National Healthand Nutrition ExaminationSurvey, 1999-2010", Undated Email (1page) dated4/9/07from EllenEisentoMark Cullen,Noah Seixasand DavidWegman re: SAB "Review" respondingtoemaildated4/8/07 on same pagefrom Mark Cullen.(From DavidWegman's third-party production inRowe/Rhodes cases.) Emaildated 5/8/07from Mark CullentoCarineSakrre: 15 MinutesforReviews, respondingtoemailon same pagefrom CarineSakr. (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Two-page emaildated 6/18/07from Robin LeonardtoThomas Beauchamp, DavidWegman, EllenEisen,Mark Cullenand Noah Seixasre: 07-04R1: FinalDecision;forwardsemailon same page dated 6/18/07from Annals ofEpidemiology. (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) Draftdocument dated 8/15/2007 authored by Robin Leonardtitled: DuPont Epidemiology Program: Statusof Program, and ResearchStrategy. (From Mark Cullen'sthird-partyproduction inRowe/Rhodes cases.) One-page undated emailfrom Dawn RittenhouseofDuPonttoHAB Members, forwardingemailon same page dated 9/6/07from SilvioDeCarliofDuPonttoDawn Rittenhousere: HAB Subpoenas. (From KevinStephen's third-partyproduction inRowe/Rhodes cases.) Letterdated 10/3/07from Noah Seixasto Robin Leonard re: meeting. (From Noah Seixas'third-party production inRowe/Rhodes cases.) Undated PowerPoint presentationslidestitled: ExposureCategorizationfortheWashington Works Mortality Analysis(40pages). (From Noah Seixas'third-partyproduction inRowe/Rhodes cases.) Undated 4-page documenttitled: DrafttextforEAB statementon importanceofexposureassessment module ofMedgate datasystem. (4pages) (From Noah Seixas'third-partyproduction inRowe/Rhodes cases.) Undated draftletterfrom the EABtotheSAB Panel (6pages). (From Mark Cullen'sthird-partyproduction in Rowe/Rhodes cases.) 8/2008Slidesfrom DuPont, "Chambers Works IHUpdateforPFOA" 11/3/2008Summary "Concernsand ResponsesforAPFO Area" Draftletterfrom BillHopkinstoWashington Works Employees regardingNew BirthWeight EpidemiologyStudy thatDuPontwillbe Starting",Undated 11/9/10 DuPont Epidemiology Program ProtocolWithdrawalforStudyTitle"BirthWeight OutcomesforChildren ofFemaleWashington Works Employees" ISEEAbstract,J.Morel Symons: Abstract#:S-139,"PotentialOutcomes AnalysesAppliedto Hazard Identification", Undated AR226-0480______________________________________________________________ 4/29/1982 Letterfrom Leonard M. Schuman, M.D.,toDr.FrankUbel regardingDatafrom theStudieson Fluorochemical Exposure AR226-0035______________________________________________________________ AR226-0032______________________________________________________________ 3M Reporton "An EpidemiologicInvestigationofClinicalChemistries, Hematologyand Hormones inRelationto Serum LevelsofPerfluorooctaneSulfonateinMale Fluorochemical Production Employees", Undated Page 138 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 234 of 277 PAGEID #: 61235 Descriptions of Documents Without Bates Numbers AR226-0022______________________________________________________________ AR226-0548______________________________________________________________ AR226-0076______________________________________________________________ AR226-0611______________________________________________________________ GearyW. Olsen, DVM, PhD: 3M Study"An EpidemiologicAnalysisofEpisodesofCareof3M DecaturChemical and Film PlantEmployees, 1993-1998", 6/25/2001 AR226-1350______________________________________________________________ AR226-1087______________________________________________________________ AR226-1088______________________________________________________________ Jean M. Burris,RN, MPH: Interim Report#2 "DeterminationofSerum Half-LivesofSeveral Fluorochemicals", 1/11/2002_______________________________________________________________ 3M EpidemiologyMedical Department FinalReportdated6/9/03: AssessmentofLipid,HepaticandThyroid FunctioninRelationtoan Occupational BiologicLimitValueforPerfluorooctanoate (41pages) AR226-1954______________________________________________________________ AR226-1908______________________________________________________________ AR226-1963______________________________________________________________ 6/29/2005 Letterfrom LarryZobel, MD, MPH, of3M toSue Shallal,PhD, regardingPFOA Review Panel-Draft Report GearyW. Olsen, DVM, PhD, etalof3M: FinalReport,"AnAnalysisofthe 2000 Fluorochemical (Perfluorooctanoate, PFOA) Medical SurveillanceProgram at3M Company's Antwerp (Belgium),CottageGrove (Minnesota),and Decatur(Alabama) Facilities",5/16/2006 6/16/2006 Letterfrom MichaelA.Santoroof3M to Mary Dominiak, EPA, regardingInformationon PerfluorooctaneSulfonate, PerfluorooctanoicAcid,and RelatedCompounds JessicalI.Lundin, MPH, etal.of3M: FinalReport"MortalityofEmployeesofan Ammonium Perfluorooctanoate Production Facility",8/22/2007 B.H.Alexander,etal:"Abstracts...OralSession8-MortalityStudies:Cancerand Cardiovascular, Mortalityof Employees ofanAmmonium Perfluorooctanoate Production Facility",Occup Environ Med 2004 Downloaded on 1/24/2008_______________________________________________________________ 6/30/2009 Letterfrom LarryR.Zobel and GearyW. Olsen of3M toTony Fletcher,DavidA.Savitzand Kyle Steenland regardingHealth Related Research EffortsPertainingto Perfluorooctanoate(PFOA) Presentationposter: DavidJ.Ehresman, etal:Abstract395 "ALongitudinalOccupationalAssessmentofthe PotentialAssociationofChanges Between Serum ConcentrationsofPerfluorooctanoateand Perfluorooctanesulfonateand Non-High-Denisity-LipoproteinCholesterol", Undated GearyOlsen,etal:ISEEAbstract#:P-205,"PFOA, PFOS, and Chronic Kidney Disease:ClearanceComes Before Causation", 2012 BH Alexander,etal:"MortalityofEmployees ofaPerfluorooctanesulphonyl FluorideManufacturing Facility, Occup Environ Med 2003; 60:722-729 GearyW. Olsen,etal:"An Occupational ExposureAssessmentofaPerfluorooctanesulfonyl FluorideProduction Site:Biomonitoring",AIHAJournal64:651-659 (2003),9/2003 GW Olsen,etal:"AnalysisofEpisodesofCare inaPerfluorooctanesulfonyl FluorideProduction Facility",Occup Environ Med., 8/2004________________________________________________________ GearyW. Olsen, DVM, PhD, etal:AnalysisofEpisodesofCare inaPerfluorooctanesulfonyl FluorideProduction Facility",JournalofOccupationaland Environmental Medicine,Vol.46, No.8,8/2004 John L.Butenhoff,etal:"Responseto Lettertothe Editor",Reg.Toxicol.& Pharmacol,42.pp.146-47 (2005), doi:10.1016/j.yrtph.2005.01.006, 2/24/2005 Page 139 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 235 of 277 PAGEID #: 61236 Descriptions of Documents Without Bates Numbers Presentationposter:G.Olsen,etal:"UrinaryBladderEndpointsinWorkers and RatsExposedto Perfluorooctanesulfonyl Fluoride(POSF)"Abstract, Undated 3M presentationabstract: G.Olsen,etal:"UrinaryBladder Endpoints inWorkers and RatsExposedto Perfluorooctanesulfonyl Fluoride(POSF)"Summary, Undated 3M presentation poster: D.Ehresman, etal:"Evaluationofthe Half-life(T%) ofEliminationof Perfluorooctanoate(PFOA)from Human Serum" Abstract, Undated Abstract: JH Raymer, etal:"ConcentrationsofPerfluorooctaneSulfonate(PFOS)and Perfluorooctanoate (PFOA) andTheirAssociationswith Human Semen QualityMeasurements", Reprod.Toxicol.,epub6/29/2011 JH Raymer, etal:"ConcentrationsofPerfluorooctaneSulfonate(PFOS)and Perfluorooctanoate(PFOA) andTheir Associationswith Human Semen QualityMeasurements", ReproductiveToxicology,doi: 10.1016/j.reprotox2011.05.024, 2011______________________________________________ 3M posterabstract:J.L.Butenhoff,etal:"Perfluorooctanoate, Perfluorooctanesulfonate,and Chronic Kidney Disease:ClearanceComes BeforeCausation",Abstract, Undated 3M posterabstract: D.J.Ehresman, etal:"A LongitudinalOccupationalAssessment ofthe PotentialAssociation ofChanges Between Serum ConcentrationsofPerfluorooctanoateand Perfluorooctanesulfonateand Non HighDenisity-LipoproteinCholesterol",Abstract, Undated Posterabstract:A.E.Loccisano,etal:"UseofPBPK Modelsto EvaluateAssociationsinEpidemiologicalStudiesof ReproductiveOutcomes with PFOA and PFOS Concentrations",Abstract, Undated Presentationabstract: LarryR.Zobel, MD, MPH, etal:"PerfluorinatedCompounds and Immunotoxicityin Children",ArticleJAMA, Vol.307, No. 18,5/9/2012______________________________________ GearyOlsen,etal:"PFOA, PFOS, and Chronic KidneyDisease:ClearanceComes BeforeCausation",Article Epidemiology,Vol.23,Issue5S,doi:10.1097.01.ede.0000417208.38915.26, 9/2012__________________ GearyW. Solsen,etal:"ACausation RoleforClearancewith EpidemiologicAssociationsRelatedtoSerum ConcentrationsofPFOA and PFOS?",Abstract, Undated Olsen,G.,etal.,"Half-LifeofSerum EliminationofPerfluorooctanesulfonate, Perfluorohexanesulfonate,and PerfluorooctanoateinRetired Fluorochemical ProductionWorkers", Env. Health Perspectives (September 2007) (2pages)________________________________________________________________ AR226-1866______________________________________________________________ 9/7/2004 Letterfrom Edward E.SheatoUSEPA regardingSubmittingaReport DescribingaMeetingwith 3M and DuPontto DiscussBiologicalMonitoringofMiteniWorkers ExposedtoPerfluorooctanoicAcid (PFOA),dated 8/23/2004_______________________________________________________________ AR226-1867______________________________________________________________ USEPA Docket: Letterto Mary EllenWeber, USEPAfrom RobertA.Bilott,regardingPFOA Human Health Effects forAR-226 and OPPT-2003-0012, 9/22/2004__________________________________________ Eleven-pagedocument dated 5/21/07titled: IssueBrief: PFOA and BreastCancerActivism (from Dezenhall Resource'sthird-partyproduction inRowe/Rhodes cases.) BrentD.Kerger,etal:"Tenuous Dose-Response CorrelationsforCommon DiseaseStates:CaseStudyof Cholesteroland Perfluorooctanoate/Sulfonate(PFOA/PFOS) intheC8 Health Project",Drugand Chemical Toxicology,doi:10.3109/01480545.2011.582502, 2011____________________________________ I.R.MacPherson, etal:"A First-in-Human Phase IClinicalTrialofCXR1002 inPatients(pts)withAdvanced Cancer",American SocietyofClinicalOncology, 2011 I.R.MacPherson, etal:"A First-in-Human Phase IClinicalTrialofCXR1002 inPatients(pts)withAdvanced Cancer",American SocietyofClinicalOncology, 2011 Page 140 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 236 of 277 PAGEID #: 61237 Descriptions of Documents Without Bates Numbers Undated 3-pagedocument authored by HarveyCheckoway entitled: Peer Review Comments on: An InternationalCollaborativeCohort MortalityStudyofWorkerswith PotentialExposuretoTFE (from Harvey Checkoway'sthird-partyproduction inRowe/Rhodes cases.) Document dated 6/19/06 authored by DavidCoggon and HarveyCheckowaytitled: PeerReview Comments on: An InternationalCollaborativeCohort MortalityStudyofWorkerswith Potential ExposuretoTFE (4pages). (From HarveyCheckoway'sthird-partyproduction inRowe/Rhodes cases.) 13-pagedocumenttitled: FluoropolymersCommittee WorkingGroup onthe Multi-Centre EpidemiologyStudy onTFE -June 19,2006 (from HarveyCheckoway'sthird-partyproduction inRowe/Rhodes cases.) 1-pagedraftletterdated 6/23/06from HarveyCheckowaytoProf.PierA.Bertazzi(from HarveyCheckoway's third-partyproduction inRowe/Rhodes cases.) Report: DarioConsonni, MD, PhD, etal:"TFE MulticentreMortalityStudy" Summary and FullReport,3/6/2012 RoyalSocietyofChemistryStudyof"ExposureAssessment MethodologyforTetrafluoroethylene(TFE)and Ammonium PerfluorooctanoateAcid (APFO)", forJournalofEnvironmental Monitoring, 2012 DarioConsonni, etal:"CancerRiskAmong TetrafluoroethyleneSynthesisand PolymerizationWorkers", AmericanJournalofEpidemiology,doi:10.1093/aje/kws588, 7/4/2013 DarioConsonni, etal:"CancerRiskAmong TetrafluoroethyleneSynthesisand PolymerizationWorkers", AmericanJournalofEpidemiology,doi:10.1093/aje/kws588, 7/4/2013 A.Sleeuwenhoek, etal:"ExposureAssessmentofTetrafluoroethyleneand Ammonium PerfluorooctanoicAcid 1951-2002",Abstract, Undated ChristopherLau:"PerfluoroalkylAcids:Recent Research Highlights",Elsevier,doi: 10.1016/j.reprotox.2012.03.002, 2012______________________________________________ WVDHHR Table"Wood CountySelectedCauses ofDeaths, 1989-1998, Number ofDeaths", 2000 Community HealthStatusReport,Washington CountyOhio, US Department ofHealthand Human Services, 7/2000_________________________________________________________________ ScotLong: "CancerinAreaAbove Average", Parkersburg News Article,9/9/2001 West VirginiaHealthStatisticsCenter,StatisticalBriefNo.6,"BirthDefectsSurveillanceSystem, 1990-1999West VirginiaResidents", Number 6,4/2002 West VirginiaHealthStatisticsCenter,StatisticalBriefNo.9,"CleftPalateand/or LipBirthDefects, 1990-1999 West VirginiaResidents", Number 9,9/2002 West VirginiaHealthStatisticsCenter,StatisticalBrief,No.7,"InfantMortalityStatisticsby RaceWest Virgina Residents", Number 7,4/2002 West VirginiaBureau forPublicHealth RatesforHeart Disease byCounty, 2000 West VirginiaDivisionofSurveillanceand DiseaseControlWebsite Page regarding"CancerinWV Incidenceand Mortality,1993-1999", 2002____________________________________________________ BeverlyKenner,etal:"CancerinWest VirginiaIncidenceand Mortality1993-1999",West VirginiaCancer Registry,3/2002 BeverlyKenner,etal:"CancerinWest VirginiaIncidenceand Mortality1993-1999",West VirginiaCancer Registry,3/2002 PatriciaColsher, PhD: "CancerinWest VirginiaIncidenceand Mortality1993-2000",West VirginiaCancer Registry,5/2003 VickiSmith: "W.Va. Fifth-WorstStateforAsthma, StudyFinds",CharlestonGazetteArticle,10/2/2003 KateYork:"CuttingRisksofCancer",The MariettaTimesArticle,11/21/2003 MichelleSaxton: "Report:W.Va. Has HighestMortalityRate",The CharlestonGazetteArticle,11/24/2003 American CancerSocietyReport, "OhioCancer Facts& Figures2003, Focus:Appalachia, 2003 Page 141 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 237 of 277 PAGEID #: 61238 Descriptions of Documents Without Bates Numbers Ohio EPA News Release"Ohio EPA Recommends BottledWater inAreasWhere C8 Has Been Detected", 10/4/2005____________________________________________________________ 7/1/2007 Ohio Department ofHealth Reporton C8 PerfluorooctanoicAcid,Commonly known asC8,isalso Called PFOA and/orAPFO: A 2006 C8 Physician Reference,What we know...,What we don'tknow...,What is takingplace. KathrynZ.Guyton, etal:"AReexamination ofthe PPAR-aActivation Mode ofActionasaBasisforAssessing Himan Cancer RisksofEnvironmental Contaminants", Environmental Health Perspectives,doi: 10.1289/ehp.0900758, 5/15/2009______________________________________________ 8/31/2009 Letterfrom HenryA.Spiller,Kentucky Regional PoisonCenter,toDr.Frumpkin,AgencyforToxic Substancesand DiseaseRegistry,regardingComments onToxicological ProfileforPerfluoroalkyls EnvironmentalWorking Group, "ToxictoAnimals& People. PersistentForever. PervasiveinHuman Blood", 2003 BiographyofEdward A.Emmett, MD, Ms, Undated DavidGray,etal:"LiverToxicityinFluorochemicalWorkers",TetraTech, Inc.,11/2003 JAZapp,Jr.,etal:"ToxicityofPyrolysisProductsof"Teflon"TetrafluoroethyleneResin",Am. Ind.Hygience Association: AbstractofAnnual Meeting,4/26/55 FactSheetregarding"Community ExposuretoC8 InThe LittleHockingArea", 12/3/2003 EnvironmentalWorking GroupWeb Article"DuPont'sSpinAbout PFOA", 2/16/2004 4/21/2004 Letterfrom BilotttoCharlesM. Auer,Oscar Hernandez, and USEPA regardingPFOA Human Health EffectsStudy:Cancer Data XJJian,etal:"ExperiencesinEmergencyTreatmentfor38 Caseswith Organofluorine", PubMed Abstract, Zhonggyo Wei Zhong BingJiJiuYiXve,5/16/2004 DuPont C8 Questionnaire (Blank),Defendant's Exhibit4,8/31/2004 AR226-1866______________________________________________________________ DanielT.Smith, MD: "CBRNE -Lung-DamagingAgents,ToxicSmokes: Nox, Hc,Rp,Fs,Fm, Sgf2,Teflon", EMedicine Article, 11/1/2004 DuPont C8 Questionnaire (Blank),Defendant's Exhibit4,8/31/2004 James Dahlgren, MD, etal:"Prevalenceand IncidenceofCancerinPopulations, Exposedto Perfluorooctanoate (PFOA)", Report, Undated Pamela Anderson-Mahoney, PhD, etal:"Self-Reported Health EffectsAmong Community ResidentExposedto Perfluorooctanoate(PFOA)", Report, Undated C8 QuestionnaireStudy Protocol,Undated 3/15/2010 Letterfrom Bilottto USEPA regardingSubmissiontoTSCA 8(e)FYIDatabase Re:PFOA/PFOS 2/7/2005 Letterfrom BilotttoUSEPAAuer, Hernandex, Seed,Weber, DominiakregardingPFOA Human Health EffectsStudy:Cancer Data 1/7/2005 Letterfrom BilotttoUSEPAAuer, Hernandex, Seed,Weber, DominiakregardingPFOA Human Health EffectsStudy:Cancer Data 2/7/2005 Letterfrom BilotttoUSEPAAuer, Hernandex, Seed,Weber, DominiakregardingPFOA Human Health EffectsStudy:Cancer Data LittleHockingWater System C8 Study FactSheet,4/11/2005 7/22/2005 Letterfrom Edward A.Emmett, MD, to Mary Dominiak regardingCommunity ExposuretoC8 UniversityofPennsylvania pressrelease8/15/2005 :"Penn StudyFindsNo RelationshipBetween ElevatedC8 Levelsand LiverorThyroidAbnormalities, HighestC8 LevelsFound intheVeryYoung and Eldest" Tony Fletcher,etal:Slides"TheScience Panel HealthStudy" DraftOutline, 10/29/2005 1/26/2006 Emailfrom Cathy Lewisto USEPA regardingEPA-HQ-OPPT-2003-0012 ~ Page 142 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 238 of 277 PAGEID #: 61239 Descriptions of Documents Without Bates Numbers 2/2006 LittleHockingWater C8 StudyCommunity Newsletter#8 Letterdated 6/1/06from Robert BilottofTaftto Dr.CharlesAuerofUSEPA, etal.re: PFOA Human Health EffectsStudy,transmittingattached researchstudies(40pages) 6/6/2006 Letterfrom BilotttoUSEPAAuer, Dominiak, Seed,Goeden, Krueger, Kriens,Seymour and Post regardingPerfluorochemical Human Health Data Michael Smith: "WaterproofingSprays Booted OffMarketOver Illness,MedPageToday.com Article,5/8/2006 Edward A.Emmett, MD, MS, etal:Manuscript Daft,"Community ExposuretoPerfluorooctanoate: Relationships Between Serum Levelsand Certain Health Parameters",JournalofOccupational and Environmental Medicine, 2006___________________________________________________________________ Edward A.Emmett, MD, MS, etal:Manuscript Daft,"Community ExposuretoPerfluorooctanoate: Relationships Between Serum Levelsand Certain Health Parameters",JournalofOccupational and Environmental Medicine, 2006___________________________________________________________________ UniversityofCincinnatiNews Release,"FirefightersFace Increased RiskforCertainCancers", 11/10/2006 Grace K.LeMasters, PhD.,etal:"CancerRiskAmong Firefighters:A Review and Meta-Analysisof32 Studies", JOEM, Volume 48, Number 11,11/2006_____________________________________________ 2/2007 LittleHockingWater C8 StudyCommunity Newsletter#11 SocietyofToxicology,"PerfluoroalkylAcidsand RelatedChemistries:Toxicokineticsand Mode ofAction", SpeakerAbstract 13, 2/14/2007 KJFairley,etal:"Exposuretothe Immunosuppresant, PerfluorooctanoicAcid,Enhancesthemurine Igeand Airway HyperreactivityResponsetoOvalbumin, PFOA EnhancesOVA InducedAllergicResponse",ToxSciArticle, doi:10.1093/toxsci/kfm053, 3/15/2007_____________________________________________ Selected References: Polymer Fume Fever,9/5/2007 DavidGray, PhD, etal:"A Reviewand CritiqueofFourRecent PFOA Papers", Report, 11/2/2007 11/29/2007Articles(10)from The C8 Science PanelWebsite The C8 SciencePanelWebsite Community StudySummary, The StudiesataGlance, Undated Media Release, European Congresson Obesity,"New Evidence LinksHormone-Mimic ChemicalstoObesity", Geneva Switzerland,5/14/2008 Letter-in-Press,Environ Health Perspect.,from R.Slama regarding"Howto ControlforGestationalAge inStudies InvolvingEnvironmental Effectson FetalGroup", doi:10.1289/ehp.11105, 6/24/2008 C8 SciencePanelC8 Study Results,10/15/2008 KyleSteenland,etal:StatusReport,"AssociationofPerfluorooctanicAcid (PFOA)and Perfluoroctanesulfonate (PFOS)with LipidsAmong AdultsinaCommunity with High Exposureto(PFOA)", 10/8/2008 VeronicaVieira,etal:"PFOA Community HealthStudies:ExposureviaDrinkingWater Contaminated byaTeflon Manufacturing Facility",Organohalogen Compounds, Vol.7,p.000732, 2008 JessicaL.Reiner,etal,Abstract, ReproductiveToxicology27,p.422-423, doi:10.1016/j.reprotox.2008.11.071, 2009___________________________________________________________________ WV UniversitySchoolofMedicineChart,"Summary ofPopulationC8 DecileGroups", 2008 WV UniversitySchoolofMedicineC8 Health ProjectResults(Webpage), 2010 WV UniversitySchoolofMedicineChart,"Population ResultsforC8 and C8 SulfonatePlasma Concentrations", 2008___________________________________________________________________ WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:DiagnosisofBirthComplications Stratifiedby Mother'sAge-Group atTime ofBirth",2008 WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:BirthDefectsStratifiedby Mother'sAge-Group atTime ofBirth",2008 Page 143 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 239 of 277 PAGEID #: 61240 Descriptions of Documents Without Bates Numbers WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:Downs Syndrome Stratifiedby Mother'sAge-Group atTime ofBirth",2008 WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:BirthDefectsStratifiedby Mother'sAge-Group atTime ofBirth",2008 WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:DiagnosisofBirthComplications Stratifiedby Mother'sAge-Group atTime ofBirth",2008 WV UniversitySchoolofMedicineChart,"FirstPregnancywithSingleLiveBirth:Downs Syndrome Stratifiedby Mother'sAge-Group atTime ofBirth",2008 1/25/2009 Emailfrom LibrettaPortaStennesto DavidW. Boothe andJohn R.FlynnregardingMeetingwith DuPont atW W 1/27/2009 C8 SciencePanel,C8 Study Results,StatusReport: "AssociationofPerfluorooctanicAcid(PFOA) and Perfluoroctanesulfonate(PFOS)with UricAcidAmong Adultswith ElevatedCommunity ExposuretoPFOA" KyleSteenland,etal:1/23/2009 C8 SciencePanel,C8 StudyResults,StatusReport:"Associationof PerfluorooctanicAcid(PFOA) and Perfluoroctanesulfonate(PFOS)with UricAcidAmong Adultswith Elevated Community Exposureto PFOA" KyleSteenland,etal:StatusReport:"ACross-SectionalAnalysisofType IIDiabetesinaCommunitywith Exposureto PerfluorooctanoicAcid(PFOA)", 11/17/2008 KyleSteenland,etal:StatusReport:"FactorsAssociateswith PFOA LevelsinaCommunity Surroundinga Chemical Plant",10/7/2008 1/27/2009 C8 SciencePanel,C8 Study Results,StatusReport: "AssociationofPerfluorooctanicAcid(PFOA) and Perfluoroctanesulfonate(PFOS)with LipidsAmong AdultsinaCommunity with High Exposureto(PFOA)", 10/8/2008_______________________________________________________________ C8 SciencePanelC8 Study Results,The StudiesAtA Glance, Undated C8 SciencePanelSummary oftheC8 Science PanelStudies,2009 SamuelYamin, MPH: "Non-Occupational Perfluorochemical (PFC)BiomonitoringinMinnesota: Interpretationof Resultsand DiscussionofPotentialHealth Indicators",StudyResults,7/14/2009 KyleSteenland,etal:"AssociationofPerfluorooctanoicAcidand PerfluorooctaneSulfonatewithSerum Lipids Among Adults LivingNearaChemical Plant",Article,AmericanJournalofEpidemiology, doi: 10.1093/aje/kwp279 10/21/2009_________________________________________________ 10/27/2009 Letterfrom DavidG.Gray, PhD,toAgencyforToxicSubstancesand Disease Registryregarding Comments on DraftToxicological ProfileforPerfluoroalkyls,DocketControl Number ATSDR-253 10/30/2009 EnvironmentalWorking Group, DraftforPublicComment, "Toxicological ProfileforPerfluoroalkyls", Comments ofOlgaV.Naidenko, PhD KathrynZ.Guyton, etal:"AReexamination ofthe PPAR-aActivation Mode ofActionasaBasisforAssessing Himan Cancer RisksofEnvironmental Contaminants", Environmental Health Perspectives,Vol.117, No. 11,doi: 10.1289/ehp.0900758, 11/2009__________________________________________________ Susan M. Pinney,etal:"PerfluorooctanoicAcid (PFOA)and Pubertal Maturation inYoung Girls",Epidemiology, Vol.20,Issue6,pS8o,doi:10.1097/01.ede.0000362949.30847.cb, 11/2009_______________________ Susan M. Pinney,etal:"PerfluorooctanoicAcid (PFOA)and Pubertal Maturation inYoung Girls",Epidemiology, Vol.20,Issue6,pS8o,doi:10.1097/01.ede.0000362949.30847.cb, 11/2009_______________________ Kate Hoffman, etal:"Exposureto PolyfluoroalkylChemicalsandAttention DeficitHyperactivityDisorderinU.S. ChildrenAged 12-15Years, Epidemiology,Vol.20,Issue6,pS70,doi:10.1097/01.ede.0000362918.40325.e9, 11/2009_________________________________________________________________ DeclarationofKathleen Burns, PhD, Emerald Coast Utilitiesv.3M Company, DuPont, etal, USDC ND FL,Case No. 3:09CV361/MCR/MD, 2/2/2010 Page 144 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 240 of 277 PAGEID #: 61241 Descriptions of Documents Without Bates Numbers 3/15/2010 Letterfrom Bilottto USEPA regardingSubmissiontoTSCA 8(e)FYIDatabase Re:PFOA/PFOS Collaborativeon Healthandthe Environment FactSheet,"PFCs PerfluorinatedChemicals, IncludingPFOA/C8", 4/2010__________________________________________________________________ H.Fromme, etal:"Pre-and Postnatal Exposureto PerfluorinatedCompounds (PFCs)",EnvironSciTechnol. Article,8/19/2001___________________________________________________________ C. Fei,etal:"Prenatal Exposureto PFOA and PFOS and RiskofHospitalizationforInfectiousDiseasesinEarly Childhood", Environ Res.Article,8/26/2010 C.Fei,etal:"Prenatal Exposureto PFOA and PFOS and RiskofHospitalizationforInfectiousDiseasesinEarly Childhood", Environ Res.Article,8/26/2010 Chunyuan Fei,etal:"Prenatalexposureto PFPAand PFOS and riskofhospitalizationforinfectiousdiseasesin earlychildhood" Environmental Research,doi:10.1016/j.envres.2010.08.004,8/30/2010 Tony Fletcher,etal:Slides"Monitoringthe HealthofPopulationswith PollutedDrinkingWater:The C8 Science PanelStudyofPerfluorinatedCompounds and Health",9/2010 SJFrisbee,etal:"PerfluorooctanoicAcid,Perfluorooctanesulfonae,and Serum LipidsinChildrenand Adolescents: Resultsfrom theC8 Health Project",Arch PediatrAdolesc Med, 9/2010 SJFrisbee,etal:"PerfluorooctanoicAcid,Perfluorooctanesulfonae,and Serum LipidsinChildrenand Adolescents: Resultsfrom theC8 Health Project",ArchivesofPediatrics& Adolescent Medicine,Vol.164, No.,9, dio: 10.1001/archpediatrics.2010.163, 9/2010 StephanieJ.JFrisbee,etal:"PerfluorooctanoicAcid,Perfluorooctanesulfonae,and Serum LipidsinChildrenand Adolescents: Resultsfrom theC8 Health Project",Arch PediatrAdolesc Med, 10/2010 KyleSteenland,etal:"StatusReport:AssociationofPerfluorooctanicAcid (C8/PFOA) and Perfluoroctanesulfonate(PFOS)with LipidsAmong Childreninthe Mid-OhioValley",9/3/2010 U.K.Health ProtectionAgency: GS Leonardi,etal:"AssociationofFluorocarbonsand Immune Biomarkers inthe Adult Mid-Ohio Valley Population", Slides,9/10/2010 KYChristensen,etal:"Exposureto PolyfluoroalkylChemicals During PregnancyisnotAssociatedwith Offspring Age atMenarche inaContemporary BritishCohort", Environ Int.,9/13/2010 KyleSteenland: "IsTeflon Bad?,The EpidemiologyofPFOA", Slides,9/13/2010 VeronicaVieira,etal:"PFOA-Contaminated SiteSurroundingaTeflon Manufacturing Facility",Slides,Undated Bethan Davies:"PFOS: PotentialImpactson PublicHealth",Abstract,9/14/2010 Abstractofpresentation: Tony Fletcher:"Monitoringthe HealthofPopulationswith PollutedDrinkingWater: The C8 SciencePanelStudyofPerfluorinatedCompounds and Health",Abstract,9/15/2010 Abstractofpresentation: Giovanni Leonard: "AssociationofFluorocarbonsand Immune Biomarkers intheAdult Mid-Ohio Valley Population", Abstract, 9/15/2010 KristaYoritaChristensen,etal:Env.International,"Exposuretopolyfluoroalkylchemicalsduringpregnancy isnot associatedwith offspringage atmenarche inacontemporary Britishcohort",doi:10.1016/j.envint.2010.08.007, 9/16/2010_______________________________________________________________ Ryan Seals,etal:"Accumulationand ClearanceofPFOA inCurrentand Former Residentsofan Exposed Community", Environmental Health PerspectivesArticle,doi:10.1289/ehp.1002346, Undated Edward A.Emmett, etal:"Community FirstCommunication: ReversingInformation DisparitiestoAchieve Environmental Justice", Environmental Justice,Vol. 3, Issue3,9/24/2010 AD Hernick,etal:"SharingUnexpected Biomarker ResultswithStudy Participants",Environ Health Perspect Article,9/29/2010___________________________________________________________ Ann D.Hernick,etal:"SharingUnexpected Biomarker ResultswithStudy Participants",Environ Health Perspect Article,doi:10.1289/ehp.1001988, 9/29/2010 Page 145 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 241 of 277 PAGEID #: 61242 Descriptions of Documents Without Bates Numbers Ann D.Hernick,etal:"SharingUnexpected Biomarker ResultswithStudy Participants",Environ Health PerspectivesArticle,doi:10.1289/ehp.1001988, 9/29/2010 Tony Fletcher:"PatternsofAge ofPubertyAmong Childreninthe Mid-OhioValleyinRelationto PerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate(PFOS)" BriefingNotes,9/30/2010 C-8SciencePanelStatusReport: "PatternsofAge ofPubertyAmong Childreninthe Mid-OhioValleyinRelation to PerfluorooctanoicAcid(PFOA)and PerfluorooctaneSulfonate(PFOS)",9/30/2010 K. Hoffman, etal:"PrivateDrinkingWaterWellsasaSourceofExposureto PFOA inCommunities Suirroundinga Fluoropolymer Production Facility",Environ Health Perspect.Article,epub date 10/4/2010 K.Hoffman, etal:"PrivateDrinkingWaterWellsasaSourceofExposureto PFOA inCommunities Suirroundinga Fluoropolymer Production Facility",Environ Health Perspect.Article,doi:10.1289/ehp.1002503, 10/4/2010 K.Hoffman, etal:"PrivateDrinkingWaterWellsasaSourceofExposureto PFOA inCommunities Suirroundinga Fluoropolymer Production Facility",Environ Health Perspect.Article,doi:10.1289/ehp.1002503, 10/4/2010 UC BerkleySeminarpresentationbyTony Fletcher:"PerfluorinatedCompounds PFOA and PFOS, Immune Markers and Age ofPuberty: Findingsfrom CrossSectionalAnalysesofan Exposed Populationinthe Mid-Ohio Valley;The BrianandJenniferMaxwell ChairSeminarSeriesinChildren'sEnvironmental Health Research", School ofPublic Health Article, 10/6/2010 CSAndersen, etal:"Prenatal Exposuresto PerfluorinatedChemicalsandAnthropometric Measures inInfancy", PubMed Abstract,Am. J.Epidemiol.epub 10/12/2010 CamillaSchou Andersen, etal:"Prenatal ExposurestoPerfluorinatedChemicalsandAnthropometric Measures in Infancy",AmericanJournalofEpidemiology,Vol.172, No. 11,doi:10.1093/aje/kwq289, 10/12/2010 CamillaSchou Andersen, etal:"Prenatal ExposurestoPerfluorinatedChemicalsandAnthropometric Measures in Infancy",AmericanJournalofEpidemiology,Vol.172, No. 11,doi:10.1093/aje/kwq289, 10/12/2010 10/15/2010 Emailfrom BilotttoC8 Science Panel regardingC8 Science PanelQuarterlyNewsletterOctober 2010 MA Kaiser,etal:"Understanding Potential ExposureSourcesofPerfluorinatedCarboxylicAcidsinthe Workplace", PubMed abstract,Ann. Occup. Hyg., Epub date 10/25/2010 Chunyuan Fei,etal:"Prenatal Exposureto PerfluorinatedChemicalsand BehavioralorCoordination Problemsat Age 7",Environmental Health Perspectives,doi:10.1289/ehp.1002026, 11/9/2010 Chunyuan Fei,etal:"Prenatal Exposureto PerfluorinatedChemicalsand BehavioralorCoordination Problemsat Age 7",Draft,Undated C-8SciencePanel: "StatusReport:AssociationofPerfluorinatedCompounds withAttention Deficit/Attention DeficitHyperactivityDisorderand LearningDisorderAmong ChildrenAged 5-18 Yearswith ElevatedCommunity Exposureto PFOA", 1/31/2011___________________________________________________ Maria-Jose Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate (PFOS)withAge ofPubertyamont Children LivingnearaChemical Plant",AbstractofArticle,11/17/2010 AbstractregardingAnimal StudiesSuggestthatPerfluorocarbons May AlterSexual Maturation, Undated News Release,"C8SciencePanel Reportson Half-Life,PregnancyOutcomes and Immune Markers", 11/29/2010 KimberlyB.Blake,etal:"AssociationsAmong Cardiometabolic RiskFactorClustering,Weight Status,and CardiovascularDiseaseinan Appalachian Population",TheJournalofClinicalHypertension,Vol.12,No. 12,doi: 10.1111/j.1751-7141.2010.00078.x, 12/2010__________________________________________ AbstractregardingComparison Between FreeSerum ThyroxiineLevels,12/15/2010 AbstractregardingAnimal StudiesHave Shown thatNegativeAssociations Between Serum LevelsofFree Thyroxineand PerfluorooctaneSulfonate, Undated Emma RaeGoosey: "Towards Understandingthe FateofPerfluoroalkylCompounds (PFCs)withinUrban Environments: ImplicationsforHuman Exposure",Abstract,2010 Page 146 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 242 of 277 PAGEID #: 61243 Descriptions of Documents Without Bates Numbers Boston UniversityDissertation/Thesisfrom ProQuestwebsite: JessicaWebb Nelson: "AnalyzingBiomonitoring SurveillanceData on Endocrine-DisruptingChemicalsforPopulation Exposure Patternsand HealthOutcomes", Abstract, 2010 Bio-Network.orgArticle"Exposureto PolyfluoroalkylChemicals During Pregnancy isNotAssociatedwith OffspringAge atMenarche inaContemporary BritishCohort", 2010 Edward A.Emmett, etal:"Community FirstCommunication: ReversingInformation DisparitiestoAchieve Environmental Justice", Environmental Justice,Vol. 3, Issue3,2010 ScottM. Bartell,etal:"DeclineofPerfluorooctanoicAcidinHuman Serum OverTwo Years Beforeand After GranularActivatedCarbon FiltrationinTwo PublicWater Supplies,and ImplicationsforHalf-LiveEstimation",C8 PanelAbstract, Undated RafaelGuerrero-Preston,etal:"Global DNA Hypomethylation isAssociatedwith inUtero ExposuretoCotinine and PerfluorinatedAlkylCompounds", ArticleEpigenetics,Vol.5,Issue6,doi:10.4161/epi.5.6.12378, Undated FardinOliaei,etal:"Updateon PFC Investigationand Health Risks",Report,2010 Hyeong-Moo Shin,etal:"Environmental Fateand Transport ModelingforPerfluorooctanoicAcid Emittedfrom theWashington Works FacilityinWest Virgina",EnvironmentalScience& TechnologyArticle,doi: 10.1021/es102769t, 1/2011_____________________________________________________ Chunyuan Fei,etal:"Prenatal Exposureto PFOA and PFOS and RiskofHospitalizationforinfectiousDiseasesin EarlyChildhood", Environmental ResearchArticle,2010 Marianne Kraugerud, etal,Norweigian SchoolofVet. Medicine: "PerfluorinatedCompounds DifferentiallyAffect Steroidogenesisinthe Human AdrenocorticalCarcinoma (H295R) inVitroCellAssay", Manuscript,Abstract, Undated KristaYoritaChristensen,etal:Env.International,"Exposuretopolyfluoroalkylchemicalsduringpregnancy isnot associatedwith offspringage atmenarche inacontemporary Britishcohort",doi:10.1016/j.envint.2010.08.007, 9/16/2010_______________________________________________________________ Kate Hoffman, etal:"PrivateDrinkingWaterWellsasaSourceofExposureto PerfluorooctanoicAcid(PFOA) in Communities SurroundingaFluoropolymer Production Facility",ArticleEnvironmental Health Perspectives,Vol. 119, No. 1,doi:10.1289/ehp.1002503, 1/2011_________________________________________ 1/18/2011 Emailfrom C8 Science PaneltoBilottregardingC8 SciencePanelQuarterlyNewsletterJanuary2011 KellynS.Betts:"A Measure ofCommunity Exposure: PFOA inWellWater CorrelateswithSerum Levels",Article ScienceSelections,doi:10.1289/ehp.119-a35a, 1/1/2011 Michele LaMerrill,PhD, MPH, etal:"ChildhoodObesityand Environmental Chemicals",ArticleinMount Sinai JournalofMedicine,doi:10.1002/msj.20229, 1/2011 EmilyChan, etal:"Perfluorinatedacidsand hypothyroxinemia inpregnantwomen", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_________________________________________________ Hyeong-Moo Shin,etal:"Environmental Fateand Transport ModelingforPerfluorooctanoicAcid Emittedfrom theWashington Works FacilityinWest Virgina",EnvironmentalScience& TechnologyArticle,doi: 10.1021/es102769t, 1/12/2011__________________________________________________ Abstractfrom FindAPhD.com website: "ExploitingChiralityto FurtherUnderstandingoftheContributionof PrecursorCompounds to Human Body Burdens ofPerfluorooctanesulfonate(PFOS)", 1/31/2011 From C-8SciencePanelwebsite: Summary oftheC8 SciencePanelStudies,QuarterlyReport, 1/2011 E.Chan, etal:"PerfluorinatedAcidsand Hypothyroxinemia inPregnantWomen", Env.Res.,ePub 2/8/2011 LSHaug, etal:"CharacterizationofHuman Exposure PathwaystoPerfluorinatedCompounds -Comparing Exposure Estimateswith BiomarkersofExposure", PubMed Article,Environ. Int.,2/17/2011 SSWhite, etal:"Endocrine DisruptingPropertiesofPerfluorooctanoicAcid",PubMed Article,J.SteroidBiochem. Mol. Biol.,,3/10/2011 Page 147 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 243 of 277 PAGEID #: 61244 Descriptions of Documents Without Bates Numbers SalleyS.White, etal:"Endocrine DisruptingPropertiesofPerfluorooctanoicAcid",Accepted Manuscriptto appearinJournalofSteroidBiochemistry& Molecular Biology,doi:10.1016/j.jsbmb.2011.03.11, 2010 A.Brieger,etal:"ImpactofPerfluorooctanesulfonateand PerfluorooctanoicAcidon Human Peripheral Leukocytes",Toxicology InVitroArticle,3/10/2011 Anne Brieger,etal:"ImpactofPerfluorooctanesulfonateand PerfluorooctanoicAcidon Human Peripheral Leukocytes",Accepted ManuscripttoAppear inToxicology InVitroArticle,3/7/2011 OutlineforConferenceofEnvironmental Epidemiology Professionals,Undated SSKnox,etal:"ImplicationsofEarlyMenopause inWomen Exposedto Perfluorocarbons",ClinEndocrinol Meta., Abstract,3/16/2011_________________________________________________________ SarahS.Knox,etal:"ImplicationsofEarlyMenopause inWomen Exposedto Perfluorocarbons",ArticleClinical Endocrinology& Metabolism, 3/16/2011 SarahS.Knox,etal:"ImplicationsofEarlyMenopause inWomen Exposedto Perfluorocarbons",ArticleClinical Endocrinology& Metabolism, doi:10.1210/jc.2010-2401, 3/16/2011 Tony Fletcher,PhD: "EpidemiologicalStudiesofPerfluorinatedCompounds -New Findingson Age ofPuberty", Slides,4/13/2011___________________________________________________________ Maria-Jose Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate (PFOS)withAge ofPubertyamong Children LivingnearaChemical Plant",Articlemanuscript, 11/17/2010 Abstractofdissertation/thesisfrom ProQuestwebsite: JessicaWebb Nelson: "AnalyzingBiomonitoring SurveillanceData on Endocrine-DisruptingChemicalsforPopulation Exposure Patternsand HealthOutcomes", 2010___________________________________________________________________ MJ Lopez-Espinosa,etal:"Comparison Between freeSerum Thyroxine Levels,Measured byAnalogand Dialysis Methods, inthe PresenceofPerfluorooctaneSulfonateand Perfluorooctanoate",AbstractReprodToxicol, 4/17/2011_______________________________________________________________ Maria-Jose Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate (PFOS)withAge ofPubertyamong Children LivingnearaChemical Plant",Environmental Science& Technology Article,doi:10.1021/es1038694, 5/2/2011___________________________________________ Maria-Jose Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate (PFOS)withAge ofPubertyamong Children LivingnearaChemical Plant",Environmental Science& Technology Article,doi:10.1021/es1038694, 5/2/2011___________________________________________ 5/9/2011 Emailfrom C8 SciencePanelto BilottregardingC8 Science PanelQuarterlyNewsletterMay 2011 IJWang, etal:"The EffectofPrenatal PerfluorinatedChemicals Exposureson PediatricAtopy", Environmental Research Abstract, 5/20/2011 IJWang, etal:"The EffectofPrenatal PerfluorinatedChemicals Exposureson PediatricAtopy", Environmental Research Article,doi: 10.1016/j.envres.2011.04.006, 5/20/2011 C8 SciencePanel Newsletter,5/18/2011 M. Kraugerub, etal:"PerfluorinatedCompounds DifferentiallyAffectSteroidogenesisand Viabilityinthe Human AndrenocorticalCarcinoma (H295R) inVitroCellAssay",Toxicol Lett.Abstract,5/27/2011 Cheryl R.Stein,etal:"Serum PerfluorinatedCompound Concentrationand Attention Deficit/Hyperactivity DisorderinChildrenAged 5to 18Years", Environmental Health PerspectivesArticle,doi:10.1289/ehp.1003538, 6/10/2011_______________________________________________________________ Posterabstract: Debapriya Mondal, etal:"TemporalTrends inPerfluoronate ExposureinA US Population Exposedto Raised LevelsofPFOA rough DrinkingWater", C8 SciencePanelSummary, 2004 T.Fletcher,etal:"PatternsofAge ofPurbertyinRelationtoExposureto PFOA and PFOSAmong Children Living an anArea with PFOA-Contaminated DrinkingWater", C8 SciencePanelAbstract,2004 Tony Fletcher,PhD: "EpidemiologyofPFOA and PFOS -New Findings",Slides,6/17/2011 Page 148 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 244 of 277 PAGEID #: 61245 Descriptions of Documents Without Bates Numbers Brooks B.Gump, etal:"Perfluorochemical (PFC) ExposureinChildren:Associationswith Impaired Response Inhibition",Environmental ScienceTechnologyArticle,6/17/2011 Brooks B.Gump, etal:"Perfluorochemical (PFC) ExposureinChildren:Associationswith Impaired Response Inhibition",Environmental ScienceTechnology,American Chemical SocietyArticle,doi:10.1021/es103712g, 2011__________________________________________________________________ DavidA.Savitz,"PFOA Contamination inthe Mid-OhioValleyand ReproductiveOutcomes", C8 Science Panel Slides,6/17/2011__________________________________________________________ JuliaGreen Brody,etal:"TestingChemicalsforEffectson BreastDevelopment,Lactation,and Cancer", Environmental Health Perspect.,doi:10.1289/ehp.1104077, 6/22/2011 Ruthann A.Rudel,etal:"Environmental Exposureand Mammary Gland Development: StateoftheScience, PublicHealth Implications,and Research Recommendations", Abstract,doi:101289, ehp.1002864, 6/22/2011 Ruthann A.Rudel,etal:"Environmental Exposureand Mammary Gland Development: StateoftheScience, PublicHealth Implications,and Research Recommendations", Environmental Health Perspectives,doi:101289, ehp.1002864, 6/22/2011______________________________________________________ Kim E.Innes,etal:"AssociationofOsteoarthritisWith Serum Levelsofthe Environmental Contaminants Perfluorooctanoateand PerfluorooctaneSulfonateinaLargeAppalachian Population",AmericanJournalof Epidemiology,doi:10.1093/aje/kwr107, 6/27/2011 James H.Raymer, etal:"ConcentrationsofPerfluorooctaneSulfonate(PFOS)and Perfluorooctanoate(PFOA) andTheirAssociationswith Human Semen QualityMeasurements", ReproductiveToxicologyArticle,doi: 10.1016/j.reprotox.2011.05.24, 5/30/2011___________________________________________ Listofsymposium presentationsre: "Prenatal ExposuretoPOPs andAge ofPuberty," Undated Listofsymposium presentationsre:"New Healthand Exposure Findingsfrom aLargeUS Population Exposedto High LevelsofPFOA, Undated The C8 SciencePanelStatusReport"The MortalityofDuPontWorkers inRelationtoExposureto PFOA (C8), 7/15/2011_______________________________________________________________ The C8 SciencePanelStatusReport"Serum PFOA and LiverFunction Markers inthe BloodofAdultsinthe MidOhio Valley", 7/15/2011______________________________________________________ The C8 SciencePanelstatusReport"PFOA (C8)Exposureand PregnancyOutcome Among ParticipantsintheC8 Health Project",7/15/2011____________________________________________________ StipulationRegardingSciencePanelStatusReports, Leachv.E.I.DuPont De Nemours and Company, 7/19/2011 News Release,"C8SciencePanelSubmitsThree ReportstoCourt",7/19/2011 BrentD.Kerger,etal:"Tenuous Dose-Response CorrelationsforCommon DiseaseStates:CaseStudyof Cholesteroland Perfluorooctanoate/Sulfonate(PFOA/PFOS) intheC8 Health Project",Drugand Chemical Toxicology,doi:10.3109/01480545.2011.582502, 2011___________________________________ JuliaGreen Brody,etal:"TestingChemicalsforEffectson BreastDevelopment, Lactation,and Cancer", Environmental Health Perspective,doi:10.1289/ehp.1104077, 8/1/2011 SSKnox,etal:"Perfluorocarbon Exposure,Gender andThyroid FunctionintheC8 Health Project",Abstract, ToxicolSci.,2011 Sunmi Kim,etal:"Trans-PlacentalTransferofThirteen PerfluorinatedCompounds and Relationswith Fetal Thyroid Hormones", Environmental Science& Technology,American Chemical Society,doi:10.1021/ex202408a 8/1/2011_______________________________________________________________ SarahS.Knox,etal:"Perfluorocarbonexposure,genderandthyroidfunctionintheC8 Health Project",Article TheJournalofToxicologySciences,Vol.36,No.4,403-410, 2011 K.W.Weirecht, etal:"Acute RespiratoryDistressAssociatedwith Inhaled Hydrocarbon",ArticleAm JIndMed, doi:10.1002/ajim.20989, 7/27/2011 Page 149 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 245 of 277 PAGEID #: 61246 Descriptions of Documents Without Bates Numbers Sunmi Kim,etal:"Trans-PlacentalTransferofThirteen PerfluorinatedCompounds and Relationswith Fetal Thyroid Hormones", Environmental Science& Technology, Manuscript,8/2/2011 8/12/2011 Emailfrom C8 Science PaneltoBilottregardingC8 SciencePanelQuarterlyNewsletterAugust 2011 The C8 SciencePanelStatusReport"Serum PFOA and LiverFunction Markers inthe BloodofAdultsinthe MidOhio Valley", 8/11/2011_______________________________________________________ The C8 SciencePanelStatusReport"Serum PFOA and LiverFunction Markers inthe BloodofAdultsinthe MidOhio Valley", 8/11/2011_______________________________________________________ A.Shankar,etal:"PerfluoroalkylChemicalsand Chronic KidneyDiseaseinUSAdults", PubMed abstract, AmericanJournal Epidemiology,8/26/2011 A.Shankar,etal:"PerfluoroalkylChemicalsand Chronic KidneyDiseaseinUSAdults",ArticleAmericanJournal Epidemiology,doi:10.1093/aje/kwr171, 8/26/2011 Natasha D.Henry,etal:"Comparison ofinVitroCytotoxicity,EstrogenicityandAnti-EstrogenicityofTriclosan, PerfluorooctaneSulfonateand PerfluorooctanoicAcid",Article,JournalofAppliedToxicology,doi: 10.1002/jat.1736, 8/8/2011____________________________________________________ USEPA web page: Extramural Research, "PFOA Concentration inSerum Collected1991-2008 and Related Health Effects", 12/16/2011_________________________________________________________ The C8 SciencePanelQuarterlyReportregardingDataAssembled, 9/2011 KyleSteenland,etal:"Cohort MortalityStudyofWorkers Exposedto PFOA", Slides,9/14/2011 The InternationalSocietyforEnvironmental EpidemiologyResearchArticle: Abstractsofthe23rdAnnual Conference ofthe InternationalSocietyofEnvironmental Epidemiology(ISEE),9/13/2011, Barcelona,Spain List: The InternationalSocietyforEnvironmental EpidemiologyResearch Symposia, 8/23/2011 K.B.Gutzkow, etal:"PlacentalTransferofPerfluorinatedCompounds isSelective-A Norwegian Mother and ChildSub-CohortStudy",AbstractIntJHyg Environ Health,9/19/2011 N.D. Henry,etal:"Comparison ofinVitroCytotoxicity,Estrogenicityand Anti-EstrogenicityofTriclosan, PerfluorooctaneSulfonateand PerfluorooctanoicAcid",ArticleJournalAppliedToxicology,doi: 10.1002/jat.1736, 9/21/2011____________________________________________________ StatusReport:C8 (PFOA) Exposureand PregnancyOutcome Based on Ohio andWest VirginiaBirthRecordsand LinkagetoC8 Health ProjectParticipants,9/23/2011 Amir Miodovnik, MD: "Environmental Neurotoxicantsand Developing Brain",Mount SinaiJournalofMedicine 78:58-77,doi:10.1002/msj.20237, 2011_____________________________________________ MJ Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate(PFOS) withAge ofPubertyAmong Children LivingNearaChemical Plant",EnvironSciTechnol.,Abstract, 10/1/2011 BB Gump, etal:"Perfluorochemical (PFC) ExposureinChildren:Associationswith Impaired Response Inhibition", AbstractEnvironSciTechnol, 10/1/2011 EC Bonefeld-Jorgensen,etal:"PerfluorinatedCompounds Are Relatedto BreastCancer RiskinGreenlandic Inuit: A Case ControlStudy",AbstractEnviron Health, 10/6/2011 EvaC.Bonefeld-Jorgensen,etal:"PerfluorinatedCompounds Are Relatedto BreastCancer RiskinGreenlandic Inuit:A CaseControlStudy", Environmental Health,doi:10.1186/1476-069X-10-88, 10/6/2011 Anoop Shankar,etal:"PerfluoroalkylChemicalsand ElevatedSerum UricAcidinUSAdults",Clinical Epidemiology, Dove Press,3 251-258, 2011 E.Okada, etal:"Prenatal Exposureto PerfluorinatedChemicalsand RelationshipwithAllergiesand Infectious DiseasesinInfants",PubMed AbstractEnviron Res.,10/24/2011 Emiko Okada, etal:"Prenatal Exposureto PerfluorinatedChemicalsand RelationshipwithAllergiesand InfectiousDiseasesinInfants",ArticleEnvironmental Research,doi:10.1016/j.envres.2011.10.003, 10/24/2011 Page 150 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 246 of 277 PAGEID #: 61247 Descriptions of Documents Without Bates Numbers JenniferFranko,etal:"Dermal Penetration PotentialofPerfluorooctanoicAcid (PFOA) inHuman and Mouse Skin",PubMed Abstract,J.Toxicol.Environ. Health doi:10.1080/15287394.2011.615108, 2012___________ Chien-Yu Lin,etal:"AssociationsBetween LevelsofSerum PerfluorinatedChemicalsand Adiponectin inaYoung HypertensionCohort inTaiwan", Environ.Sci.Technol., dx.doi.org/10.1021/es201964x, 11/2/2011 JenniferFranko,etal:"Dermal Penetration PotentialofPerfluorooctanoicAcid (PFOA) inHuman and Mouse Skin",JournalofToxicologyand Environmental Health, PartA.75:50-62,doi:10.1080/15287394.2011.615108, 2011___________________________________________________________________ CynthiaJ.Wolf,etal:"ActivationofMouse and Human Peroxisome Proliferator-Activated Receptor-Alpha (PPARa) byPerfluoroalkylAcids(PFAAs): FurtherInvestigationofC4-C12 Compounds", AbstractReproductive Toxicology,doi:10.1016/reprotox.2011.09.009, 11/15/2011_________________________________ J. E.Klaunig,etal:"Mode ofActionAnalysisofPerfluorooctanoicAcid(PFOA)Tumorigenicityand Human Relevance", Abstract Reprod Toxicol., 11/22/2011 JamieC.DeWitt,etal:"ImmunotoxicityofPerfluorinatedCompounds: Recent Developments",Article ToxicologicPathology,doi:10.1177/0192623311428473, 2011_______________________________ K. J.Silk,etal:"Investigatingthe ImpactofMessage Format, Involvement, ScientificLiteracy,and Education on AttitudeToward ReducingCancer RiskThrough Regulation",AbstractJournalCancer Educ.,11/29/2011 Jamie DeWittofEastCarolina University: ReportpreparedforU.S.Army: FinalReport"Immunopathogenesis in Autism: RegulatoryT-Cellsand Autoimmunity inNeurodevelopement", 12/2011 InstituteofMedicine Report Brief,"BreastCancerandThe Environment,A LifeCourseApproach", 12/2011 InstituteofMedicine PrepublicationCopy: Uncorrected Proofs,"BreastCancerandThe Environment,A Life CourseApproach", 2012 The C8 SciencePanelStatusReport"PFOA andAdultThyroid Diseaseinthe Mid-OhioValley",12/5/2011 C8 SciencePanel Reportsand Findings,"Probable LinkFindings,Pregnancy Induced Hypertension", 12/5/2011 C8 SciencePanel Reportsand Findings,"Probable LinkFindings,Pregnancy Induced Hypertension",Slides, 12/5/2011_______________________________________________________________ 12/5/2011 Letterfrom CliffordF.Kinney,Jr.,toCaroleJones,ClerkWood CountyCircuitCourt,regardingLeach, etalv.E.I.Du Pointde Nemours and Company, CivilAction No.01-C-608,enclosingStipulationRegarding Science PanelStatusReports The C8 SciencePanelStatusReport"Changes inSerum PFOA/PFOS and Serum LipidsBetween 2005 and 2010 in the Mid-OhioValley,12/5/2011__________________________________________________ The C8 SciencePanelStatusReport"PFOA andAdultThyroid Diseaseinthe Mid-OhioValley",12/5/2011 The C8 SciencePanelStatusReport"ProspectiveStudyofReproductive HealthOutcomes inthe Mid-OhioValley, 12/5/2011_______________________________________________________________ ArticlebyJuliaBrodyOfSilentSpringInstitute:"Opinion: News StoriesMiss Important PointsofBreastCancer Report", Environmental Health News, 12/13/2011 InstituteofMedicine Report: "BreastCancerandThe Environment,A LifeCourseApproach", 12/13/2010 C.LaRocca,etal:"Exposureand EffectiveDose BiomarkersforPerfluorooctaneSulfonicAcid(PFOS)and PerfluorooctanoicAcid (PFOA) inInfertileSubjects: PreliminaryResultsofthe PrevieniProject",AbstractIntJHyg Environ Health, 12/23/2011 U.C.Nygaard, etal:"PerfluorinatedCompounds and Immune HealthOutcomes in3-year-oldChildren", Division ofEnvironmental Medicine, Norwegian InstituteofPublicHealth,Abstract,2012 James E.Klaunig,etal:"Mode ofActionAnalysisofPerfluorooctanoicAcid(PFOA)Tumorigenicityand Human Relevance",ArticleReproductiveToxicology,doi:10.1016/j.reprotox.2011.10.14, 10/2011 Page 151 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 247 of 277 PAGEID #: 61248 Descriptions of Documents Without Bates Numbers CynthiaJ.Wolf,etal:"ActivationofMouse and Human Peroxisome Proliferator-Activated Receptor-Alpha (PPARa) byPerfluoroalkylAcids(PFAAs): FurtherInvestigationofC4-C12 Compounds", ArticleReproductive Toxicology,doi:10.1016/reprotox.2011.09.009, 9/2011 Chien-Yu Lin,etal:"AssociationsBetween LevelsofSerum PerfluorinatedChemicalsand Adiponectin inaYoung HypertensionCohort inTaiwan",American Chemical Society,dx.doi.org/10.1021/es201964x, 11/2/2011 EmilyChan, etal:"Perfluorinatedacidsand hypothyroxinemia inpregnantwomen", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_________________________________________________ IanT.Cousins,etal:Lettertothe Editorregarding,"PolyfluorinatedCompounds: Past,Present,and Future", American Chemical SocietyArticle,10/28/2011 USEPA web page: Extramural Research: 'SusanM. Pinney,etal:USEPA Extramural Research 2011 Progress Report: PFOA Concentration inSerum Collected 1991-2008and Related Health Effects,8/22/2011 MJ Lopez-Espinosa,etal:"Thyroid Function, PFOA and PFOS inChildren LivingNearaChemical Plant",C8 Science Panel FactSheet, Undated Marlene Boas,etal:"Thyroid EffectsofEndocrine DisruptingChemicals", Molecularand CellularEndocrinology Article,doi:10.1016/j.mce.2011.09.005, 9/10/2011______________________________________ QixiaoJiang,etal:"PerflurooctanoicAcid Induces Development CardiotxicityinChicken Embryos and Hatchlings",ToxicologyArticle,doi:10.1016/j.tox.2012.01.005, 1/18/2012 PhilippeGrandjean, etal:"Serum VaccineAntibodyConcentrations inChildren Exposedto Perfluorinated Compounds", JAMA, Vol.307, No.4,1/25/2012________________________________________ PhilippeGrandjean, etal:"PFCs:CountlessApplications, New Health Risks",JAMA, Vol.307, pgs.291-7, 1/24/2012_______________________________________________________________ Anne Sleeuwenhoek, etal:"ExposureAssessmentofTetrafluoroethyleneand Ammonium Perfluorooctanoic Acid 1951-2002,JournalofEnvironmental Monitoring,doi:10.1039/C2EM10930A, 1/27/2012 ValentinaGallo,etal:"Serum Perfluorooctanoate (PFOA)and PerfluorooctaneSulfonate(PFOS)Concentrations and LiverFunction Biomarkers inaPopulationwith Elevated PFOA Exposure",AbstractResearchArticle, 1/30/2012_______________________________________________________________ ValentinaGallo,etal:"Serum Perfluorooctanoate (PFOA)and PerfluorooctaneSulfonate(PFOS)Concentrations and LiverFunction Biomarkers inaPopulationwith Elevated PFOA Exposure",ArticleEnvironmental Health Perspectives,doi:10.1289/eph.1104436, 1/30/2012______________________________________ PhilippeGrandjean, etal:"Serum VaccineAntibodyConcentrations inChildren Exposedto Perfluorinated Compounds", JAMA Abstract,doi:10.1001.jamia.2011.2034, 2011 S. Peng,etal:"HepatotoxicityofPerfluorooctanoicAcid inHuman Hepatocytes UsingMetabolomics", Se Pu Feb. 30(2):123-7, PubMed Abstract,2/2012______________________________________________ ThorhallurI.Halldorsson,etal:"Prenatal Exposureto Perfluorooctanoateand RiskofOverweightat20Yearsof Age:A ProspectiveCohortStudy", National InstituteofEnvironmental HealthSciences, dx.doi.org/10.1289/ehp.1104034, 2/3/2012___________________________________________ Slides"Non-MalignantThyroid DiseaseStatusReport",C-8Science Panel,Undated ScottM. Bartell:"BiasinHalf-LifeEstimatesUsingLogConcentration Regression inthe PresenceofBackground Exposures,and PotentialSolutions",JournalofExposureScienceand Environmental Epidemiology,doi: 10.1038/jes.2012.2, 2/15/2012___________________________________________________ DavidA.Savitz,etal:"PerfluorooctanoicAcid Exposureand PregnancyOutcome inaHighlyExposed Community", EpidemiologyArticle,doi:10.1097/EDE.0b013e31824cb93b, 2/24/2012 Chunyuan Fei,etal:"Commentary: PerfluorinatedChemicalsandTimetoPregnancy:A LinkBased on Reverse Causation?, EpidemiologyArticle,Vol.23,Issue2,p264-266, doi:10.1097/EDE.0b013e3182467608, 3/2012 Page 152 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 248 of 277 PAGEID #: 61249 Descriptions of Documents Without Bates Numbers KristinaW. Whitworth, etal:"PerfluorinatedCompounds and SubfecundityinPregnantWomen", Epidemiology Article,Volume 23,Number 2,doi:10.1097/EDE.0b013e31823b5031, 3/2012______________________ The C8 SciencePanelQuarterlyReportJantoMar 2012 regardingSufficientResultstoStartthe FirstofaSeries ofProbable LinkDeterminations 7thSpace InteractiveArticle"SocialDisparitiesinExposuresto BisphenolA and PolyfluoroalkylChemicals;A Cross-SectionalStudyWithin NHANES 2003-2006" Env. Health 2012 11:10, 3/6/2012_________________ JessicaW. Nelson etal:"SocialDisparitiesinExposuresto BisphenolA and PolyfluoroalkylChemicals;A Cross SectionalStudyWithin NHANES 2003-2006", Environmental HealthArticle,doi:10.1086/1476-069X-11-10 03.06.12________________________________________________________________ Morten SondergaardJensen,etal:"Phthalatesand PerfluorooctanesulfonicAcid inHuman Amniotic Fluid: TemporalTrends andTimingofAmniocentesis inPregnancy",AbstractArticle,Environmental Health Perspective,doi:10.1289/ehp.1104522, 3/7/2012_______________________________________ ChristopherLau:"PerfluoroalkylAcids:Recent Research Highlights",ReproductiveToxicology,doi: 10.1016/j.reprotox.2012.03.002, 3/9/2012___________________________________________ QixiaoJiang,etal:"PerflurooctanoicAcid Induces Development CardiotxicityinChicken Embryos and Hatchlings",ToxicologyAbstract,, doi: 10.1016/j.tox.2012.01.005, 3/11/2012 Laura n.Vandenberg, etal:"Hormones and Endocrine-DisruptingChemicals: Low-Dose Effectsand Nonmonotoic Dose Responses",The EndocrineSociety,doi:10.1210/er.2011, 6/2012 IOSpecht,etal:"Sperm DNA IntegrityinRelationtoExposureto Environmental PerfluoroalkylSubstances-A StudyofSpouses ofPregnantWomen inThree Geographical Regions", ReprodToxicologyAbstract,ePub 3/15/2012_______________________________________________________________ Maria-Jose Lopez-Espinosa,etal:"Thyroid Functionand PerfluoroalkylAcidsinChildren LivingNearaChemical Plant",Environmental Health Perspectives,dx.doi.org/10.1289/ehp.1104370, 3/27/2012 Michael Bloom, etal:"Exposureto PersistentOrganohalogen PollutantsisAssociatedwithThyroid Function Among OlderResidentsofUpper Hudson RiverCommunities", ISEEAbstract#:S-042,2012 C.Lau:"PerfluoroalkylAcids:Recent Research Highlights",ReproToxicology,doi: 10.1016/j.reprotox.2012.03.002, 2012______________________________________________ LindaS.Birnbaum: "Environmental Chemicals: EvaluatingLow-Dose Effects",Environmental Health Perspectives, Vol.120, No.4,doi:10.1289/ehp.1205179, 4/2012______________________________________ D. J.Ehresman, etal:"A LongitudinalOccupationalAssessment ofthe PotentialAssociationofChanges Between Serum ConcentrationsofPerfluorooctanoateand Perfluorooctanesulfonateand Non High-Denisity-Lipoprotein Cholesterol", PosterBoardAbstract, Undated J.L.Butenhoff,etal:"Perfluorooctanoate, Perfluorooctanesulfonate,and Chronic Kidney Disease:Clearance Comes BeforeCausation", PosterBoard Abstract, Undated U.C.Nygaard, etal:"PerfluorinatedCompounds and Immune HealthOutcomes in3-year-oldChildren", Division ofEnvironmental Medicine, Norwegian InstituteofPublicHealth, Presentation Poster,,2012 The C8 SciencePanel Report"Probable LinkEvaluationofDiabetes,4/13/2012 The C8 SciencePanel Report"Probable LinkEvaluationofCancer,4/15/2012 The C8 SciencePanel PressRelease"C8SciencePanelAnnounces Probable LinksBetween C8 andTesticular, KidneyCancers",4/16/2012 The C8 SciencePanel PressRelease"C8SciencePanelAnnounces Probable LinksBetween C8 andTesticular, KidneyCancers",4/16/2012 The C8 SciencePanel PressRelease"C8SciencePanelAnnounces Probable LinksBetween C8 andTesticular, Kidney Cancers", Slides, Undated Page 153 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 249 of 277 PAGEID #: 61250 Descriptions of Documents Without Bates Numbers K.W.Whitworth, etal:"PerfluorinatedCompounds inRelationto BirthWeight inthe Norwegian Motherand ChildCohortStudy",AmericanJournal EpidemiologyAbstract,4/19/2012 Susan R.Woskle, etal:"Retrospective ExposureAssessmentofPerfluorooctanoicAcidSerum Concentrationsat aFluoropolymerManufacturing Plant,AnnalsofOccupational HygieneArticle,doi:10.1093/annhyg/mes023, 4/26/2012_______________________________________________________________ S.R.Woskie, etal:"Retrospective ExposureAssessment ofPerfluorooctanoicAcidSerum Concentrationsata Fluoropolymer Manufacturing Plant,AnnalsofOccupational HygieneArticle,doi:10.1093/annhyg/mes023, 4/26/2012_______________________________________________________________ Susan R.Woskle, etal:"Retrospective ExposureAssessmentofPerfluorooctanoicAcidSerum Concentrationsat aFluoropolymerManufacturing Plant,AnnalsofOccupational HygieneArticle,doi:10.1093/annhyg/mes023, 4/26/2012_______________________________________________________________ Tony Fletcher,etal:The C8 SciencePanel "Endocrine EffectsofPerfluoroalkylAcids-DelayinPubertyinRelation to PFOA and PFOS", Slides,Undated DavidA.Savitz,etal:"PerfluorooctanoicAcid Exposureand PregnancyOutcome inaHighlyExposed Community", EpidemiologyArticle,doi:10.1097/EDE.0b013e31824cb93b, 2/24/2012 ValentiaGallo,etal:"Serum Perfluoroocatanoate (PFOA)and PerfluorooctaneSulfonate(PFOS)Concentrations and LiverFunction Biomarkers inaPopulationwith Elevated PFOA Exposure", Environmental Health Perspectives Abstract,ePub 5/25/2012 LarryR.Zobel, MD, MPH, etal:"PerfluorinatedCompounds and ImmunotoxicityinChildren",ArticleJAMA, Vol. 307, No. 18,5/9/2012________________________________________________________ LarryR.Zobel, MD, MPH, etal:"PerfluorinatedCompounds and ImmunotoxicityinChildren",ArticleJAMA, Vol. 307, No. 18,5/9/2012________________________________________________________ K.Ji,etal:"Serum ConcentrationsofMajor PerfluorinatedCompounds Among theGeral Population inKorea: DietarySourcesand PotentialimpactonThyroid Hormones", Environ Int.Abstract,5/9/2012 K.Ji,etal:"Serum ConcentrationsofMajor PerfluorinatedCompounds Among theGeral Population inKorea: DietarySourcesand PotentialimpactonThyroid Hormones", Environment InternationalArticle,doi: 10.1016/j.envint.2012.03.007 5/9/2012_____________________________________________ E. Scharmach, etal:"PerfluorooctanoicAcidAffectstheActivityofthe Hepatocyte Nuclear Factor4Alpha (NHF4a)",Toxicol LettAbstract,5/15/2012____________________________________________ E.Scharmach, etal:"PerfluorooctanoicAcidAffectstheActivityofthe Hepatocyte Nuclear Factor4Alpha (NHF4a)", Toxicology LettersArticle,5/15/2012 Omayma Alshaarawy, etal:"PerfluoralkylChemicalsand PrediabetesinUS Adults",SocietyforEpidemiologic ResearchAbstract#:197-Sforpresentation, Undated G.Toft,etal:"ExposuretoPerfluorinatedCompounds and Human Semen QualityinArcticand European Populations", Hum Reprod Abstract,ePub 5/30/2012 Jin-YoungMin,etal:"PerfluorooctanoicAcid Exposure isAssociatedwith Elevated Homocysteine and Hypertension inUSAdults",Occup. Environ. Med., doi:10.1136/oemed-2011-100288, 5/31/2012 Jin-YoungMin,etal:"PerfluorooctanoicAcid Exposure isAssociatedwith Elevated Homocysteine and Hypertension inUSAdults",Occup. Environ. Med..,doi:10.1136/oemed-2011-100288, 5/31/2012 M. Song,etal:"Changes inThyroid PeroxidaseActivityinResponsetoVariousChemicals",Journalof Environmental MonitoringAbstract,6/15/2012 M. Song,etal:"Changes inThyroid PeroxidaseActivityinResponsetoVariousChemicals",Journalof Environmental MonitoringArticle,doi:10.1039/c2em30106g, 6/15/2012 The C8 SciencePanel Report"Infections,Obesityand ClinicalMarkers inChildreninRelationtoPFOA Serum LevelDuring Pregnancy inMothers inthe Mid-OhioValley",5/10/2012 Page 154 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 250 of 277 PAGEID #: 61251 Descriptions of Documents Without Bates Numbers Germain Luis,etal:"PersistentEnvironmental Pollutantsand Couple Fecundity, LifeStudy,2005-2009", ISEE Abstract#:O-054, 2012_______________________________________________________ Vaughn Barry,etal:"BreastCancer IncidenceAmong Women withSubstantial PFOA Exposure", ISEEAbstract#: O-062, 2012______________________________________________________________ Andrea Winquist,etal:"Association Between Cumulative PFOA ExposureandThyroid DiseaseinCommunity and Worker Cohorts", ISEEAbstract#: O-063, Undated Tony Fletcher,etal:"LongitudinalChanges inBiomarkersinRelationto DecliningTrends inPFOA and PFOS in Adultsinthe Mid-OhioValley",ISEEAbstract#:O-064, Undated KyleSteenland,etal:"CancerIncidenceinaPopulationwithSubstantial PFOA Exposure", ISEEAbstract#:O065, Undated VeronicaVieira,etal:"Geographic PatternsofCancer inaCommunity SurroundingaTeflon-Manufacturing Facility",ISEEAbstract#:O-066, Undated Conny Karnes,etal:"DiabetesIncidenceinaCohortwith Substantial Exposureto PFOA", ISEE Abstract#:O-098, Undated Lyndsey Darrow, etal:"Serum PerfluorooctanoicAcidConcentrationsand PregnancyOutcome inthe Mid-Ohio Valley,2005-2010", ISEEAbstract#:O-099, Undated_____________________________________ Rosana HernandezWeldon, etal:"InUtero Exposureto PFOA: AssociationswithClinicalMarkers, BMI and MetabolicSyndrome inChildren Born inthe Mid-OhioValley",ISEEAbstract#:O-101, Undated Tony Fletcher,etal:"InfectiousDisease RiskinChildrenand InUtero ExposureofChildrento PFAAs inthe MidOhioValley",ISEEAbstract#:O-102, Undated Chien-Yu Lin,etal:"The RoleofGene Polymorphisms asModifiersofthe EffectofPerfluorinatedChemicalson Carotid Intima-MediaThickness", ISEE Abstract#: P-207, Undated Pau-ChungChen: "Introductionand FindingsoftheTaiwan BirthPanelstudy(TBPS)on Children'sEnvironmental Health", ISEEAbstract#:S-015, Undated Michael Bloom, etal:"Exposureto PersistentOrganohalogen PollutantsisAssociatedwithThyroid Function Among OlderResidentsofUpper Hudson RiverCommunities", ISEEAbstract#:S-042,2012 KushengWu, etal:"AssociationBetween Maternal ExposuretoPerfluorooctanoicAcid (PFOA)from Electronic Waste Recyclingand Neonatal HealthOutcomes", Environmental International,Vol.48,pgs 1-8,doi: 10.1016/j.envint.2012.06.018, 11/1/2012____________________________________________ KushengWu, etal:"AssociationBetween Maternal ExposuretoPerfluorooctanoicAcid (PFOA)from Electronic Waste Recyclingand Neonatal HealthOutcomes", Environmental International,Vol.48,pgs 1-8,doi: 10.1016/j.envint.2012.06.018, 11/1/2012____________________________________________ The C8 SciencePanelStatusReport"ExposuretoPerfluoroalkylAcidsand MarkersofKidneyFunctioninChildren and Adolescents", 7/25/2012 The C8 SciencePanel PressRelease"Exposureto PerfluoroalkylAcidsand Markers ofKidney Function inChildren and Adolescents", 7/30/2012 The C8 SciencePanel PressRelease"C8SciencePanelAnnounces Probable LinksBetween C8 and Ulcerative Colitis,Thyroid Disease",7/30/2012 The C8 SciencePanel Report"Probable LinkEvaluationofInfectiousDisease",7/30/2012 The C8 SciencePanel Report"Probable LinkEvaluationofStroke",7/30/2012 The C8 SciencePanel Report"Probable LinkEvaluationforNon-InfectiousLung DiseaseAsthma and Chronic Obstructive Pulmonary Disease-COPD", 7/30/2012 The C8 SciencePanel Report"Probable LinkEvaluationforNeurodevelopmental DisordersinChildren", 7/30/2012_______________________________________________________________ The C8 SciencePanel Report"Probable LinkEvaluationofAutoimmune Disease",7/30/2012 Page 155 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 251 of 277 PAGEID #: 61252 Descriptions of Documents Without Bates Numbers The C8 SciencePanel Report"Probable LinkEvaluationofThyroid Disease",7/30/2012 GearyW. Olsen,etal:"LongitudinalAssessmentofLipidand HepaticClinicalParameters inWorkers Involved withthe DemolitionofPerfluoroalkyl Manufacturing Facilities",JOEM, Vol.54,NO. 8,doi: 10.1097/JOM.0b013e31825461d2, 8/2012___________________________________________ Tony Fletcher,etal:"AssociationsBetween PFOA orPFOS and Changes inthe ExpressionofGenes Involvedin Cholesterol Metabolism inHumans", C8 SciencePanelAbstract,8/2012 JianscheWang, etal:"AssociationofPerfluorooctanoicAcidwith HDL Cholesteroland CirculatingmiR-26band miR-199-3p inWorkers ofaFluorochemical Plantand Nearby Residents", Environmental Science& Technology, American Chemical SocietyArticle,doi:10.1021/es300906q, 8/3/2012 M.H. Chen, etal:"PerfluorinatedCompounds inUmbilicalCord Bloodand Adverse BirthOutcomes", PLoSOne Abstract,2012, 7(8),e42474, 8/3/2012______________________________________________ JianscheWang, etal:"AssociationofPerfluorooctanoicAcidwith HDL Cholesteroland CirculatingmiR-26band miR-199-3p inWorkers ofaFluorochemical Plantand Nearby Residents", Environmental Science& Technology, American Chemical SocietyArticle,doi:10.1021/es300906q, 8/3/2012 Andrea Winquist,etal:"Association Between Cumulative PFOA ExposureandThyroid DiseaseinCommunity and Worker Cohorts",forISEEconference presentation,Abstract#:O-063, Undated Vaughn Barry,etal:"BreastCancer IncidenceAmong Women withSubstantial PFOA Exposure", Epidemiology, Vol.23,Issue5X,doi:10.1097/01.ede.0000416720.72173.c5, 8/26/2012_________________________ Vaughn Barry,etal:"BreastCancer IncidenceAmong Women withSubstantial PFOA Exposure", Epidemiology, Vol.23,Issue5X,doi:10.1097/01.ede.0000416720.72173.c5, 8/26/2012_________________________ VeronicaVieira,etal:"Geographic PatternsofCancer inaCommunity SurroundingaTeflon-Manufacturing Facility",Epidemiology,Vol.23,Issue5X,doi:10.1097/o1.ede.0000416724.95044.6d, 9/2012____________ Conny Karnes,etal:"DiabetesIncidenceinaCohortwith Substantial Exposureto PFOA", Epidemiology,Vol.23, Issue5S,doi:10.1097/01.ede.0000416756.49234.82, 9/2012________________________________ Lyndsey Darrow, etal:"Serum PerfluorooctanoicAcidConcentrationsand PregnancyOutcome inthe Mid-Ohio Valley,2005-2010", Epidemiology,Vol.23,Issue5S,doi:10.1097/01.ede.0000416757.49234.cb, 9/2012_____ Cheryl R.Stein,etal:"Perfluorooctanoate Exposureand Neurobehavioral Development inChildrenAged 6-12", Epidemiology,Vol.23,Issue5S,doi:10.1097/01.ede.0000416758.26363.d3, 9/2012__________________ Rosana HernandezWeldon, etal:"InUtero Exposureto PFOA: AssociationswithClinicalMarkers, BMI and MetabolicSyndrome inChildren Born inthe Mid-OhioValley",Epidemiology,Vol.23,Issue5S,doi: 10.1097/01.ede.0000416759.33987.6e, 9/2012________________________________________ Tony Fletcher,etal:"InfectiousDisease RiskinChildrenand InUtero ExposureofChildrento PFAAs inthe MidOhioValley",Epidemiology,Vol.23,Issue5S,doi:10.1097/01.ede.0000416760.33987.e3, 9/2012_________ KristaChristensen,etal:"Method toAssess MultipleClassesofEnvironmental Chemicalsand LiverDisease: NHANES 2003-2006, Epidemiology,Vol.23,Issue5S,doi:10.1097/01.ede.0000416890.04536.cf, 9/2012_____ DeborahJ.Watkins, etal:"Serum PerfluorooctanoicAcid (PFOA) and MarkersofKidneyFunction:Are Both Affected byKidneyDiseaseorby PFOA Exposure?", EpidemiologyArticle,Vol.23,Issue5S,doi: 10.1097/01.ede.0000416930.17998.31, 9/2012________________________________________ SanjayBeesoon, etal:HighSerum LevelsofPFHxS InA Canadian FamilyLinkedto MultipleScotchgard Applications-A CaseStudy, EpidemiologyArticle,Vol.23,Issue5S,doi:10.1097/01.ede.0000417067.13465.05, 9/2012_________________________________________________________________ Tony Fletcher:"Potential BiasinStudiesofBiomarkersfrom DrinkingWater Contaminants, EpidemiologyArticle, Vol.23,Issue5S,doi:10.1097/01.ede.0000416933.63739.5e, 9/2012 Page 156 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 252 of 277 PAGEID #: 61253 Descriptions of Documents Without Bates Numbers Tony Fletcher:"LongitudinalChanges inBiomarkers inRelationto DecliningTrends inPFOA and PFOS inAdultsin the Mid-OhioValley",EpidemiologyArticle,Vol.23,Issue5S,doi:10.1097/01.ede.0000416722.17915.bb, 9/2012_________________________________________________________________ Mildred Maisonet, etal:"Maternal ConcentrationsofPolyfluoroalkylCompounds During Pregnancyand Fetal and PostnatalGrowth inBritishGirls",Environmental Health Perspectives,dx.doi.org/10.1289/ehp.1003096, 8/30/2012_______________________________________________________________ KyleSteenland: "PFOA and StudiesbytheC8 SciencePanel inthe Mid-OhioValley",Slides,Undated Anoop Shankar,etal:"PerfluorooctanoicAcidand CardiovascularDiseaseinUS Adults",Arch InternMed Article, doi:10.1001/archinternmed.2012.3393, 9/3/2012_______________________________________ Debabrata Mukherjee: "PerfluorooctanoicAcid Exposureand CardiovascularDisease",Arch InternMed, ePub Article,9/3/2012___________________________________________________________ Anoop Shankar,etal:"PerfluorooctanoicAcidand CardiovascularDiseaseinUS Adults",Arch InternMed Article, doi:10.1001/archinternmed.2012.3393, 9/3/2012_______________________________________ Y.J.Lee,etal:"ConcentrationsofPerfluoroalkylCompounds inMaternal and UmbilicalCord Seraand Birth Outcomes inKorea",Chemosphere abstract,doi:10.1016/j.chemosphere.2012.08.035, 9/15/2012 Youn JuLee,etal:"ConcentrationsofPerfluoroalkylCompounds inMaternal and UmbilicalCord Seraand Birth Outcomes inKorea",Chemosphere Article,doi:10.1016/j.chemosphere.2012.08.035, 9/15/2012 LinusKvist,etal:"Serum LevelsofPerfluorinatedCompounds and Sperm Y:XChromosome RatioinTwo European Populationsand inInuitfrom Greenland", ReproductiveToxicologyArticle,doi: 10.1016/reprotox.2012.09.007, 10/5/2012___________________________________________ Germain M. Buck Louis,etal:"Perfluorochemicalsand Endometriosis,The ENDO Study",epidemiologyArticle, Volume 23,No.6,doi:10.1097.EDE.0b013e31826cc0cf, 11/2012______________________________ KyleSteenland,etal:"Cohort MortalityStudyofWorkers Exposedto PerflurooctanoicAcid"AmericanJournalof Epidemiology,doi:10.1093/aje/kws171, 10/18/2012 KyleSteenland,etal:"Cohort MortalityStudyofWorkers Exposedto PerfluorooctanoicAcid"AmericanJournal ofEpidemiologyAbstract,doi:10.1093/aje/kws171, 10/18/2012 KyleSteenland,etal:"Cohort MortalityStudyofWorkers Exposedto PerfluorooctanoicAcid",AmericanJournal ofEpidemiologyAbstract,doi:10.1093/aje/kws171, 10/18/2012 M.C. Power, etal:"Cross-SectionalAssociation Between PolyfluoroalkylChemicalsand CognitiveLimitationin the National Healthand NutritionExaminationSurvey", NeuroepidemiologyAbstract, 10/24/2012 C8 SciencePanel Report"Probable LinkEvaluationforHeart Disease(includinghighblood pressure,high cholesterol, coronary arterydisease), 10/26/2012 C8 SciencePanel Report"Probable LinkEvaluationforChronic Kidney Disease, 10/26/2012 C8 SciencePanel Report"Probable LinkEvaluationofOsteoarthritis",10/29/2012 C8 SciencePanel Report"Probable LinkEvaluationforLiverDiseases", 10/29/2012 C8 SciencePanel Report"Probable LinkEvaluationforParkinson'sDisease", 10/29/2012 C8 SciencePanel News Release"SciencePanelCompletes Studies;FindsProbable LinkBetween C8, High Cholesterol", 10/29/2012______________________________________________________ Melinda C.Power, etal:"Cross-SectionalAssociation Between PolyfluoroalkylChemicalsand Cognitive Limitationinthe National Healthand NutritionExaminationSurvey", Neuroepidemiology,Vol.40, No. 2,doi: 10.1159/000342310,11/8/2012__________________________________________________ C.Kunacheva, etal:"WorldwideSurveysofPerfluorooctaneSulfonate(PFOS)and PerfluorooctanoicAcid (PFOA) inWater Environment inRecentYears",Water SciTechnolAbstract,doi:10.2166/wst.2012.518, 2012 Page 157 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 253 of 277 PAGEID #: 61254 Descriptions of Documents Without Bates Numbers Chinagarn Kunacheva, etal:"Worldwide SurveysofPerfluorooctaneSulfonate(PFOS)and Perfluorooctanoic Acid (PFOA) inWater Environment inRecentYears",Water Science& TechnologyAbstract,doi: 10.2166/wst.2012.518, 2012____________________________________________________ C.Y.Lin,etal:"TheAssociationsBetween Serum PerfluorinatedChemicalsandThyroid FunctioninAdolescents andYoungAdults",JHM Abstract,doi:10.1016/j.jhazmat.2012.10.019, 11/2/2012 SohelSaikat,etal:"The ImpactofPFOS on Health intheGeneral Population:A Review", Environmental Science Article,doi:10.1039/C3EM30698K, 11/29/2012________________________________________ Yu Gao, etal:"AssessmentofEstrogenicActivityofPerfluoroalkylAcids Based on Ligand-Induced Conformation StateofHuman Estrogen Receptors", Environmental Science& TechnologyArticle,doi:10.1021/es304030x, 12/7/2012_______________________________________________________________ UllaNordstrom, etal:"PFOS (perfluorooctanesulfonate)inSerum isNegativelyAssociatedwithTestosterone Levels,but NotwithSemen Quality,inHealthy Men", Human ReproductionAbstract,doi: 10.1093/humrep/des425, 12/18/2012______________________________________________ B. Javins,etal:"CirculatingMaternal PerfluoroalklySubstances DuringPregnancy intheC8 HealthStudy", Environmental Science& TechnologyAbstract, 12/28/2012 B.Javins,etal:"CirculatingMaternal PerfluoroalklySubstances DuringPregnancy intheC8 HealthStudy", Environmental Science& TechnologyAbstract,doi:10.1021/es3028082, 12/28/2012 H.Viberg,etal:"AdultDose-Dependent Behavioraland CognitiveDisturbancesAfteraSingleNeonatal PFHxS Dose",ToxicologyAbstract,doi:10.1016/j.tox.2012.12.013, 12/31/2012 VeronicaVieier,etal:"Geographic PattersofCancerStudy",Slides,Undated Maria-Jose Lopez-Espinosa,etal:"Comparison Between FreeSerum Thyroxine Levels,Measured byAnalogand DialysisMethods, inthe PresenceofPerfluorooctaneSulfonateand Perfluorooctanoate", Reproductive ToxicologyArticle,doi: 10.1016/j.reprotox.2011.04.002, 4/17/2011 Andrea Winquist, KyleSteenland: "AssociationBetween Cumulative PFOA ExposureandThyroid Diseasein Community and Worker Cohorts",Slides,Undated BethJavins,etal:"CirculatingMaternal PerfluoroalklySubstances During Pregnancy intheC8 HealthStudy", Environmental Science& TechnologyArticle,doi:10.1021/es3028082, 12/28/2012 Guang-Hui Dong, etal:"Serum PolyfluoroalkylConcentrations,Asthma Outcomes, and Immunological Markers inaCase-ControlStudyofTaiwanese Children",Environmental Health Perspectives,doi:10.1289/ehp.1205351, 1/8/2013________________________________________________________________ Veronica M. Vieira,etal:"PerfluorooctanoicAcid Exposureand CancerOutcomes inaContaminated Community: A GeographicAnalysis",Environmental Health Perspectives,doi:10.1289/ehp.1205829, 1/8/2013 B.Granum, etal:"Pre-Natal Exposureto PerfluoroalkylSubstances May beAssociatedwithAlteredVaccine AntibodyLevelsand Immune-Related HealthOutcomes inEarlyChildhood",JImmunotoxicol Abstract, 1/25/2013_______________________________________________________________ BeritGranum, etal:"Pre-Natal Exposureto PerfluoroalkylSubstances May beAssociatedwithAlteredVaccine AntibodyLevelsand Immune-Related HealthOutcomes inEarlyChildhood",JournalofImmunotoxicologyArticle, doi:10.3109/1547691X.2012.755580, 1/25/2013_______________________________________ Anne Vested,etal:"AssociationsofinUtero Exposureto PerfluorinatedAlkylAcidswith Human Semen Quality and Reproductive Hormones inAdultMen", Environmental Health Perspectives,doi:10.1289.ehp.1205118, 1/28/2013_______________________________________________________________ USEPA Extramural Researchweb page,"PFOA Concentration inSerum Collected1991-2008and Related Health Effects", 12/16/2011_________________________________________________________ USEPA Extramural Researchweb page, "2011 Progress Report: PFOA Concentration inSerum Collected1991 2008 and Related Health Effects",2011 Page 158 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 254 of 277 PAGEID #: 61255 Descriptions of Documents Without Bates Numbers SarahA.Uhl,etal:"AssociationofOsteoarthritiswith Perfluorooctanoateand PerfluorooctaneSulfonatein NHANES 2003-2009", Environmental Health Perspectives,doi:10.1289/ehp.1205673, 2/8/2013__________ KirstenT.Eriksen,etal:"AssociationBetween Plasma PFOA and PFOSLevelsandTotalCholesterolinaMiddleAged Danish Population", PLOSONE, doi:10.1371/journal.pone.0056969, 2/18/2013 H.Nilsson,etal:"ProfessionalSkiWaxers' Exposureto PFAS andAerosolConcentrationsinGas Phase and Different ParticleSize Fractions", Environ SciProcess Impacts Abstract, 2/21/2013 Helena Nilsson,etal:"ProfessionalSkiWaxers' Exposureto PFASand AerosolConcentrationsinGas Phase and DifferentParticleSizeFractions",Environmental ScienceProcesses& ImpactsArticle,doi:10.1039/c3em30739e, 2013___________________________________________________________________ USEPA web page-GrantsAwards Database: "ProjectTitle:PFOA Serum Concentration & Related Health Effects",2/28/2013__________________________________________________________ USEPA Extramural Researchweb page: "PFOA Concentration inSerum Collected 1991-2008and Related Health Effects",Susan M. Pinney, Investigator,8/22/2011 USEPA Extramural Researchweb page: "PFOA Concentration inSerum Collected1991-2008and Related Health Effects",Susan M. Pinney, Investigator,8/22/2011 J.P.Antignac,etal:"OccurrenceofPerfluorinatedAlkylatedSubstancesinBreastMilkofFrenchWomen and Relationwith Socio-Demographical and ClinicalParameters: Resultsofthe ELFE PilotStudy",Chemosphere Abstract,doi:10.1016/j.chemospher.2013.01.088, 3/6/2013 R. B.Jain:"ContributionofDietand Other Factorstothe LevelsofSelected PolyfluorinatedCompounds: Data from NHANES 2003-2008", IntJHyg Environ Health,doi:10.1016/j.ijheh.2013.03.008,3/27/2013_________ DavidC.Bellinger:"Prenatal Exposuresto Environmental Chemicalsand Children'sNeurodevelopment: An Update", Safetyand HealthatWork Article,doi:10.5491/shaw.2013.4.1.1, 2013 S. D.Geiger,etal:"PositiveAssociation Between PerfluoroalkylChemicalsand Hyperuricemia inChildren", American Journal of EpidemiologyAbstract, 4/3/2013 Sarah Dee Geiger,etal:"PositiveAssociationBetween PerfluoroalkylChemicalsand Hyperuricemia inChildren", American Journal of EpidemiologyArticle,doi: 10/1093/1je/kws392, 4/3/2013 Richard DeGrandchamp, PhD ofUniversityofColorado, Denver: "PerfluorinatedChemicals:Toxicologyand PublicHealth Perspective",Slides,4/23/2013 R.B.Jain:"EffectofPregnancyonthe LevelsofSelected PerfluoroalkylCompounds forFemalesAged 17-39 Years: Datafrom National Healthand NutritionExaminationSurvey2003-2008",JToxicol Environ Health Abstract,doi:10.1080/15287394.2013.771547, 2013_____________________________________ Mei-HueiChen, etal:"PerfluorinatedCompounds inUmbilicalCord Bloodand Adverse BirthOutcomes", PLOS One Abstract,doi:10.1371/journal.pone.0042474, 8/3/2012 R.B.Jain:"EffectofPregnancyonthe LevelsofSelected PerfluoroalkylCompounds forFemalesAged 17-39 Years: Datafrom National Healthand NutritionExaminationSurvey2003-2008",JToxicol Environ Health Abstract,doi:10.1080/15287394.2013.771547, 2013_____________________________________ C8 Medical Panel Report,5/24/2013 C.Y.Lin,etal:"TheAssociationsBetween LevelsofSerum PerfluorooctaneSulfateand CarotidArteryIntima MediaThicknessinAdolescentsandYoung Adults", IntJCardiolAbstract,doi:10.1016/j.ijcard.2013.04.042, 5/7/2013________________________________________________________________ Cheryl R.Stein,etal:"Perfluorooctanoateand Neuropsychological Outcomes inChildren",Epidemiology Abstract,Vol.24,No.4,doi:10.1097/EDE.0b013e3182944432, 7/2013__________________________ Andrea Winquist,etal:"Design,Methods and PopulationforaStudyofPFOA Health EffectsAmong Highly Exposed Mid-OhioValleyCommunity Residentsand Workers", Environmental Health PerspectivesArticle,doi: 10.1289/ehp.1206450, 6/4/2013 Page 159 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 255 of 277 PAGEID #: 61256 Descriptions of Documents Without Bates Numbers KyleSteenland,etal:"UlcerativeColitisand PerfluorooctanoicAcid (PFOA) inHighlyExposed Populationof Community ResidentsandWorkers inthe Mid-OhioValley",Environmental Health PerspectivesArticle,doi: 10.1289/ehp.1206449, 6/4/2013__________________________________________________ V. Gallo,etal:"Serum PerfluoroalkylAcidsConcentrationsand Memory Impairment inaLargeCross-Sectional Study", BMJ Open Abstract,doi:101136/bmjopen-2012-002414, 6/20/2013_______________________ IgorBurstyn:"Commentary: Country DoctorVersus Epidemiologist: How UncertaintyAnalysisCan HelpSee What isinPlainView", EpidemiologyArticle,Vol.24,Issue4,doi:10.1097/EDE.0b013e3182953272, 7/2013 Nicola Fitz-Simon,etal:"Rejoinder: Understanding UncertaintiesinaChange VersusChange Study", EpidemiologyArticle,Vol.24,Issue4,doi:10.1097/EDE.0b013e3182961926, 7/2013_________________ Cheryl R.Stein,etal:"Perfluorooctanoateand Neuropsychological Outcomes inChildren",EpidemiologyArticle, doi:10.1097/EDE.0b013e3182944432, 7/2013_________________________________________ Nicola Fitz-Simon,etal:"Reductions inSerum Lipidswith a4-yearDeclineinSerum PerfluorooctanoicAcidand PerfluorooctanesulfonicAcid",Epidemiology,Volume 24,Number 4,doi:10.1097/EDE.0b013e318294443ee, 7/2013__________________________________________________________________ C.S.Andersen, etal:"Prenatal Exposuresto PerfluorinatedChemicalsand Anthropometryat7YearsofAge", American Journal of EpidemiologyAbstract, 7/3/2013 CamillaSchou Andersen, etal:"Prenatal ExposurestoPerfluorinatedChemicalsandAnthropometry at7Yearsof Age",AmericanJournalofEpidemiologyArticle,doi:10.1093/aje/kwt057, 7/3/2013 LyndseyA.Darrow, etal:"Serum PerfluorooctanoicAcidand PerfluorooctaneSulfonateConcentrationsin Relationto BirthOutcomes inthe Mid-OhioValley,2005-2010", Environmental Health Perspectives,doi: 10.1289/ehp.1206372, 12/6/2012_________________________________________________ LiLiWen, etal:"Association Between Serum PerfluorinatedChemicalsand Thyroid FunctioninU.S.Adults:The National Healthand NutritionExaminationSurvey2007-2010",J.Clin.Endocrin. Metab.,doi:10.1210/jc.20131282, 7/17/2013____________________________________________________________ Kashino Ikuka,etal:"Prenatal Exposureto 11 PerfluorinatedCompounds (PFCs)and InfantWeight inthe Hokkaido Studyon Environmental and Children'sHealth", Environmentand HealthConference, Basel, SwitzerlandAbstract,8/19/2013 KristianToreJorgensen,etal:"PerfluorinatedCompounds andTimeto PregnancyinCouplesfrom Greenland, Polandand Ukraine",AbstractforEnvironmentand Healthconference, Basel,Switzerland,8/19/2013 Joseph Braun,etal:"Gestational Endocrine DisruptingChemical ExposureandAutisticBehaviorsin4to5Year OldChildrenfrom CincinnatiOH",AbstractforEnvironmentand Healthconference, Basel,Switzerland, 8/19/2013_______________________________________________________________ Anne Starling,etal:"PerfluoroalkylSubstances inMid-Pregnancyand Preeclampsia inthe Norwegian Mother and ChildCohortStudy",AbstractforEnvironmentand Healthconference, Basel,Switzerland,8/19/2013 Jia-ShianShiu,etal:"Prenatal Exposureto PerfluorinatedChemicalsandAttention Deficit/Hyperactivity Symptoms inChildrenat7YearsofAge",AbstractforEnvironmentand Healthconference, Basel,Switzerland, 8/19/2013 PhilippeGrandjean, etal:"Decreased Serum VaccineAntibodyConcentrationsasCriticalOutcome ofExposure to PerfluorinatedCompounds", AbstractforEnvironmentand Health conference, Basel,Switzerland,8/19/2013 CherylStein,etal:"Perfluorooctanoate Exposureand Maternal ReportofBirthDefects", Abstractfor Environmentand Healthconference, Basel,Switzerland,8/19/2013 Vaughn Barry,etal:"PerfluorooctanoicAcid(PFOA) Exposuresand IncidentCancersAmong Adults LivingNeara Chemical Plant",Environmental Health PerspectivesArticle,doi:10.1289/ehp.1306615, 9/5/2013 Page 160 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 256 of 277 PAGEID #: 61257 Descriptions of Documents Without Bates Numbers M.H. Chen, etal:"PerfluorinatedCompound LevelsinCord Bloodand Neurodevelopment at2YearsofAge", EpidemiologyAbstract,ePub 9/12/2013 Susan M. Pinney,etal:"Exposureto PolyfluroalkylCompounds inthe Mid Ohio RiverValleyand Associations withConsumption ofOhio RiverWater", AbstractforEnvironmentand Healthconference, Basel,Switzerland, 8/19/2013_______________________________________________________________ SrishtiSrestha,etal:"PerfluorinatedCompounds and Thyroid Function inOlderAdults",Abstractfor Environmentand Healthconference, Basel,Switzerland, 8/19/2013 Andrea Winquist,etal:"Association Between Cumulative PFOA Exposureand CoronaryArteryDisease, Hypertensionand HighCholesterol inCommunity and Worker Cohorts",AbstractforEnvironmentand Health conference, Basel,Switzerland,8/19/2013 PaulaJohnson, etal:"The NavigationGuide-Evidence-Based Medicine Meets Environmental Health: PFOA and FetalGrowth",AbstractfroEnvironmentand Healthconference, Basel,Switzerland,8/19/2013 XiaHuo, etal:"Human DevelopmentalToxicityby ExposuretoMixtureChemicalsofE-Waste Recycling", AbstractforEnvironmentand Healthconference, Basel,Switzerland,8/19/2013 GlenysWebster, etal:"PerfluoroalkylAcids(PFASs)andThyroid DisruptioninUS Adults(NHANES 2007-2008)", Abstractfor Environmentand Healthconference, Basel,Switzerland,8/19/2013 Rosana Weldon, etal:"InUtero PFOA and High Blood PressureAmong Pre-AdolescentChildreninWest Virginia", AbstractforEnvironmentand Healthconference, Basel,Switzerland,8/19/2013 E.C.Bonefeld-Jorgensen,etal:"EffectsofPerfluorinateCompounds inVitro/ExVivoandthe RiskofHuman BreastCancer",Abstractforconferencepresentation, Undated ChrisSimpson, etal:"Relation Between PerfluorooctanoicAcid Exposureand StrokesinaLargeCohort Living NearaChemical Plant",Environmental ResearchArticle,doi:10.1016/j.envres.2013.10.002, 10/2013 S.L.Kristensen,etal:"Long-Term EffectsofPrenatal Exposureto PerfluoroalkylSubstanceson Female Reproduction", Human ReproductionArticle,Vol.0,No.0,doi:10.1093/humrep/det382, 10/15/2013 J.Lyngso,etal:"Menstrual CycleCharacteristicsinFertileWomen from Greenland, Poland and Ukraine Exposed to PerfluorinatedChemicals:A Cross-SectionalStudy", Human ReproductionArticle,Vol.0,No.0,doi: 10.1093/humrep/det390, 10/25/2013______________________________________________ E.Hardell,etal:"Case-ControlStudyon PerfluorinatedAlkylAcids(PFAAs)andthe RiskofProstateCancer", Environ IntAbstract,doi:10.1016/j.envint.2013.10.005, 11/15/2013 BarbaraJ.Keller,etal:"InhibitionofMitochondrial Respirationand Oxygen-Dependent HepatotoxicitybySix StructurallyDissimilarPeroxiaomal ProliferatingAgents"; Toxicology, 71,pp.49-61,1992 Gary E.Marchant: "GeneticSusceptibilityand BiomarkersinToxicInjuryLitigation",Article,41Jurimetrics,67 109, 2000________________________________________________________________ YibinKang,etal:"A MultigenicProgram Mediating BreastCancer Metastasisto Bone",Article,CancerCellVol.3, 6/2003__________________________________________________________________ Wenyue Hu,etal:"IdentificationofGenes ResponsivetoPFOS UsingGene Expression Profiling",Environmental Toxicologyand PharmacologyAbstract,doi:10.1016/j.etap.2004.04.008, 2004 K. S.Guruge, etal:"Gene Expression ProfilesinRatLiverTreatedwith PerfluorooctanoicAcid (PFOA)",Toxicology SciAbstract,89(1): 93-107, 2006_________________________________________________ C LePage,etal:"Gene Expression ProfilingofPrimaryCulturesofOvarian EpithelialCellsidentifiesNovel ModecularClassifiersofOvarianCancer", BritishJournalofCancerArticle,doi:10.1038/sj.bjc.6602933, 1/17/2006_______________________________________________________________ Gary E.Marchant: "Genetic Data inToxicTortLitigation",JournalofLaw and Policy,14J.L.& Policy7,2006 BruceGillis,etal:"IdentificationofHuman CellResponsesto Benzeneand Benzene Metabolites", Abstract, Geonomics, doi:10.1016/j.ygeno.2007.05.003, 2/2/2007 Page 161 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 257 of 277 PAGEID #: 61258 Descriptions of Documents Without Bates Numbers James A.Bjork,etal:"PerfluorooctaneSulfonate-InducedChanges inFetalRatLiverGene Expression", ToxicologyAccepted Manuscript,doi:10.1016/j.tox.2008.06.007, 2007 M.B. Rosen,etal:"Gene Expression ProfilinginWild-Typeand PPARa-Null Mice Exposedto Perfluorooctane Sulfonate Reveals PPARa-Independent Effects",Abstract, PPAR Res.,9/27/2010 V.Vongphachan, etal:"EffectsofPerfluoroalkylCompounds (PFCs)on mRNA Expression LevelsofThyroid Hormone-Responsive Genes inPrimaryCulturesofAvian Neuronal Cells",ToxicolSciAbstract, 1/6/2011 W. Xia,etal:"PFOS Prenatal Exposure induce Mitochondrial injuryand Gene ExpressionChange inHeartsof Weaned SD Rats",ToxicologyAbstract, 1/18/2011 Rebecca E.Bathke,Oregon StateUniversity:"EffectsofPerfluorinatedCompounds on GnRH Gene Expression in Vitro",Slides,Undated J.A.Bjork,etal:"MultiplicityofNuclearReceptorActivationby PFOA and PFOS inPrimaryHuman and Rodent Hepatocytes",ToxicologyAbstract,ePub 6/23/2011 C.Rylander,etal:"UsingBlood Gene SignaturesforAssessingEffectsofExposuretoPerfluoroalkylAcids(PFAAs) inHumans: The NOWAC Postgenome Study", IntJMol EpidemiologyGenetAbstract,8/30/2011 Charlotta Rylander,etal:"UsingBlood Gene SignaturesforAssessingEffectsofExposureto PerfluoroalkylAcids (PFAAs)inHumans: The NOWAC Postgenome Study", IntJMol EpidemiologyGenetAbstract,8/30/2011 J. E.Naile,etal:"TranscriptionalEffectsofPerfluorinatedCompounds inRatHepatoma Cells",Chemosphere Abstract, 11/7/2011_________________________________________________________ D.Salter,etal:"ShortTerm PFOA Administration Does Not MarkedlyAffectKey LipogenicandAntioxicantGene Expression inAdiposeTissue",PosterBoardAbstract, Undated K.Midgett,etal:"EffectsofPerfluorooctaneSulfonate(PFOS)and PerfluorooctanoicAcid(PFOA)on IL-2 Production inthe Human JurkatT-cell Line",PosterBoardAbstract, Undated T. Signh,etal:"PerfluorooctanoicAcid InducesMast Cell-MediatedAllergicInflammation: ReleaseofHistamine, InvolvementofCalcium,Caspase-1,COX-2 and NuclearFactor-kB", PosterBoardAbstract, Undated S.Peng,etal:"HepatotoxicityofPerfluorooctanoicAcid inHuman Hepatocytes UsingMeabonomics", PubMed Abstract,Se Pu,30(2): 123-7,2/2012_______________________________________________ H.G. Lee,etal:"PerfluorooctaneSulfonateInducesApoptosisofCerebellarGranuleCellsviaaROS-Dependent Protein KinaseCSignalingPathway", NeurotoxicologyAbstract,6/2012 Tony Fletcher,etal:"GeneticVariationsinKidneyTransporter Proteinsand Serum Half-Livesof PerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonicAcid (PFOS)", EpidemiologyArticle,Vol.23,Issue5S, doi:10.1097/01.ede.0000417207.31291.7e, 9/2012______________________________________ Tony Fletcher,etal:"Gene Expressionaand EpigeneticModification inLipidRegulatingGenes inRelationto PFOA and PFOS", EpidemiologyArticle,Vol.23,Issue5S,doi:10.1097/01.ede.0000416791.76157.2f, 9/2012 FengTan,etal:"Global LiverProteomeAnalysisUsingiTRAQLabelingQuantitativeProteomicTechnologyto Reveal BiomarkersinMice Exposedto PerfluorooctaneSulfonate(PFOS)", Environmental Science& Technology Article,doi:10.1021/es3027715, 10/9/2012___________________________________________ A.Watkins, etal:"EffectsofGestational Exposureto PFOA on PPAR Proteinand mRNA ExpressioninVitalOrgans ofFetaland Postnatal Mice",Abstract, USEPAweb page, 10/22/2010 A. K.Rosenmai, etal:"Fluorochemicals Used inFood PackaginginhibitMale SexHormone Synthesis",Toxicol Appl Pharmacol Abstract,doi:10.1016/j.taap.2012.10.022, 11/7/2012 B.Wens, etal:"Cultured Human Peripheral Blood MononuclearCellsAlterTheirGene ExpressionWhen Challengedwith Endocrine-DisruptingChemicals",Toxicology,doi:10.1016/j.tox.2012.10.019, 11/9/2012 J.H.Oh, etal:"AlternationsinDifferentiallyExpressedGenes AfterRepeated Exposureto Perfluorooctanoate and PerfluorooctanesulfonateinLiverofOryziasLatipes",Arch EnvronContam ToxicolAbstract, 12/6/2012 Page 162 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 258 of 277 PAGEID #: 61259 Descriptions of Documents Without Bates Numbers L. M. Eldasher,etal:"Hepaticand Renal BcrpTransporter ExpressioninMiceTreatedwith Perfluorooctanoic Acid",ToxicologyAbstract,doi:10.1016/j.tox.2013.02.009, 2/19/2013 M. B.Rosen,etal:"EvaluationofPerfluoroalkylAcidActivityUsingPrimary Mouse and Human Hepatocytes", ToxicologyAbstract, doi: 10.1016/j.tox.2013.03.011, 4/5/2013 Tony Fletcher,etal:"AssociationsBetween PFOA orPFOS and Changes inthe ExpressionofGenes Involvedin Cholesterol Metabolism inHumans", Environ IntAbstract,doi:10.1016/j.envint.2013.03.008,4/24/2013 Tony Fletcher,etal:"AssociationsBetween PFOA orPFOS and Changes inthe ExpressionofGenes Involvedin Cholesterol Metabolism inHumans", Environment InternationalAbstract,doi: 10.1016/j.envint.2013.03.008,2013________________________________________________ H.Tsang,etal:"PerfluorooctanoateSuppressesSpheroidAttachment on Endometrial EpithelialCellsThrough Peroxisome Proliferator-Activated ReceptorAlphaand Down-Regulation ofWnt Signaling",ReprodToxicol Abstract, doi: 10.16/j.reprotox.2013.08.001, 8/23/2013 A.C.Dankers,etal:"Endocrine DisruptorsDifferentiallyTargetATP-bindingCassetteTransportersinthe BloodTestis Barrierand Affect LeydigCellTestosterone Secretion inVitro",Toxicol SciAbstract, 9/6/2013 Tony Fletcher,etal:"GeneticandTranscriptiomicStudiesofPF"OAand PFOS:Thyroid Hormones, Lipid Metabolism andTransporterProteins",AbstractforEnvironmentand Healthconference, Basel,Switzerland, 8/19/2013_______________________________________________________________ Deborah Watkins, etal:"AssociationsBetween Serum PerfluoroalkylAcidsand LINE-1 DNA Methylation ina HighlyExposed Population",AbstractforEnvironmentand Health conference, Basel,Switzerland,8/19/2013 John P.Vanden Heuvel Lettertothe Editor,Environment International,"Comment on "AssociationsBetween PFOA, PFOS and Changes inthe ExpressionofGenes Involved inCholesterol Metabolism inHumans" by Fletcher, etal,Environment Internation57-58 (2013)2-10",doi:10.1016/j.envint.2013.09.004, 2013 Manhai Long,etal:"EffectsofPerfluoroalkylAcidsonthe FunctionoftheThyroid Hormone andtheAryl Hydrocarbon Receptor", Abstractforconference presentation,Undated John P.Vanden Heuvel: "EffectsofPFOA and PFOS on Cholesterol EffluxinMacrophage-Derived Foam Cells", Abstractforconferencepresentation, Undated D.J.Watkins, etal:"AssociationsBetween Serum PerfluoroalkylAcidsand LINE-1 DNA Methylation", Environ Int Abstract,doi:10.1016/j.envint.2013.10.018, 11/18/2013___________________________________ 9/17/2009 USEPA ConsentAgreement and FinalOrder 3/6/2001 Bilottletterto USEPA rerequestforimmediategovernmental action 12/6/2004 USEPA ComplaintreDuPont United StatesDistrictCourtSouthern DistrictofOhio Eastern Division,Complaint, EarlEdgarFrum v.E.I.DuPont De Nemours and Company, 2/7/2013 7/8/2004 USEPA Complaint reDuPont HongxiangTeng: "Overview ofthe Development ofthe FluoropolymerIndustry",Appl.Sci.2012, 2,496-512; doi: 10.3390, 5/29/2012__________________________________________________________ Paul D.Thacker: "TheWeinberg Proposal", Environmental Science& Technology, 05/01/2006; andAR226-1693 04/29/2003 Correspondence RichardW. Clapp,etal:"Environmental and Health:VitalIntersectionorContestedTerritory?",AmericanJournal ofLaw and Medicine; 2004, 30,2/3;Health Module David Michaels, PhD, MPH, etal:"Manufacturing Uncertainty:Contested Scienceandthe Protectionofthe Public'sHealthand Environment",AmericanJournalofPublicHealth,Supplement 1,Vol.95,No.S1,2005 James Huff,PhD: "IndustryInfluenceon Occupational and Environmental PublicHealth", INTJOccup Environ Health,Vol.12/No 1,JAN/Mar 2007 Page 163 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 259 of 277 PAGEID #: 61260 Descriptions of Documents Without Bates Numbers RoniA.Neff,ScM, etal:"RegulatoryParallelsto Daubert:StakeholderInfluence,"Sound Science,"andthe DelayedAdoption ofHealth-ProtectiveStandards",AmericanJournalofPublicHealth,Supplement 1,Vol.95,No. S1,2005_________________________________________________________________ David Michaels: "Doubt IsTheirProduct";ScientificAmerican, Inc.;June 2005 David Michaels: "Doubt How Industry'sAssaulton ScienceisTheirThreatensYour Health Product",Oxford University Press 2008 KyleSteenland,etal:"Commentary: ClassAction Lawsuits:CanTheyAdvance EpidemiologicResearch?", Epidemiology,Volume 25,Issue2-p 167-169, doi:10.1097/EDE.0000000000000067, 3/2014____________ Rena Steinzor,etal:"CozyingUp: How the ManufacturersofToxicChemicalsSeektoCo-optTheirRegulators", CenterforProgressiveReform,White Paper#1211, September 2012 WVU report-Kevin M. Leyden, PhD.,etal:"ChronicleoftheC8 Health Project" Ubel, F.A.,etal.,"HealthStatusofPlantWorkers ExposedtoFluorochemicals-A PreliminaryReport," American IndustrialHygieneAssociationJournal,August 1980 3M memo dated5/25/82from D.E.RoachtoF.A.Ubel re: Fluorochemical ControlStudy(8pages) 3M memo dated5/25/82from D.E.RoachtoF.A.Ubel re: Fluorochemical ControlStudy(8pages) DoctoralThesissubmittedtothe UniversityofMinnesota by FrankGilliland: "Fluorocarbonsand Human health: Studiesinan Occupational Cohort",October 1992 Gilliland,F.D.,Mandel,J.S.,"MortalityAmong Employees ofaPerfluorooctanoicAcid Production Plant,"JOM, Vol.35,No.9,September 1993 GearyW. Olsen,etal:"Plasma Cholecystokininand HepaticEnzymes, Cholesteroland Lipoproteinsin Ammonium Perfluorooctanoate ProductionWorkers", Marcel Dekker, Inc.,Drugand ChemicalToxicology, 23(4), 603-620, 2000_____________________________________________________________ Bruce H.Alexander, PhD: "FinalReport, MortalityStudyofWorkers Employed atthe3M CottageGrove Facility", DivisionofEnvironmental and Occupational Health,School ofPublicHealth, UniversityofMinnesota, 04/26/2001_______________________________________________________________ GearyW. Olsen, DVM, PhD, etal:"EpidemiologicAssessment ofWorker Serum Perfluorooctanesulfonate(PFOS) and Perfluorooctanoate (PFOA)Concentrationsand Medical SurveillanceExaminations",JOEM, Volume 45, Number 3,3/2003 B.H.Alexander, PhD: "MortalityofEmployees ofaPerfluorooctanesulphonyl FluorideManufacturing Facility", Occup Environ Med; 60:722-729, 2003 GearyW. Olsen, DVM, PhD, etal:"AnalysisofEpisodesofCareinaPerfluorooctanesulfonyl FluorideProduction Facility",JournalofOccupationaland Environmental Medicine,Volume 46, Number 8,8/2004 AR226-1865, AR226-1866, AR226-1869 ~ Studyauthored by PatriciaColsherofWV Caner Registry,etal."ExaminationofCommunity Concernsabout Water Contamination with PerfluorooctanoicAcidand RelatedChemicals UsingPopulation-BasedCancer Registry Data", 3/1/06 Grace K.LeMasters, PhD.,etal:"CancerRiskAmong Firefighters:A Review and Meta-Analysisof32 Studies", JOEM, Volume 48, Number 11,11/2006_____________________________________________ RobinC.Leonard, PhD, etal:RetrospectiveCohort MortalityStudyofWorkers inaPolymer Production Plant IncludingaReference PopulationofRegionalWorkers", Elsevier,Inc.,ArticleinPress,doi: 10.1016/j.annepidem.2007.06.011, 2007_____________________________________________ CarineJ.Sakr,MD, MPH, etal:"Cross-SectionalStudyofLipidsand LiverEnzymes RelatedtoaSerum Biomarker ofExposure(ammonium perfluorooctanoateorAPFO) asPartofaGeneral HealthSurveyinaCohortof OccupationallyExposed Workers",JOEM, Volume 49, Number 10,doi:10.1097/JOM.0b013e318156eca3, Page 164 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 260 of 277 PAGEID #: 61261 Descriptions of Documents Without Bates Numbers 2008WVU School ofMedicine,The C8 Health Project:How aClassAction LawsuitCan Interactwith Public Health-HistoryofEvents Dr.KyleSteenland,etal:"AssociationofPerfluorooctanoicAcidand PerfluorooctaneSulfonatewith Serum LipidsAmong LivingNearaChemical Plant".AmericanJournalofEpidemiology DOI:10.1093/AJE/KWP279 Page 1 of 11, 10/21/2009___________________________________________________________ KyleSteenland,etal:"AssociationOf PFOA and PFOSwith UricAcidamong Adultswith ElevatedCommunity Exposureto PFOA", D0I:10.1289/EHP.0900940 10/22/2009________________________________ Pinney,Susan M, etal:"PerfluorooctanoicAcid (PFOA)and Pubertal Maturation inYoung Girls",Epidemiology, November 2009,Vol.20 (6)pS80,doi:10.1097/01.ede.0000362949.30847.cb page 1ofp1______________ Exposureto PolyfluoroalkylChemicalsand Cholesterol, BodyWeight and InsulinResistanceintheGeneral U.S Population,JessicaNelson,doi10.1289/ehp.0901165 online11/2/2009 Chein-Yu LinMD,MPH, al:TheAmericanJournalofGastroenterology,onlinepublication15,12/2009; doi:10.1038/ajg-2009.707, "InvestigationoftheAssociationsBetween Low-Dose Serum Perfluorinated Chemicalsand LiverEnzymes inUS Adults" David Melzer,etal;Environmental Health Perspectives,"Association Between Serum PerfluorooctanoicAcid (PFOA)andThyroid Diseaseinthe NHANES Study",doi:10.1289/ehp.0901584, 01/10/2010_____________ Chunyuan Fei,etal:"Prenatalexposureto PFPAand PFOS and riskofhospitalizationforinfectiousdiseasesin earlychildhood" Environmental Research,doi:10.1016/j.envres.2010.08.004 StephanieJ.Frisbee,MSc, etal:"PerfluorooctanoicAcid,Perfluorooctanesulfonate,andSerum LipidsinChildren andAdolescents" Resultsfrom theC8 Health Project,American MedicalAssociation,VOL 164 (NO 9)10/7/2010 KristaYoritaChristensen,etal:Env.International,"Exposuretopolyfluoroalkylchemicalsduringpregnancy isnot associatedwith offspringage atmenarche inacontemporary Britishcohort",doi:10.1016/j.envint.2010.08.007 Maria-Jose Lopez-Espinosa,etal:"AssociationofPerfluorooctanoicAcid (PFOA)and PerfluorooctaneSulfonate (PFOS)withAge ofPubertyamong Children LivingnearaChemical Plant",Environmental Science& Technology, doi: 10.1021/es1038694_______________________________________________________ CamillaSchou Anderson, etal:"Prenatal Exposuresto PerfluorinatedChemicalsand Anthropometic Measures in Infancy",AmericanJournalofEpidemiology,Vol. 172 NO.11,doi:10.1093/aje/kwq289, 10.12.2010 Chunyuan Fei,etal:"Prenatal Exposureto PerfluorinatedChemicalsand BehaviororCoordination Problemsat Age 7",Env. Health Perspectives,doi:10.1289/ehpo.1002026, 11/9/2010 Cheryl R.Steinetal:"Serum PerfluorinatedCompound Concentration and Attention Deficit/Hyperactivity DisorderinChildren5-18YearsofAge, Env. Health Perspectives,Vol 119, No 10,10/2011 EmilyChan, etal:"Perfluorinatedacidsand hypothyroxinemia inpregnantwomen", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_________________________________________________ Sarah Knox,etal:"ImplicationsofEarlyMenopause inWomen Exposedto Perflurocarbons",The Endocrine Society,doi:10.1210/jc.2010-2401,6/2011____________________________________________ I-JenWang, etal:"The effectofprenatal perfluorinatedchemicalsexposureson pediatricatopy", Env. Research (2011),doi:10.1016/j.envres.4/6/2011______________________________________________ Kim E.Innes,etat:"AssociationofOsteoarthritisWith Serum Levelsofthe Environmental Contaminants Perfluorooctanoateand PerfluorooctaneSulfonateinaLargeAppalachian Population",AmericanJournalof Epidemiology,doi:10.1093/aje/kwr107, 06/27/2011 James H.Raymer, etal:"Concentrationsofperfluorooctanesulfonate(PFOS)and perfluorooctanoate(PFOA) and theirassociationswith human semen qualitymeasurements", ReproductiveToxicology,doi:10.1016/j.reprotox 05/24/2011 Page 165 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 261 of 277 PAGEID #: 61262 Descriptions of Documents Without Bates Numbers KyleSteenland,etal:"Cohort MortalityStudyofWorkers Exposedto PerflurooctanoicAcid"AmericanJournalof Epidemiology, doi:10.1093/aje/kws171,10.18.2012 ValentinaGallo,etal:"Serum Perfluorooctanoate(PFOA) and PerflurooctaneSulfonate(PFOS)Concentrations and LiverFunction Biomarkers inaPopulationwith Elevated PFOA Exposure", Env. Health Perspectives, dx.doi.org/10.1289/ehp.1104436, 1/30/2012__________________________________________ DavidA.Savitz,etal:"PerfluorooctanoicAcid Exposureand PregnancyOutcome inaHighlyExposed Community", EpidemiologyVol.23,No 3/5/2012 SarahS.Knox,etal:"Perfluorocarbonexposure,genderandthyroidfunctionintheC8 Health Project",The Journal ofToxicology Sciences,VOL.36,No.4,403-410,2011 Sunmi Kim,etal:"Trans-PlacentalTransferofThirteen PerfluorinatedCompounds and Relationswith Fetal Thyroid Hormones", Environmental Science& Technology, 8/1/2011 Maria-Jose Lopez-Espinosa,etal:"Thyroid Functionand PerfluoroalkylAcidsinChildren LivingNearaChemical Plant",Environmental Health Perspectives,dx.doi.org/10.1289/ehp.1104370, 3/27/2012 Anoop Shankar,etal:"PerfluoroalkylChemicalsand Chronic KidneyDiseaseinUS Adults",AmericanJournalof EpidemiologyAdvanceAccess,doi:10.1093/aje/kwr171, 8/26/2011 DavidA.Savitz,etal:"RelationshipofPerfluorooctanoicAcid Exposureto PregnancyOutcome Based on Birth Recordsinthe Mid-OhioValley",Environmental Health Perspectives,dx.doi.org/10.1289/ehp.1104752, 3/26/2012_______________________________________________________________ Anoop Shankar,etal:"PerfluoroalkylChemicalsand ElevatedSerum UricAcidinUSAdults",Clinical Epidemiology, Dove Press,3 251-258, 2011 EvaC.Bonefeld-Jorgensen: "PerfluorinatedCompounds are RelatedtoBreastCancer RiskinGreenlandic Inuit:A Case ControlStudy", Environmental Health, BioMed Central,doi:10.1186/1476-069X-10-88, 10/6/2011 EmiloOkada, etal:"Prenatal Exposureto PerfluorinatedChemicalsand RelationshipwithAllergiesand Infectious DiseasesinInfants",ElsevierEnvironmental Research,doi:10.1016/j.envres.2011.10.003, 2011 KristinaW. Whitworth, etal:"PerfluorinatedCompounds and SubfecundityinPregnantWomen", Epidemiology, Volume 23,Number 2,doi:10.1097/EDE.0b013e31823b5031, 3/2012___________________________ Chien-Yu Lin,etal:"AssociationsBetween LevelsofSerum PerfluorinatedChemicalsand Adiponectin inaYoung HypertensionCohort inTaiwan",American Chemical Society,dx.doi.org/10.1021/es201964x, 2011 "Probable LinkEvaluationofPregnancy Induced Hypertensionand Preeclampsia", 12/5/2011 "Probable LinkEvaluationofMiscarriageand Stillbirths",12/5/2011 "Probable LinkEvaluationofPreterm Birthand Low Birthweight", 12/5/2011 "Probable LinkEvaluationofBirthDefects", 12/5/2011 KyleSteenland,etal:StatusReport"PFOA andAdultThyroid Diseaseinthe Mid-OhioValley",12/5/2011 KyleSteenland,etal:StatusReport"ProspectiveStudyofReproductive Healthoutcomes inthe Mid-Ohio Valley", 12/5/2011__________________________________________________________ Nicola Fitz-Simon,etal:"Reductions inSerum Lipidswith a4-yearDeclineinSerum PerfluorooctanoicAcidand PerfluorooctanesulfonicAcid",Epidemiology,Volume 24,Number 4,doi:10.1097/EDE.0b013e318294443ee, 7/2013__________________________________________________________________ 3/15/2010 Correspondencefrom Bilottto USEPA: SubmissiontoTSCA 8e databaserePFOA/PFOS PhilippeGrandjean, MD, DMSc, etal:"Serum VaccineAntibodyConcentrationsinChildren Exposedto PerfluorinatedCompounds", JournalAmerican MedicalAssociation,Vol.307. No.4,1/25/2012 ThorhallurI.Halldorsson,etal:"Prenatal Exposureto Perfluorooctanoateand RiskofOverweightat20Yearsof Age:A ProspectiveCohortStudy", National InstituteofEnvironmental HealthSciences, dx.doi.org/10.1289/ehp.1104034, 2/3/2012 Page 166 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 262 of 277 PAGEID #: 61263 Descriptions of Documents Without Bates Numbers John L.Butenhoff,etal:"DistributionofPerfluorooctanesulfonateand Perfluorooctanoate intoHuman Plasma Lipoprotein Fractions",ElsevierIreland,Ltd.,doi:10.1016/j.toxlet.2012.02.013,2012 Specht IO,etal:"Sperm DNA IntegrityinRelationtoExposureto Environmental PerfluoroalkylSubstances-A StudyofSpouses ofPregnantWomen inThree Geographical Regions", PubMed, 03/15/2012 Abstract: J.L.Butenhoff,etal:"Perfluorooctanoate, Perfluorooctanesulfonate,and Chronic Kidney Disease: ClearanceComes BeforeCausation" GearyW. Olsen, DVM, PhD, etal:"LongitudinalAssessmentofLipidand HepaticClinicalParametersinWorkers InvolvedWiththe DemolitionofPerfluoroalkylManufacturingFacilities",JOEM, Volume 54,Number 8,doi: 10.1097/JOM.0b013e31825461d2, 8/2012 U.C.Nygaard, etal:"PerfluorinatedCompounds and Immune HealthOutcomes in3-year-oldChildren", Division ofEnvironmental Medicine, Norwegian InstituteofPublicHealth,2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofDiabetes",4/13/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofCancer",4/15/2012 Tony Fletcher,etal,The C8 SciencePanel:"Infections,Obesityand ClinicalMarkers inChildreninRelationto PFOA Serum LevelDuring PregnancyinMothers inthe Mid-OhioValley",5/10/2012 Jin-YoungMin,etal:"PerfluorooctanoicAcid Exposure isAssociatedwith Elevated Homocysteine and Hypertension inUSAdults", BMJ PublishingGroup Ltd.,doi:10.1136/oemed-2011-100288, 5/31/2012 Michael Bloom, etal:"Exposureto PersistentOrganohalogen PollutantsisAssociatedwithThyroid Function Among OlderResidentsofUpper Hudson RiverCommunities", ISEEAbstract#:S-042,2012 KristaChristensen,etal:"Method toAssess MultipleClassesofEnvironmental Chemicalsand LiverDisease: NHANES 2003-2006, ISEE Abstract#:S-036,2012 KushengWu, etal:"AssociationBetween Maternal ExposuretoPerfluorooctanoicAcid (PFOA)from Electronic Waste Recyclingand Neonatal HealthOutcomes", ElsevierLtd.,doi:10.1016/j.envint.2012.06.018, 2012 DeborahJ.Watkins, etal:"Exposureto PerfluoroalkylAcidsand MarkersofKidneyFunctionAmong Childrenand Adolescents LivingNearaChemical Plant",Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1205838, 3/11/2013 StudybytheC8 Science Panel:"Probable LinkEvaluationofThyroid Disease",7/30/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofAutoimmune Disease",7/30/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofNeurodevelopmental DisordersinChildren", 7/30/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationforNon-infectious Lung Disease(Asthma and Chronic Obstructive Pulmonary Disease-COPD)", 7/30/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofStroke",7/30/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationofInfectiousDisease",7/30/2012 JiansheWang, etal:"AssociationofPefluorooctanoicAcidwith HDL Cholesteroland CirculatingmiR-26b and miR199-3p inWorkers ofaFluorochemical Plantand Nearby Residents", Environmental Science& Technology, doi: 10.1021/es300906q, 8/3/2012 Mildred Maisonet, etal:"Maternal ConcentrationsofPolyfluoroalkylCompounds During Pregnancyand Fetal and PostnatalGrowth inBritishGirls",Environmental Health Perspectives,dx.doi.org/10.1289/ehp.1003096, 8/30/2012 Anoop Shankar, MD, PhD, etal:"PerfluorooctanoicAcidand CardiovascularDiseaseinUSAdults",American MedicalAssociation,doi:10.1001/archinternmed.2012.3393, 9/3/2012 Tony Fletcher,etal:"AssociationsBetween PFOA orPFOS and Changes inthe ExpressionofGenes Involvedin Cholesterol Metabolism inHumans", C8 SciencePanel,8/2012 Page 167 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 263 of 277 PAGEID #: 61264 Descriptions of Documents Without Bates Numbers Youn JuLee,etal:"ConcentrationsofPerfluoroalkylCompounds inMaternal and UmbilicalCord Seraand Birth Outcomes inKorea", Elsevierltd.,dx.doi.org/10.1016/j.chmosphere.2012.08.035, 2012 Germaine M. Buck Louis,etal:"Perfluorochemicalsand Endometriosis,The ENDO Study", Epidemiology,Volume 23,Number 6,doi:10.1097/EDE.0b013e31826cc8cf, 11/2012________________________________ StudybytheC8 Science Panel:"Probable LinkEvaluationforHeart Disease(includingHigh Blood Pressure,High Cholesterol, Coronary Artery Disease)", 10/26/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationforChronic KidneyDisease", 10/29/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationforLiverDiseases", 10/29/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationforOsteoarthritis",10/29/2012 StudybytheC8 Science Panel:"Probable LinkEvaluationforParkinson'sDisease", 10/29/2012 Melinda C.Power, etal:"Cross-SectionalAssociation Between PolyfluoroalkylChemicalsand Cognitive Limitationinthe National Healthand NutritionExaminationSurvey", Neuroepidemiology,Vol.40, No. 2,doi: 10.1159/000342310,11/8/2012__________________________________________________ Guang-Hui Dong, etal:"Serum PolyfluoroalkylConcentrations,Asthma Outcomes, and Immunological Markers inaCase-ControlStudyofTaiwanese Children",Environmental Health Perspectives,doi:10.1289/ehp.1205351, 1/8/2013________________________________________________________________ Veronica M. Vieira,etal:"PerfluorooctanoicAcid Exposureand CancerOutcomes inaContaminated Community: A GeographicAnalysis",Environmental Health Perspectives,doi:10.1289/ehp.1205829, 1/8/2013 BeritGrahum, etal:"Pre-Natal Exposureto PerfluoroalkylSubstances May beAssociatedwithAlteredVaccine AntibodyLevelsand Immune-Related HealthOutcomes inEarlyChildhood",JournalofImmunotoxicology, doi: 10.3109/1547691X, 1/25/2013___________________________________________________ Anne Vested,etal:"AssociationsofinUtero ExposuretoPerfluorinatedAlkylAcidswith Human Semen Quality and Reproductive Hormones inAdultMen", Environmental Health Perspectives,doi:10.1289.ehp.1205118, 1/28/2013_______________________________________________________________ SarahA.Uhl,etal:"AssociationofOsteoarthritiswith Perfluorooctanoateand PerfluorooctaneSulfonatein NHANES 2003-2009", Environmental Health Perspectives,doi:10.1289/ehp.1205673, 2/8/2013___________ KirstenT.Eriksen,etal:"AssociationBetween Plasma PFOA and PFOS LevelsandTotalCholesterolinaMiddleAged Danish Population", PLOSONE, doi:10.1371/journal.pone.0056969, 2/18/2013 Sarah Dee Geiger,etal:"PositiveAssociationBetween PerfluoroalkylChemicalsand Hyeruricemia inChildren", AmericanJournalofEpidemiologyAdvance Access,doi:10.1093/aje/kws392,4/3/2013 Cheryl R.Stein,etal:"Perfluorooctanoateand Neuropsychological Outcomes inChildren",Epidemiology,Vol.24, No.4,doi:10.1097/EDE.0b013e3182944432, 7/2013_____________________________________ KyleSteenland,etal:"UlcerativeColitisand PerfluorooctanoicAcid (PFOA) inHighlyExposed Populationof Community ResidentsandWorkers inthe Mid-OhioValley",Environmental Health Perspectives,doi: 10.1289/ehp.1206449, 6/4/2013__________________________________________________ LyndseyA.Darrow, etal:"Serum PerfluorooctanoicAcidand PerfluorooctaneSulfonateConcentrationsin Relationto BirthOutcomes inthe Mid-OhioValley,2005-2010", Environmental Health Perspectives,doi: 10.1289/ehp.1206372, 12/6/2012_________________________________________________ Li-LiWen, etal:"Association Between Serum PerfluorinatedChemicalsandThyroid Function inU.S.Adults:The National Healthand NutritionExaminationSurvey2007-2010",The EndocrineSociety,doi:10.1210/jc.20131282, 7/17/2013____________________________________________________________ DarioConsonni, etal:"CancerRiskAmong TetrafluoroethyleneSynthesisand PolymerizationWorkers", AmericanJournalofEpidemiology,doi:10.1093/aje/kws588, 7/4/2013 Vaughn Barry,etal:"PerfluorooctanoicAcid(PFOA) Exposuresand IncidentCancersAmong Adultslivingneara Chemical Plant",Environmental Health Perspectives,Vol.121, Nos. 11-12,doi:10.1289/ehp.1306615, 11/2013 Page 168 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 264 of 277 PAGEID #: 61265 Descriptions of Documents Without Bates Numbers Vaughn Barry,etal:"PerfluorooctanoicAcid(PFOA) Exposuresand IncidentCancersAmong Adultslivingneara Chemical Plant",Environmental Health Perspectives,,doi:10.1289/ehp.1306615, 9/5/2013 ChrisSimpson, etal:"Relation Between PerfluorooctanoicAcid Exposureand StrokesinaLargeCohort Living NearaChemical Plant",Environmental ResearchArticle,doi:10.1016/j.envres.2013.10.002, 10/2013 S.L.Kristensen,etal:"Long-Term EffectsofPrenatal Exposureto PerfluoroalkylSubstanceson Female Reproduction", Human ReproductionArticle,Vol.0,No.0,doi:10.1093/humrep/det382, 10/15/2013 J.Lyngso,etal:"Menstrual CycleCharacteristicsinFertileWomen from Greenland, Poland and Ukraine Exposed to PerfluorinatedChemicals:A Cross-SectionalStudy", Human ReproductionArticle,Vol.0,No.0,doi: 10.1093/humrep/det390, 10/25/2013______________________________________________ SarahDee Geiger,etal:"TheAssociation Between PFOA, PFOSand Serum LipidLevelsinAdolescents", Chemosphere Article,2013 KylaW. Tayloretal:"PolyfluoroalkylChemicalsand Menopause among Women 20-65YearsofAge (NHANES) Environmental Health PerspectivesArticle,doi:10.1289/ehp.1306707, 11/26/2013 Conny Karnes,etal:"IncidenceofType IIDiabetesinaCohortWith Substantial ExposuretoPerfluorooctanoic Acid",Environmental ResearchArticle,doi:10.1016/j.envres.2013.11.003, 11.11.2013 LarsLind,etal:"CirculatingLevelsofPerfluoroalkylSubstancesand PrevalentDiabetesinthe Elder", DiabetologiaArticle,doi:10.1007/s00125-013-3126-3, 8/29/2013____________________________ Andrea Winquistetal,:"PerfluorooctanoicAcid ExposureandThyroid DiseaseinCommunity andWorker Cohorts",Article, Epidemiology,Volume 25,No.2,3/2014 Kim Innes,eta.:"Inverseassociationofcolorectalcancerprevalencetoserum levelsofperfluorooctane sulfonate(PFOS)and perfluorooctanoate(PFOA) inalargeAppalachian population",Article,BMC Cancer 2014, doi:10.1186/1471-2407-14-45,1/27/2014___________________________________________ KylaW. Tayloretal:"PolyfluoroalkylChemicalsand Menopause among Women 20-65YearsofAge (NHANES)", Article, Environmental Health Perspectives,Vol.122, No.2,2/2014 From UK ClinicalResearch Networkweb site: PortfolioDatabase: "Phase IClinicalTrialofCXR 1002 inPatients withAdvanced Cancer", Undated Presentationabstract: Anna L.Barnett,etal:"Anti-TumorActivityofCXR1002, A NovelAnti-CancerCompound thatInduces ERStress:Human Tumor XengraftEfficacyand InVitroMode ofAction",AmericanAssociationfor Cancer Research, 4/17/2010 US DistrictCourtfortheSouthern DistrictofWest VirginiaatParkersburg,Wilber EarlTennant, etalv.E.I. DuPont De Nemours and Company, DuPont'sSupplemental ResponsetoPlaintiffs'FourthSetofInterrogatories and Responsesto FifthSetofDocument Requests, 2/1/2001 AR226_1011; MR47027_______________________________________________________ ENVIRON InternationalCorporation: "AHazard NarrativeforPerfluorooctanoate(PFOA) Final",1/24/2002 M. Ann BradleyEmail,1/31/2002toJ.Bowman and B.Reillyredraftmonograph USEPA Faxto R.Bilott3/12/2002transmittingNews Releaseand ConsentOrder reDuPontWashington Works AR226-1146 ~ AR226; 63030000001; MR64426; ML64776; AR226_1146 -AR226_1148_________________________ DuPont Nov. 2003 memo from Seshu Dharmavaram, PhD, P.E.,toDavidVan Bramer, etalattachingdraft "QuantitativeRiskAssessment, FluoroproductOperations DuPont: "TheTaleofTeflon", DuPont (1Page) AR226-1879______________________________________________________________ ScottE.Loveless,PhD etal:"An InternalApproachtothe RiskAssessmentofPFOA -A BiopersistentChemical", Michigan StateUniversity,1/31/2008 Page 169 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 265 of 277 PAGEID #: 61266 Descriptions of Documents Without Bates Numbers Gerald L.Kennedy,Jr.,etal:"TheToxicologyofPerfluorooctanoate",Taylor& FrancisHealthSciences,doi: 10.1080/10408440490464705__________________________________________________ S.T.Washburn, etal:"ExposureAssessmentand RiskCharacterizationforPerfluorooctanoate inSelected ConsumerArticles",PubMed, EnvironSciTechnol,6/1/2005 John L.Butenhoff,etal:"Responseto Lettertothe Editor",Elsevier,Inc.,doi:10.1016/j.yrtph.2005.01.006, 2/24/2005_______________________________________________________________ 3M memo datedfrom John Butenhoffand Robert Roy to LarryZobel re: 3M DrinkingWater HealthAdvisory APFO transmittingattached report: Derivationofa3M LifetimeDrinkingWater HealthAdvisoryforAmmonium Perfluorooctanoate(APFO) (8pages) 3M memo datedfrom John Butenhoffand Robert Roy to LarryZobel re: 3M DrinkingWater HealthAdvisory APFO transmittingattached report: Derivationofa3M LifetimeDrinkingWater HealthAdvisoryforAmmonium Perfluorooctanoate(APFO) (8pages) 3M document dated 1/28/02: LifetimeDrinkingWater HealthAdvisoryforPerfluorooctanoate(14pages) 3M LifetimeDrinkingWater HealthAdvisoryforPerflurooctanoatedated 1/28/02,authored byJohn Butenhoff and Robert Roy (14pages) Letterdated4/12/04from Michael Santoroof3M to Mary DominiakofUSEPA re: 3M monitoringprograms; enclosesdata (17pages). John L.Butenhoff,etal:"CharacterizationofRiskforGeneral Population Exposureto Perfluorooctanoate", Elsevier, Inc.,doi: 10.1016/j.yrtph.2004.03.003, 4/16/2004_________________________________ Whelan, Elizabeth,"Our 'StolenFuture'andthe PrecautionaryPrinciple", American Councilon Scienceand Health,Vol8,No.3,1996 (2pages) AR226-1055______________________________________________________________ AR226-1727 Letterdated 2/20/03from John HeinzeofEnvironmental Health Research Foundationto Donald Duncan, ofThe Societyofthe PlasticsIndustrytransmittingattachedSummary and AnalysisofHealth Dataon perfluorooctanoic Acid (PFOA)dated 2/20/03 (3pages). (Non-Bates numbered document produced by DuPont inthe Leach case.) PortionofEnvironmental Health Research FoundationSummary and AnalysisofHealth Dataon perfluorooctanoicAcid (PFOA)dated 2/20/03 (7pages) (Non-Batesnumbered document produced by DuPont in Leach case.) TrevorButterworth: "Teflon Pan ScareComes with SalesPitch":StatisticalAssessmentService,3/15/2007 RecipientsofGrantsfrom 3M forPFOS orPFOA Research,3/2007 RobertG.Tardiff,etal:"DerivationofaDrinkingWater EquivalentConcentration and Maximum Contaminant LevelGoal (MCLG) forPerfluorooctanoicAcid(PFOA),aPersistentWater SolubleCompound", Journalof RegulatoryToxicologyand Pharmacology, 11/18/2008 RobertG.Tardiffemailto Rickard,7/20/2009 reTox Forum slides RobertG.Tardiff,PhD,ATS: "Update: PFOA DrinkingWater EquivalentLevels",PresentedatToxicologyForum, 7/15/2009_______________________________________________________________ RobertG.Tardiffemailto Rickard,7/28/2009 reSapphireGroup presentation JeffreyM. Peters,etal:"Why ToxicEquivalencyFactorsAre NotSuitableforPerfluoroalkylChemicals",American Chemical SocietyPublications,doi:101021/tx200616x Tables1through 10 ofPFOA Studies(nootheridentifiers) PatWare: "DrinkingWater OMB Reviewing EPA'sDeterminationsOn RegulatingContaminantsofConcern" Bloomberg BNA DailyEnvironmental Report,9/12/2013 Page 170 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 266 of 277 PAGEID #: 61267 Descriptions of Documents Without Bates Numbers The HED ToxicologyScienceAdvisoryCouncil:"HepatocellularHypertrophy", HED Guidance Document #G0201, 10/21/2002______________________________________________________________ ChristopherLau,etal:"Embryonicand FetalProgramming ofPhysiologicalDisordersinAdulthood",Whiley-Liss, Inc.,doi:10.1002/bdrc.20029, 2004_______________________________________________ John B.Stephenson, etal:"Low Productivityand New InteragencyReview Process Limitthe Usefulnessand CredibilityofEPA's Integrated RiskInformationSystem", U.S.Government AccountabilityOffice,3/2008 Timothy Donaghy, etal:"Interferenceatthe EPA,Scienceand Politicsatthe U.S.Environmental Protection Agency", Union ofConcerned Scientists,4/2008 Chip Reid:"PoliticsKeeping EPAfrom ToxinWarnings?", CBS Evening News, 4/28/2008 USEPA StrategicPlan FiscalYear2011-2015, 9/30/2010___________________________________ USEPA News Release,01/18/2011 announcingWaterTechnology InnovationCluster DavidC.Trimble,etal:"SafeDrinkingWater Act,EPA Should Improve Implementation ofRequirements on Whetherto RegulateAdditionalContaminants", UnitedStatesGovernment AccountabilityOffice,5/2011 Pagesfrom WaterTechnology InnovationClusterwebsite: BillMcCann: "CincinnatiWaterTechnologyClusterto Support Economic Growth", IWA Publishing,4/2011 USEPA ScientificIntegrityPolicyDraft,8/5/2011 SafeChemicalsActof2011, Summary ofProposed LegislativeChanges Avery Fellow:"ToxicSubstances, EPASeekingGreater RegulatoryAuthorityOver Chemicals,OfficialTells Lawmakers",The Bureau ofNationalAffairs,Inc.,7/25/2012 Memorandum authored byLoriWeigle ofPublicOpinionStrategies,07/16/2012 re: keyfindingsfrom surveyre regulation ofchemicals United StatesSenate LettertoThe Honorable FrankLautenberg,7/23/2012 American AllianceforInnovation LettertoThe Honorable Barbara BoxerandThe Honorable FrankLautenberg, 7/23/2012_______________________________________________________________ PatRizzuto:"ToxicSubstances,SenateCommittee PassesTSCA Reform Bill;RepublicansCallforFurther Negotiations",The Bureau ofNationalAffairs,Inc.,7/26/2012 DavidC.Trimble: "EPA Has Increased EffortstoAssessand ControlChemicalsbutCouldStrengthen Its Approach", United StatesGovernment AccountabilityOffice,3/2013 AR226-0938 ~ USEPA Faxto Bilott,3/12/2002,transmittingUSEPA news releaseand DuPont ConsentOrder AR226-1093 ~ AR226-1112______________________________________________________________ AR226-1114______________________________________________________________ AR226-1117______________________________________________________________ AR226-1116______________________________________________________________ AR226-1121______________________________________________________________ AR226-1120______________________________________________________________ AR226-1122______________________________________________________________ AR226-1127______________________________________________________________ AR226-1129______________________________________________________________ AR226-1134______________________________________________________________ AR226-1130______________________________________________________________ AR226-1311______________________________________________________________ PowerPoint presentationauthored by Rich Purdy:"ScreeningLevelCumulative RiskAssessment Perfluorinated AlkylAcidson Human Health" Page 171 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 267 of 277 PAGEID #: 61268 Descriptions of Documents Without Bates Numbers OPPT-2003-0012-0071 ~ OPPT-2003-0012-0086________________________________________________________ AR226-1528______________________________________________________________ USEPA DraftRiskAssessmentforPFOA, 1/4/2005 USEPA Memorandum from SueShallaltoVanessaVu, 1/13/2005 reUSEPA riskassessment GearyOlsen, DVM, PhD, etal:"Comments of3M Company tothe EPA ScienceAdvisory Board PFOA Review Panel", 2/10/2005__________________________________________________________ JohnA.Moore, D.V.M. ofHollyhouse, Inc.correspondencetoEPA rePFOA riskassessment, 2/20/2005 BilottLetterto USEPA, 2/11/2005 reSAB RiskAssessmentforPFOA Timothy Kropp, PhD, LettertoBoard Members, USEPA's DraftRiskAssessmenton PFOA, 2/11/2005 DavidGray, PhD, Letterto USEPA, 2/11/2005 recomments on PFOA riskassessment JosephV.Rodricks, PhD., Letterto USEPA, ScienceAdvisoryBoard, 2/11/2005 recomments on riskassessment James A.Popp, DVM, PhD: "Comments on RodentTumor Sections, EPA DraftRiskAssessmentofPFOA" RobinC.Leonard, PhD, Letterto USEPA, 2/15/2005 relimitationsofDuPont surveillancedata USEPA DraftAgenda, 2/22/2005 reSAB meeting JosephV.Rodricks, PhD, DABT PowerPoint presentation:"Comments on EPA's DraftPFOA RiskAssessment" Bob Griffin,LittleHockingWaterAssociation, Inc.,Comments regardingUSEPA PublicScienceAdvisoryPanel PerfluorooctanoicAcid (PFOA) RiskAssessment Review Panel,02/22/2005 EnvironmentalWorking Group PowerPoint presentation: Human Health Risksfrom ExposuretoPFOA RobertW. Rickard,PhD., LettertoUSEPA, 3/9/2005______________________________________ Staff:"AgencyContradicted InternalAgency GuidelinesinHealthAssessmentforToxicTeflonChemical", EnvironmentalWorking Group, 3/15/2005 BilottLetterto USEPA, 3/22/2005: Supplemental comments reSAB PFOA riskassessment John L.Butenhoff, PhD, etal:"AdditionalComments of3M Company tothe EPA ScienceAdvisoryBoard PFOA Review Panel",3M Company, 4/18/2005 AR226-2722______________________________________________________________ Kathleen M. Roberts,American ChemistryCouncilletterto NCICOPPT EPA, 12/19/2005 submittingcomments to EPA onTSCA 8e reporting. Emaildated 1/26/06from Cathy Lewisto NCICOPPT@EPA re: EPA-Hq-QPPT-2003-0012 ~ EPA: "Premanufacture NotificationExemptionforPolymers;Amendment ofPolymer Exemption Ruleto Exclude Certain PerfluorinatedPolymers", Federal Register,Vol.71,No.44,3/7/2006 Lynne R.Harris,ScienceandTechnology, Letterto EPA,4/21/2006 reproposed ruleon premanufacture notificationforpolymers Anne Meininger5/9/2006 EmailtoGeraldine HiltonofUSEPA regardingComments from the Peoples Republicof Chinaon docketOPPT-2002-0051 Letterdated 5/5/06from International Imaging IndustryAssociationtoOPPT fordocket EPA-HQ-OPPT-2002- 0051 (4pages) Emaildated 5/8/06from SocietyofPlasticsIndustryto EPAOPPT re: EPA-HQ-OPPT-2002-0051 Andrea V.Malinowski Letterto USEPA, 5/12/2006 rewellsamplingresults Correspondenceto USEPAfrom Dr.M. Granger Morgan and Dr.Deborah Cory-Slechta,5/30/2006 recomments on EPAdraftPFOA riskassessment USEPA Memorandum from ChristopherP.Weis, PhD, DABT,toWalker Smith, 11/17/2006 C.Lau,etal:"PerfluoroalkylAcids:A Review ofMonitoringandToxicological Findings",ToxicolSci.,PubMed, 5/22/2007 Page 172 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 268 of 277 PAGEID #: 61269 Descriptions of Documents Without Bates Numbers ChristopherLau,etal:"PerfluoroalkylAcids:A Review ofMonitoringand Toxicological Findings",Toxicological Sciences,5/22/2007 USEPA emailto Bilott,8/2/2007announcingToxCast Phase Ichemicals Emailfrom CharlesM. AuertoRobertW. Rickard,11/2/2007 Superfund Report, IndustryasksRationaleforEPA PFOA RiskResearch,CitingPhase-Out, 11/19/2007 Emailfrom DavidW. BoothetoAlan Roberson, 3/27/2008 Correspondencefrom Bilottto USEPA, 5/29/2008 redocumentsforAR226 docket DuPont PowerPoint presentation: Chemical SafetyAssessment PFOA Under Reach, EPA Meeting, 7/9/2008 USEPA Correspondencefrom Dr.Deborah Swackhamer and Dr.Joan B.RosetoStephenJohnson ofUSEPA re SAB Advisoryon EPA'sdraftCCL3,Undated USEPA PFC News Report,Vol.1,Issue1,10/2008 ~ USEPA ProvisionalHealthAdvisoryforPFOA and PFOS 1/8/2009 Emailchainfrom DanielA.Turnerand KenWard, Jr.,1/14/2009 reHealthAdvisoryforPFOA Alan Kovski,"EPA IssuesAdvisorieson Safe LevelsofExposuretoTwo PerfluorinatedChemicals", Daily Environment Report, 1/21/2009 Correspondencefrom Kathryn K.McCord toJamesJonesand Wendy Cleland-HamnettofUSEPA rePFOA, 3/25/2009_______________________________________________________________ Letterfrom DavidW. BoothtoUSEPA remeetingwith USEPA regardingperfluorinatedcompounds 7/22/2009 USEPA Emailfrom PriscillaFlatteryto RobertW. RickardrePFOA riskassessment,7/31/2009 Jane Kay,"EPA UnveilsPlanto Review 6ControversialChemicals, Reform USToxicsPolicy",Environmental Health News, 9/29/2009______________________________________________________ AgendaforPerfluorinatedChemicals (PFOA, PFOS, PFHxA, PFBA)Science PresentationforEPAOfficeofWater, 11/5/2009_______________________________________________________________ Emailfrom DavidW. BoothetoJoyce Donohue remeeting, 10/21/2009 Emailfrom Joyce Donohue to DavidW. Boothe remeeting, 10/20/2009 PowerPoint presentation: ProvisionalHealthAdvisoriesforPFOA and PFOS, FishForum, Portland,Oregon, 11/3/2009_______________________________________________________________ JerroldJ.Heindel, PhD, National InstituteofEnvironmental HealthSciences,"Chemicals inthe Environment: What Doesn'tMake Us Sick....MakesusFatter!,Environmental Chemical (Obesogen) HypothesisofObesity, 12/7/2009_______________________________________________________________ Correspondencefrom RobertA.BilotttoUSEPA rePFAA Research,scientificmeetings, 2/22/2010 DuPont PowerPoint presentation: DiscussionofShort-ChainAlternativesto Long-Chain Perfluorinated Compounds, 3/25/2010 JoeTwitchell PowerPoint presentation: "MerckAdvanced Fluorosurfactants,A New Product Linefrom Merck KGaA, A Presentation tothe USEPA",4/2010 AR226-0550______________________________________________________________ Federal RegisterNotice,Vol.75,No.200, 10/18/2010, pages63827-30 Federal RegisterNotice,Vol.75,No.221, 11/17/2010, pp.70248-54 ~ Federal RegisterNotice,Vol.75,No. 221, 11/17/2010, pp.70558-68___________________________ USEPA PowerPoint: PerfluorinatedChemical (PFC) Uses, Issuesand Management Techniques inElectroplating Processes, Undated (30pages) Federal RegisterProposed Rules,Vol.76,No.42,pp.11713-11737, 3/3/2011 TAFTwebsitearticle: EPA'sFirst"Group" DrinkingWater Regulations,3/9/2011 Ohio EPACorrespondencefrom ScottJ.Nallyto USEPAWater Docket-Ohio'scomments on proposed UCMR 3 Correspondencefrom Andrew Eaton, PhD,toUSEPAWater Docket,comments on proposed UCMR 3,4/25/2011 Page 173 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 269 of 277 PAGEID #: 61270 Descriptions of Documents Without Bates Numbers Societyofthe PlasticsIndustryMeetingSign-InSheet,4/28/2011, New JerseyDEP Correspondencefrom GaryA.Buchanan, PhD,toUSEPA, comments on UCMR3, 5/2/2011 Correspondencefrom JessicaS.Steinhilber,FluoroCouncil,to USEPA, comments on UCMR3, 5/2/2011 Correspondencefrom Thomas W. Curtis,American Water Works Association,toUSEPA, 5/2/2011 AssociationofStateDrinkingWaterAdministrators,Comments on the UnregulatedContaminant Monitoring Rule-ThirdCycle(UCMR3), 5/2/2011_______________________________________________ Correspondencefrom OlgaV.Naidenko, PhD, EnvironmentalWorking Group, comments on UCMR3, to USEPA, 5/2/2011________________________________________________________________ Correspondencefrom LarryR.Zobel, M.D., MPH, 3M, to USEPA,comments on UCMR 3,5/2/2011 Correspondencefrom Deborah H.Metz, GreaterCincinnatiWater Works,to USEPA, comments on UCMR 3, 5/2/2011________________________________________________________________ Correspondencefrom Richard Harrison, PE,Northern KentuckyWater DistricttoUSEPA, comments on UCMR 3, 5/2/2011________________________________________________________________ Correspondencefrom William L.Kovacs, U.S.Chamber ofCommerce to U.S.OMB, CassSunstein,reEPA's proposal to listchemicals, 6/7/2011 The Bureau ofNationalAffairs,Inc.,Article:EPA Releases104 Health,SafetyStudiesNaming ChemicalsTested by Manufacturers, 6/9/2011 PowerPoint presentation: USEPA Regulatory DeterminationsfortheThirdDrinkingWater Contaminant Candidate List,StakeholderMeeting,Washington D.C.,6/16/2011 The Bureau ofNationalAffairs,Inc.,Article:EPA ExpectstoAnnounce inMid-2012 ContaminantsTargetedfor Regulation, 6/6/2011 Correspondencefrom CenterforProgressiveReform toOfficeofInformationand RegulatoryAffairsreEPA's ProposaltoListChemicals UndertheToxicSubstancesControlAct(TSCA5(b)(4),6/20/2011 PowerPoint presentation: FluoroCouncil ProposedANPR ApproachforLong-Chain PerfluorinatedChemicals Action Plan,7/13/2011________________________________________________________ USEPA FactSheet,TSCA InventoryUpdate ReportingModifications;Chemical Data Reporting; FinalRule,8/2011 Andrew B.Lindstrom, "PolyfluorinatedCompounds: Past,Present,and Future", EnvironmentalScience& Technology, doi:10.1021/es2011622, 8/25/2011________________________________________ Andrew B.Lindstrom, "PolyfluorinatedCompounds: Past,Present,and Future", EnvironmentalScience& Technology, doi:10.1021/es2011622, 8/25/2011________________________________________ Andrew B.Lindstrom,etal:"GuestComment: PerfluoroalkylAcid Focus Issue",Environmental Science& Technology, dio:10.1021/es202963p, 9/29/2011_______________________________________ SPIMeetingSign-InSheet, 12/8/2011 USEPA Correspondencefrom David E.Giamporcaroto RobertA.Bilottrework planchemicals,3/1/2012 USEPA 2012 Editionofthe DrinkingWater Standardsand HealthAdvisories,4/2012 ScienceSeminarwith3M and USEPA, Sign-InSheetand Agenda,4/4/2012 Comments on Grandjean etal,Serum VaccineAntibodyConcentrations inChildren ExposedtoPerfluorinated Compounds, JAMA, 1/25/2012 PowerPoint presentation: GearyOlsen,etal:"IsClearanceaCommon ExplanationAcrossthe Epidemiological Associations Reported at"Low" PFOA and PFOS Concentrations?",4/4/2012 PowerPoint presentation:John Butenhoff, PhD, DABT, "EffectofDietaryFactorson Plasma PFOA and Non-HDL Cholesterol inApoE*3.Leiden.CETP Mice", Undated Federal RegisterRulesand Regulations,Vol.77,No.85,pp.26072-26101, 5/2/2012 USEPA External Review Draft,FrameworkforHuman Health RiskAssessmentto Inform Decision Making, 7/12/2012 Page 174 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 270 of 277 PAGEID #: 61271 Descriptions of Documents Without Bates Numbers EPAOPPT proposed rule:"PerfluoroalkylSulfonatesand Long-Chain PerfluoroalkylCarboxylateChemical Substances; Proposed SignificantNew Use Rule[FRL9358-7]",8/7/2012 Federal RegisterProposed Rules,Vol.77,No. 158,p.48924, 8/15/2012 Federal RegisterProposed Rules,Vol.77,No. 158,p.48858, 8/15/2012 Correspondencefrom Bilottto USEPA reregulationofPFOA indrinkingwater,8/20/2012 USEPA Correspondencefrom Nancy K.StonertoRobertA.BilottreregulationofPFOA indrinkingwater, 9/18/2012_______________________________________________________________ Correspondencefrom Marie R.Martinkoto KatherineSleasman, USEPA, 10/15/2012 USEPA, Comments Submitted byTheAssociationofGlobalAutomakers, Inc.,regardingthe Proposed Significant New RuleforPerfluoroalkylSulfonatesand Long-Chain PerfluoroalkyleCarboxylateChemical Substances, Undated USEPA Summary of12/19/2012 MeetingwiththeSocietyofthe PlasticsIndustry(SPI)from KatherineSleasman Sign-InSheetforMeetingwiththeSocietyofthe Plasticsindustry(SPI),12/19/2012 USEPA America'sChildrenandthe Environment,ThirdEdition,1/25/2013, Pre-PublicationCopy The Bureau ofNationalAffairs,Inc.,DailyEnvironment Report,"RuletoTargetChemicals DiscontinuedAfter 2015,3/14/2013___________________________________________________________ PowerPoint presentation: USEPA, EricaKoustas, PhD,TestDrivingthe NavigationGuide Methodologyto Evaluate Human Health EffectsofEnvironmental Contaminants, Undated Correspondencefrom J.PhillipBerrier,InnovativeChemicalTechnologies, Inc.to USEPA: comments on proposed SNUR reperfluorochemicals,5/6/2013 Federal RegisterNotices,Vol.78,No. 115,p.35922, 6/14/2013 Federal Register: USEPA Endocrine DisruptorScreening Program; FinalSecond ListofChemicalsand Substances forTier 1Screening, 6/14/2013 Bloomberg BNA, DailyEnvironment Report,Substances Removed from DraftList,6/14/2013 PowerPoint presentation:ApplyingSystematic ReviewtoAssessmentsofHealth EffectsofChemical Exposures, EPAWorkshop, 8/26/2013_____________________________________________________ USEPA News Release, EPATakesStepstoAllow RestrictionofImportsofHarmful CategoryofChemicals Used in Carpets, 9/30/2013 USEPA PerfluoroalkylSulfonatesand Long-Chain PerfluoralkylCarboxylateChemical Substances; FinalSignificant New Use Rule,9/30/2013______________________________________________________ Federal RegisterRulesand Regulations,Vol.78,No. 204, p.62443, 10/22/2013 Undated documenttitled: RiskInformation Update: OverviewofAssessmentActivitiesofPFOS and PFOA, authored byJenniferSeed (1page) JenniferSeed, USEPA, PowerPoint presentation: "RiskInformation Update: Overview ofAssessmentActivitiesof PFOS and PFOA, Undated______________________________________________________ Undated PowerPoint presentationslides: Overview ofPerfluorooctaneSulfonateand PerfluorooctanoicAcid, authored byJenniferSeed (14pages) Samuel M. Cohen, etal:"The Human RelevanceofInformationon CarcinogenicModes ofAction:Overview", Taylorand Francis,Inc.,CriticalReviews inToxicology,doi:10.1080/10408440390250073, 2003 USEPA memo dated 3/5/2004:TransmittalofMeeting Minutesofthe FIFRAScientificAdvisory Panel Meeting Held 12/9/2003____________________________________________________________ NationalToxicologyProgram, DraftNTP ApproachforReachingConclusionsforLiterature-Based Evidence Assessments, NTP Board ofScientificCounselorsWorking Group Meeting, 8/28/2012 Correspondencefrom Michael P.Walls,American ChemistryCounciltoDr.LoriWhite, EPA NTP re: Approachfor Systematic Reviewand Evidence IntegrationforLiterature-based HealthAssessments, 11/27/2012 Page 175 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 271 of 277 PAGEID #: 61272 Descriptions of Documents Without Bates Numbers Comments from the Natural Resources Defense Counciltothe December 11th NTP Board ofScientific Counselors Meetingonthe NTP ApproachforSystematic Review and Evidence IntegrationforLiterature-based HealthAssessments, 12/7/2012 PowerPoint presentation: LynnGoldman, NTP BSCWorking Group Reporton the DraftNTP Report, 12/11/2012 NationalToxicologyProgram, Board ofScientificCounselors,Summary Minutes, 12/11/2012 Lynn Goldman, MD, etal:"DraftReportofthe NationalToxicologyProgram Board ofScientificCounselors Working Group on EvaluatingNTP'sApproachforReachingConclusionsforLiterature-Based Evidence Assessments", 12/11/2012 NationalToxicologyProgram, Revised DraftNTP ApproachforSystematic Review and Evidence Integrationfor Literature-Based HealthAssessments, 12/11/2012 Federal RegisterNotice,Vol.78,No.37,p.12764, 2/25/2013 ~ NationalToxicologyProgram, Systematic Reviewto Evaluatethe Evidenceforan Association Between PerfluorooctanoicAcid (PFOA)orPerflurooctaneSulfonate(PFOS) Exposureand Immunotoxicity,4/9/2013 DraftNationalToxicology Program,Appendix 2:GuidanceforAssessingRiskofBiasinthe ProtocolforEvaluating the EvidenceforanAssociation Between PFOA and PFOS Exposureand Immunotoxicity,4/9/2013 NationalToxicologyProgram,websitedocument: OHAT Implementation ofSystematic Review, 2/25/2013 TraceyJ.Woodruff, PhD, MPH, etal:"A Path ForwardforSystematic Reviews inEnvironmental Health:The NavigationGuide Methodology", 8/26/2013 Federal RegisterNotice,Vol.78,No. 183,p.57868, 9/20/2013 Federal RegisterNotice,Vol.78,No. 183,p.57868, 9/20/2013 ATSDR ToxGuideforPerfluoroalkyls,5/2009 AgencyforToxicSubstancesand DiseaseRegistry(ATSDR)Correspondencefrom LoraSiegmann Werner, MPH, to BarbaraTaylorofWV Health& Human Resources,6/24/2009 PowerPoint presentation: Thomas Sinks,PhD, CDC/ATSDR Environmental PublicHealth Perfluorinated Compounds, Undated Correspondencefrom PerryCohn, PhD, MPH, New JerseyDepartment ofHealthand SeniorServices,to NickoletteRoney,ATSDR redraftperfluoroalkylstoxicologyprofile,10/30/2009 Correspondencefrom RobertA.BilotttoNickoletteRoney,ATSDR, redraftperfluoroalkylstoxicologyprofile, 9/19/2011_______________________________________________________________ ATSDR HealthConsultation, Exposure InvestigationReport, PerfluorochemicalSerum SamplingintheVicinityof Decatur,Alabama, 4/1/2013 Federal RegisterNotice,Vol.68,No. 189,p.56296, 9/30/2003 CentersforDiseaseControl 2009 Fourth National Reporton Human ExposuretoEnvironmental Chemicals(10 pages)__________________________________________________________________ CentersforDiseaseControl 2009 Fourth National Reporton Human ExposuretoEnvironmental Chemicals(p. 247through 257) CentersforDiseaseControland Prevention FactSheet, PerfluorooctanoicAcid(PFOA),4/3/2012 EnvironmentalWorking Group Chemical IndustryConsultant Runs Federal Reproductive HealthAgency, Firm Tiedto Dow, R.J.Reynolds Leads Review ofPlasticsCompound, 2/28/2007 EnvironmentalWorking Group CorrespondencetoDavidA.Schwartz, M.D., National InstituteofEnvironmental HealthSciences,from RichardWiles reNTP'sCERHR management and review process,2/28/2007 MarlaCone, LosAngelesTimes: "PublicHeathAgency LinkedtoChemical Industry",3/4/2007 Dr.Joseph Mercolawebsitearticle:"Another Pro-BusinessFederalAgency PlaysFavoritesand EndangersYour Health Again", 3/4/2007_______________________________________________________ "Editorial:Flawed Oversighton Chemicals'Safety",MinneapolisStarTribune.com,3/11/2007 Page 176 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 272 of 277 PAGEID #: 61273 Descriptions of Documents Without Bates Numbers EnvironmentalWorking Group "ConflictofInterestStillLooms Over NIH Contractor: Independent Investigation intoSI'sTiestoChemical industryNeeded", 4/3/2007 MarlaCone: "NIH SidelinesContractorinConflictInquiry",LosAngelesTimes,4/4/2007 MarlaCone: "NIH SidelinesContractorinConflictInquiry",LosAngelesTimes,4/4/2007 MarlaCone: "NIH SidelinesContractorinConflictInquiry",EnvironmentalWorking Group,4/4/2007 EnvironmentalWorking Group "NIH SuspendsConsultantTiedtoIndustry,Orders Review ofAllContractors' Conflicts",4/4/2007; and EnvironmentalWorking Group "ConflictofInterestStillLooms Over NIH Contractor: Independent InvestigationintoSI'sChemical industryNeeded", 4/3/2007 AllianceforRiskAssessment "PFOA-PFOS Interim RiskAssessmentforContaminated Sites",8/24/2012 National InstituteofEnvironmental HealthSciences report: 2012-2017 StrategicPlan,AdvancingScience, Improving Health:A PlanforEnvironmental Health Research,8/2012 National InstituteofEnvironmental HealthSciencesFactSheet,"PerfluorinatedChemicals(PFCs)",Sept.2012 DuPont PowerPoint presentation: "PFOA PhaseOut, ReviewforDOD", 6/26/2008 Memorandum from Wayne Arny,Officeofthe Under SecretaryofDefense regardingPhase-Outof PerfluorooctanoicAcid (PFOA),8/7/2008 EmailChain between DavidW. Booth, DuPont, and Shannon CunniffregardingDOD Followup on PFOA, 10/27/2008_______________________________________________________________ RonaldC.Porter,PhD: "AFCEE/TDV Emerging Issue:PerfluorinatedCompounds", Noblis,Inc.,Undated LindaS.Birnbaum, Ph.D.:"Endocrine Disruption,Where do we gofrom here?", National Instituteof Environmental HealthSciences,6/11/2012 ConsentOrder between EPAand DuPont, 11/14/2001 Department ofEnvironmental ProtectionWest VirginiaNews Release, Multi-AgencyOrder Enteredto Investigate UnregulatedChemical, 11/15/2001 USEPA Region 9 PreliminaryRemediation GoalsTable, Undated Summary: WVDEP MeetingofC8Assessment ofToxicityTeam (CATT)Toxicologists,5/6/2002 WVDEP PowerPoint presentation: PublicMeeting RegardingC8,5/15/2002 TERA InternalDeliberativeDraft,Pre-Meeting Review ofthe Human Healthand ToxicologyLiteratureon C8 WVDEP Letterfrom ChristopherD.Negleyto RobertA.BilottreCATteam opinion regardingC-8,5/9/2002 WVDEP News Release, Health LevelforC8Announced by ExpertTeam; PublicMeeting May 15,5/9/2002 Table:AlternativeDerivationofthe RfDand RfCValuesforC8,2002 TERA InternalDeliberativeDraft,Summaries ofPotentialCriticalStudiesforDerivationofRfd/RfCsforC8 TERA InternalDeliberativeDraftTable,AlternativeDerivationofthe RfDand RfCValuesforC8 TERA InternalDeliberativeTable,AlternativeDerivationofthe RfDand RfCValuesforC8 Faxcoversheetdated 6/5/02from Washington Occupational HealthAssociatestoHeatherJonesofSpilmanfirm transmittingattached notesand pagesfrom draftreportregardingderivationofRfD/RfCsforC8 (38pages). (Non-Bates numbered document produced by DuPont inthe Leach case.) Letterfrom RobertA.BilottregardingC8 AssessmentofToxicityTeam Work Under November 14,2001 Consent Order Between DuPont and StateofWest Virgina(OrderNo.GRW-2001-019), 6/10/2002 Letterdated 6/13/02from Michael Dourson ofTERAto Robert BilottofTaftinresponsetorequestforinterim deliberativedraftsofstudy (2pages) InjunctionOrder Directedto DeeAnn Staats,Ph.DandTheWVDEP inLeach case,6/25/2002 WVDEP Letterfrom PerryD.McDaniel, 7/1/2002transmittingTERA notesfrom CATteam meeting WVDEP FinalAmmonium Perfluorooctanoate (C8)AssessmentofToxicityTeam (CATT) Report,8/2002 Sign-insheetregardingC8AssessmentofToxicityToxicologistPanel Meeting, 8/2002 WVDEP FinalDraftAmmonium Perfluorooctanoate(C8)AssessmentofToxicityTeam (CATT) Report,8/2002 Page 177 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 273 of 277 PAGEID #: 61274 Descriptions of Documents Without Bates Numbers FinalReportC8AssessmentofToxicityTeam (CATT) ReportAddendum Aquatic LifeAdvisoryConcentrationfor C8, 10/2002______________________________________________________________ Emailfrom Theresa EllsworthtoWVDEP Dee Ann StaatsenclosingC8AssessmentofToxicityTeam (CATT) ReportAddendum Aquatic LifeAdvisoryConcentrationforC8, 10/9/2002 WVDEP News ReleasereC-8report, 11/14/2002 ~ Table:AlternativeDerivationofthe RfDand RfCValuesforC8,Undated Table:AlternativeDerivationofthe RfDand RfCValuesforC8,Undated National InstituteforChemical Studies,NICSAnnounces aOne-DayWorkshop on "Protectingthe Publicina Hazardous Matt Emergency" March 25,2003 inCharleston,W.Va., 1/2/2003 KenWard, Jr.:"C8Study"Tainted,"Group SaysGovernor UrgedtoAppointan Indepenedent Panel",Charleston Gazette, 3/13/2003 KenWard, Jr.:"Profile:Environment isaPriorityforWise, saysNew DEP Chielf",CharlestonGazette,4/14/2003 OrderGranting Plaintiffs'Second MotionforSanctionsAgainstDuPont inLeachcase,4/29/2003 WVDEP EmailreC-8SciencePanel,1/6/2006__________________________________________ WVDEP Emailfrom M. Ann Bradleyto Randy Huffman, 3/16/2006 GISTMeetingAgenda, 3/28/2006 WVDEP Sign-InSheet,GISTMeeting, 3/28/2006 ~ GISTQuestions, Undated GISTMeeting Minutes,Groundwater investigationSteeringTeam, 3/28/2006 Handwritten notesofGISTmeeting Letterfrom M. Ann BradleytoPerryMcDaniel,WVDEP reDuPont MOU, 4/10/2006 7/12/2006 DuPont Letterfrom Robert L.RitcheytoCliffD.Whyte regardingLetter,CliffD.Whyte to R.L.Richey, December 16,2005 and Letter,Robert L.RitcheytoCliffD.Whyte, January12,2006 WVDEP ConsentOrder3/9/2009__________________________________________________ Summary ofDiscussions,3/19/2009WVDEP-DuPont Meetingon C8 Issues,3/23/2009 3/26/2009 Emailfrom DavidW. BoothetoBillToomey, WV Department ofHealthand Human Services, regardingWater Guidance LevelsorLimits From WVDEP website: DivisionofWater and Waste Management listofC8 Investigation Reportsasof9/3/09 11/21/2011 Letterfrom KatherineCrocketttoYogesh Pate,WVDEP, regardingExecuted DraftConsentOrder No. 7418___________________________________________________________________ Table:AlternativeDerivationsofthe RfDand RfCValuesforC8,Undated USEPA Region 9 PreliminaryRemediation Goalssummary, Undated 1/6/2003 Ohio EPA Inter-OfficeCommunicationfrom ChrisJonestoCindy HafnerregardingCATTeam Reporton C8____________________________________________________________________ 10/4/2005 Ohio EPA News ReleasetoJim Leachand KevinJohnson regardingOhio EPA Recommends Bottled Water inAreasWhere C8 Has Been Detected 1/24/2007 Ohio Department ofHealth Reporton C8 PerfluorooctanoicAcid,Commonly known asC8,isalso Called PFOA and/orAPFO, A 2006 C8 Physician Reference,What we know...,What we don'tknow...,What is takingplace. 1/24/2007 Ohio Department ofHealth Reporton C8 PerfluorooctanoicAcid,Commonly known asC8,isalso Called PFOA and/orAPFO, A 2006 C8 Physician Reference,What we know., What we don'tknow., What is takingplace. 5/5/2009 PowerPoint presentation: DuPont BriefingtoOhio EPA 6/23/2009Letterfrom DavidW. Bootheto Michael Baker,Ohio EPA, regardingDuPont Update MeetingofMay 5,2009 Page 178 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 274 of 277 PAGEID #: 61275 Descriptions of Documents Without Bates Numbers 8/5/2012 Ohio Department ofHealth Reporton C8 PerfluorooctanoicAcid,Commonly known asC8,isalso Called PFOA and/orAPFO, A 2006 C8 Physician Reference,What we know... 8/2/2012 Ohio Department ofHealth, Bureau ofEnvironmental Health, HealthAssessmentSection,C8,C8 isalso Known asPerfluorooctanoicAcidand/or PFOA FactSheet 6/2013 Ohio Department ofHealth, Bureau ofEnvironmental Health, HealthAssessmentSection,C8,C8 isalso Known asPerfluorooctanoicAcidand/or PFOA FactSheet 8/6/2013 InternationAgencyforResearch on Cancer, Upcoming Meetings regardingPerfluoro-octanoicAcid, Tetrafluoroethylene, 1,2-Dichloromethane, andAmbientAirPollution EnvironmentalWorking Group,The Power ofInformation regardingDuPont HidTeflon PollutionsforDecades, Undated EnvironmentalWorking Group,ToxictoAnimals& People. PersistentForever. PervasiveinHuman Blood., Undated 5/14/2003 EnvironmentalWorking Group Canariesinthe Kitchen:TeflonToxicosis,EWG FindsHeatedTeflon PanscanTurnToxicFasterthan DuPont Claims Jane Houlihan,etal,EnvironmentalWorking Group: "Body Burden,The PollutioninNewborns", 7/14/2005 3/20/2009 EnvironmentalWorking Group, EWG "Letter:EPA/DuPont DealContradictsSound Scienceand EPA Principles",LettertoThe Honorable LisaJacksonfrom RichardWiles AR226-1005, NotetoFilefrom Karen Lannon regarding3/26/2001 PerfluoroalkanoicAcids,3/28/2001 AR226-1532, Screening LevelCumulative RiskAssessment PerfluorinatedAlkylAcidson Human Health, Rich Purdy, 10/9/2003___________________________________________________________ 10/14/2003 Emailfrom USEPAto RobertA.BilottregardingAR-226 Requests,enclosingAR226-1532, Screening LevelCumulative RiskAssessment PerfluorinatedAlkylAcidson Human Health, Rich Purdy, 10/9/2003 4/28/2009 Letterfrom Maya van Rossum, Delaware Riverkeeper,toMark N.Mauriello, NJDEP, regardingPFOA PollutionintheVicinityofthe DuPont Chambers Works Facility,Deepwater, Salem County, New Jersey 4/19/2010 Food and ChemicalToxicologyLettertothe EditorregardingDerivationofaDrinkingWater Quivalent Level(DWEL) Relatedtothe Maximum Contaminant LevelGoalforPerfluorooctanoicAcid (PFOA),aPersistent Water SolubleCompound, KeithR.Cooper, RutgersUniversity 3/18/2011 News Releasefrom Maya K.van Rossum, Delaware Riverkeeper, regardingDelaware Riverkeeper Network Questions New JerseyDepartment ofEnvironmental ProtectionAbout PublicDrinkingWater Protections Report: 6/2011 NationalConversation on PublicHealthand Chemical Exposures Report,"Addressing Public Healthand Chemical Exposures,An ActionAgenda, LeadershipCouncil YG Zhao, etal:PubMed Article,"RiskAssessmentforHuman Consumption ofPerfluorinatedCompoundContaminated Freshwaterand Marine Fishfrom Hong Kong andXiamen", 6/24/2011 From AllianceforRiskAssessmentWebsite: :"PFOA-PFOS Interim RiskAssessmentforContaminated Sites", 2012___________________________________________________________________ PhilippeGrandjean, etal:"ImmunotoxicityofPerfluorinatedAlkylates:CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",Environ. Health,doi:10.1186/1476-069X-12-35, 1/22/2013 PhilippeGrandjean, etal:Author's ResponsetoReviews, "ImmunotoxicityofPerfluorinatedAlkylates: CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",3/26/2013 Glorida Post,Reviewer's Report, "ImmunotoxicityofPerfluorinatedAlkylates:CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",3/19/2013 PhilippeGrandjean, etal:Author's ResponsetoReviews, "ImmunotoxicityofPerfluorinatedAlkylates: CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",3/14/2013 Page 179 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 275 of 277 PAGEID #: 61276 Descriptions of Documents Without Bates Numbers PhilippeGrandjean, etal:Author's ResponsetoReviews, "ImmunotoxicityofPerfluorinatedAlkylates: CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",3/13/2013 AllenAllenDavis,Reviewer's Report, "ImmunotoxicityofPerfluorinatedAlkylates:CalculationofBenchmark Doses Based on Serum Concentrations inChildren",2/13/2013 DoriR.Germolec, Reviewer'sReport,"ImmunotoxicityofPerfluorinatedAlkylates:CalculationofBenchmark Doses Based on Serum Concentrations inChildren",2/12/2013 GloriaPost,Reviewer's Report,"ImmunotoxicityofPerfluorinatedAlkylates:CalculationofBenchmark Doses Based on Serum ConcentrationsinChildren",2/8/2013 abstract: Tony Fletcher:"RiskAssessmentand SettingNo Adverse EffectLevelsforPFOA", Environmentand Health, BaselSwitzerland,8/19/2013 PowerPoint presentationauthored by Rich Purdy:"ScreeningLevelCumulative RiskAssessment Perfluorinated AlkylAcidson Human Health", Undated PowerPoint presentationauthoredJenniferSass,PhD, etalofNRDC: "The DelayGame, How theChemical IndustryDucks Regulationofthe MostToxicSubstances", 10/2011 D.Chimeddulam, etal:"RiverWater Contaminatedwith PerfluorinatedCompounds PotentiallyPosingthe GreatestRisktoYoung Children",doi:10.1016/j.chemospher.2012.08.039, 9/26/2012 Variouspublicly-availabledocuments, inadditiontothose listedabove,whichwere obtainedfrom stateor federalagenciespursuantto FOIA/records requests,aswellaspagesprintedfrom thoseagencies'websites Page 180 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 276 of 277 PAGEID #: 61277 Deposition Transcripts and Exhibits Darleen Bailey, taken in Leach v. DuPont case on 6/15/04 Glenn Evers, taken in Leach v. DuPont case on 4/30/04 William Fayerweather, taken in Leach v. DuPont case on 6/3/04 Philip Guzelian (2 vols.), taken in Rowe v. DuPont case on 3/13/08 and 12/11/09 Robert Ingalls, taken in Leach v. DuPont case on 5/19/04 Bruce Karrh (2 vols.), taken in Leach v. DuPont case on 4/14/04 and 4/15/04 Gerald Kennedy (2 vols.), taken in Leach v. DuPont case on 7/31/02 and 8/1/02 Robin Leonard, taken in Leach v. DuPont case on 6/25/04 Robin Leonard, taken in Rhodes v. DuPont case on 10/2/07 Anthony Playtis, taken in Tennant v. DuPont case on 1/31/01 (no exhibits marked) DuPont 30(b)(6) witness (Robert Rickard), taken in Rowe v. DuPont case on 12/10/07 Karen Robinson, taken in Leach v. DuPont case on 6/16/04 Howard Smith, taken in Leach v. DuPont case on 5/21/04____________________________ Dee Ann Staats (2 vols.), taken in Leach v. DuPont case on 6/6/02 and 6/7/02 Robert Tardiff, taken in Rowe v. DuPont case on 9/10/10____________________________ Judy Walrath, taken in Leach v. DuPont case on 6/24/04____________________________ Kenneth Wamsley (2 vols.), taken in Leach v. DuPont and Rhodes v. DuPont cases on 2/27/07 (exhibits not included) David Wegman, taken in Rowe v. DuPont case on 10/3/07 DuPont 30(b)(6) witness (Robert Buck), taken on 1/10/13 in the Little Hocking Water Association v. DuPont case (without exhibits) DuPont 30(b)(6) witness (Gerald Kennedy), taken on 7/31/02 in the Leach v. DuPont case Robert Rickard, taken on 1/9/13 in the Little Hocking Water Association v. DuPont case (without exhibits) Page 181 of 182 Case: 2:13-md-02433-EAS-EPD Doc #: 3441-10 Filed: 05/15/15 Page: 277 of 277 PAGEID #: 61278 Deposition Transcripts and Exhibits DuPont 30(b)(6) Witness (Robert Rickard), taken on 1/11/13 in the Little Hocking Water Association v. DuPont case (without exhibits) James Cox (2 vols.), taken in Leach v. DuPont case on 3/30/04 and 3/31/04 DuPont 30(b)(6) witness (Robert Rickard), taken on 8/27/14 in the MDL case James Becker, taken in Rhodes v. DuPont case on 6/1/09 Patricia Buffler (2 vols.), taken in Rowe v. DuPont case on 3/25/08 and 3/26/08 Richard Clapp, taken in Leach v. DuPont case on 8/31/04____________________________ Barbara Dawson, taken in Leach v. DuPont case on 8/27/04 David Gray, taken in Rhodes v. DuPont case on 1/25/08____________________________ David Gray, taken in Rhodes v. DuPont case on 1/31/08____________________________ David Gray, taken in Rhodes v. DuPont case on 6/2/09_____________________________ David Gray, taken in Rowe v. DuPont case on 4/3/08________________________________ David Gray, taken in Rowe v. DuPont case on 10/9/09_______________________________ Robert James, taken in Rhodes v. DuPont case on 6/3/09_____________________________ Robert James, taken in Rowe v. DuPont case on 1/26/10 Barry Levy (2 vols.), taken taken in Rhodes v. DuPont case on 1/29/08 and 1/30/08 Barry Levy, taken in Rhodes v. DuPont case on 5/28/09_______________________________ Barry Levy (2 vols.), taken in Rowe v. DuPont case on 3/27/08 and 3/28/08 Barry Levy, taken in Rowe v. DuPont case on 10/1/09_______________________________ Barry Levy, taken in Rowe v. DuPont case on 10/26/09______________________________ John Whysner (2 vols.), taken in Rowe v. DuPont case on 3/10/08 and 3/11/08 Page 182 of 182